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ABSTRACT 
Introduction 
Prescribing accounts for 11% of the total NHS budget. In the UK, there is an aging population 
who receive nearly half of all prescriptions, with the increasing age of the population, the 
prevalence of long-term conditions, cost and complexity of prescribing is likely to rise.  
Prescribing is influenced by numerous factors such as new drugs; aging populations; 
polypharmacy; and increased concern about adverse reactions.  Although numerous initiatives 
are targeted at general practitioners to encourage application of research evidence the 
significant variation in prescribing quality and cost is difficult to explain. Previous studies have 
explored the influences of type of drug, focused clinical area, guidelines and the doctor/patient 
relationship.  No study was found which has explored the details of the prescribing process 
using the ethnographic approach.   
Methods 
This ethnographic study of three different general practices, involved participant observation, 
documentary review and semi-structured interviews.  Analysis was an iterative process 
conducted in Atlas.ti by borrowing on grounded theory techniques and interpretative 
description. Practices were selected using prescribing quality indicators developed by Audit 
Scotland via PRISMS (Prescribing Information System for Scotland), which collects 
prescribing data for all practices in Scotland.  Two practices which were ranked highly and one 
practice which was ranked low were observed.  
Results 
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Practices made two different kinds of prescribing decision; macro and micro.  Macro 
prescribing decisions are strategic, influenced by EBM and practice data, and consider the 
‘average patient’.  Micro prescribing decisions are made with an individual patient, considering 
their unique biology, context and perspectives.  
Practice pharmacists were instrumental in leading prescribing quality improvement in the larger 
practices and had an important role interpreting practice level data in light of the changing 
evidence.  In the high ranking practices these changes were formulated into macro prescribing 
policy to rationalise and standardise their prescribing.  The lower ranking practice suggested 
practices had to value collective decision-making and consistency in their prescribing 
behaviour to formulate a macro prescribing policy.  Consistency in prescribing behaviour was 
facilitated by effective communication, which was important for shared values and practice 
identity. Practice identity influenced practice values, communication and organisation thus had 
a direct impact on their macro prescribing policy formulation and implementation.  
GPs used mindlines when making prescribing decisions at the micro prescribing level.  GPs did 
not refer to explicit sources when seeking information but used personal prescribing 
formularies. These mindlines were iteratively developed from social networks with colleagues, 
secondary care and patient specific information from the practice pharmacist and from past 
experience.  Through effective communication with colleagues these mindlines were shared.   
Conclusion 
Practices made two different kinds of prescribing decision; macro and micro. Both types of 
prescribing were dependent on effective communication channels, organisation, values and 
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practice identity, illustrating the importance of communication for shared values, collective 
behaviour and prescribing decision-making.   
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C h a p t e r  1  
INTRODUCTION 
This PhD investigates the various influences on GP prescribing using ethnographic methods to 
explore in-depth and better understand the influences GPs recognise and don’t recognise when 
making prescribing decisions. The initial idea for this study emerged from discussions between 
the researcher and her first supervisor (JD).  The researcher had an interest and some 
experience of prescribing research and qualitative research methods and was keen to expand 
her research skills into ethnography.  Dr Jon Dowell was aware, despite much research, it was 
not clear ‘what influences prescribing in general practice’ and felt ethnographic methods could 
provide a unique insight. As much of the research has been quantitative the intention was by 
studying treatment decisions in context would allow the researcher to understand and 
appreciate the complexity of the prescribing decision-making process.  
Prescribing is the most common treatment method in the NHS (Barber et al., 2003).  
Prescribing accounts for 11% of the total cost of the NHS budget, with 825.8 million 
prescriptions dispensed in primary care alone each year (The Association of the British 
Pharmaceutical Society, 2007). In the U.K we have an aging population; they receive nearly 
half of all prescriptions (Department of Health, 2000), which is likely to increase with the rise 
in long-term conditions and poly-pharmacy, illustrating the importance of research into 
prescribing.  
The importance of prescribing has ensured it has been subject to much research; in clinical 
areas; cholesterol (Bertoni et al., 2009), sore throats (Butler et al., 1998), hypertension 
(Cranney and Walley, 1996, Montgomery et al., 2000, Carter et al., 2009), asthma and angina 
(Eccles et al., 2002), (Greenfield et al., 2005), depression (Kendrick et al., 2005); in types of 
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drugs prescribed; non-steroidal anti-inflammatory drugs (Bloor and Maynard, 1996), antibiotics 
(Walker et al., 2001, Dowell et al., 2001, Lipman and Price, 2000), lipid lowering agents 
(Evans et al., 1995), antidepressants (Hyde et al., 2005), statins (Kedward and Dakin, 2003), 
new drugs (Jacoby et al., 2003, Jones et al., 2001b, Prosser et al., 2003, Prosser and Walley, 
2003); in long-term prescribing (Cantrill, 2000, Cantrill et al., 2000, Harris and Dajda, 1996); 
in prescribing systems (Barber, 2004, Barber et al., 2003, Avery et al., 2007); and the influence 
of patients (Cheraghi-Sohi et al., 2008, Dowell et al., 1996, Stevenson et al., 2000a, Virji et al., 
1991, Britten et al., 2000, Britten and Ukoumunne, 1997, Bradley, 1992b, Carlsen and 
Norheim, 2005). This list is not exhaustive but illustrates there is extensive topic specific 
prescribing literature. 
It is widely accepted research evidence alone is not adequate to guide action (Haynes et al., 
2002). It has become clear that reliance on passive dissemination of information to keep health 
professionals up-to-date is ineffective when around two million articles on medical issues are 
published annually (Mulrow, 1994). There has been substantial investment in technologies and 
interventions to improve prescribing and bring it in line with evidence based medicine 
(Grimshaw et al., 2004, Grol and Grimshaw, 2003).  Much of this extensive literature has been 
systematically reviewed; audit and feedback (Jamtvedt  et al., 2006), educational meetings 
(Forsetlund et al., 2009), educational outreach visits (O'Brien et al., 2009), outreach 
pharmacists (Beney et al., 2009) and the reviews have concluded when these interventions are 
effective, the effects are generally small to moderate.  So when it comes to changing 
professional practice there appears to be ‘no magic bullets’ (Oxman et al., 1995) and multiple 
factors are involved in GPs decisions to change their prescribing habits (Armstrong et al., 
1996).  It is recognised multi-faceted interventions are more likely to improve quality 
prescribing (Bertoni et al., 2009, Prosser et al., 2003), yet we still know little about why.  
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Despite these efforts, prescribing quality varies and remains a problem (Carthy et al., 2000, 
Davis et al., 2002, Marshall and Mohammed, 2003, Prosser et al., 2003). 
Health policy reforms (Griffiths, 1983, Secretary of State for Health et al., 1989)  and 
management reforms (Department of Health and NHS Confederation, 2003) show the 
Government sees a change in culture within NHS organisations as prerequisite for successful 
quality improvement (Department of Health, 1998). Clinical governance aimed to reform the 
NHS creating an environment conducive to providing high quality care (Scally and Donaldson, 
1998), and prescribing is a key concern of clinical governance (Campbell et al., 2000).  There 
is wide spread interest in the NHS in managing organisational cultures in order to improve 
quality and safety (Mannion et al., 2009). This literature is focused on organisations which are 
larger units and are under direct NHS control such as hospitals (Davies et al., 2007, Kennedy, 
2001, Mannion et al., 2005) or primary care trusts (Mannion et al., 2009, Marshall et al., 2002), 
rather than general practices, which are traditionally independently managed.  Previous studies 
using ethnographic methods have explored the culture of general practice in relation to 
financial incentives (McDonald et al., 2007) and nGMS contract (Checkland et al., 2008, Huby 
et al., 2008, Grant et al., 2009) and knowledge management (Gabbay and le May, 2004). No 
study, to date, has empirically explored all aspects of prescribing in general practice using 
ethnographic methods. It has been claimed insights from qualitative research are needed to 
understand prescribing in primary care (Bradley, 2002) as prescribing is not straightforward 
and involves a complicated decision-making process, by both patient and doctor, whose 
intricacies and influencing factors are not yet fully understood (Jackson et al., 2004, 
Thistlethwaite et al., 2010).  
To ensure the researcher was using the most appropriate methods to answer the research 
question, ‘what influences prescribing in general practice?’ time was spent giving consideration 
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to the research question and potential research methods.  As most of the research which had 
already been carried out was quantitative and the researcher’s literature review had identified a 
need for more qualitative work exploring prescribing in primary care.  A decision was made to 
primarily focus on qualitative methods to gain an in-depth insight.  
A case study research strategy was considered.  A case study strategy would have allowed the 
researcher to adopt an exploratory research design.  According to Yin (1994) case studies; want 
to uncover contextual conditions, believing these to be important; they rely on multiple sources 
of evidence (for triangulation); and they tend to rely or benefit from theoretical propositions to 
aid data collection and analysis. This research design would have been more prescriptive than 
the ethnographic approach but may have allowed the researcher to explore more general 
practices increasing the external validity of the study. 
A case study research strategy begins with a research plan detailing the components of the 
research design. The first stage of this process is to identify the research questions and the 
propositions to guide the research.  If a case study design had been adopted the researcher 
would have searched the literature to identify these propositions. With an ethnographic 
approach the researcher tried to enter the field with an open mind and not to let theoretical 
propositions guide the data collection and analysis. 
A case study is known as a triangulated research strategy.  According to Stake (1995) the need 
for triangulation arises from an ethical need to confirm the validity of the processes and this 
could be done by using multiple sources of data. In the design phase of a case study the 
research questions and the theoretical propositions guide the various methods adopted.  There is 
not a prescriptive set of methods to use.  The researcher can adopt qualitative and/or 
quantitative methods.  Direct observation is often conducted in case study research however the 
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distinguishing feature of this type of observation from ethnographic observation is the length of 
time spent in the field (Yin, 1994). 
Gabbay and Le May’s (2004) work was of interest to the researcher before she commenced this 
research. This paper could have been the basis of some of the propositions used in the research 
design. This would have guided the researcher to be interested in ‘communities of practice’. 
Taking guidance from Gabbay and le May (2004) could have been a good way to answer ‘what 
influences prescribing in primary care?’ This would have guided the research towards direct 
observation of practice meetings and other communication channels. The advantage a case 
study design offered the researcher over ethnographic research was the opportunity to sample a 
larger number of practices.  Focus groups and semi-structured interviews could have provided 
supporting methods to triangulate the findings.  Individual interviews could have been 
conducted with all prescribers and practice pharmacists in each of the practices exploring their 
personal views and preferences.  Focus groups would have allowed the researcher to validate 
and triangulate the findings of the observation and interviews in a practice setting. Focus 
groups would also have allowed the researcher to explore their collective behaviour and beliefs. 
As practices would be the unit of analysis practice based focus groups had the potential to 
generate a range of experiences, views and responses from the different disciplines.  
In a case study research design plan the researcher specifies the units of analysis, the logic 
linking the data to the propositions and the criteria for interpreting the findings (Yin, 1994).  
This guides the data collection to ensure the researcher focuses on the propositions. The idea is 
that every investigation should commence with a general analytic strategy to prioritise what to 
analyse and why.  This is more prescriptive than an ethnographic approach and does not allow 
the data collected to guide the subsequent research in the same manner.  Considering the 
amount of research which had been conducted into prescribing, the researcher was keen to 
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enter the field with an open mind and let the research evolve through responding to the data 
collected and the demands of the fieldwork context. 
Ethnography provided the opportunity to study prescribers in their workplace setting, and allow 
the researcher to gain experience and empathise with the complexities of prescribing decision-
making.  Ethnography draws on a range of methods (qualitative and quantitative) where the 
researcher chooses which are most appropriate to answer the research question and suits the 
demands of the fieldwork context. This PhD has a mixed methods approach by drawing on 
quantitative data for sampling, and participant observation, interviews and review of practice 
documentation for the data collection methods. As the researcher was interested in exploring 
the fieldwork setting from the participant’s perspective participant observation was chosen as 
the primary research method.  With the researcher not being a clinician she had the perspective 
of a stranger and could potentially notice things which had become so familiar to those working 
in general practice they were taken for granted.  To be able to experience the full range of 
potential influences it was felt the research would benefit from studying practices over time. 
Also by spending extended time in general practices allowed GPs and other practice staff time 
to get used to the researcher being around and revert to their everyday behaviour. As “people 
can alter their behaviour when someone new enters the scene, but they can only keep this up for 
a short time” (O'Reilly, 2005; 93). 
Investigating this topic through studying for a PhD has allowed extended fieldwork, in 
particular more time for resource intensive observation, facilitating an in-depth study of 
prescribing from the perspective of three Scottish general practices.  
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1.1 Overview 
Chapter 2 provides a literature review which discusses why prescribing is an important area to 
study defines what is meant by ‘quality prescribing’ and discusses the two common types of 
prescribing decision made in general practice; acute and repeat.  The review then discusses the 
rise of the evidence based medicine movement and various interventions and mechanisms 
designed to improve prescribing quality and shows there are ‘no magic bullets’ (Oxman et al., 
1995).  This chapter also briefly discusses the government initiatives which have tried to 
influence behaviour and establish accountability frameworks.  The discussion focuses on health 
boards that are responsible for quality of care through clinical governance, where prescribing is 
a key objective of this statutory duty and describes the initiatives health boards have adopted to 
influence quality of prescribing. The discussion then gives consideration to the influence of 
hospital led prescribing, pharmaceutical drug representatives and of course the patient, as 
prescribing decisions should incorporate patient’s preferences and values with the research 
evidence.  This chapter shows prescribing is a complex process with a large number of factors 
to consider and how we still know little about how these influences impact on general 
practitioners prescribing behaviour.  
Chapter 3 discusses the aims and objectives of this PhD study and describes ethnography and 
why it is an appropriate method to answer the research questions posed. As well as describing 
the methodological process and the methods in detail, this chapter also describes the theoretical 
and philosophical framework adopted and its implications for the research findings.  The 
methods chapter then describes the sampling frame and the recruitment process in detail. An 
important part of any ethnography is to be reflective so the researcher can consider their impact 
on the research setting and findings so the chapter also discusses the researcher’s field research 
experience and decisions and the researcher reflects upon these.   These are issues such as 
gaining access; establishing a role as a participant observer; generating data whilst building 
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rapport and relationships and describing these different experiences in the three practices. The 
methods chapter also delineates the supporting data collection; opportunistic and formal 
interviews and review of practice documentation and describes the data management process, 
such as the recording of field notes and managing all this data in the analytic software, Atlas.ti.  
The chapter concludes by describing the analytic process; initially, a descriptive approach was 
adopted to understand each practice, the context and influences on prescribing, which forms the 
basis of the following three chapters and three theoretical models were used to help give a 
deeper interpretation and explanation of the prescribing behaviour observed.  An interpretative 
approach was then adopted to explain and understand the differences between the three 
practices, with the findings presented in the comparative chapter. 
Chapter 4 is the first of three chapters which presents the descriptive findings of the study by 
describing the first practice’s (Rubain) characteristics, organisation, processes and systems.  As 
this is the first chapter more contextual background is given which is common to all three 
practices but is not repeated in the following two chapters. A prescribing model was devised for 
each practice. These models have been designed to visually depict prescribing influences, with 
the aim of showing the differences in organisation between the practices specific to prescribing.  
The models also aim to show how and where these influences filter into the practice through to 
the consultation and how the practice’s values affect how they organise themselves around 
these influences.  The models show the processes which link these structural parts of the 
practice prescribing culture, the most common process is communication.  The prescribing 
model for ‘Rubain’, the first practice, is described in detail and the patient specific part of the 
model, which is the same for all three practices, is only described in this chapter.  The practice 
narrative around their prescribing influences and values is given in the accompanying text.  The 
chapter then describes the external influences which are standard to the three practices and 
again the description of these is given in more detail in this chapter. This description then 
  23  
explains how these influences are assimilated into this practice’s prescribing policy.  The 
practice prescribing policy was formulated through their communication channels which are 
also described in detail. This chapter then described the prescriber specific influences, such as 
medical training, experience, personal beliefs and attitudes and their perception and relationship 
with the individual patients.  Chapter 4 concludes by providing an overview of the structure of 
a consultation and discusses continuity of care. 
Chapter 5 presents a description and explanation of the second practice in this study, Rosnish. 
This chapter commences with a description of the practice characteristics, processes and 
systems. Again the chapter has been structured around a practice specific prescribing model 
describing and explaining how this practice considers and formulates these influences into their 
practice prescribing policy. The chapter then discusses the influence of other practice staff and 
the prescriber’s core values, which were not viewed equally, so are presented in a hierarchy.  
Finally, micro prescribing decisions were discussed in the consultation or interaction between 
GP and patient and the importance of continuity of care to patients. 
Chapter 6 gives a description and explanation of the third practice in the study, the Haun.  This 
chapter follows the same structure as the previous two chapters and takes the explanation to a 
more analytic and interpretive level by starting to draw comparison across the three practices.  
Chapter 7 interpretively compares the three practices.  This chapter draws on similarities and 
differences across the range of influences which were shown to shape prescribing decision-
making at two different levels, macro and micro and presents the findings of this PhD study.  
Chapter 8 is the discussion chapter which presents the concepts and findings which emerged 
through the analysis and discusses these in light of the existing literature.  In this chapter 
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theories have been applied to the findings to help gain a deeper interpretation and 
understanding of the influences on prescribing decision-making and how they have their effect.  
This chapter also discusses whether the research methodology was appropriate in answering the 
research questions and the extent to which the findings are transferable to another population.  
The final chapter, 9, initially reviews the main findings from this study, followed by a 
discussion of the implications of these findings for future quality improvement work and 
further research.   
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C h a p t e r  2  
LITERATURE REVIEW 
2.1 Why is Prescribing Important? 
This section will illustrate the importance of prescribing, the financial burden it places on the 
NHS and importance of the changing demographics of the population places on prescribing in 
the future.     
Prescribing is the most common treatment method in the NHS (Barber et al., 2003). The aim of 
prescribing is to manage a disease and/or a condition; to alleviate symptoms; to prevent 
deterioration or to cure; and to improve quality of life.   
Prescribing accounts for 11% of the total cost of the NHS, with 825.8 million prescriptions 
dispensed in primary care alone each year (The Association of the British Pharmaceutical 
Society, 2007). In Scotland alone, the NHS spent £1 billion in 2004-2005 on prescription drugs 
(Information and Statistics Division Scotland, 2004-2005).  In England, the net ingredient cost 
of all prescriptions dispensed increased by 0.6% to £8,325.5 million in 2008; 842.5 million 
prescriptions were dispensed, this is an increase of 5.8% on 2007 (NHS The Information 
Centre, 2008).  
In the U.K we have an aging population; the elderly have an increased prevalence of long-term 
conditions which require appropriate pharmaceutical intervention (Office for National 
Statistics, 2010).  They receive nearly half of all prescriptions (Department of Health, 2000).  In 
2005, 17.5 million people reported a long-term condition and for some people, in particular the 
elderly, they were more likely to report more than one condition (Department of Health, 2007). 
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The impact of managing this means huge financial impact on the NHS but also more complex 
decision making for clinicians. 
Prescribing is fundamental part of modern medicine; ensuring patients enjoy an improved 
quality of life or are cured altogether. With an ever aging population the need for 
pharmaceutical drugs is likely to increase thus the financial burden to the NHS is likely to keep 
rising.   
2.2 Quality Prescribing Decisions 
Prescribing is complex, it incorporates a huge number of factors, so is difficult to define and 
evaluate.  This section will describe ‘what is quality prescribing’ and explain why many 
prescribing decisions are not always based on the evidence, illustrating the complexity of 
prescribing decisions. 
2.2.1 What is quality in prescribing? 
Prescribing quality is difficult to define.  As (Hemminki, 1975; 111) pointed out “if only 
medical factors influenced prescribing, the variation in prescribing practices might be explained 
by differing patient populations but many other factors....have been found to affect 
prescribing”. Thus, quality cannot be judged on pharmacology alone. This section will discuss 
previous definitions and the discussions in the literature surrounding prescribing quality.   
Parish (1973) established the first definition of ‘good’ prescribing; ‘appropriate, safe, effective 
and economic.’  This definition has been widely sighted but at over 30 years old it is still 
correct but has been exceeded by more specific definitions. Bradley’s (1991) literature review 
included reports of characteristics of ‘quality’ prescribing but most of the studies included 
looked at the characteristics of prescribers or practices, or looked more at bio-markers, and the 
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majority were not in primary care. Although an important part of good prescribing this 
definition sees the person as a disease or condition rather than as a person (Barber, 1995), and 
does not look at the patients perspective and the importance of shared decision-making.  The 
Audit Commission Report (1994)  ‘A prescription for improvement’, concluded that ‘more 
rational prescribing by GPs will lead to both better quality care for patients and to minor 
economies of drug expenditure.’ These definitions do not appreciate the individual nature of 
each prescribing decision and do not take account of the social aspects of prescribing.  These 
previous definitions were rejected by Barber who believed that rather than defining ‘good’ 
prescribing, the aims of prescribing decision-making and monitoring should be defined.  He 
established four aims; to ‘maximise effectiveness; minimise risks; minimise costs; to respect 
the patient’s choices.’ Prior, to 2000 this was the established ‘definition’ of ‘quality 
prescribing’ as it takes account of the fact that ‘good’ prescribing cannot always be achieved, 
illustrates awareness of the numerous factors and how the patients perspective and 
circumstances impact on the prescribing decision. 
2.2.1.1 Maximise effectiveness 
Effects are usually measured in a biomedical way, by assigning a numerical value to assess 
effectiveness, such as measuring blood pressure. The value of any prescribed drug is often 
established through cumulative research evidence e.g. in Cochrane reviews and is formulated 
into guidelines, which establish optimal treatment.  For example, blood pressure where a 
patient’s blood pressure should not be more than systolic BP ≥ 160 mm Hg or diastolic BP ≥ 
100 mm Hg (Scottish Intercollegiate Guidelines Network, 2007).  Effectiveness also involves 
protecting the population from resistance of antimicrobials, therefore only prescribing 
medication when needed, and ensuring what is prescribed is evidence-based. Effectiveness can 
be measured through a relevant clinical outcome such as blood pressure below the 
recommended levels, or control of angina symptoms, or free from infection.  However, often 
  28  
the endpoint is subjective such as relief from pain and in these more subjective measures 
patient satisfaction or empowerment is the only real assessment of success (Sullivan and 
MacNaughton, 1996, Cribb and Barber, 1997, Hynes, 1992). 
2.2.1.2 Minimise risks 
Risk is the chance of an adverse reaction, interaction or side-effect from prescribed medication.  
“Safety is a level of risk that is acceptable to a culture, context, or individual” (Barber, 1995; 
924). Since Barber’s (1995) paper the U.S Institute of Medicine has published two widely cited 
reports: ‘To Err is Human; Building a Safer Health Care System’ (U.S. Institute of Medicine, 
2000) and ‘Crossing the Quality Chasm’ (U.S. Institute of Medicine, 2001), which have 
highlighted the importance of safety and this is now recognised as an important aspect of 
quality.  ‘To Err is Human’ was the first report published in 2000 and highlighted medical 
errors pushing for an awareness of patient safety.  ‘Crossing the Quality Chasm’ published two 
years later furthered many of these points.  These two publications highlight that clinicians do 
make mistakes when prescribing medication which, in some cases, can compromise safety. 
Patients on repeat medication must be reviewed regularly to check their medication is still 
needed and is at the required dose.  Patients need to be monitored to ensure they comply with 
treatment, their prescriptions are wanted, they know what to do and they are taking them 
properly. This is a long-term issue, as our population ages and there is an increase in poly-
pharmacy and thus the risk of drug interactions increases.   
2.2.1.3 Minimise costs 
When assessing cost, consideration should not just be given to the cost of the drug alone, costs 
such as the administration of the drug (nurse time or monitoring), the cost to the patient (such 
as travel, time, loss of time at work) and the cost of dispensing should be taken into account.  
However, direct costs are important, drugs become cheaper when they come off patent and 
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prescribers are strongly encouraged to prescribe a generic preparation where ever possible. 
Clinicians must ensure there is no drug wastage and monitor long-term prescribing; as costs can 
be reduced by improved cost-effectiveness.  Clinicians have a moral obligation to try and keep 
costs at a minimum; the NHS is funded by public money and by keeping costs down the money 
can benefit other sectors of the NHS (Barber, 1995). 
2.2.1.4 Respect patient wishes 
Ultimately, it is the patient’s wishes which govern any prescribing decision, as it is up to the 
patient whether to have the medication dispensed, whether to take the medication and how they 
are going to take it (Barber, 1995).  Therefore, it is important the patient is educated and is able 
to make informed choices about their health care.  The patient must be able to express their 
expectations, have effective communication with the clinician, have a trusting relationship and 
be able to come to a decision which is favourable to both the clinician and the patient. Patients 
should be able to express what they would like from the treatment, (e.g. the degree of side 
effects versus effectiveness) and the frequency of their treatment regime.  The treatment regime 
should suit the patient, but not at the expense of the ‘social good’, i.e. not at the expense of 
other patients, so costs should be kept to a minimum.  Each prescribing decision is unique and 
has its own complexities, this, combined with cost minimisation, means the ratification of each 
prescribing decision should be at the prescribers discretion.  Each decision should observe all 
these principles and preserve clinical autonomy. 
Through describing prescribing quality, the complexities of prescribing decision making have 
been highlighted.  Prescribing decisions should be evidence-based whenever possible;  
• ensuring there are no adverse drug reactions, side effects or contraindications (Avery et 
al., 2007, Howard et al., 2008);  
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• be based on effective communication between practitioner and patient, ensuring the 
patient’s wishes are respected (Charles et al., 1997, Stevenson et al., 2000a); 
• the patient understands the importance of compliance (Cameron, 1996).  
 
This should all be done in a 10 minute consultation.  Autonomy should be given to the 
prescriber to weigh up these issues, to come to the optimal decision with the available 
information, within the available time. 
 (Adapted from Barber, 1995) 
2.3 The prescribing process 
The aims of quality prescribing decision-making have been discussed however, it is important 
to pay attention to the two different kinds of prescribing decision made by general practitioners. 
There are two different types of prescription, the one off prescription, for say an infection, and 
the repeat prescription for long term conditions.  A prescribing decision is about what drug to 
prescribe but to also about reviewing and changing medication, or stopping it all together.  
Prescribing decisions are not straight forward so it is important to understand how prescribing 
decisions are reached.  This section will describe the two different types of prescription (acute 
and repeat) and discuss how prescribing decisions are reached. 
2.3.1 Acute prescriptions 
An acute prescription is one which the patient usually receives on a one off basis for a 
condition which is short lived. A patient presents in the consultation with a problem and after a 
verbal and sometimes physical examination the doctor makes a diagnosis and if necessary 
recommendations for treatment. Normally the doctor writes and signs the prescription in a 
consultation with the patient after some discussion; however they can be recommended by a 
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hospital consultant after a patients visit to secondary care. There is a knowledge gap between 
the GP and the patient so the GP must try to bridge this gap through clear communication, and 
identify the patient’s priorities (Bradley, 1992a). 
2.3.2 Repeat prescriptions 
A repeat prescription is one where the patient receives the prescription for an extended period 
of time, usually for a long-term condition. Repeat prescriptions are usually issued without a 
consultation with the patient (Zermansky, 1996) and the majority of drugs prescribed (80%) by 
GPs in the UK are repeat prescriptions (Harris and Dajda, 1996). The oral contraceptive is an 
example of medication which will go straight onto repeats and given a six month supply, other 
medication will usually be given a 3 or 2 month supply (McGavock et al., 1999). Repeat 
prescriptions are printed by computer usually in large batches, which means that it is less likely 
the doctor will spend time thinking about individual prescriptions (Harris and Dajda, 1996). 
Thus, how the process is managed is very important. Zermansky (1996) found that 72% of 
repeat prescribing in a sample of 50 practices had not been reviewed in 15 months.  This is both 
wasteful and dangerous, as patients change and their illnesses change.  McGavock et al., (1999) 
found that repeat prescribing was poorly managed in substantial proportion of the practices in 
their study.   
The nGMS contract (Department of Health and NHS Confederation, 2003) requires an annual 
medication review to ensure appropriateness of medications and to check potential side effects 
or interactions, so the management of repeat prescriptions is likely to have improved since 
McGavock’s study (1999). One of the challenges of this recommendation is the time to conduct 
through reviews (Avery et al., 2002). Computers can automate some of this; they can be used 
to monitor compliance and can be used to set prompts as reminders. Also the electronic patient 
record presents the patients information in a clearer format than the old paper records (Sullivan 
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and Wyatt, 2005).  Zermansky et al (2001) have shown that pharmacists are effective at 
conducting medication reviews.  Also, practices have clinics for specific health problems, such 
as asthma and diabetes, where patient medication is reviewed and these are often conducted by 
a specialist nurse. Although time is an issue, monitoring of repeat medication is important for 
prescribing quality and improvement can be facilitated by computers and by medication 
reviews conducted by other members of the primary care team.  
Prescribing decisions are not straight forward and normally come in two formats in primary 
care.  Important to understand how prescribing decisions are reached.   
2.3.3 How are prescribing decisions reached? 
2.3.3.1 Choice of drug 
In the first stage of a prescribing decision, the doctor decides whether a drug is required 
(Bradley, 1991).  Little et al (2004) found doctor’s behaviour in a consultation is most strongly 
associated with perceived medical need of the patient.  This initial decision is a decision of 
benefit versus risk (Denig and Bradley, 1998), do the benefits of the medication outweigh the 
risks associated with medication in the individual patient.  For example, every time a clinician 
prescribes a statin they are aware of the potential risks to a patient’s liver.  Clinicians generally 
do a liver function test and monitor this.  However, they have to consider whether the risks to 
the patient’s liver outweigh the risks of a heart attack.  Once doctors have decided to prescribe 
they then chose a drug treatment.  Doctors decide whether to adopt a (new) drug or to choose a 
drug which they know well (Denig and Bradley, 1998).  Firstly, the decision to choose a drug 
they know well is explored and then the decision of whether to adopt a new drug. 
Each doctor has a personal set of drugs with which he or she is familiar (Taylor and Bond, 
1991). They normally choose from this set when confronted with an individual patient (Denig 
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and Bradley, 1998).  Doctors do not weigh the risks and benefits of medication each time they 
make a prescribing decision; they make shortcuts in their decision-making process (Gabbay and 
le May, 2004).  Denig and Bradley (1998) suggest three different decision strategies used as 
shortcuts in the prescribing decision; pragmatic, intuitive and emotional.  The pragmatic 
approach recognises that doctors will not continually consider the same trade-offs, so in 
situations which are repetitive they will adopt a routine behaviour.  Denig and Haaijer-
Ruskamp (1994) found in relatively simple cases (urinary tract infection) GPs made their 
treatment decisions with little deliberation, suggesting routine behaviour.   Their study showed 
in more complex cases (such as stomach and reflux complaints) GPs engaged in more 
evaluation of possible management and treatment options.  The intuitive approach recognises 
doctors may sometimes base decisions on intuition and personal experience. Doctors may 
chose treatments because they worked well in previous cases. For example, there are no 
guidelines on what selective serotonin reuptake inhibitor (SSRI) to prescribe so a clinician is 
likely to prescribe one which has worked well for patients in the past.  The emotional approach 
highlights that doctors are not just driven by cognitive factors but also emotional factors (Denig 
and Bradley, 1998), such as acting to please others.  For example, a patient may come into the 
surgery asking for an antibiotic because they are going on holiday.  The clinician may feel the 
symptoms are likely to go away by themselves but the patient is being forceful as they are 
concerned about their holiday. These decisions may go against the doctor’s judgement and 
leave them feeling uncomfortable (Bradley, 1992b).  The strategy which is followed depends 
on the nature of the prescribing decision, the context and the doctor.  “The use of a particular 
strategy can be part a characteristic of a particular doctor” (Denig and Bradley, 1998, Denig 
and Bradley, 1998; 83). 
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New drug 
Prosser et al (2003) found doctors initiated new drugs by proxy (based on another clinician’s 
decision) or through their own personal choice. When doctors personally made the decision to 
initiate a new drug they were influenced by its perceived economic or pharmacological 
advantages over alternative treatments (Prosser et al., 2003).  However, GPs did not actively 
seek information and thus relied heavily on advertising and pharmaceutical representatives to 
learn about new drugs (Prosser et al., 2003, Jones et al., 2001b).  This information may not be 
comprehensive.  
Further work on this issue by Prosser and Walley (2003) ranked practices into high or low 
prescribers of new drugs using the local health authority prescribing data.  Both groups felt they 
would only prescribe a new drug when they felt they offered a relative advantage over current 
therapy.  The most frequently cited influence for the high prescribers was the pharmaceutical 
representative.   The low prescribers managed risks by adopting a ‘wait and see’ policy and 
high prescribers on the other hand appeared either to accept uncertainty and the risks involved, 
or considered risks to be minimal on the grounds that the approving licensing authority had 
considered safety.   This research shows the differences in attitudes to innovation, risk 
perception and benefit between these two groups of doctors.   These findings are supported by 
Jacoby et al (2003) who found a difference in attitudes between low and high prescribers of 
new drugs.  
In conclusion, doctors prescribing decision are not always a rational trade-off involving a 
number of different outcomes.  Doctors use short-cuts. In frequently made decisions they 
prescribe routinely.  Doctors also rely on intuition and experience and may make prescribing 
decisions based on emotion, usually to please others.  When prescribing a new drug GPs are 
usually influenced by perceived economic or pharmacological advantages and their attitudes 
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towards risk perception versus benefit.  Thus some variation in prescribing can be attributed to 
differing doctor characteristics.  
2.4 Attempts to improve prescribing 
Traditionally clinical experience guided the choice of treatment (Armstrong, 2002). Cochrane 
(1972) argued this left treatment decisions open to subjective interpretation with the result that 
different doctors often arrived at different conclusions about the effectiveness of the same 
intervention.  Cochrane’s solution was to subject treatments to the randomised controlled trial 
(RCT).   The RCT became the pinnacle of a new hierarchy of medical knowledge as it could 
weigh scientific evidence for or against a clinical intervention (Ho et al., 2008).  This heralded 
the start of the evidence based medicine (EBM) movement, where this new knowledge could 
be disseminated and used to inform clinical decision-making.  
This section will discuss the evidence based medicine movement and then the strategies and 
techniques which have been developed and used for dissemination and implementation.  
2.4.1 Evidence based medicine 
The EBM movement is aimed at helping health care practitioners, patients and policy makers 
make decisions with regard to health care, including prescribing, by basing these decisions on 
the best evidence available (Grol, 2001). Thus, EBM offered a more rational basis for 
prescribing to replace the idiosyncrasies of individual practitioner judgement (Armstrong and 
Ogden, 2006). Early publications championing EBM advocated for the need to move beyond 
clinical experience and physiological principles to a rigorous evaluation of the consequences of 
clinical actions’ (Oxman et al., 1993, Group, 1992).  These early publications were all about 
the research evidence.   However, a paradigm shift occurred with the seminal publication by 
Sackett et al. (1996) which advocated shared decision-making with the patient. “Evidence 
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based medicine is the conscientious, explicit, and judicious use of current best evidence in 
making decisions about the care of individual patients.  The practice of evidence based 
medicine means integrating individual clinical expertise with the best available external clinical 
evidence from systematic research.  By individual clinical expertise we mean the proficiency 
and judgement that individual clinicians acquire through clinical experience and clinical 
practice” (Sackett et al., 1996; 71).  This paper introduced the idea of integrating the evidence 
with patient’s choices and preferences and clinical judgement.  
The underlying assumption of EBM is that not all evidence is equal. At the top of the list is the 
randomised controlled trial, followed by the non-randomised controlled studies and case 
studies.  The seminal paper by Sackett et al. (1996) also reformed how evidence should be 
considered; “evidence based medicine is not restricted to randomised trials and meta-analyses.  
It involves tracking down the best available evidence with which to answer our clinical 
questions” (Sackett et al., 1996; 71). 
The fundamental principles of EBM are widely accepted but implementation is patchy (Barratt, 
2008).  Over time, as it has become apparent that implementation is not rational and linear so 
the EBM movement has started to focus on the organisational and behavioural barriers to 
getting research into practice (Bero et al., 1998, Haines and Donald, 1998). Initially, it was 
assumed that the implementation gap (between research evidence and practice) was due to 
information not being easily accessible. So summarised evidence in the form of guidelines 
(discussed in further detail in section 2.4.1.1) were published and disseminated assuming that 
changes in practice would automatically happen. It has become clear that reliance on passive 
dissemination of information to keep health professionals up-to-date is ineffective when around 
two million articles on medical issues are published annually (Mulrow, 1994).  
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Attempts have been made to make EBM more accessible and digestible to reduce the 
implementation gap between research evidence and practice.  This section will discuss the 
various strategies to improve quality prescribing and reduce the implementation gap. 
2.4.1.1 Guidelines 
Guidelines are recommendations for clinical practice, designed to aid decision-making. They 
are made up of synthesised scientific evidence and expert opinion and knowledge about the 
delivery of health care, published in paper and electronic format.  As health care involves large 
amounts of complex information, guidelines provide an efficient means to summarise this 
(Moreira et al., 2006).  Clinical practice guidelines are the accumulation of empirical study of 
medical treatment efficacy.  They are intended to improve clinical performance and outcomes 
by enhancing clinician’s knowledge and skills (Graham et al., 2000). 
The Scottish Intercollegiate Guidelines Network (SIGN) was formed in 1993 and develops 
evidence based practice guidelines for the NHS in Scotland (Scottish Intercollegiate Guidelines 
Network, 2009). The National Institute for Health and Clinical Excellence (NICE) was set up in 
April 1999 to provide patients, health professionals, and the public with guidance on best 
practice (National Institute for Health and Clinical Excellence, 2010). 
Wathen and Dean (2004) found that NICE guidance on its own had little impact on GP 
prescribing. A review carried out by the Cochrane Collaboration concluded that passive 
dissemination had a small impact on practice and substantial change was unlikely to be 
achieved by this method (Farmer et al., 2008).  No effect was found of computerised evidence 
based guidelines on the management of asthma or angina in adults in primary care (Eccles et 
al., 2002). The authors concluded this was due to low levels of use of the software. 
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Berg commented that one of the problems with guidelines is that they see patient management 
as a series of formal rational decisions and there is a single optimal solution to every 
medication problem (Berg, 1997).  Eccles et al (2002) felt even if they overcame the technical 
problems of the computerised guidelines, there remained the challenge of integrating this into 
clinical encounters where clinicians manage patients with complex and co-morbidities.   
A study exploring the attributes of guidelines, to establish which factors influenced their use, 
found guidance was followed in 61% of the decisions and that evidence based 
recommendations were followed more than recommendations not based on research evidence 
(71% versus 57%).  The authors conclude the organisations publishing guidelines should take 
account of some of the other attributes of recommendations for clinical practice (Grol et al., 
1998). 
2.4.1.2 Computer decision support systems 
Computer decision support systems are designed to improve clinical decision making by 
incorporating knowledge in guidelines to allow patient specific decision-making. The 
characteristics of individual patients are matched to a computerised knowledge base, and 
software algorithms generate patient specific recommendations (Garg et al., 2005).  They are 
designed to help with complex decision making, e.g. drug dosing in particular children and the 
elderly (Franke et al., 2000), or to help with drug interactions or previous allergic reactions to 
the drug (Barber, 2004).  These support systems are flexible enough to factor in individual 
patient views and preferences (Montgomery et al., 2000).   These are designed to be used 
during the consultation (Sullivan and Wyatt, 2005) and are designed to be helpful for managing 
patients with complex and multiple conditions.   
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A systematic review of computerised clinical decision support systems on practitioner 
performance and patient outcomes concluded many CDSSs improve practitioner performance 
but the effects on patient outcomes remain under-researched (Garg et al., 2005). A randomised 
controlled trial has shown that using a computer based clinical decision support system did not 
find any additional benefits compared with chart guidelines and may have impaired the 
interpretation of evidence to individual patients (Montgomery et al., 2000). An evaluation of a 
RCT found significant barriers to the use of a CDSS for chronic disease by general 
practitioners.  The key issues were the relevance and accuracy of messages and the lack of 
flexibility to respond to other factors influencing decision making in primary care (Rousseau et 
al., 2003). The authors concluded primary care consultations are complex interactions between 
a professional and patient and intervening at this interpersonal level is difficult. 
There are significant opportunities for improving the safety of general practice computer 
systems and priorities include improving the knowledge base of clinical decision support 
(Avery et al., 2007), however, it remains unclear if they can intervene in a meaningful way 
between the doctor-patient relationships. 
2.4.2 Health Board initiatives 
In Scotland health boards are responsible for quality improvement through clinical governance 
(clinical governance is discussed in section 2.5.1).  The health boards have adopted some 
commonly used techniques for reducing the implementation gap and improving the quality of 
prescribing.   
2.4.2.1 Prescribing data and indicators 
Health boards monitor prescribing data to support medicines management and clinical 
governance (Kendall, 2004). Currently, after dispensing, prescriptions are sent to either the 
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Prescription Pricing Authority in England, to the Common Services Agency in Scotland or to 
Health Solutions in Wales.  The health boards receive this information from these organisations 
which they use to manage and monitor prescribing. This is aggregated data, based on 
prescriptions dispensed rather than prescriptions written and is not linked to patient medical 
records.  
Measurement plays an important part in quality improvement (Donabedian, 2003). Prescribing 
data are used to help benchmark the performance of prescribers and NHS organisations.  This 
benchmarking is achieved through the use of prescribing indicators or performance indicators.  
Prescribing indicators are used for a range of purposes but for those used to measure 
appropriateness, availability, efficacy and effectiveness should be based on robust evidence to 
promote the wider use of evidence based interventions (McColl et al., 1998a). By applying 
prescribing indicators to data, standards are set (Bateman et al., 1996) and health boards can 
identify variation in prescribing across general practices (Avery et al., 1998) and possible areas 
for improvement. 
Current prescribing indicators are criticised due to the limitations of the prescribing data.  
Although the data is comprehensive and timely, the data is not combined with diagnosis, data 
on specific patients or on any outcome measures (Campbell et al., 2000). Indicators are 
criticised for reflecting access and efficiency rather than effectiveness (McColl et al., 1998a).  
Anecdotal evidence suggests that prescribing indicators are more appropriately related to cost 
than quality; particularly at the practice level (the unit of analysis for most prescribing 
indicators) (Campbell et al., 2000). However, Morris et al (2006) have shown applying 
prescribing indicators to practice data can be used to facilitate practice-wide discussions on 
medicines management.  
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Audits are used to apply these indicators to the data and identify variation.  Variation in 
prescribing could indicate variable quality of care (Kendall, 2004).   The next section discusses 
audit and feedback.  
2.4.2.2 Audit and feedback 
Audit and feedback is a widely used strategy to promote the implementation of research 
evidence and encourage change in prescribing behaviour. Practitioners are prompted to modify 
their prescribing behaviour by being compared to their peers or by clinical guidelines (Jamtvedt  
et al., 2006).  EBM based quantitative measures and standards, called prescribing indicators 
(discussed above) are applied to prescribing data to identify variation.   
A systematic review found audit and feedback to be effective at improving professional 
practice, however when it is effective, the effects are generally small to moderate.  The authors 
concluded the relative effectiveness of audit and feedback was likely to be greater when 
baseline adherence to recommended practice is lower and when feedback is delivered more 
intensively (Jamtvedt  et al., 2006).  The timing of feedback delivery can affect the result of 
behaviour change (Robinson, 1994) as can the credibility of the feedback source (Exworthy et 
al., 2003). Individualised feedback was found to work well at improving quality and reducing 
costs in Spain (Madridejos-Mora et al., 2004), however due to repeat prescribing systems in the 
UK this is difficult to achieve.  
Foy et al (2005) tried to assess whether current guidance and systematic review evidence can 
sufficiently inform practical decisions about how to use audit and feedback to improve quality 
of care.  The authors showed the evidence suggests that audit and feedback can be effective in 
changing healthcare professional practice. However, the evidence said little about the detail of 
how to use audit and feedback most efficiently.  Foy et al (2005)  conclude audit and feedback 
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will continue to be an unreliable approach to quality improvement until we learn how and when 
it works best.   
2.4.2.3 Educational outreach 
Educational outreach is also commonly referred to as academic detailing or educational 
meetings.  These are a form of continuing medical education where a trained health 
professional such as a clinician or a pharmacist visits general practitioners in their surgeries to 
provide evidence based information (Allen et al., 2007). Educational meetings are commonly 
used for continuing medical education with the aim of improving professional practice and 
thereby, patient outcomes (Forsetlund et al., 2009).  
A systematic review of literature relating to the effectiveness of educational strategies deigned 
to change physician behaviour. Davis et al., (1995) found widely used delivery methods such 
as conferences have little direct impact on improving professional practice, so more outreach 
visits are now more commonly used. A review found that interactive educational sessions that 
enhance participant activity and provide the opportunity to practice skills can effect change in 
professional practice.  Didactic sessions do not appear to be effective in changing physician 
performance (Davis et al., 1999). 
A systematic review of continuing education meetings and workshops found educational 
meetings alone or combined with other interventions, can improve professional practice and 
healthcare outcomes for the patients but the effect is most likely to be small and similar to other 
types of continuing medical education, such as audit and feedback (Forsetlund et al., 2009).  
Allen et al., (2007) found practitioners highly value the merit of educational outreach meetings 
and tend to view information from other sources more critically because of its evidence based 
approach. 
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Educational outreach meetings are commonly carried out by pharmacists and originally were 
perceived to be a useful and cost effective way to improve the quality of prescribing in the US 
(Avorn and Soumerai, 1983).  A RCT of the effect of educational outreach by community 
pharmacists on prescribing in UK general practice found in large practices, educational 
outreach alone is unlikely to achieve worthwhile change; however, there was good evidence to 
support the use of educational outreach visits in small practices (Freemantle et al., 2002). 
Watkins (2004) found it is important for preparing the practice adequately, which included 
providing protected time for all GPs to attend the educational intervention. Another UK RCT 
found in practices with good baseline prescribing there was limited capacity for improvement 
and the trial failed to provide evidence that guidelines and educational outreach visits by 
community pharmacists lead to substantial improvements in prescribing behaviour (Watson et 
al., 2001).  
2.4.2.4 Practice pharmacists/prescribing advisors 
Pharmacists are increasingly being used to influence prescribing in primary care (Lipman and 
Price, 2000) and are frequently referred to as pharmaceutical advisors or practice pharmacists.  
These terms are often used interchangeably and distinctions between the terms are often not 
clear.  Pharmacists are employed by Health Boards in Scotland and Primary Care Trusts in 
England to advise on prescribing processes, all aspects of drug therapy (including adhering 
with the health board formulary) and to help contain prescribing costs.   A common distinction 
is that practice pharmacists are practice based whereas prescribing advisors are not but this is 
based on anecdotal evidence rather than peer reviewed research. Whether they are based in a 
practice or not, pharmacists with both titles have the same objective; to promote rational 
prescribing and evidence-based medicine, to improve the pharmaceutical care of patient and to 
help the practice contain its prescribing costs.  
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Pharmacists working in primary care have been found to improve pharmaceutical care in a 
number of clinical areas, diabetes care (Jameson and Baty 2010, Lindenmeyer et al., 2006), 
hypertension (Rozenfeld et al., 2006), chronic pain management (McDermott et al., 2006), and 
in medication review (Krska et al., 2001). A systematic review of pharmacist led-medication 
reviews found pharmacists were not more likely to reduce mortality or hospital admissions.  
The authors found patients were more likely to take less medication and may have improved 
drug knowledge and adherence but there was insufficient data to measure quality of life 
(Holland et al., 2008). 
This literature review identified little evidence supporting the effectiveness of pharmacists at 
promoting rational prescribing and reducing prescribing costs. The effect of integrating a 
pharmacist into primary care has not been extensively studied (Dolovich et al., 2008, Tonna et 
al., 2007).  Teal et al (2002) found it was hard to quantify and estimate the effect of practice 
pharmacists, which is possibly why there is limited research. A pharmacist intervention 
program in primary care was associated with a significant increase in adherence to guidelines 
for ACE or ARB therapy and for aspirin therapy in diabetic patients (LaMarr et al., 2010). A 
randomised controlled trial of the effect of routine use of untargeted educational outreach visits 
by pharmaceutical advisors concluded they may not be a worthwhile strategy (Eccles et al., 
2007).  Whereas a qualitative study found GPs appreciated the enhanced group interaction, 
reliable drug information and a greater sense of team-working with pharmacists employed in 
practices (Pottie et al., 2008). 
2.4.2.5 Health Board formularies 
The British National Formulary (BNF) is a joint publication of the British Medical Association 
and the Royal Pharmaceutical Society of Great Britain. The BNF aims to provide prescribers, 
pharmacists and other health professionals with sound up-to-date information about the use of 
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medicines. The BNF as an independent professional publication is highly respected and widely 
used by health care professionals in the U.K. (Cantrill, 2000). 
Each health board produces a local area health board prescribing formulary, which generally 
contains fewer medications than the BNF as the aim is to rationalise and standardise 
prescribing across the health board.  The health board formulary is commonly held on general 
practice computer systems and defaults to the generic substitution (Barber, 2004).  
Increasingly, practices are adopting their own practice formulary, which is a limited list of 
medications from the health board formulary, from which a general practitioner prescribes. By 
prescribing from a formulary, the practice has focused on a limited list of which the clinician is 
able to know more about these medications. Thus, much of the preliminary prescribing 
decisions are made by the practice not by individual (Jacoby et al., 2003). Avery et al (1997) 
found GPs prescribe from a narrower range of drugs with a formulary and the number of drugs 
on the formulary has been found to increase with practice size (McCarthy et al., 1992).  In a 
utilitarian system such as the NHS generic substitution and the use of a formulary can be used 
to benefit other parts of the system (Barber, 2004).  
2.5 Government Initiatives 
Running concurrently with the EBM movement have been a number of government initiatives 
and reforms. This section will discuss two important reforms for prescribing quality 
improvement; clinical governance and the nGMS contract. 
In the early years of the NHS it was a demand led system with quality inherent in the system, 
maintained and sustained through the ethos and skills of its health professionals (Donaldson 
and Gray, 1998). By the 1980s, it was widely recognised that the NHS was demand led with 
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the largest share of resources being used to manage the pressures of the acute hospital sector 
and cost containment was an increasing problem. As a result of the NHS Management Inquiry 
chaired by Roy Griffiths, led to the Griffiths Report (1983) which led to the introduction of 
general managers at every level of the NHS (Day and Klein, 1983) who were responsible for 
performance. Although this resulted in a heightened awareness of accountability for 
performance, managers were accountable for financial and workload targets and responsibility 
for quality of care still lay with the clinicians (Donaldson and Gray, 1998). 
With the new Conservative Government came a new publication ‘Working for patients’ 
(Secretary of State for Health, 1989) which introduced an internal market, creating the 
purchaser provider split.  This created general practitioners as the purchasers of care and Health 
Boards in Scotland and Primary Care Trusts in England as the providers of community and 
hospital services. General practitioners purchased services to meet the needs of their local 
population. The intention was to create incentives, create efficiencies and improve quality. This 
created the opportunity for general practices to become fundholders and have responsibility for 
their own prescribing budgets.  Not all practices took up this opportunity but in those who did 
they prescribed a significantly higher proportion of their items as generics, which are cheaper 
than the brand equivalents (Audit Commission, 1994).  The internal market was controversial 
until it was abandoned by the new Labour Government who came into power in 1997. It was 
controversial as the inherent notions of competition were perceived as wrong in a publically 
funded service (Dixon and Mays, 1997). 
The new Labour Government published a white paper for the NHS, The new NHS: modern and 
dependable (Department of Health, 1997) which sought to establish a culture and a spirit of 
collaboration, openness, and fairness (Donaldson and Gray, 1998).  This new policy also 
introduced a statutory duty for quality improvement at a local level; clinical governance.   
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2.5.1 Clinical governance 
Clinical governance established a statutory duty for high quality care to be delivered throughout 
the NHS.  The widely used definition of clinical governance is “a framework through which the 
NHS organisations are accountable for continuously improving the quality of their services and 
safeguarding high standards of care by creating an environment in which excellence in clinical 
care will flourish” (Scally and Donaldson, 1998; 61). Clinical governance sought to establish a 
no blame culture and to readdress the relationship between clinicians and management and 
doctors and patients (Halligan and Donaldson, 2001).  
Clinical governance incorporated clinical performance into management systems (Exworthy et 
al., 2003) and brought clinical decision making into a management and organisational 
framework (Donaldson and Gray, 1998).  This established a clear accountability framework 
and prescribing is a key clinical governance objective of primary care trusts and boards 
(Campbell et al., 2000). As a result health boards have adopted a number of the quality 
improvement techniques described in section 2.4.2.  
2.5.2 New General Medical Services Contract 
In 2004 a new contract was introduced for General Practitioners in the UK, which introduced a 
significant element of ‘pay-for–performance’ (Checkland et al., 2008).  The nGMS contract 
established a new system of reimbursement linked to performance indicators, the Quality and 
Outcomes Framework (QOF) which created a number of new measures for quality of care. This 
radically reformed the GPs method of payment. This has been described as “an initiative to 
improve the quality of primary care that is the boldest such proposal on this scale ever 
attempted anywhere in the world’ (Shekelle, 2003; 457).  This new contract is radical as it 
subjects independent contractors, who traditionally had a great deal of autonomy, to external 
scrutiny and control (Huby et al., 2008).  
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The Quality and Outcomes Framework is comprised of 146 indicators drawn from a number of 
domains: chronic disease management (76 indicators covering eleven chronic diseases), 
‘practice organisation’ (56 indicators), ‘patient experience’ (4 indicators) and additional 
services (10 indicators); and an additional ‘bonus’ indicator ‘access’ (1 indicator) (Department 
of Health and NHS Confederation, 2003). 
In the first year of the nGMS contract the average QOF achievement was 959 (91%) which 
polarised views, with newspaper headlines suggesting ‘Doctors get 20% pay rise just for doing 
their jobs’ while others argued that primary care had ‘stepped up’ and worked hard to improve 
patient care (Timmins, 2005).  This shows the tension in views as to whether QOF rewards past 
and ongoing achievements or whether it acts as an incentive, whereas in reality it is both 
(Lester et al., 2006). An expert panel was convened in 2005 to review QOF which resulted in 
small but significant changes; fewer points are allocated to organisational areas and recognising 
improvements have been achieved is now part of standard rather than quality of care. It has 
been said the glory financial days of the new contract are over and GPs are working to strive 
for quality and financial remuneration (David Gill, Pharmacy Clinical Lead, NHS Tayside, 
personal communication).  
2.6 Further Influences on Prescribing 
2.6.1 Hospital led prescribing 
There are two predominate forms of prescription in general practice; the GP-driven prescription 
and the hospital-led prescription. Hospital led prescribing is where the prescribing of 
medication is initiated in hospital. Prosser et al (2003) found hospital led prescribing and drug 
representatives were cited as the most common reasons for prescribing a new drug after failure 
of current therapy or adverse drug reactions (Prosser et al., 2003).  Hospital consultants are an 
important influence on GP prescribing (Prosser and Walley, 2003, Jacoby et al., 2003), with a 
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significant number of new drugs prescribed being hospital initiated or hospital led (Jacoby et 
al., 2003). Hospital initiated prescriptions are responsible for a significant proportion, in both 
cost and volume of GP prescribing (Feely et al., 1999, Avery et al., 1998, Avery et al., 2000).  
GPs find it difficult to change or refuse to prescribe medication which had been initiated in 
hospital because they feel it could be damaging to their relationship both with their patients and 
consultants (Jones et al., 2001a).  This has important cost implications for chronic medications 
where the extent of repeat prescribing is high (de Vries et al., 1995).   
Hospital consultants are reported to be an important source of information on new drugs 
(McGettigan et al., 2001).  When prescribing new drugs, practitioners are trying to balance a 
range of factors, such as potential side effects, long-term effects, and the range of therapeutic 
indications and for which there is relatively little information available and much of this 
medication they may have little or no practice experience (Jacoby et al., 2003). Under these 
circumstances prescribing may be more ‘an act of faith’ than a rational process (Mapes, 1977), 
so it is understandable GPs will follow the expert’s advice. As well as following hospital 
recommendations, GPs are also influenced by the experience of seeing patients who had been 
prescribed particular drugs by a consultant and then following their example (Jones et al., 
2001b). 
2.6.2 Pharmaceutical drug representatives 
Pharmaceutical drug representatives are employed by drug companies to promote their 
products.  The pharmaceutical industry spends £850 million marketing its products to GPs 
(National Audit Office, 2007).  Studies from several countries show that 80-95% of doctors see 
drug representatives regularly (Moynihan, 2003). Jones et al (2001b) showed some GPs have 
often used drug company information as their sole source of information on new drugs. 
Obtaining drug information from drug representatives requires minimal effort, as these 
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representatives come into general practices with information packaged in ‘bite-size’ pieces, 
which is marketed well and often accompanied by a free lunch. Although this information 
appears to be supported by the evidence it is full of emotional appeals and misconceptions, so 
general practitioners need to be constantly vigilant to be able to separate the wheat from the 
chaff (Shaughnessy et al., 1994).  
Concerns have been raised about pharmaceutical drug representatives.  Drug representatives 
have been found to make claims about medication which is not supported by the approved 
product information and GPs were found to be unable to detect inaccurate statements (Ziegler 
et al., 1995). Drug representatives are associated with inappropriate prescribing (Berings et al., 
1994) and with increases in the cost of prescribing (Caudill et al., 1996, Watkins et al., 2003).  
Gifts from drugs representatives, such as pens and other promotion material were found to be 
desirable (Thomson et al., 1994) and GPs who accept samples are more likely to be early 
prescribers (Wazana, 2000).  
Pharmaceutical representatives are a well used source of information on new medications. The 
increase in prescribing of new drugs seems to be greater than can be accounted for by an 
increase in patients with specific conditions for these drugs (McGavock et al., 1993).  
Therefore have been found to influence prescribing (McGettigan et al., 2001, Prosser et al., 
2003).  
2.6.3 Patient 
As mentioned in section 2.2.1.4 the patients views and opinions are important to the prescribing 
decision, and the GP should respect the patient’s wishes (Barber, 1995). Patients have their own 
views and opinions; these will be shaped by their age, social factors, lifestyle factors and 
personal circumstances. It is now widely recognised that a prescribing decision should be 
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‘shared’ and made between the clinician and patient (Charles et al., 1997, Murray et al., 2006).  
Shared decision-making requires open information sharing on both sides (Snadden, 2007) and 
prescribing decisions are about integrating EBM with patient preferences (Barratt, 2008).  
Stevenson et al (2000a) study showed the majority of consultations ended in a prescription 
(66%)  and although communication about medicines took place, shared decision-making 
rarely took place. 
Patient pressure has been found to influence GPs prescribing (Virji et al., 1991) but also there 
can be misunderstandings between GPs and patients (Britten et al., 2000). In Britten et al.’s 
study all misunderstandings were associated with lack of patients’ participation in the 
consultation in terms of voicing their expectations and preferences or voicing of responses to 
doctors’ decisions and actions. Patient demand for prescriptions was over estimated and 
perpetuated by GPs wishing to maintain the doctor patient relationship (Stevenson et al., 
2000b). Patient pressure can be for or against taking medication and not always clearly 
expressed so doctors need to enquire about patient’s views when they are considering writing a 
prescription (Britten et al., 2004). A GP’s perception of the patient’s hopes for a prescription 
was found to be the strongest influence on whether a prescription was written or not (Britten 
and Ukoumunne, 1997, Bradley, 1992a).  The implications are that GPs need to explore patient 
views and preferences when taking medicines.  
Patients’ expectations and anxiety of their presenting problem influences the GPs’ prescribing 
behaviour (Webb and Lloyd, 1994). GPs find it difficult to say no the patient when a decision is 
based on rationing, such as prescribing a generic or from the practice formulary, as this is in 
conflict with other important objectives of a GP (Carlsen and Norheim, 2005). There is a 
balance here between clinical, technical knowledge and good interpersonal skills (Howie et al., 
2004), which requires a good relationship between the GP and the patient.  An important part of 
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patient involvement is a good relationship between the GP and the patient, often reaching an 
appropriate decision is not easy due to the large number of factors to take account of. The 
balance between patient-centred and evidence-based care may be difficult to achieve (Stewart 
et al., 2003) and it is impossible to predict which patients will respond in an average or extreme 
way to a medication, and matching values and preferences to the evidence is a complex task 
(Snadden, 2007). 
2.7 So why are quality prescribing decisions not always made?  
This chapter has described the number and range of influences on GP prescribing and 
illustrated prescribing decision-making is a complex process. Prescribing decisions take 
account of social, psychological, physiological, political, economic, pharmacological and 
patient specific factors.   The prescriber is “struggling to balance several disparate 
considerations and work out what to do for the best. There is a rationale; it is just not purely 
pharmacological” (Bradley, 1992a; 296). When it comes to changing professional practice 
there appears to be ‘no magic bullets’ (Oxman et al., 1995) and multiple factors are involved in 
GPs decisions to change their prescribing habits (Armstrong et al., 1996).  It is widely 
recognised multi-faceted interventions are more likely to improve quality prescribing (Bertoni 
et al., 2009, Prosser et al., 2003), yet we still know little about why.   
Many studies have looked at aspects of prescribing (Harris and Dajda, 1996, Cantrill, 2000, 
Britten and Ukoumunne, 1997, Britten et al., 2004, Jacoby et al., 2003) or specific drug groups 
(Jones et al., 2001b, Hyde et al., 2005, Evans et al., 1995) or within a specific disease 
(Greenfield et al., 2005, Dowrick et al., 2000, Dowell et al., 2001, Cranney and Walley, 1996, 
Kedward and Dakin, 2003, Kendrick et al., 2005), yet little is understood about why 
practitioners behave the way they do (Checkland, 2007) and ‘what influences their prescribing 
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behaviour’. No study to-date has holistically looked at all influences on prescribing in primary 
care using ethnographic methods. 
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C h a p t e r  3  
METHODS CHAPTER 
This chapter will explain the aims and objectives of the study, the underpinning methodology 
and the methods adopted.  Through discussing the methods adopted the research will reflect on 
decisions made in the field. 
3.1 Research Aim 
The overall aim of the study was to explore what influences prescribing decisions in general 
practice. 
3.1.1 Principle research questions 
How are prescribing decisions made in primary care? What are the influences on these 
prescribing decisions and how do they exert their effect? 
3.1.2 Objectives 
- Investigate how prescribing decisions are made by general practitioners; 
- Explore the main influences on prescribing in general practice; 
- Investigate the influences that general practitioners recognise and do not recognise 
when making prescribing decisions and their perceptions of these; 
- Describe Primary Care Pharmacists initiatives, exemplified by the programme 
operating in Tayside Health Board.  
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3.2 Choice of Methodology 
As this investigation is attempting to describe and understand prescribing decisions, a 
qualitative study, utilising an ethnographic methodology was deemed the most appropriate 
design, as the researcher is interested in ‘how’ and ‘why’ prescribing decisions are made in 
primary care not ‘how many’ or ‘how accurate’.  
3.2.1 Why qualitative research? 
Qualitative research aims to gain a rich, in-depth understanding of human behaviour.  By 
exploring the understandings and experiences of participants, and discovering how their social 
process, relationships, institutions work and the meanings these generate. Qualitative research 
seeks depth, context and richness, and usually explores small numbers to achieve this (Mason, 
2002; 1).  
Qualitative research is difficult to define as it has evolved from numerous disciplines and 
schools of thought (for example, interpretivist sociology, phenomenology and symbolic 
interactionism; anthropology; human geography; and education). Each of these schools of 
thought or disciplines has different ideas about what is important in the world, how it can be 
investigated and how we can illustrate this through empirical research. Qualitative research is 
therefore is not a unified set of techniques or philosophies (Mason, 2002; 2), but a wide range 
of methodologies and research methods. The distinctions between these different theoretical 
perspectives are not clear cut, which led (Denzin and Lincoln, 1994) to describe qualitative 
research as ‘defined primarily by a series of tensions, contradictions and hesitations’. However, 
although qualitative research is not prescriptive, it does have some core characteristics:   
1. It is grounded in interpretivism, a philosophical position concerned with how the social 
world is interpreted, experienced, understood, or produced.    
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2. It is based on methods which are iterative, flexible and sensitive to the context rather 
than being standardised and contextually removed. 
3. Qualitative methods are based on analysis and interpretation which develops 
understanding of complexity, detail and context; this emerges from the data rather than 
a predetermined hypothesis being tested (Mason, 2002, Pope et al., 2000, Snape and 
Spencer, 2003). 
The most common qualitative methods are participant and non-participant observation, in-
depth interviewing, focus groups and the analysis of documentation, all which focus on speech 
and text rather than numbers.  Silverman (1993) is critical of trying to identify core features of 
qualitative research, seeing it as not acknowledging the range of research strategies qualitative 
research can adopt.  However, qualitative research is a research strategy which needs to be 
described to understand its nature (Bryman, 2004).  Description is important in qualitative 
research as it gives context to the research to aid understanding.  The researcher needs to 
articulate the methodologies and methods available and why certain choices were made for the 
specific project.  Thus, it is through careful consideration, planning, through methods of data 
collection and analysis, and an explicit articulation of why certain decisions were made that 
qualitative research derives its rigour (Pope et al., 2000).  
3.2.2 Theoretical and Philosophical Framework 
How qualitative research is carried out depends on a researcher’s ontology (the nature of the 
social world and what can be known about it) and epistemology (their view of the nature of 
knowledge and how it can be acquired), along with their research aim, audience and funders 
(Snape and Spencer, 2003).   
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Ontology is concerned with what can be known about the world, what is the nature and essence 
of the social world (Mason, 2002; 14). “Within social research, key ontological questions 
concern: whether or not social reality exists independently of human conceptions and 
interpretations; whether there is a common, shared, social reality or just multiple context-
specific realities; and whether or not social behaviour is governed by ‘laws’ that can be seen as 
immutable or generalisable” (Snape and Spencer, 2003; 11).  There are three broad 
philosophical positions, realism, materialism and idealism, however, these have been 
continually debated and have established new terms which are less severe.  What is important is 
that researchers cannot pick and chose bits of one and another; they have to engage and allow 
these philosophies to help guide decision-making (Mason, 2002; 15).  
Epistemology is concerned with knowledge and the basis of knowledge. The main 
epistemological stances in social research are positivism and interpretivism. Positivism views 
the social world as governed by law-like regularities that can be investigated by objective, 
value-free observations (Snape and Spencer, 2003). The opposing view is interpretivism, which 
believes people construct and interpret their social world; they apply meaning to situations and 
are not governed by law like regularities. “Society is not presented as a fixed and unchanging 
entity, ‘out there’ somewhere external to the person, but is a shifting, changing entity that is 
constructed or reconstructed by the people themselves” (Brewer, 2000; 34).  Qualitative 
research is grounded in interpretivism, examining ‘how’ people interpret their social world and 
the meanings they attach to phenomena.  As the social world is not independent, the researched 
and the social world can be affected by their relationship to the researcher, and thus the 
researcher cannot produce an independent and objective account.    
A researcher’s epistemological and ontological perspectives make up their theoretical and 
philosophical framework.  “We should know how the social world is constituted, or what we 
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think it is (ontology) , shapes how we think we can know about it, but conversely how we look 
(the epistemology and methods we use) shapes what we can see” (Mason, 2002; 59). These 
assumptions influence the choice of methodology chosen by a researcher, which in turn 
provides legitimacy to the methods applied and the claims to knowledge generated. 
Figure 1: Diagram of theoretical framework: 
 
 
The researcher adopted a constructivist ontology and epistemology.  By adopting this position 
the researcher accepts knowledge is socially and contextually constructed (Lincoln and Guba, 
1985). “There exist multiple, socially constructed realities ungoverned by laws, natural or 
otherwise...these constructions are devised by individuals as they attempt to make sense of their 
experiences...constructions can be and usually are shared...this does not make them more real 
but simply more commonly assented to” (Guba and Lincoln, 1989; 86)(original emphasis). The 
central tenet of constructivism is what we understand to be objective knowledge is irreducibly 
the result of perspective (Schwandt, 1997).   
Ontology 
Epistemology 
Methodology 
Methods 
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3.2.2.1 Why an ethnographic methodology? 
This doctoral study aimed at being a piece of applied research to influence policy and practice.  
Applied research does not tend to apply as much concern to theoretical and philosophical 
assumptions and perspectives, as emphasis is placed on the kinds of data that can be generated 
from particular research methods (e.g. interviews and focus groups) rather than on particular 
epistemological positions.  However, researchers need to be aware of these perspectives and 
how they can aid decision-making and help the researcher to be systematic and rigorous.   
The researcher wanted to explore what influences prescribing from the perspective of the 
prescribers and not by a theory testing means. The ethnographic methodology is inductive, so 
the researcher should have an open mind and few preconceptions, to allow theory to emerge 
from the data.  However, the researcher does need to know where to start and how to design the 
study, so does have some preconceived ideas and preferences (these are discussed in section 
3.5.2.1).  
3.2.3 What is ethnography? 
Ethnography is both a methodology and a method.  
Ethnography is a methodology which allows the study of people and cultures in an in-depth 
manner, from their own perspective.  It is about understanding the knowledge and experience 
of a group or community in context, representing and presenting their views in an objective and 
reflective manner to the outside world. 
Ethnography is a very flexible methodology involving a range of qualitative and quantitative 
methods. However, the term is often used synonymously with qualitative research which does 
not help to establish a definition and thus has a tendency to ignore its mixed method strengths.  
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There is no defined set of methods to use; the researcher uses whatever methods suit the 
research question, however, these are always methods which facilitate studying people in 
naturally occurring situations where the researcher participates. Ethnography does have some 
core features: it uses several methods; has an iterative-inductive design (the research design 
evolves with the study and is not predetermined); involves observing and/or participating in 
people’s lives or their work environment for an extended period of time, watching what 
happens, listening to what is said and asking questions; reflecting on your presence as a 
researcher on these accounts and also on your own written work. The result is an in-depth 
account, which has not been generalised and maintains the richness of knowledge and 
experience of the observed (O'Reilly, 2005).  
3.2.4 Why use ethnography for a study interested in prescribing? 
Prescribing decisions are complex; we don’t really know how prescriptions happen due to the 
huge number of factors at play (see literature review for full argument)  (Armstrong and Ogden, 
2006, Greenfield et al., 2005, Armstrong et al., 1996, Bradley, 1991).  Prescribing decisions 
consider social, medical and logistical factors, to name a few (Bradley, 1992a).  Essentially 
there are two people involved, the patient and the prescriber and they have their own views and 
opinions.  However, this insight is not new; the prescribing of medicines consumes a large part 
of the NHS budget and has been subject to extensive research, but this has predominantly been 
quantitative.   Quantitative research investigates the social world in a way which emulates the 
natural sciences, by emphasising hypothesis testing, causal explanations, generalisation and 
prediction (Snape and Spencer, 2003).  It generally uses statistical techniques to quantify the 
data. This is not to say that quantitative methods are unsuitable, they have their place but it is 
still not clear ‘how’ prescribing decisions are made. Thus studying treatment decisions in 
context will allow the researcher to appreciate the complexity of the decision-making process. 
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Primary care is multidisciplinary profession with prescribing decisions traditionally being made 
by GPs.  Recent legislation has created nurse, pharmacist and allied health professional 
prescribers (The Scottish Government, 2010a, The Scottish Government, 2010b, The Scottish 
Government, 2007). The medical literature has focused on the importance of shared decision-
making with patients, ensuring their views are taken on board when considering the best course 
of treatment. Prescribing decisions are commonly multifactorial and patient specific (for 
example, take account of evidence based medicine, the GP, community nurse and allied health 
professional opinions and take account of minimising risk and cost), so can only truly be 
understood qualitatively. Qualitative methods, in particular, ethnography, allows us to focus on 
local context and what is culturally specific and important to the primary care team. However, 
it also facilitates the study of the differences within the professional and social groups, the 
different accounts given by each role and the play of power within the group.  “It regards the 
knowledge and practice of ‘experts’ as locally variable _ as are the knowledge and practice of 
lay people _ and it includes both within the boundaries of empirical enquiry” (Lambert and 
McKevitt, 2002). 
3.3 Method 
3.3.1 Ethical approval and sponsorship 
An application of ethical approval was granted by Tayside Research Ethics Committee on the 
10
th
 November 2006. The University of Dundee accepted the responsibilities of sponsorship. 
(Appendix 1) 
3.3.2 Broad overview of study 
This is an ethnographic study of primary care prescribing behaviour, conducted in three 
Tayside general practices.  All practices in Tayside were ranked using Audit Scotland quality 
prescribing indicators (Audit Scotland, 2003).  Two practices which achieved a high ranking 
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and one practice which achieved a low ranking score were recruited.  The primary research 
method was participant observation, which has been validated by interviews and practice 
documentation.  Over 390 hours of participant observation was conducted in GPs surgeries, in 
scheduled practice prescribing meetings, chronic disease management clinics, and shadowing 
the reception staff, practice manager, practice pharmacist, nursing staff and allied health 
professionals.  Informal interviews were ongoing during the period of observation to clarify any 
misunderstandings.  Formal interviews with key members of staff were conducted after the 
period of observation to triangulate the research findings.  Patients were invited by the practice 
to take part. The researcher was not interested in a specific group of patients or following these 
people up post-consultation so patients who had an appointment on day of observation were 
recruited and no identifiable data was recorded.  Analysis was on-going and was used to 
influence the researcher’s observations in the field.  For each practice observation took place 
over six months in the first two practices and for four months in the third practice observed and 
contact was maintained for approximately one year with all three practices. 
3.3.3 Sample 
This section is about how general practices were identified. 
General practices are unique; they serve different populations and have different characteristics 
and cultures. By only sampling one practice the results of this study would have limited 
generalisability and external validity. By looking at more than one practice comparisons could 
be made leading to richer data, greater validity and more robust findings (Miles and Huberman, 
1994). 
The complexity of prescribing within practices and the time available meant it was not possible 
to gain rich data from a large number of practices. So purposeful sampling was deemed to be 
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the most appropriate. The plan was to recruit four practices with different characteristics; all the 
characteristics were not prespecified at the beginning to allow for the project to progress 
iteratively with the analysis. Responsiveness to indicators of prescribing quality was felt to be 
the most pertinent characteristic and by sampling extreme cases would lead to rich data which 
would be useful to a wide range of general practices. Practices which performed well against 
the prescribing indicators were likely to demonstrate best practice which is what we wish to 
enable to happen and practices which did not perform as well were likely to provide valuable 
insights gained by contrasting practices and their processes. 
A purposeful sample of prescribing practices was identified through the PRISMS database 
(Prescribing Information System for Scotland).  PRISMS collects prescribing data for all 
practices in Scotland, on prescriptions dispensed rather than including prescriptions which are 
written but not dispensed.  National prescribing indicators for quality prescribing developed by 
(Audit Scotland, 2003) (appendix 2) have been used to rank all Tayside practices according to 
quality. These indicators were applied to one year (April 2005 – March 2006) of PRISMS data 
for all Tayside practices (72 at the time).  Each individual Audit Scotland indicator is very 
specific, for example ‘Single diuretics as a percentage of single and combined diuretics’ or 
‘Established antibiotics as a percentage of all oral antibiotics’.  As each of these indicators is 
very specific taking all the Audit Scotland indicators of prescribing quality gives the best 
available measure of good practice, taking one individual prescribing indicator by itself would 
not be a good measure of a practice’s prescribing.  It is commonly possible to justify why one 
practice is poor by one prescribing indicator, often there is a very good reason, however, it is 
more difficult to justify this across all the prescribing indicators (Dr Jan Jones, Prescribing 
Advisor, personal communication).  
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Prescribing indicators are used to foster quality improvement by establishing standards to 
monitor performance (Sheldon, 1998). The purpose is not to monitor performance for 
judgement but to highlight variation for further exploration as to ‘why’ they are different from 
the norm and for continuous learning and development. The aim is to promote quality and 
illustrate ‘good’ practice is desirable. 
Practices which performed well were initially selected as they are more likely to consent to take 
part, would be more likely to allow access to the practice documentation and demonstrate best 
practice which is what we wish to enable to happen.   With ethnographic research underutilized 
in health services research it was highly likely there would be misunderstanding of what is 
involved or suspicion the research is covert from practices which had performed poorly. 
However, after careful consideration it was felt that valuable insights could be gained by 
comparison of practices.  
3.3.4 Practice characteristics 
This section shows the different practices and their characteristics used in sampling decision-
making. 
The top ranking practice for prescribing quality was a single-handed practice with a list size of 
2000 patients, in a rural and affluent area.  As this not typical of Scottish general practices or 
their populations so recruiting this practice was deliberated upon, but as it was ‘the best’ it was 
felt there were important lessons there. 
The second practice identified was a practice which did not perform well against the 
prescribing indicators (the second from bottom).  It was an urban practice in a deprived area, 
with seven GPs, the majority of these working part-time. This practice has a list size of 
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approximately 8, 500 patients but due to their large student population this can vary by 
approximately 500 between term time and holidays. 
The initial intention had been to recruit four practices, but as the project progressed and 
observation in both practices had proven to take longer than planned for different reasons.  The 
lack of experience of the researcher and the lack of processes assumed to have taken place in 
the first practice recruited meant the observation took longer than planned, and in the second 
practice, with the majority of part-time staff and lack of systems and formal processes also 
proved problematic.  Thus it was only possible to recruit a third practice.  The characteristics 
sought for the third practice were more generalisable to the Scottish general practice 
population; their list size, number of partners and their population. Also the majority of the 
practice partners worked full-time which would facilitate the research. 
The third practice identified was within the top five for prescribing quality, it was a four 
partnered practice, with a list size of 5, 800 patient, in a small town and three of the four 
partners work full-time. 
As the third practice recruited was more typical of general practice characteristics, this practice 
is described first in the results section of this PhD.  Thus the order in which the observation 
took place was out of sync for writing and referring to the practices as one, two and three 
became complex so fictional names have been given to the practices to aid reading of this 
study. 
3.3.5 Sampling within cases 
In ethnography the researcher desires to observe every activity that is taking place and be a fly-
on-the-wall, particularly with non-participant observation. Participant observation demands that 
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the researcher becomes not just a fly-on-the-wall but an active participant in that social world. 
Thus the ethnographer’s understanding of that context can also be developed through becoming 
part of that social world alongside ‘being there’.  However, this is often not possible, 
particularly in professional working environments such as general practices so the researcher 
has to decide what activities they are going to sample.  Here the researcher has tried to show the 
sampling decisions which had to be made on a day-to-day basis and the rationale for these 
decisions. 
In each general practice there are a number of activities which are directly prescribing related 
such as consultations and clinics with patients and visits from drug company representatives. 
Prescribing by different members of staff; GPs, practice nurses, community nurses and practice 
pharmacists in varying situations. By only observing activities where prescribing could be 
taking place would mean the researcher could miss valuable information which is prescribing 
related.  Reception and the coffee room were observed intermittently every day and the practice 
manager was shadowed for a day in each practice. Participant observation was carried out at 
different times of the day, different days, trying as much as possible over a few months to try 
and experience as much as possible. 
Even on days when what was observed had been arranged in advance, circumstances changed 
as each day progressed. Systematic sampling within cases was not possible and numerous 
decisions had to be made on the spot. Decisions were made on a day to day basis, who to 
observe, what to say, what to ask, what to write down. In the early days of observation in each 
practice the less invasive approach was selected but as rapport was built and the researcher’s 
understanding grew it became easier to ask, or to be expected, to observe the richer or more 
subjective data.  In the rural practices they seemed to see purpose in visiting the practice for a 
whole day so less negotiation was required for observing informal interactions. However, as the 
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urban practice was so central in location the staff seemed to think that I would have something 
more important to do and did not present as many opportunities, therefore continuous 
negotiation was required. 
3.4 Recruitment and Informed Consent 
Recruitment is covered in four sections; recruitment of the practices and then of the patients 
and of informed consent, staff and patients. 
3.4.1 Practice recruitment 
Recruitment of practices had the potential to be problematic; as ethnography is under utilised in 
primary care it was highly likely that the research intention could be misinterpreted and 
perceived as a quality assurance process. Fortunately, all practices had a relationship with the 
researcher’s department. 
3.4.1.1 Rosnish 
‘Rosnish’ was the first practice recruited and this was straight forward.  This practice has an 
established relationship with the Tayside Centre for General Practice and the GP is a personal 
friend of one of the researcher’s supervisors (FS).  Thus FS contacted the GP by telephone to 
inform him of the study, why his practice had been selected and to ask if he would be interested 
in taking part. Subsequently, the researcher and supervisor (JD) visited the practice and had an 
informal meeting explaining what was involved.  As the GP was happy to take part, 
information sheets and consent forms were left for the other members of staff. Informed 
consent was received from all staff before the research began. 
3.4.1.2 ‘Haun’ 
Approaching a practice which had not performed well against the prescribing quality measures 
had to be done with caution.  The practice which had the lowest ranking had a different 
  68  
organisational structure from the norm (running personal lists) and with the second lowest 
practice having a more standard organisational structure and strong links with the Tayside 
Centre for General Practice (a GP at the practice is also a teaching fellow at the department), 
this practice was approached first through the GP teaching fellow.  This GP was aware of their 
practice’s poorer performance and thought as a result the practice would be interested to 
hopefully enable them to improve their prescribing.  As this is an academic GP the risk of 
misunderstanding what is involved in an ethnographic study was reduced.  The GP teaching 
fellow established that most of the GPs agreed in principle, so the researcher went and met with 
the practice manager.  She was very cautious and found the lack of a specific timeframe and the 
flexible nature difficult to grasp.  The researcher spent time trying to explain the project and left 
information sheets and consent forms and with the practice manager. After a couple of weeks 
the researcher met with the practice pharmacist and two of the GPs at the practice, where she 
did a small informal presentation and answered any questions. All members of staff agreed to 
take part and informed consent was received before any participant observation took place. 
3.4.1.3 ‘Rubain’ 
Recruitment of the third practice was opportunistic. This practice also had strong links with the 
Tayside Centre for General Practice. JD was at the practice for a meeting, where he informed 
them off the study, why they had been selected and asked them if they would be interested in 
taking part.  Provisionally, they were agreeable.  However, they were looking for more 
information about what was involved. The researcher went out to the practice and gave an 
informal presentation to the partners and the practice pharmacist. The practice manager 
contacted the researcher a week later stating that everyone was happy to take part and with a 
time table of when to visit the practice. The practice manger collected informed consent from 
all members of staff before the researcher’s first visit. 
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The Tayside Centre for General Practice’s strong links with the practices was fundamental in 
recruitment.  These practices were open to listening to the research proposal and what was 
involved, which might not have been the case in other practices.  The research project was 
designed to have minimum impact on the day-to-day running of the practice and as the 
researcher was the data collection tool there were not additional tasks for the practice staff to do 
(apart from handout patient information sheets and consent forms).  
3.4.1.4 Informed consent 
Informed consent was collected from all practice staff before the observational period at each 
practice began. 
3.4.2 Patient recruitment 
Consultations with patients show prescribing decisions made in context.  By observing these 
the researcher was able to gain a handle on the aspects of the decision-making process such as 
the patient’s perspective and the doctor-patient relationship. The process of recruiting patients 
is described below. 
Recruitment of patients in all practices took a similar process: 
 - Patients were invited by the practices to take part.  Due to the fact that practices are strongly 
encouraged to offer a patient an appointment within 48 hours meant it was virtually impossible 
to post out an information sheet and consent form in advance.  All patients are offered an 
appointment within 48 hours now as part of the nGMS contract (Health and Confederation, 
2003). 
 - Receptionists invited the patients to take part when they reported to the reception desk. The 
receptionists gave the patients a brief description of the project and an information sheet and 
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consent form. All receptionists were all briefed about the project by the researcher and given 
the opportunity to ask any questions.    
 - In Rubain and Rosnish posters were displayed in the surgery informing patients of the study. 
In Rosnish copies of this poster were also displayed in the village community pharmacy and 
post office. (Appendix 3).  
 - The health care professionals (GPs, practice nurses, community nurses or practice 
pharmacists) checked with the patient that they knew they were taking part in a research study 
and confirmed the researcher was observing them and not the patient.  Consent forms were 
collected from the patient, when they entered the consulting room.   
 - After the consultation the patient was offered the opportunity to withdraw consent at the end 
of the consultation but no one took this up. 
The majority of patients who were invited to take part consented and did not withdraw this 
consent.  In the Haun practice, one GP tended to see more patients with psychological problems 
and a large number of these patients did not consent.  The researcher sat quietly at the back of 
the consulting rooms and only spoke if spoken too.  No notes were written in front of the 
patients. 
3.5 Empirical Field Research and Reflections 
 An important part of any ethnography is to be reflective so the researcher can be aware of their 
impact on the research setting and findings.  Researchers are central to the project and thus 
shape the data collection and interpretation. The research is a product of the relationship 
between the researcher and their participants so a different researcher could unearth a different 
story (Finlay, 2003). To enable the researcher to reflect on her influence which is difficult to do 
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in the third person the remainder of this chapter will be written in the first person, in keeping 
with an ethnographic methodology. 
3.5.1 Access 
In this study recruitment and access to each practice were separate issues.  Accessing the data 
the researcher was interested in took time; this was a period of relationship building and 
gaining trust and respect.  Each practice was different and each experience is described below. 
3.5.1.1 ‘Rosnish’ 
Recruitment of the first practice was relatively easy and went smoothly, particularly as it was 
single-handed but access to the information I sought was not so easy.  It was an unnerving 
experience for me, the GP and his practice staff.  This was the first time I had undertaken any 
observational field work so I was unsure, nervous and learning as I progressed. Initial visits 
were directed by the GP, where he had thought it would be good to review the practice 
documentation and to get a handle on the practice systems.  However, this led to me asking too 
many sensitive questions about finance and quality improvement which was far too sensitive 
too quickly and helped breed some suspicions early on.  As soon as the sensitivities became 
apparent reviewing of the documentation was stopped and observation of reception 
commenced.  In the first few weeks everything had to be negotiated with the GP, who acted as 
gatekeeper to his practice.  
As all members of staff at the surgery were aware of the purpose of the research, the uneasiness 
and wariness by the GP is it is natural.  Scott (1985) describes the feelings in this initial period 
very well, “You can both feel and appear very strange, the early stages especially are filled with 
a mixture of elation and, depression, missteps and drudgery that any anthropologist will 
recognise.”  In the early stages I felt like I was threatening the GPs control. Although a research 
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orientated GP who knew what the term ethnography meant, he had not really thought or 
understood what it would be like in his practice.  Coming from a medical background, from the 
positivistic paradigm the open, incidental and flexible nature of ethnography seemed foreign to 
them.  Negotiating access to areas which were not directly prescribing related was problematic, 
it was hard for all the practice staff to understand why I would want to observe them carrying 
out these tasks.  To negotiate access I had to demonstrate I knew enough about the subject area 
to justify why I would want access and to generate discussion but not to show too much 
knowledge to make it seem pointless.  These discussions were crucial in the relationship 
building stage of the research.  It is through these discussions I learned the boundaries of what 
was acceptable and unacceptable and learned more about their personalities. After a few weeks 
of careful negotiation and relationship building all the practice staff became used to my 
presence and constant inquisitive nature. 
After my initial period of unease at the practice I was treated more as a member of the team, 
although I did inform the GP of what observation I was undertaking.  The practice staff were 
used to me being around and I was much more comfortable in what I was doing.  I was 
accepted and trusted, had gained access to their thoughts, they were no longer giving me the 
politically correct answer and were now openly discussing issues in front of me, eventually 
asking my opinion. I was given the freedom to come and go without being asked what I was 
doing, the conversations were more natural, with personal information exchanged. The practice 
openly discussed sensitive issues in front of me. I felt I had become more of a participant than 
observer. 
3.5.1.2 ‘Haun’ 
When I started my field work in the second practice I was much more confident with myself; I 
was familiar of what I was there to do and how to go about this. I knew how to dress and act, 
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but I had also gained a lot of understanding about how general practices operate, the jargon, 
acronyms, and many of the pressures placed on each member of staff.  I was also much more 
acquainted with the drugs being prescribed and what they were for. From my experiences from 
Rosnish I knew observing reception was a good place to start.   
Building relationships takes time, but by spending time in reception I was introduced to 
everyone and people got used to me being around. I did not have to report to anyone about 
what I doing, but I had to arrange to observe someone every day before entering the building, 
as the practice manager frequently asked me who I was observing today. The negotiation of 
access meant I could not spend all day everyday at the practice.  As in Rosnish, it was often 
difficult for them to understand why I would want to be watching the mundane, particularly 
when it was not specific to prescribing. My visits to the practice were planned so that I did 
cover each day of the week and at different time periods. Despite these efforts, I did not achieve 
the same level of intimacy as I had in Rosnish due to the practice characteristics, such as the 
majority of staff being part-time, the extensive use of IT for communication, the laid back 
culture and the fact that prescribers did not linger in the coffee room.  As most of the staff 
worked part-time and behind closed doors I could go for long-periods of time without meeting 
some members of staff.  I had acceptance but not as much proximity and rapport as I desired. 
My relationship with each member of staff was not fluid and built up over regular contact. I 
would build rapport when observing one GP but then could end up going long periods of time 
without seeing them, feeling I lost what rapport had been built.  This led me to feel like I was 
receiving the ‘politically correct’ answer to my questions. 
As practice formularies are established through collective decision-making I had assumed that 
the GP’s prescribing behaviour would be socially constructed through practice meetings.  But 
in this practice, one GP meets with the practice pharmacist and their decisions and issues are 
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circulated by email, thus I never saw all GPs at a meeting together.  This is not to say it does 
not happen.  I was aware of more pressing business issues dominating the partners meetings, 
(which meant I could not attend these). Prescribing issues could have been raised at these 
meetings. 
My gatekeeper and informant was the practice pharmacist; she was not a formal gatekeeper in 
the traditional sense, it was more of an informal role. She had been very supportive of my 
research at the practice before they agreed to take part and I was reliant on her goodwill for 
much of my access to data and to the practice staff and prescribing documents.  We built a 
good relationship where I felt there was trust, openness, rapport where she kept me up to date 
with the developments in the practice, thus, I had full access with the practice pharmacist.   
Building a relationship with the practice manager was also very important in gaining access to 
the practice and being free to come and go as I desired and not driven by the practice. Due to 
the nature of her job she was interested in what I was doing, we developed a relationship where 
she trusted me enough to freely come and go but not enough to be completely honest in sharing 
her views and opinions.  The GPs eventually got used to me being around but due to the 
organisational issues maintaining a relationship was impossible, thus I felt I was not around 
them enough to observe their natural behaviour and not to receive the ‘politically correct’ 
answer. 
My time at the practice came to a natural end; I was not observing anything new in the areas I 
had access too, the staff were asking how much longer I would be there and I felt much more 
time and effort was required to gain access to the ‘hidden’ data. During my time at this practice 
they were under financial pressure and as a result had private meetings among the partners.  
Only one partner made me aware they were having ‘issues’ and gave a brief explanation.  This 
  75  
had explained all the closed door meetings and whispering but left me unsure if there was data I 
missing.  My greatest concern was that important prescribing issues could have been discussed 
at these meetings whilst all partners were present, as it was an opportune moment. As most 
staff seemed to feel uncomfortable mentioning these meetings to the ‘outsider’, it felt 
inappropriate to ask if prescribing issues were discussed. I was constrained by time and 
resources and had to accept I was more of an observer than participant. However, by 
maintaining contact with the practice pharmacist I was invited back for significant events. 
3.5.1.3 ‘Rubain’ 
On arrival, I had experience of observing practices for over a year thus I was more self-
confident.  I was more knowledgeable of practice systems and cultures and as a result how to 
behave and dress, and of terminology and acronyms.  In turn, the participants were thus more at 
ease with a researcher who was familiar, confident and focused. 
My initial visits were controlled by the practice manager who put together a rota time tabling 
my first month.  She had assumed I would only need a month, which meant my initial time in 
the practice was not as uneasy as it did not involve as much negotiation as had been the case in 
the other two practices.  The rota had me at the practice for whole weeks which was excellent 
for getting to know people and building a rapport, particularly as most staff was full-time and 
all members of staff regularly use the coffee room throughout the day.  However, this rota also 
had a controlling nature, it reinforced the fact they thought I was there for a short period of time 
and did not really allow the freedom desired.  As mentioned in the section ‘sampling within 
cases’ it is important to be flexible and to adapt to issues as they arise.  By having a rota I did 
not negotiate access in the early stages like I had in the previous practices but later in my 
observational period and with the practice manager, not the GPs themselves. This did not allow 
the observation to flow and naturally progress. Gaining access to practice documentation was 
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not as easy as it had been in the other practices. Despite having consented to take part and allow 
the researcher access to the data the practice support staff were not keen to show the researcher 
data although the GPs seemed to have no issue with sharing this information. 
The observational period at this practice was abruptly stopped as the researcher had an accident 
and damaged her knee, which resulted in her not being able to walk or drive for 6 weeks. 
During this period of time I carried on with my analysis and felt I had sufficient data.  I did 
return to the practice to interview key members of staff, which also gave me opportunity to 
speak to the other members of staff and more appropriately exit my field work and time with 
the practice. 
3.5.2 Participant observation and the role of the researcher 
The distinguishing feature of ethnographic research is usually participant or non-participant 
observation. Being a non-clinician allowed the researcher to come with an open mind and no 
predetermined questions but with a focus on what she was interested in.  This allowed her to 
observe, review and reflect and explore, often in areas that were not expected. By spending an 
extended period of time in the practices, the researcher was seeking to better understand the 
meaning of events and relationships, and the incentives and pressures each practice and general 
practice was a whole are under.  As I came to understand more, I had fewer questions and was 
able to test my knowledge in conversations with participants.  Participants came to ask for my 
opinion.  
Participant and non-participant observation mean very different things for the researcher.  
Participant observation is about getting involved, being one of the group and being completely 
immersed. Non-participant observation is to be completely separated from the group’s 
activities, such as observing video-taped consultations.  However, there are varying degrees of 
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participation on a continuum; only certain types of research questions involve rigorously 
sticking to one or the other.  Researchers often decide on their level of participation but then the 
extent of their participation changes over time as the project progresses and relationships 
change (Patton, 2002). 
In all three practices I was never completely a participant, as I am not a health care practitioner.  
As an outsider I had an ‘etic’ perspective; I did not have the assumptions and biases a health 
care practitioner would have but had other assumptions which are discussed below. An 
outsider’s view allows for more accurate comparisons and more of an analytical perspective. 
GPs operate a strong professional network, there is a real empathy among fellow clinicians, and 
as one GP put it ‘one of us’.  The practice pharmacists are close to this network and are given a 
high degree of professional respect and trust but they are still outsiders.  As a result of this I 
could never go ‘native’ and have ‘real’ access and thus be a complete participant.  
3.5.2.1 Prior assumptions 
Prior to commencing my field work, primarily through reading the literature I had come to 
make some assumptions, which are listed and discussed below: 
- Practice policy prescribing decisions were made in practice meetings by all 
prescribers; 
- The practice pharmacist was fundamental in formulating and influencing prescribing 
decisions; 
- I had assumed more influence on the GPs prescribing behaviour from the pharmacists 
and community nurses and less from the practice nurses; 
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-  Gabbay and le May’s (2004) paper on mindlines had aided my research design and 
heightened my awareness to the importance of interaction.  As my research developed 
this paper helped me conceptualise my findings by identifying the differences in 
findings between what they found and I found.   
3.5.3 Data generation and relations with participants – my reflections 
Ethnography is by its nature is an interpersonal and shared experience between the researched 
and researcher.  This section attempts to represent the field relations through discussing data 
generation.  I have chosen the term ‘data generation’ rather than ‘data gathering’ to highlight 
my active role in the research process. 
Data was generated from a number of sources: participant observation, informal conversational 
interviewing, and formal interviewing and practice documentation. I was particularly interested 
in the behaviour of GPs and their interactions, between themselves and the practice staff, and 
their accounts of their behaviour.  As much prescribing decision-making is now by practice I 
was interested in their individual and collective understandings and interpretations.  Examining 
their perceptions of their actions and justification of this was fundamental to explaining their 
prescribing behaviour.   
By seeking to explore the behaviour, perceptions and understandings of participants in their 
work place setting it was important to describe the relations that were formed during this period 
and to what degree trust and respect were mutually established.  It is important to try and 
describe these working relationships and interactions in context. 
Relationships were formed over a period of time; where participant observation was conducted 
regularly in ‘Rosnish’ for 5 months, in the Haun regularly also for 5 months and conducted in 
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‘Rubain’ intensively for one month and then regularly for 1 month after that.  By regularly I 
mean at least once a week, and by intensively, all day, every day.  These interactions formed 
the majority of my data which was reliant on the relationships established over these time 
periods (over 390 hours of observation was conducted in the three practices).  The contact 
which was maintained with the practices after the period of observation was hugely dependent 
on the strength of these relationships. 
My role was to understand the behaviour, experiences and interactions of the practice staff in 
three different practices.   The quality of fieldwork and thus the data generated is dependent on 
my experiences of the field and the relationships established and maintained. In each practice I 
had a gatekeeper who was also my key informant and these were who I developed the strongest 
relationships with.  Personally, it was important for me to have a good rapport with all the 
participants in the project however; it was not possible to develop every rapport into a 
relationship with trust and respect.  As a result I was reliant on key individuals in each practice 
and could not afford to lose their friendships. 
Relationships are established through building rapport and trust, as it was my work that 
suffered, the onus was on me to work at building and maintaining these relationships.  Access 
to the practices and the foundations of these relationships are discussed in section 3.5.1.  
Finding a balance between engaging and participating and being analytic and objective was 
extremely difficult particularly in Rosnish.  In Rubain and the Haun I had come to know some 
of the norms and was more relaxed.  Yet, these practices are the gatekeepers of patients’ 
healthcare and had already given me access to their practice and patients, gaining access to 
their thoughts and understandings had to be earned.  
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Building relationships was reliant on the participants willing to do so and I found all the 
practice staff in the each practice receptive.  However, in the Haun I found maintaining the ties 
and rapport very difficult, due to the number of part-time staff and as most of the GPs did not 
linger in the coffee room.  My relationship with the practice pharmacist, my key informant was 
instrumental in fieldwork and data gathering.  Naturally, as the practice pharmacist with a role 
of influencing prescribing I would spend a considerable amount of my fieldwork time with her.  
However, we did genuinely get on, we shared similar interests, and over time our interactions 
developed into us sharing some personal stories and emotional feelings.   
Finding similar interests was important, it made the relationships less fragile as they were not 
just about the project and fieldwork, and these discussions helped build a relationship, 
establishing more than a rapport. I ensured on every visit to spend time chatting with the 
practice staff and finding common interests to maintain communication through the duration of 
the project.  After the period of intense observation, communication with the practices was 
maintained through email but, unfortunately, this was with only one member of the practice 
team.  On return visits to the practices it was obvious the relationships and rapport had been 
lost with everyone apart from my email contact.  In Rubain my contact was the practice 
manager, in Rosnish the lead GP, and the practice pharmacist in the Haun. 
My key informant and email contacts were my main source of access to the data. In Rosnish 
was the lead GP.  I was constantly aware he liked to know what was going on at all times and 
thus was aware when I was with other members of staff.  Gaining his trust and respect was 
fundamental to understanding why this practice had performed well against the prescribing 
indicators.  Finding common interests was important and being patient, not asking too much too 
early on and being sensitive to the situation.  On one occasion I went out with the whole 
practice for dinner to a local hotel where we met my friend and her family. As this is a rural 
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community they knew my friend’s family, which gave them an insight into my life which was 
not self-reported.  Until this point I had not been aware of how much trust and respect I had 
expected of them.  This night felt like a turning point in building a stronger relationship. 
In practices Rubain and Haun I found reciprocity difficult, but particularly in Rubain. I was 
asking a lot of questions about their practice, their behaviour, their beliefs and norms with little 
in return.  These practices knew I had been at other practices before so asked about what I had 
experienced and observed. They were interested in the other practices systems and processes.  I 
felt there was a real imbalance.  Ethically I was not at liberty to share any information but yet, I 
needed share some of my experiences and demonstrate some knowledge to gain access to their 
experiences and understandings.  I would share some information and tried to keep the 
practices anonymous.  
As these relationships developed I became more acutely aware of the dichotomies of 
ethnography: involvement versus detachment, stranger versus friend, distance versus intimacy. 
“The friendships we experience are part of the contradictions and ambiguities that denote the 
essence of fieldwork. Friendships can help to clarify the inherent tensions of the fieldwork 
experience and sharpen our abilities for critical reflection” (Coffey, 1999; 47).  My fieldwork 
and these relationships were on a commitment from both sides, albeit for different reasons. As a 
doctoral student researcher my commitment was due to an interest in the field and to 
completing my PhD.  For the practices which had performed well against the quality measures 
it was a commitment to evidence based medicine, altruism, sharing their knowledge and 
maintaining good relationships with the academic department.  For the Haun taking part was to 
maintain good relations with the department and improving the quality of their prescribing. 
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The reason for the relationships is the fieldwork, but this does not distract from the nature of 
these relationships (Coffey, 1999).  But there is contention between these friendships; I was 
researching looking for information and they had information they want to ‘hide’ or to present 
in a favourable light. Despite efforts to build a good rapport emphasis was always on 
observation rather than participation.  I could not completely immerse as I do not have the 
training to fully participate.  As a result the practices were unlikely to forget that they are being 
researched, I tried to disrupt the practice as little as possible, by being sensitive to the setting 
and the issues as they arose.  I allowed myself to be directed to help build rapport and try and 
reduce the fear of being ‘spied on’ and to try and get staff to act naturally.  I ensured I was 
dressed in a similar manner to the female staff not in uniform, which was usually the GPs and 
practice pharmacists. 
I managed to fit into each practice and found everyone open, receptive and approachable. 
However, I only really felt like I knew two people well enough to know if I was really getting a 
genuine reply.  Maintaining email contact and the occasional visit with these two people a year 
after fieldwork had finished was a real testament to the quality of the friendship and to their 
commitment to the project.  At the end of my time of fieldwork in Rosnish was a sad occasion 
for me and for the practice staff.  They had got used to me being around, with this being a small 
practice they enjoyed the extra social interaction and they genuinely did not want me to leave.  
3.5.4 Confidentiality 
Fieldnotes were stored securely on the University server and password protected.  No 
identifiable data was recorded about patients; the staff at all the practices was given a code, to 
try to make the data as anonymous as possible.  Particularly in Rosnish, being small and single-
handed it is not possible to make these fieldnotes anonymous. This was explained to practices 
and they were given the opportunity to make the researcher aware when they would not like 
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data recorded. All consent forms were stored in a secure cabinet in the Tayside Centre for 
General Practice, The University of Dundee. 
3.6 Supporting Data Collection and Management 
Participant observation was the main method of data collection, but should be supported with 
other methods (Brewer, 2000). This section will describe the supporting methods and how data 
generated was recorded and stored. 
3.6.1. Fieldnotes 
Fieldnotes were typed up as soon as possible after the observational period, usually that 
evening or the next day.  During the period of observation time constraints meant often there 
was not an opportunity to write detailed notes, just keywords and abbreviations only 
comprehensible to the researcher.  As by ethical approval the researcher did not write anything 
in her note book in front of the patients.  These notes were written once the patient had left the 
room and while the GP, nurse or pharmacist was typing their notes after the consultation.  This 
was when the researcher was able to ask questions to clarify her understanding.   
In the early days of the research the researcher wrote very detailed notes covering every detail 
in each consultation.  This proved to be a very time consuming and laborious process. As time 
progressed, the researcher realised she was writing too many clinical notes and not enough 
description about language, body language, relationships, patient views, to name a few.  This 
study was not an audit assessing the quality of their prescribing but how they prescribe, not 
what they prescribe. The researcher became more sensitive to the setting and to the concepts 
which were proving to be important and thus the study became more focused.  In Rosnish the 
researcher noticed that the GP’s knowledge and relationships with his patient were important to 
his prescribing decisions, so the researcher became more sensitive to continuity of care issues.  
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Eventually, the researcher was satisfied there was sufficient data to justify this claim and 
became more sensitive to other issues, in this case the relationship, trust and influence of other 
health care staff working in the building. 
Reviewing the literature as an ongoing process which allowed the researcher to consider other 
issues.  It is very easy when in the field to become focused on a narrow range of issues and only 
‘see’ these issues when observing.  Reviewing the literature allowed the researcher to become 
sensitised to a wider range of issues.  First supervisor, JD, was also instrumental in ensuring the 
researcher did not become too focused on one area. 
3.6.2 Interview Data 
Two different types of interview were conducted during the study period; opportunistic 
interviews and formal, scheduled interviews.  The formal interviews were conducted after the 
period of observation. 
3.6.2.1 Opportunistic interviewing 
Most of the interviewing was on-going during the participant observation, as questions arose in 
context.  This is often referred to as opportunistic interviewing (O'Reilly, 2005) or informal 
conversational interviewing (Patton, 2002).  However, the nature of the general practice setting 
meant the researcher felt many of the answers to her questions were not thought through due to 
time pressures.  Especially when observing consultations there was the next patient waiting 
outside or when in reception, a member of staff would be giving an answer but then a patient 
would appear at the desk so the answer was cut short.  Often the issue was returned to at an 
opportune moment but the observed often could not remember the specifics of the situation, or 
if in a group scenario it is harder to ask questions.  The researcher felt it was better to take 
people aside and ask them questions away from interruptions when a time and place was set 
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aside to really have time to get at what they mean.  As well as looking for depth the researcher 
was also using the arranged interviews as an opportunity to fill holes in the data discovered 
through analysis, to explore their thoughts, meanings and ideas and to validate the model 
developed. 
3.6.2.2 Formal interviews 
Nine semi-structured interviews were conducted with key members of staff in each practice 
after the period of observation.  These ‘key’ members of staff had a strong interest in 
prescribing or were influential in the practice. In Rubain, interviews were conducted with two 
GPs; in Rosnish, with the lead GP, the senior receptionist and the practice pharmacist; and in 
the Haun with three GPs (the full-time GPs and a part-time GP) and the practice pharmacist. 
All interviews were conducted in their general practices; they lasted approximately an hour and 
were audio-recorded and transcribed verbatim. The topic guide used in the interviews is 
provided in appendix 4. 
A few core questions were asked to each respondent and specific questions were asked relevant 
to each practice and their role within the practice to allow a deeper exploration and to 
triangulate existing findings.  Once the researcher was satisfied she had explored the topics in 
sufficient detail she showed the interviewees the prescribing model devised for each practice 
and asked for comments. As the researcher already had a rapport with the interviewees, they 
were at ease and the researcher felt she obtained a more genuine answer. The researcher was 
interpreting their responses during the interview but these were consistent with the findings 
from the observation so were used to gain a richer understanding. 
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3.6.3 Practice Documentation 
A number of practice documents were obtained during the period of observation.  These were 
mainly copies of policies, protocols, procedures and copies of evidence or CHP policy which 
had influenced their behaviour.  The information surrounding these was written up in the 
fieldnotes but copies of the documentation were filed and stored in a securely locked cabinet in 
the Tayside Centre for General Practice as they provided greater detail to the fieldnotes.   
3.6.4 Computer storage and software 
The fieldnotes were stored on a password protected laptop and backups were stored securely on 
a university server.  The fieldnotes were imported into a computer software package, Atlas.ti 
5.2 specifically designed for qualitative data storage and analysis. 
3.7 Analysis 
Initially a descriptive approach was adopted to gain an understanding of the practices, context 
and influences on prescribing. An interpretative approach was then adopted to help explain and 
understand the similarities and differences between the three practices. Finally, to gain a deeper 
interpretation and explanation of the data three sociological theoretical models were used.  This 
is a broad overview of the analysis in this thesis and the following section will give a much 
more detailed description of the analytic process. Initially the author describes how she came to 
her analysis approach. 
The ethnographic literature gave no clear direction or prescriptive rules as to analysing this 
messy and complex data.  As ethnography is so diverse “the analytical process varies slightly in 
the different types of ethnography” (Brewer, 2000; 107). The ethnographic literature did have 
some core recommendations which were followed; coding, organising into patterns, categories 
and concepts and looking for relationships between them (Brewer, 2000, O'Reilly, 2005). A 
  87  
number of texts had described ethnographic analysis to be similar to ‘analytic induction’ or 
‘grounded theory’ however, it was difficult to conduct grounded theory due to the nature of 
ethnographic data. Grounded theory requires counter cases to revise the hypothesis and return 
to the field (Brewer, 2000, Hammersley and Atkinson, 2007).  I struggled with Strauss and 
Corbin’s (1990) text on grounded theory; however I found their techniques of constant 
comparison, flip-flop and red flag useful.  After some time I discovered Charmaz’s (2006) text 
which suggests incident comparisons rather than line-by-line coding and relies on memo-
writing for interpretation which suited my data and means of working. This was a turning point 
in my analysis and I was comfortable in my modified method of grounded theory.  However, I 
felt I could not call my analysis ‘grounded theory’ as I was using their techniques to describe, 
explain and interpret rather than to generate a theory.  Due to time pressures it was clear I did 
not have time to revisit the field to test and saturate the emerging analysis. After a lot of reading 
and trial and error I came across ‘Interpretive Description’ (Thorne, 2008), which described an 
applied analytic method very much in line with what I had been doing, at last I had my label! 
3.7.1 What is interpretive description? 
Interpretive description is a qualitative methodology which seeks to generate empirical 
knowledge about complex phenomenon for depth and contextual understanding (Thorne, 
2008).  The philosophy behind ‘interpretive description’ is to use appropriate applied methods 
to answer meaningful questions.  Thorne (2008) advocates borrowing from the tenets of 
grounded theory, phenomenology and ethnography to answer applied research questions which 
do not always fit the methodological rules of sociology, psychology and anthropology. 
Description is useful for knowledge development and provides important contextual 
information but it does not answer the question ‘what does this mean?’  Interpretive description 
“seeks to discover associations, relationships and patterns within the phenomena which has 
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been described” (Thorne, 2008; 50) and searches for underlying meanings which might shed 
light on what is happening and develop a deeper understanding, in this case of prescribing 
decision-making.  Interpretative description is not formulaic and structured like grounded 
theory but creates a framework with which to follow; ‘pieces to patterns’, ‘patterns to 
relationships’ and ‘data analysis at play’. To ensure rigour and to avoid methodological 
eclecticism, this study is strongly orientated with ethnography and a detailed account of the 
analytic process is given below. 
This section will describe my analytic process in light of ‘interpretive description’.  
Analysis of the data started when the field work commenced.  The analytic process was not 
distinct from data collection and writing but is described as such for the purposes of this 
chapter.  Analysis was the process of managing, organising and interpreting the data in a 
comprehensive, systematic and rigorous manner (but in one which is not rigid).  This section 
will show how the large amount of complex data generated was organised into categories, 
patterns and relationships. Firstly, it is important to discuss the nature of this data. 
3.7.2 Nature of ethnographic data 
Ethnographic data by its nature is subjective, chaotic, and complex. The data gathered in this 
study came from a number of sources; fieldnotes, interview data, practice documents, memos, 
and the researcher’s reflective diary.   
Fieldnotes, memos and the researcher’s reflective diary are products of observation, which are 
selective.  As Miles and Huberman (1994; 56) describe “the researcher is constantly making 
choices about what to register and what to leave out.”  It is impossible to record everything that 
happens in the field so the researcher has to be selective and as a result the data will always be 
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incomplete or partial versions of the observation.  As well as what is being recorded, it is how 
the observations are being recorded that subjects them to further interpretation.  As mentioned 
above the detailed fieldnotes were typed from scribbles taken during the day.  The fieldnotes 
being typed by the researcher are inadvertently being interpreted.  The notes taken in the field 
are not structured; they are messy as life in a GP practice is not orderly and structured. The GPs 
were often doing more than one task, utilising data from more than one area, and being 
interrupted. The researcher typed these notes into a more structured and logical fieldnotes and 
in doing so was interpreting as well as organising the data. Coffey and Atkinson (1996; 9) 
claim “..there is no such thing as pure description, it takes a human observer to accomplish 
description”. 
As it is impossible for the researcher to record everything that happens in the field it is 
important that what is recorded and used as data has the same meaning as it had for the 
participants in the field.  The researcher must ensure the data retain its context and the 
complexity of meaning (Brewer, 2000).  However, as what has been observed has been 
interpreted through me, these are my accounts of what has happened, not the participants. 
3.7.3 Coding of data 
Coding of the data was an on-going, continuous task which ran simultaneously with data 
collection. Initially, the fieldnotes were imported into Atlas.ti and assigned codes. These codes 
were developed through reading and re-reading the field notes and asking ‘what is this about’.  
At this stage this was very open and exploring what was in the data, starting to structure it and 
organise it for data management. 
 As more data was collected and coded, the codes changed and more were added. The coding 
was an iterative process which progressed with the data collection. Through this iterative 
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process the researcher’s understanding of the setting, its language and processes were 
developing. Codes were a mixture of ‘in-vivo’ codes and codes developed by the researcher; 
‘in-vivo’ codes are recurring phrases used by the participants in the field. In ethnography the 
emphasis is on action, what people do and why so it is important to understand socially shared 
meanings and the esoteric knowledge, which is why a mixture of ‘in-vivo’ codes and codes 
derived by the researcher were used. The definitions of the researcher developed codes had 
evolved inductively and their definitions became clearer and tighter as collected data was 
included and excluded in analysis.  Commencing data collection and analysis in a new practice 
generated new codes which involved re-reading the fieldnotes to search for these new codes. 
The ‘constant comparison’ technique of grounded theory was useful in exploring the codes, 
generating new ideas and tightening definitions.  I found the line-by-line coding suggested in 
grounded theory unhelpful for analysing my fieldnotes.  These had already been interpreted by 
me and written in a coherent fashion, often I tried to include contextual information and 
interactions so was coding was about one incident.  This had taken me away from grounded 
theory until I discovered Charmaz’s (2006) text, which offers ‘incident’ coding as an option 
instead of ‘line-by-line’.  Charmaz (2006) recommends using the ‘constant comparison’ 
technique to compare incidents; this was particularly useful for making comparisons across the 
practices but also within and across codes (and then later on with categories and concepts). 
During the fieldwork and coding for practice three it became clear the language used had not 
changed and few new codes were developed, the codes which had been suitable for the other 
practices had also worked there.  As a result all the data was cleaned and checked for validity 
and consistency.  The researcher re-read the field notes and checked all the coding for 
consistency across the field notes for all three practices.  A sample of coding was selected by 
my supervisor (JD) and verified for meaning and consistency. 
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3.7.4 Category and concept generation 
Through analysis it became obvious certain codes belonged under a category, such as 
‘knowledge of the patient’ and ‘relationship with the patient’ belonging under the ‘in-vivo’ 
category of ‘continuity of care’ (which was so strong went on to become a concept).  A couple 
of codes stood out as categories in their own right, however, the majority of category 
development required interpretation and thought. ‘Memos’, which are analytic notes, were 
extremely useful in helping me analyse and interpret the data. I wrote memos as ideas emerged 
through reading the fieldnotes, through looking at each code and exploring what was going on 
and exploring the links between codes. In memos, I wrote ideas as they came into my head, 
they were useful as they were not structured and allowed free flowing thought.  Memos were 
useful for comparing ideas and data, and also for reflecting on ‘what was going on’ and 
generating new ideas and areas to explore. Strauss and Corbin’s (1990) techniques of flip flop 
and red flag were useful in memo writing when ideas did not just ‘pop’ into my head.   
As memos helped me develop categories and then concepts, I used Strauss and Corbin’s (1990) 
axial coding to specify the properties of a category or concept within a memo.  This technique 
was useful in clarify the definitions of each category and seeing links between them. Through 
this process it became clear some codes and eventually categories were redundant and did not 
add to the data.  Simultaneously with ‘axial coding’ I was writing memos, in some cases 
writing new memos and in other cases adding to existing memos.  It was through the ‘constant 
comparative’ method of comparing categories, and identifying similarities which lead to the 
generation of concepts. The concepts were not ‘new’ but were pre-existing notions and terms, 
such as organisation and communication. The analytic process was reiterated for concepts, 
where the properties were defined and memos were written to help explain and understand the 
concepts and relationships between them. I was writing up my thesis when I was exploring the 
relationships between concepts, which helped me gain a deeper understanding of the 
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relationships between the concepts.  This is discussed in section 3.7.6.  From concepts to 
theoretical models, however, it is important to first discuss how the interview data was used in 
the analysis process.  
3.7.5 The use of interview data 
Codes and categories were developed as the fieldwork was on-going.  At the end of the period 
of field work in each practice qualitative interviews were conducted with key members of staff 
(discussed in section 3.6.2.2).  Initially this data was analysed separately, however no new 
themes emerged. This data was used to help focus on the categories and to gain a deeper 
understanding of the interviewees interpretations of their actions and of the researcher’s 
findings to date.  The interviewees were not asked specific questions relating to the analysis.  
However once the ‘interview’ was finished the interviewees were shown the practice 
prescribing models and asked to comment. Also, I did have a heightened awareness of the 
findings to-date which could have influenced the line of questioning or explain why no new 
findings emerged from the analysis. The interviews from Rosnish were carried out and 
analysed before observation in the Haun and Rubain commenced. Due to a number of pressures 
and commitments the interviews with the Haun and Rubain were carried out after the 
observation period was finished in both practices.  
At this stage the analysis was still in categories with the researcher clear some categories were 
concepts. The interview data triangulated the observational data and provided a deeper 
interpretation of the data from the interviewee’s perspective.  
 3.7.6 From concepts to use of theoretical models 
During the writing and re-writing process I became acutely aware of the important elements of 
the data set and the key messages and findings I had to clearly articulate to the reader. Working 
  93  
in Atlas.ti, in my memos and scraps of paper and drawings, I thought I had synthesised my data 
into clear findings with comprehensive relationships and patterns linking them. However, when 
I came to write these up I realised some of my work was still a description and explanation 
under categories and concepts, and some of the relationships were not as articulate and firm as I 
had thought.  The writing process and thinking more about my data did help, but at the same 
time I turned to the literature and explored different theories and theoretical models to try and 
gain a deeper explanation of the data. I did not find one overall theory which provided an 
infrastructure for presenting the findings and had an appreciation of all concepts, contexts and 
the relationships between them, however I did find three theories which provided a deeper 
understanding of one or more concepts.   
Three theories proved to be invaluable in this process Sheaff et al.’s (2003) work on ‘soft 
governance’; Weick’s (2001) work on ‘organisational sense-making’ and Gabbay and le May’s 
(2004) work on mindlines.  Sheaff et al.’s (2003) work on ‘soft governance’ helped me to 
explain the CHP policies and mechanism which were exerting pressure upon the practices.  By 
exploring ‘soft governance’ I was able to see the data in a different light and understand how 
important the GP’s unique contractual status was to their engagement with CHP mechanisms 
and EBM. Through the analysis it became clear the practices were guided by their values and 
practice culture.  Weick’s (2001) work on organisational sense-making lead me to see values 
and culture were important parts of the practice’s identity.  Organisation and communication 
were also important concepts and Weick’s (2001) work allowed a deeper understanding of how 
practice identity is both influenced by and influences the practices organisation and 
communication strategies.   Through analysis it became clear prescribing decisions were made 
in two different contexts; macro and micro and Gabbay and le May’s (2004) work helped 
explain and structure the findings at the micro level.  
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3.7.7 Negative case 
The final and important step in analysis is to search for negative cases (Brewer, 2000). The 
Haun practice was the negative case in this study and considered throughout the whole research 
process.  
3.7.8 Presentation of analysis by practice 
3.7.8.1 Description and explanation 
Each practice is unique.  They have common characteristics of being a practice in Tayside, 
Scotland, being part of the same health board and government and thus subject to the same 
laws, controls and constraints. However have a great number of different characteristics; 
different settings, populations, staff, relationships, processes and systems which were described 
to help facilitate understanding for the reader.  Initially the researcher tried to write these as 
purely descriptive chapters with minimal researcher inference, but this was naive, I had been 
constantly interpreting the data.  Through describing and explaining each practice’s values and 
systems I had interpreted the data; themes, patterns and relationships had been explored to 
structure and organise what was going on. This explanation was basic analysis (at the coding 
level) to attempt to show the data in context rather than being subject to much more detailed 
interpretation. 
3.7.8.2 Comparison chapter 
This chapter presented the concepts and categories which emerged from the analysis and 
presented the findings.  Analysis at this level identified what data was important, grouped and 
sorted the data into concepts and considered the relationship between these concepts. Three 
theoretical models were applied to structure the argument and give a deeper understanding and 
move the analysis from descriptive to analytic.  
  95  
3.7.8.3 Discussion chapter 
This chapter presented the findings of the study, discussed the strengths and weaknesses of the 
study and the appropriateness of the methods adopted.  The findings of the study were 
discussed in relation to the wider literature and what is already known.  
3.8 The dominant narrative presented 
The descriptive chapters are written from the observation and informal interview data. This 
explanation was basic analysis (at the coding level) to attempt to show the data in context rather 
than being subject to much more detailed interpretation and was reporting the practice 
characteristics and organisational structure to aid the reader’s interpretation of the subsequent 
data presented.  
In the comparative chapter the data presented is from the observational data and from the 
formal practice interviews. The practice narratives were co-constructed between the researcher 
and the practice staff as the researcher developed understanding in the field and was able to 
check emerging analysis and interpretations and thus, misunderstandings.  As the analysis 
became more developed I was able to probe and ask questions which were more nuanced, thus 
much of the data was co-constructed between the researcher and participants, in particular my 
key informants. In the Haun, there was conflict between what I observed and in what some 
respondents said, in particular around the practice organisation and communication.  In these 
situations it was my narrative and perception which dominated, based on what was observed. 
The interviews provided an opportunity to present my analysis and discuss any conflicts.  
However, there were no disagreements.  In the interviews, I felt the respondents were honest in 
their responses due to the extent of in-depth observation and the opportunities to check 
emerging analysis and interpretation during the observational periods.  
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The discussion chapter situates the interpretation and analysis in the broader context with the 
wider literature. The theories which were used helped the researcher make sense of her data and 
analysis and pull the account together. At this point the narrative presented is the researcher’s 
own interpretation of the analysis and how these theories explain the data presented.  
3.9 Operational definition of prescribing 
There are blurred definitions of what constitutes prescribing (Weiss and Sutton, 2009) so it is 
important to be clear what is meant by a prescribing decision in the context of this PhD.  
Decisions involving medication where medication was initiated, changed, signed for another 
repeat term and decisions about the practice prescribing policy. In all three practices most of 
these decisions were made by GPs, practice pharmacists did make dose titrations but 
pharmacists and other supplementary prescribers were considered as an influence on 
prescribing rather than as a prescriber.  Primarily, as GPs were signing off many of these 
supplementary prescribing decisions and pharmacists were employed by the CHPs to influence 
practice prescribing. 
3.9 Conclusion 
This chapter has discussed the ethnographic methodology and methods adopted in this study.  
The researcher has described her endeavour with ethnographic analysis and her use of 
‘interpretive description’ as a label which facilitated confidence in her description, explanation 
and comparison of prescribing behaviour in three very different general practices. This study 
has placed within a constructivist framework which acknowledges it is impossible to have 
certainty about knowledge claims and accepts the researcher is part of the study to research it 
(Hammersley and Atkinson, 1995).  Thus the researcher has presented the findings with which 
she is reasonably confident.  In this chapter the researcher has reflexively discussed the 
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methods adopted and decisions made the field to allow the reader to decide whether the 
findings are transferable to their setting. 
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C h a p t e r  4  
‘RUBAIN’ ~ THE MARKET TOWN PRACTICE; A DESCRIPTION AND 
EXPLANTION 
This chapter will describe the practice characteristics and organisation to provide contextual 
background to the second section of this chapter, which will show the various influences on a 
prescriber and how they impact on the consultation.  External influences on the prescriber and 
practice are discussed in light of how they influence practice prescribing policy. Supporting 
evidence is provided via extracts from fieldnotes and from interviews transcripts.  These 
quotations are from fieldnotes unless otherwise stated.  
4.1 The Setting 
This section will describe the practice characteristics, their systems and organisation. 
4.1.1 The town 
This was a market town with a population of approximately 13,500 surrounded by agricultural 
farmland.  
4.1.2 Practice population and list size 
The practice list size was approximately 5800, where the practice population was a cross 
section of society and with no demographic group more prominent, fairly typical of the UK 
average (~5, 400 patients, ~ 3GPs) (Grant et al., 2009). 
4.1.3 The health centre 
This was a large old building with a number of consulting rooms off a long corridor.  Patients 
were called for their appointment via a tannoy system in the waiting room.   
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4.1.4 Opening times 
The surgery was open Monday to Friday, 8.30am – 6pm excluding Thursday when it closes 
from 12.45 -2pm (This is to test the fire alarm and allows for any office training or to catch up). 
Receptionists are in from 8am but they only take phone calls for home visits and emergencies, 
patients must phone back after 8.30am for any other issues. 
4.2 Staff 
4.2.1 Clinical Staff 
This practice had four full time GPs (3 male and one female), and at the time of observation 
had two retainer GPs.  The partners are mainly in their 40s and have been with the practice a 
number of years and are settled.  Two partners’ surgeries typically overran significantly.  
The part-time practice pharmacist, (2.5 days), has been with the practice for 11 years, since the 
Tayside practice pharmacist initiative started. He had previously worked as a hospital 
pharmacist and was experienced with medication and working with clinicians. 
4.2.2 Practice Nurses 
There are two full-time practice nurses who have been with the practice for a number of years. 
The surgery took on another practice nurse during the period of observation due to the heavy 
workload. 
4.2.3 Reception/Administrative Staff 
This practice has two managers one for administration and planning and another for IT and 
finance. Both are female and work part-time (33 hours). The practice manager for 
administration already had some NHS management experience and was brought into to manage 
reception, she moved from this role to become one of the job share practice managers.   The 
  100 
practice manager for finance and IT has been with the practice for 18 years and has worked up 
from a receptionist into this role. 
The reception team leader has been with the practice for 10 years and had progressed into this 
role from being a receptionist.  She was in charge of the day to day management of reception. 
Each receptionist was responsible for a clinical area, where they send out the appropriate letters 
for review and appointments. 
4.2.4 Locums 
Two GPs pay for a locum one afternoon a week.  A partner who worked part-time (1.5 days) 
left the practice and they have not replaced him, they have chosen to use locums instead.  
During the period of observation the practice was paying for five locum shifts a week.  These 
locums primarily do the on the day appointments.  This allowed the permanent GPs to see their 
regular patients without acute problems and maintain continuity of care. 
4.2.5 Practice pharmacist role  
The practice pharmacist primarily works on audits and optimising the doctors prescribing 
behaviour.  He also runs medication review clinics and an open door policy for GPs looking for 
advice about individual patients.  His main role was to filter evidence, guidelines and 
implement changes to prescribing. This is a role the practice pharmacist had chosen to carve for 
himself rather than one which has been dictated by the practice but was accepted and valued by 
the GPs.  The practice pharmacist role is deconstructed in section 4.8.1.  
4.2.6 Relationships 
This practice had a stable workforce, with most of the GPs having worked at the practice for 
over 10 years. The relationships were friendly and collaborative.  The practice engaged in 
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collaborative working and maintained good working relationships through being jovial and 
having digs at each other through jokes. 
4.2.7 Ethos & Atmosphere of practice 
The ethos of practice was one of being patient-centred, striving to be the best through a friendly 
and humorous manner.  They can be caring for different generations of a family, for individual 
patients and across their families and value this continuity of care.  The practice was part of the 
local community and they value this stature and worked to maintain this respect.   
The clinical staff all had a mindset which valued prescribing.  The practice valued both quality 
and cost effective prescribing. They were aware the NHS had limited resources and saw no 
value in unnecessarily expensive prescribing as this would prevent the funds being available for 
another patient.  They also valued consistency in prescribing within the practice and across the 
CHP.  They would challenge esoteric prescribing within the practice through humour to 
achieve consistency.  As the practice pharmacist compared the practice’s prescribing against 
other practices in the CHP they did not like to be outliers or not seen to be following CHP 
policy. The GPs appreciated they were accountable for their prescribing and saw value in the 
practice formulary.  
The GPs at the practice seemed to have a good working relationship, which was democratic 
and based on humour. There was no senior partner so were all equal partners.  They valued 
team working and collaborated closely through regular practice meetings. All the practice 
partners saw strength in collaborative decision-making.  Any issues seemed to be raised 
through humour and addressed in a friendly and supportive manner.    
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4.3 Communication 
Communication was an important part of the culture of this practice so they had a few different 
communication strategies which are discussed in turn below. 
4.3.1 Daily 
The practice had an 11 am meeting every day. Two GPs are not very punctual and frequently 
use this as time to catch up but do attend, albeit late.  This meeting was to catch up with one 
another, discuss any issues and to divide up the home visits and ward round at the local 
hospital.  The home visits are carried out by the on call GP prior to 11am.  A note of what time 
slot each GP has for home visits was left on the table by one of the PMs.  
The senior receptionist and the on duty GPs are always in attendance, the practice managers 
were sometimes there if they need to address something but not always.  The practice 
pharmacist, practice and district nurses were rarely there, but know it was a good time to catch 
the GPs if they have an urgent issue.   
When reception take messages for the GPs they write on blue pieces of paper specifically 
designed for communication.  These pieces of paper had been designed to ensure the 
receptionist can fill them in quickly with all required information.  It had space to write the 
patient’s name and date of birth, information such as GP’s initials and time am/pm to circle 
accordingly and then to write the details of the inquiry, with a further box for the GP to 
complete once sanctioned.  These blue slips were placed on the desk in the library/coffee room 
for the 11am meeting alongside summarised patient notes of those requiring a home visit.  This 
was a demonstration of the investment this practice placed in refining their communication 
channels. 
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4.3.2 Informal 
All the GPs eat their lunch in the coffee room at some point between 1-2pm.  They would not 
linger unless they were discussing clinical or organisational issues. They would also pop in and 
out regularly through the day. The community nurses also tried to make an attendance at the 
daily 11am meetings but were only observed once at a meeting.  I observed the GPs 
communicating more frequently with the community nurse in the coffee room over lunch or 
while passing through. These conversations primarily centred on the community nurses 
updating the GPs on housebound patients, asking the GPs to visit a patient or to prescribe a 
medication and discussing treatment options.  
The coffee room was an important part of this practices communication.  Through spending 
time with colleagues the GPs were party to information that may not have been communicated 
through other channels. One example of a conversation in the coffee room was over the 
practice pharmacist’s coffee break, which centred on a prescribing decision.  The GP had 
received a letter from a consultant in secondary care telling him to prescribe xxxx but when the 
GP had gone to prescribe this a hook on the computer had told the GP that the drug was not 
licensed for the patient’s condition.  The GP was delighted the computer system had flagged up 
such an error and was informing the practice pharmacist the benefits of the current IT system. 
The coffee room provided the GPs with an opportunity to have informal meetings with the 
community nurses and the practice pharmacist and to gain contextual information from the 
receptionists.  Communication was an important part of the practice’s culture and the coffee 
room played an integral part. 
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4.3.3 Formal 
This practice also had formal practice meetings every Friday at lunchtime.  Once a month these 
were prescribing meetings held by the practice pharmacist and the remaining Fridays these 
were administration, finance and organisational meetings held by the practice managers.  The 
atmosphere between these meetings differed; the prescribing meetings were punctually 
attended by all clinical staff on duty that day, followed a PowerPoint presentation with an 
agenda and was chaired more strictly.  These meetings used humour to have digs at prescribing 
behaviour. (Further description and explanation of these prescribing meetings are in given in 
section 4.8.1.1).  The practice manager led meetings were not punctually attended, not always 
well attended by all GPs on duty. These meetings tended to be more laid back, were more 
jovial and more prone to move off topic. 
Communication was an important part of this practices culture.  They valued shared decision-
making and good working relationships and felt this could be achieved by communicating face-
to-face regularly.  
4.4 Organisation 
This practice valued being organised and efficient and as a result had invested time refining 
their processes and systems which are discussed below. 
4.4.1 Appointment system 
Patients were offered an appointment within 48 hours.  The practice had a system where 
appointments are embargoed and then released so they are available for patients within 48 
hours.  The practice also regularly uses locums and they consult for the on the day 
appointments.  Also during some of my time at ‘Rubain’ one of the GPs was pregnant and 
suffering badly from morning sickness so during this time she also was only scheduled for on 
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the day appointments.  This practice valued offering continuity of care for long-term conditions 
so used locums for rapid access for acute problems. 
4.4.2 Home visits 
The practice has a rota for home visits and emergencies, each morning one GP was on call from 
8am-11am, 11-1pm, 3-4pm, 4-5pm, 5-6pm.  
4.4.3 Information Technology 
This practice was using an IT system called Synergy during the period of observation.  They 
were not keen to be going over to Vision but were accepting this (HB policy).  The practice had 
been operating this system for years, utilising a complex reminder system (‘hooks’) and 
appointment monitoring system. 
The reminder system was another form of communication between the pharmacist and GP. The 
biggest concern around losing this system was these ‘hooks’ which helped them be consistent 
with their prescribing policy.  The practice pharmacist had put these on the system so that when 
a GP selected a drug and they should be prescribing generically it asks if they have checked this 
first which prompted them to question why they were not prescribing the generic medication.  
This system also reminded them, if necessary, of cheaper prescribing such as that it would be 
cheaper to prescribe two half doses or capsules rather than tablets.   
4.4.4 Evidence based medicine 
The practice pharmacist filtered evidence and guidelines related to prescribing on behalf of the 
practice and helped the GPs refine the evidence for their local population (this is discussed in 
further detail in section 4.8).   
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The practice had used the IT system to facilitate adherence to their values of organisation, 
continuity of care and consistency in prescribing behaviour. 
4.5 Systems 
The practice had developed two systems which were pertinent to their prescribing behaviour. 
4.5.1 Repeat Prescriptions 
Once a patient was stable on their medication they were given a two month prescription.  After 
two months, they can hand in the re-order slip (when the doctor prints a prescription it has two 
sides, one with their medication to be dispensed and the other has their repeat medication with 
tick boxes, to re-order), call an answering machine and leave a message or request their 
medication at the reception desk.  The practice asks that patients allow 48 hours for processing 
of the prescription. 
Nursing home patients are issued a one month prescription, and these must be requested a week 
in advance to allow for processing, due to number of patients and the large number of 
medications these patients are taking.  The Nursing homes send a copy of the patient’s 
medication administration record, which is administered by a pharmacy, to the practice by mail. 
4.5.2 Chronic Disease Management 
Patients are invited to the practice around the time of their birthday for what the practice calls 
their birthday bloods, although some patients are reviewed without blood test results.  All 
patients on repeat medication are invited into the practice, usually for a blood test with the 
practice nurse around the time of their birthday; it was usually the month before.  When a 
request comes in for more medication around the time of their birthday, the receptionist was 
warned by the computer that it was the time of their birthday and they can check if the patient’s 
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results are back.  If the results are back, then the receptionist attaches a card to the prescription 
informing the initiating GP that their results are in file for checking.  If their results are OK then 
the GP re-issues their medication for another year.  If not, the patient was contacted to make 
another appointment.  An equivalent system was also in place for patients not needing bloods.  
This was a complex system which has evolved over years, which ensures at least an annual 
check is offered to all patients and was automated as far as possible due to the heavy workload. 
This section has described the practice characteristics and organisational and clinical systems to 
provide contextual information to allow the reader to better understand the information which is 
to follow. The chapter will now provide explanation with the description to clarify the readers 
understanding of Rubain’s prescribing behaviour, where the practice’s prescribing model is 
presented which illustrates the various influences on the practice and how they organise 
themselves.   
4.6 Practice Prescribing Model 
Practice prescribing models have been devised for each practice.  These models have been 
designed in a similar way so the reader can easily depict the differences between the three 
practices. These models have been designed to visually depict prescribing influences and to 
show the differences in organisation between the practices specific to prescribing.  They are 
designed to show how and where these influences filter into the practice through to the 
consultation and how the practices values affect how they organise themselves around these 
influences.  The models also show the processes which link these structural parts of the practice 
prescribing culture, the most common process is communication.  The prescribing model for 
‘Rubain’ will be described in detail.  The patient specific influences are the same for all three 
practices so will only be discussed for Rubain. 
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Figure 2: Rubain practice prescribing model 
 
  109 
Rubain’s practice prescribing model visually depicts influences and how they have an effect. A 
key has been included in the model to aid interpretation.  A table of supporting evidence can be 
found in the appendix (7).  This section will now give an overview and explanation to provide 
the reader with a framework to interpret the model.  A more detailed description of each box 
will follow.  
The purple box indicates the patient and the potential influences upon them. Each individual 
patient has personal views, expectations and circumstances which may lead them to exert 
pressure towards one or more medications. The patient’s personal views, expectations and 
circumstances may have been considered by the prescriber during the consultation.  
The blue circles indicate the initial encounter (acute prescription), and the potential preceding 
consultations (long-term conditions, repeat prescriptions/continuity of care) indicating optimum 
levels of continuity of care.  The lines through the depth of these circles indicates the different 
types of continuity of care present; relationship, information, and management. 
The green boxes indicate the prescriber and the potential influences on the prescriber both 
internal and external to the practice.  The top green box represents the external influences on 
prescribers which filter into the practice.  The following green box below represents the other 
practice staff.  The practice nurses and community nurses would speak to the GPs about 
specific patients and ask them to prescribe.  This box also includes the receptionists who would 
make suggestions or recommendations which would influence the organisation or systems of 
care. Unlike the other practice prescribing models, the practice pharmacist has a box to himself 
due to the strong influence he had on practice prescribing.  The practice pharmacist would 
present practice prescribing data to inform the practice of their prescribing behaviour and make 
suggestions for improvement.  The practice pharmacist would filter CHP recommendations into 
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the practice.  This is indicated by the CHP box overlapping the practice pharmacist box.  The 
practice pharmacist would also filter EBM into the practice, indicated by the green line running 
from the ‘influences’ box to the pharmacist box.  The line from the pharmacist to the patient 
indicates the medication reviews and chronic disease management clinics the pharmacist would 
run. The line from influences to other practices staff and to prescribers shows their attendance 
at pharmacist lead prescribing meetings.  Influences would also go straight to the prescribers 
and other practice staff.  They would share this if they felt it was relevant.  The final green box 
is the prescriber, each prescriber has a number of personal influences which they may bring to 
the consultation and these are listed in this box.  The prescriber, other practice staff and practice 
pharmacist boxes overlap to indicate the high levels of communication and shared decision-
making at this practice.  
The lines between the boxes indicate communication as well as the overlapping of the green 
boxes.  The overlapping of the prescriber and patient boxes over the blue circles indicates their 
active involvement in the prescribing decision-making made in the consultation. 
Each of the boxes in the model now described in detail. 
4.6.1 Patient 
4.6.1.1 Introduction 
Each patient is unique; they have their own ideas, views, experiences, social circumstances and 
psychological factors.  These views and opinions are shaped by previous experience and 
through friends and family and the media.  How a patient’s views, expectations, understanding 
impact on a consultation are considered below. 
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4.6.1.2 Patient Views 
Patients have their own views about medicines; people are very diverse and have very different 
views, opinions and perceptions of medication.  These views are based on a personal set of 
beliefs and understandings influenced by factors including their own personal experience, from 
family and friend’s experiences, culture, education, and social circumstances.  
4.6.1.2.1 Origins and Nature 
Patient’s beliefs and views about medication originated from antecedents listed below: 
Personal experience – a patient’s experience of medication influenced their views either 
towards or against medication.  An example of a patient’s experience influencing views 
towards medication is given. HRT had made such a dramatic difference to one woman’s life 
she was against coming off the medication despite the health risks. 
An instance of a patient being against taking a medication was when the patient was advised to 
start blood pressure medication. This patient had no symptoms as a result of their high blood 
pressure and appeared not understand why they should start medication. (Section 4.6.1.2.2 
below will describe how patient’s views were expressed). 
Word of mouth – patient’s views towards medication also originated from word of mouth 
from friends and family.  An example was smoking cessation treatment. Numerous patients 
were observed asking for Champix, as this medication had worked for someone they knew. 
Media – The media reporting of either the benefits or risks of certain types of medication had 
influenced patient’s views.  An exemplar of bad press coverage was HRT. One woman was 
against taking HRT because of the bad press it had received despite suffering distressing 
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symptoms.  During the consultation she asked more than once if there was any other treatment 
to prevent her symptoms. 
4.6.1.2.2 Expression 
Each patient brings their beliefs and views to the consultation and some patients openly express 
their views, some patients expressed their views when they were given one treatment option 
over another and some patients expressed non-verbal clues to the clinician such as body 
language, hesitation, facial expressions, which gave indication to the clinician to probe a little 
deeper to elicit these views. (This will be explored further in the consultation/interaction section 
later on).    
Patients expressed their views in various ways which are addressed below: 
Spontaneous and overt – Patients expressed their views about medication in an open and 
unprompted manner (e.g. An example is given from a consultation); a patient who was given a 
prescription for a new inhaler in her last consultation and returned as she did not like the new 
delivery system which spits out medication rather than old inhalation technique.  The patient 
was prescribed her old inhaler.  
Sought by GP – On most occasions patients expressed their views once the issue had been 
addressed by the GP, where the GP was suggesting initiating medication, stopping medication, 
different treatment options or asking how they were.  One patient expressed their views against 
taking medication when the GP suggested they start medication for their blood pressure.  An 
example of patients expressing their views against stopping medication was a patient on HRT 
who did not want her symptoms to return.  Frequently different treatment options were 
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discussed and patient’s expressed their views over one option over another such as treatment 
for a dry and itchy scalp, would the patient prefer ointment, shampoo or cream. 
Hints and cues – Patient’s frequently expressed their views in a subtle manner.  They would 
tell stories about their condition, symptoms and circumstances, or would use body language 
such as moving around on their seat, facial expressions, or hesitations such as saying 
‘mmmmm’.  The GPs would use these cues if they felt they needed to probe for more 
information. 
The effectiveness of patient’s expression of their views depended very much on the GP’s 
views. 
4.6.1.3 Patient expectations 
In some cases patients came to the consultation expecting something; information, education, 
reassurance, advice or a prescription.  As this study did not ask patients about their expectations 
it was not clear how much of an influence or impact this could have played.  The researcher 
could only go by her and the GPs perceptions of the patient’s expectations unless they were 
explicitly expressed. In some cases the researcher perceived the patients to be looking for 
advice or reassurance when the GP thought they were seeking a prescription. When patients did 
make it clear they were only looking for advice, or reassurance they were typically given an 
explanation of their concern and further education about their condition.  When patients come 
to the consultation expecting a prescription and they expressed this, this has been described in 
the section below as patient pressure. 
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Figure 3: Patient expectations and patient 
pressure diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6.1.4 Patient pressure 
The diagram above shows patients expectations and the consultation path which follows when 
patients exert pressure. 
Patient pressure was when the patient was trying to influence the prescribing decision either 
towards a prescription of their choice or against receiving a prescription.  As this study did not 
ask patients about their expectations from the consultations this section is based on the 
researcher’s perception. In most cases patients were perceived to be pressing for a prescription 
however, consultations were observed when patients were against receiving a prescription. 
Expectation 
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For Against 
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When patient’s entered the consulting room expecting a prescription they tried to influence the 
prescriber’s behaviour in a more subtle manner than demanding medication; 
By verbally by asking for drug by name; a patient presented a list of medication she would 
like to be treated with.  Her husband was a clinician.  She was given the medication she 
requested despite them not being a generic preparation.  
Telling stories of their symptoms; a patient who was an alcoholic entered the consulting 
room and asked for more diazepam and dihydrocodeine. The GP refused saying it was only 
Wednesday and he had been given plenty on Friday.  The patient then started telling the GP he 
had a chest infection and a cough.  The GP examined him and his lungs were clear. He was 
offered an antibiotic but no more of the medication he was after.  He stormed out. 
Explaining their symptoms again, an example was of a patient who was looking for 
something to help her sleep.  The GP emphasised that she needed a routine before bed but the 
patient repeated her symptoms, to which the GP told her to try’ rescue remedy’. She did not 
leave with prescription but lots of advice about what to do before bed to help her sleep. 
By not getting up from seat; one patient had been suffering from her symptoms for less than 
48 hours so the GP told her to rest and come back if symptoms did not clear by themselves.  
She did not get up from her chair and in the end was given a ‘delayed prescription’. (A delayed 
prescription was when the GP gives the patient a prescription to cash if their symptoms do not 
improve in the subsequent days). 
Not making any indication of leaving the room; one patient had sore feet and was looking 
for medication to make her more comfortable on a long walk she had planned with friends in a 
few days.  The GP told her she did not think she could go and educated her about appropriate 
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footwear.  After some discussion the GP suggested corn pads and was trying to conclude the 
consultation but the patient was still talking about her walk and the risk of infection.  The 
patient remained in her seat after a period of silence and resulting in the GP giving her a 
delayed prescription for cream in case of infection. The difference between this and patient’s 
not getting up from their seat was the silence.  When patients did not get up from their seat they 
would still speak, often discussing their symptoms, allowing the GP opportunity to reassure 
them.  ‘Not making any indication of leaving the room’ was a much stronger expression of 
pressure, alluding to not leaving the consulting room without a prescription. 
GPs perceived pressure simply because the patient had attended the surgery.  There were 
some occasions when I perceived the patient to only be looking for advice, education or 
reassurance and the GP thought they were after a prescription.  An exemplar was; a patient who 
was suffering from a cough and cold.  I had thought they were just there for some reassurance 
due to their questions and statements emphasising it that it was not severe whereas the GP had 
perceived they were there they wanted an antibiotic. In some cases patients were asking lots of 
questions, just for reassurance and this made me think they were not necessarily looking for a 
prescription. 
Patient’s usually exerted pressure at a point in the consultation when the GP indicated a 
prescription would not be issued. Consultations are allocated ten minutes which limits the 
available time for discussion and debate; however, patients can have strong views either for or 
against a prescription despite the discussion and debate. This can result in patients receiving the 
prescription they have sought against the GP’s better judgement. Antibiotics were the most 
commonly sought after medication which was received against the GP’s judgement.  In these 
cases patients might be told it was a delayed prescription in an attempt to compromise.  
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4.6.1.5 Patient Circumstances 
Patients’ circumstances have a huge impact on a prescribing decision, whether they encourage, 
discourage a prescription or influence choice of preparation. 
4.6.1.5.1 Encourage a prescription: 
Life expectancy – Limited life expectancy can encourage the generation of a prescription.  For 
example: patients who are prescribed more opiate based medication to make them more 
comfortable in their final days or months as it does not matter if they become dependent on the 
medication or not. 
Living conditions – A patient’s living conditions can affect whether they receive a prescription 
or not.  For example, a patient was suffering from a cold/flu and would not normally have been 
given an antibiotic but as her husband suffered from severe COPD the GP did not want an 
infection brought into the home so the prescription was given as a precaution. 
Working conditions:  An interaction was observed where a patient worked offshore and they 
were given a prescription rather than asking the patient to wait or come back if their condition 
deteriorated. 
4.6.1.5.2 Discourage a prescription: 
Living conditions: Patients’ living conditions can also discourage a prescription.  For example, 
a drug addict who lived in a hostel was looking for a range of medication which had been 
stolen from him.  The GP was not happy to prescribe the medication while the patient’s was 
still living at the same address and at risk of theft again. 
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4.6.1.5.3 Influence choice of preparation:  
Living conditions: A patient’s living conditions can also influence the choice of preparation.  
For example, a mother of young children suffering from sciatica had tried numerous pain 
killers which were making her drowsy and she was scared she would not wake during the night 
if her children needed her or were not strong enough and she could not sleep. The GP 
suggested amitryptyline, which is not licensed for this use but is used by neuro-surgeons for 
this purpose, the patient was willing to try.  
A patient’s views, expectations and circumstances do influence the prescribing decision-
making process however, they tended to influence the choice of treatment rather than whether 
to prescribe or not.  The consideration of their views was ‘occasional’ based on the severity of 
their condition and their mitigating circumstances. 
4.7 External Influences on Practice and Prescriber 
This section will present external influences which are standard for all practices within Tayside 
Health Board.  However, each practice was unique in how they assimilate these into the 
practice prescribing policy.  Each of these external influences are not viewed equally but in a 
hierarchy described in turn below.  This practice’s prescribing policy was formulated through 
discussion with the practice staff and these mechanisms are discussed in the next section; other 
practice staff. 
4.7.1 Evidence based medicine (EBM) 
Evidence based medicine is the process of getting evidence into practice.  Evidence arrives in 
general practices via papers, expert opinion and practice and syntheses such as systematic 
reviews and guidelines.  
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4.7.1.1 Guidelines 
Guidelines are recommendations for clinical practice based on synthesised research evidence 
which are designed to aid decision-making and reduce variation in prescribing practice. 
Publication of a new guideline triggered practices to consider their prescribing behaviour in 
light of this evidence. Guidelines are published by a number of organisations, agencies and 
professional bodies such as; The British Association of Dermatologists, The British Thoracic 
Society, The Royal College of Physicians, Royal College of Obstetricians and Gynaecologists 
and The National Patient Safety Agency. The Scottish Intercollegiate Guidelines Network 
(SIGN) also publishes guidelines and it was the publication of these guidelines which had the 
biggest impact in each practice.  SIGN is part of NHS Quality Improvement Scotland and 
produces guidelines on a wide range of disease areas.  SIGN’s equivalent in England is NICE 
(National Institute for Clinical Excellence). When SIGN publishes a new guideline they are 
disseminated to all general practices by their health board. Practices are responsible for the 
implementation of these guidelines relevant to the needs of their population. During the period 
of observation SIGN 97 was published and is discussed later on in section 4.8.1.3. 
4.7.2 Journal articles 
“Evidence based medicine (EBM) is the conscientious, explicit, and judicious use of current 
best evidence in making decisions about the care of individual patients” (Sackett et al., 1996). 
EBM refers to journals and other guidance which are peer-reviewed and publish the latest 
research.  GPs are expected to read journals regularly, critically appraise relevant papers and 
incorporate the research evidence into their clinical practice.   EBM is about incorporating 
research evidence into clinical decision-making aiding their clinical judgement about optimum 
treatment for individual patients.  This clinical evidence can inform clinical judgement but it 
cannot replace expertise or patient choice.  Nearly all GPs observed commented that one 
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journal article did not change behaviour and it took an accumulation of research papers in an 
area to completely change behaviour.   
4.7.2.1 ‘Comics’ 
News type journals, often referred to as the ‘comics’ are also sent regularly to health care 
professionals.  These are not peer-reviewed but they condense and summarise evidence in a 
way which was more digestible. As they are not peer reviewed these articles carry less weight 
but they can highlight issues which clinicians should be aware of. ‘GP-Update’ was regularly 
seen around all practices. This publication is funded by adverts so has implications for 
influencing their prescribing of new medications.  
4.7.2.1 Practice library 
This practice had a library which was kept up-to-date with one journal, the British Medical 
Journal.  There were paper copies of other journals available but not all were up-to-date.  All 
the GPs received the BMJ and a ‘comic’ ‘GP-update’. Clinicians do not read these journals 
cover to cover but will read articles which they find interesting or relevant.  This practice also 
had a log-in for the NHS elibrary, which allows clinicians to search for relevant journal articles 
however I did not see any clinicians using this facility.   
4.7.3 Community Health Partnerships (CHP) 
Community Health Partnerships are part of the local Health Board but are smaller units, which 
are designed to work more closely with other service providers such as social work.  They hold 
the prescribing budget and are tasked with influencing prescribing behaviour. In Tayside health 
board there are 3 CHPs; Angus, Perth and Kinross and Dundee city.  These CHPs provide local 
area prescribing advice and guidance via the practice pharmacist to the general practices.  This 
advice was based around constraining costs and promoting quality prescribing.  To influence 
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practices’ prescribing the CHPs publish a quarterly prescribing report from data extracted from 
PRISMs which compares each practice in the CHP against one another by Audit Scotland 
(2003) prescribing indicators for both quality and cost. They also seek to influence prescribing 
by providing information, such as the formulary, running incentive schemes and providing 
professional input from practice pharmacists.  This practice relied on their practice pharmacist 
to help them incorporate EBM into their prescribing practice which is discussed in section 
4.8.1.3. 
The CHPs regularly conduct audits of prescribing practices and have initiatives to improve 
prescribing.  An example of this was for fluoxetine (antidepressant), where all the CHP 
practices were prescribing above the Scottish and Tayside averages.  The CHP gave each 
practice a financial incentive to improve their prescribing practices. At this practice the practice 
pharmacist regularly conducted audits of the practices prescribing and set reminders on the 
computer system, really pushing the GPs to change their prescribing behaviour.   
4.7.4 Health Board formulary 
Tayside Health Board publish a local area prescribing guide which was designed to be the 
foundation of prescribing practice for all general practices.   The guide was divided into 
sections (as in the BNF) and each section contains the core drug formulary. It was intended to 
guide choice and improve consistency in prescribing across the health board area.  The drugs 
which are included are selected on the basis of clinical efficacy, safety, patient acceptability and 
cost effectiveness (NHS Tayside, 2006).  All practices observed used this prescribing formulary 
as the basis of their practices prescribing policy. In ‘Rubain’ the practice pharmacist 
manipulated the IT system by making only drugs available on the formulary appear in the drop 
down boxes of medications from which they could select.  Changes in the Tayside prescribing 
guide were brought to the attention of the practice by the pharmacist. 
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4.7.4 Drug Representatives and drug companies 
Drug representatives (drug reps) are used at this practice for occasional lunches where one GP, 
usually the first to arrive, makes an effort to listen to what the drug representative has to say.  
The GPs knew that the drug representative was giving a marketing speech trying to sell the 
company product but they pay little attention.  One went on to say that it must have some 
influence otherwise the drug companies would not spend so much money on this type of 
promotion.  The drug representatives leave pens, mugs, notepads and information brochures of 
the drugs they have been promoting, which seek to refresh the memories of the GPs who spoke 
to them.  The drug representatives were also quick to mention the drugs they were promoting 
were on the Tayside area prescribing guide in an attempt to encourage GPs to prescribe the 
medication. 
4.7.5 Secondary Care 
Patients who had attended an outpatient clinic, had been discharged from hospital or had seen a 
consultant were frequently discharged with recommendations of medications or were started on 
medication.  GPs do regularly follow the consultant’s recommendations, illustrated from this 
extract: 
This patient has polymalgia and recently had an angioplasty and was in for her results.  She 
admitted she was feeling sore herself.  She had been at a 50th birthday party, and although she 
had nothing to drink she admitted she did vigorously jive to 4 or 5 songs.  She increased her 
dose herself after this event from 5 to 6.  The Doctor checked the consultant’s 
recommendations on the computer and it said if she has a flare up increase by 2.  The patient 
admitted this but said she wanted to see if she could get away with one but no, she was sore.  
They had a discussion and agreed between them to increase the steroid dose by 2 for a month, 
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and then down by 1 for a month and then down again by 1 for a month.  This was the Doctor’s 
suggestion and she agreed. 
On occasion, these recommendations or initiations could be expensive or not available on the 
Tayside formulary.  The GPs at this practice felt that they should try and get the patient onto a 
cheaper preparation but this could be difficult if the patient was happy and stable on the 
medication.  They did rely on the practice pharmacist to help them find an appropriate 
alternative preparation if they were unsure. When patients had been for an outpatient 
appointment or to see a consultant they were given a letter for the GP with recommendations 
for the GP to prescribe. Often in these situations the consultant or outpatients had discussed the 
medication with the patient and meant it was difficult for the GP to contradict these 
recommendations. As one GP commented “they often make recommendations which are hard 
to contradict, the patient has been to the clinic and the doctor has told them that is the 
medication they should have, it is difficult to then prescribe an alternative or decline to 
prescribe it.”  The GPs were aware these were only recommendations but also had to gauge the 
patient’s reaction and maintain both doctor-patient relationships. 
The GPs also become aware of what the local consultants are prescribing for a particular 
disease and tend to follow this trend.  If a GP has prescribed a medication for a patient and they 
are not familiar with it they will inform themselves to be able to look after the patient 
appropriately.  Consultants from the local hospital also give talks at GP meetings which educate 
GPs about the latest medication in their field.  As the GPs look after more and more patients on 
the medication they gradually become familiar with medication and will start prescribing the 
drug themselves. 
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There were a number of external influences on the practice’s prescribing behaviour, these 
varied in their impact, with SIGN guidelines having the most immediate and noticeable effect.   
4.8 Other practice staff 
This section describes the influence the other practice staff had on GPs prescribing behaviour.  
Practice pharmacists are employed by the CHP and community nurses are employed by the 
health board however, they were viewed by the practice as part of the team. 
4.8.1 Practice pharmacist 
When Tayside Health Board introduced practice based pharmacists in 1997 they were the only 
health board at the time to invest in prescribing in this way.  As pharmacists have specialist 
knowledge, placing them in primary care gave them the opportunity to educate GPs, to 
influence practices to deliver high quality prescribing and as one potential mechanism to reduce 
their prescribing costs. As this was innovative and atypical each of the CHPs were given 
autonomy as to how the pharmacists should operate and to define their role.  The CHPs passed 
this autonomy onto the practice pharmacists to meet the unique needs and requirements of each 
practice.  At the time of observation the practice based pharmacist’s roles were still loosely 
defined to reflect practice need. They provided advice to GPs, helped practices update their 
prescribing formularies, and ran clinics such as anti-coagulant and medication review and 
signed off expensive prescriptions. As employees of the CHP their remit was also to implement 
CHP prescribing guidance.  
4.8.1.1 Specific practice pharmacist role 
The practice pharmacist was fundamental to this practice’s prescribing policy.  The pharmacist 
has been at this practice for 11 years during which time he has built a rapport with all GPs and 
established a position of trust.  Now the GPs rely on the practice pharmacist to inform them of 
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the latest research evidence related to prescribing.  The pharmacist has a monthly meeting with 
all the GPs and practice nurses and on occasion the practice managers will also attend.  At this 
meeting the practice pharmacist presents research evidence and any changes in prescribing 
policy at CHP or health board level and any issues flagged up during clinical practice.  
Quarterly he also presents the CHP prescribing report.   
4.8.1.2 Practice prescribing meeting 
The CHP report compared prescribing practice of all general practices in the CHP against one 
another for both quality and cost.  This report helped the practice review the areas in which 
they are outliers and agree on a course of action to improve their prescribing. The pharmacist 
presented a PowerPoint presentation showing diagrammatically changes in prescribing and 
how they have improved compared to the other practices in the CHP.  Presenting the report in 
this way was intended to fuel a competitive drive and breed motivation.  The GPs in ‘Rubain’ 
were very interested in where they were in comparison to their CHP counterparts, in particular 
practices which were serving a similar population. Through discussion and debate chaired by 
the practice pharmacist all prescribers reached an agreement about the most appropriate drug to 
be prescribed first-line, second and third line. Most discussion in these prescribing meetings 
was not around initiating new medication but altering doses or changing medications within the 
same therapeutic group. An example of this is described below: 
The practice pharmacist presented data on one indicator showing the practice was an outlier.  
Prescribing simvastatin 10mg was considered as poor prescribing by the indicators used in the 
CHP report and the presented quarterly report indicated the practice was prescribing a lot. 
The GPs argued that if the patient was responding well and was stable why should they 
increase the dose. However, the evidence behind the indicators suggests that 10mg was not 
effective.  This sparked discussion and debate. The GPs gave examples of potential patient 
  126 
cholesterol levels and asked why they should increase the dose.  They also give an example 
using patient age asking why should they increase the dosage for a patient who is 95 years old. 
The practice pharmacist agreed that it was pointless in very old patients with co-morbidities 
but there must be cases when prescribing 10mg was inappropriate as the report has identified 
17% of the practice population.  The GPs muttered and did not speak up and say they agreed 
but did not argue or comment back.  
New guidelines were also discussed at these meetings.  The practice pharmacist presented the 
evidence from the guideline and the recommendations and through informed discussion and 
debate they revise their prescribing policy.  For example, SIGN 97 was published during the 
period of observation, which was a guideline on estimating the risk and prevention of 
cardiovascular disease.  The practice debated how they could assess the risk factors, such as the 
various risk factor calculators available on websites and computer systems as to the most 
appropriate. They also discussed how they measure cardiovascular risk and if there were 
improvements that could be made when the nurses are taking the clinical recordings. It took the 
three prescribing meetings to discuss and debate all the relevant information and agree on 
their revised practice policy, although this was not all the information which was discussed at 
these meetings.  The practice pharmacist chaired these meetings and ensured the discussion did 
not dwell on points, all meetings observed had a longer agenda than they managed to get 
through.  
4.8.1.3 IT 
A summary of these meetings and the decisions made was circulated round the clinical staff by 
the pharmacist.  He waited for a response and after a short period of time, dependent on work 
commitments he updated the hooks on the computer system.  Hooks were invaluable to this 
practices prescribing practice.  Hooks are reminders which pop up on the clinical IT system 
  127 
reminding prescribers of the practice’s prescribing policy.  For example, when a GP clicks on 
the prescribing box and selects a medication a hook will pop up if what has been selected is not 
part of the practices prescribing formulary.  The IT system would allow the GP to prescribe this 
medication if they so wished, the ‘hook’ was a reminder not an order.   
4.8.1.4 Clinical Role 
The practice pharmacist also gave advice on individual patients, ran audits and medication 
review clinics, however, the pharmacist primarily viewed his role as one of influencing 
prescribing in terms of quality and cost; influencing prescribing policy and containing the 
practice’s prescribing costs.   
4.8.1.5 Cost-efficiency role 
The CHP had a limited drug budget and part of the practice pharmacist’s role was to bridge the 
gap between the CHP and the practice, in particular by constraining their prescribing costs. At 
the monthly meetings the practice pharmacist regularly informed the GPs that they should now 
be prescribing something because it was cheaper.  For example, pregablin was deemed to be 
very expensive and they should prescribe gabapentin instead.  Or they should prescribe two 
times 300mg rather than one 600mg as it was cheaper or to prescribe tablets instead of 
capsules.  He also informs them when drugs are coming off patent.  Again they relied heavily 
on the practice computer system to remind them of these changes. 
Patients were regularly discharged from secondary care on expensive medication. Many drugs 
are cheaper in secondary care than they are in the primary care sector, so when patients are 
discharged this cost was passed onto the practices. This was deliberate loss leading by 
pharmaceutical companies. Many of the recommendations from secondary care are also for 
these expensive drugs and drugs which are not on the Tayside prescribing formulary, thus they 
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are drugs GPs were not familiar with. The practice pharmacist regularly took these 
recommendations and was able to advise the GPs of appropriate medication for the patient 
which was within the same class of drug, and had the same effect but was not as expensive. As 
one GP put it “he helps them fine tune the instructions from secondary care”. 
The pharmacist was the main influence on practice prescribing, filtering and processing the 
external influences on prescribing and providing expert advice on medication which allowed 
the GPs to concentrate on other aspects of their job.   
4.8.2 Practice nurses 
Two of the practice nurses ran chronic disease management clinics and were able to alter 
patients’ doses.  The practice nurses would also inform the GPs in the coffee room of any 
contextual information from patients which they felt were important to the patient’s wellbeing. 
4.8.3 Community nurses 
The community nurses would update the GPs on patients in the community, they frequently 
asked the GPs to visit a patient or to prescribe a medication and they would engage in 
discussions with the GPs about treatment options.   
4.8.4 Post-graduate doctors 
This practice was a training practice, which means they take doctors for their post-graduate 
training in general practice.  One GP’s comment illustrates the influence these doctors had on 
the GPs; “they keep you on your toes; they often know things you don’t know, especially with 
some modern slants to things.” 
This practice had good working relationships and the GPs appeared to trust their colleagues and 
take their information and advice onboard.  
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4.9 The Prescriber 
Although the GPs are strongly influenced by the practice prescribing policy and in many 
consultations this was the dominant influence, they still have clinical autonomy. Each GP has 
core influences which affect each prescribing decision; their experience, medical training and 
preferences, their personal beliefs and attitudes and their relationship, knowledge and 
perception of the patient.   
4.9.1 Medical Training 
Students undertake five years of undergraduate education to become a doctor and then 
undertake a minimum of four years post-graduate training in a range of specialisms of their 
choosing. This education and post-graduate training was the core of a GPs experience and 
knowledge. Their experiences during this time influenced their choice of specialism.  During 
their post-graduate training these young doctors are exposed to a variety of medical decisions, 
including prescribing. Some GPs did mention their post-graduate training had influenced a 
medical decision; this was more prevalent in the younger GPs.  As one GP commented “what 
you prescribe depends on where you are in your career.”  When this GP first started she was 
more familiar with hospital medication but said as time goes on you get more confident and 
you learn yourself and you try different medications. 
4.9.2 Experience 
A GPs experience had the strongest influence over their prescribing.  They had to be 
comfortable and knowledgeable about the medication that they were prescribing, and this came 
with experience. These GPs tended to prescribe from a range of drugs which they knew well 
and did not need to look up to prescribe.  This experience was gained through their years of 
practicing as a GP. The knowledge they gained at medical school was core but has been shaped 
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through their years of practicing. With experience come habits, techniques and preferences, 
which have moulded them into the practitioners they are today. 
At this practice all the GPs are experienced and have been practicing medicine for a number of 
years. Through this time they have seen many different prescribing decisions, with a wide 
variety of drugs with many different patients who have different circumstances, conditions and 
outcomes.  Their experiences did not have to be identical as the GPs seemed to have the 
capacity to see similarities and to draw on these similarities and differences to aid their 
decision-making and to make evaluations.  Practicing medicine was about experimenting or 
trial and error which leads on to new knowledge.  As one GP said “It is trial and error, 
everyone is different, prescribing is not an exact science.” 
GPs frequently see the same patients over again so they also have knowledge and experience of 
the current patient, their circumstances and conditions, and experience of their views and 
opinions towards medication.   
4.9.3 Knowledge of the patient 
A GP’s knowledge of the patient varied.  In some cases, they knew the patient very well, 
usually patients with multiple co-morbidities were they often had an established relationship 
built on trust and respect and knew about the patient’s medical condition(s) and personal life. 
This usually involved knowing some of their medical history but also to know about their 
family and social life, their issues, concerns, problems, support networks and hobbies.  With 
those patients who consulted less often GPs tended to be more acquainted with their 
information. The amount of information a GP knew about a patient was also dependent on the 
length of time they had worked at the practice and how long the patient had been registered.  
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The influences on a prescriber have been described (these were the green boxes in the model). 
Through describing each box the writer has tried to illustrate how they overlap and link 
together.  This next section discusses the consultation between doctor and patient, where the 
prescribing decisions are made. 
4.10 Interaction/Consultation 
This section will provide an overview of the structure of an interaction or consultation between 
a patient and doctor and discuss continuity of care between GP and patient (illustrated by the 
multiple rings in the model).  
4.10.1 Interaction 
An interaction between a GP and patient follows a standard structure.  Once the patient has 
entered the consulting room the GP establishes an initial rapport and identifies the reasons for 
the consultation.  In some cases the patient comes with more than one problem so the GP 
makes the structure of the consultation clear. This leads on to the GP exploring the patient’s 
problem/s to gain a clinical perspective and the patient’s perspective of the problem.  The GP 
also looks for background information which can help give context and further understanding.  
If necessary, a physical examination of the problem was carried out, to further the clinical 
perspective. 
After the examination the GPs explain to the patient the clinical perspective in a way in which 
the patient would understand, using lay language and trying giving the right amount of 
information to aid their understanding and then subsequent recall. The GP reads the patient’s 
body language and facial expressions and probes to explore their understanding and how they 
have incorporated this into their perspective of their illness.  In some cases planning was 
required, possibly a treatment plan or further investigations.  The GP shares their views on the 
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next course of action and through shared decision-making with the patient usually formulates a 
plan of action. 
4.10.2 Continuity of care 
Continuity of care refers to how a patient’s care is connected over time. Continuity of care is 
recognised as having three different types; informational, relationship and management 
continuity.  Informational continuity is the GPs tacit knowledge of the patient’s preferences and 
values, relationship continuity is the information GPs know about their patients which they do 
not record in their notes and management continuity is maintained through the patient’s notes 
and management plans. 
All patients have had previous interactions with a health professional.  Unless they are a new 
patient at the practice they will have consulted a GP at the practice and this interaction was 
recorded in their notes.  Young, healthy people rarely visit their health centre and only for 
minor or acute problems so continuity of care established through their notes. Patients who are 
older or suffering from a chronic or limiting condition will tend to see the same GP and build a 
relationship.  In the medical profession how a patient’s health care is connected over time is 
referred to as continuity of care (the multiple circles in the model illustrate this continuity). 
4.10.2.1 Patient’s notes 
Patients’ notes are a medical record of the patient’s name, address, age, past medical history, 
previous visits at a GP with the diagnosis and outcome of this consultation.  At this practice 
most GPs read over the patient’s notes quickly before most patients entered the consulting 
room, primarily to refresh their memories on the specifics of the last consultation or to see if the 
patient has consulted with another health professional and the outcome.  Some consultations 
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were observed where the GPs did not need to look at the patients notes to refresh their memory.  
An extract from fieldnotes illustrates the common use of patient notes: 
“Before the patient came in the room the doctor gave me a quick summary of their background 
whilst she read the notes. Most of the patients she seemed to know who they were and appeared 
to remember quite a lot about them, the information in the notes seemed to jog her memory.” 
Patient notes provided continuity of care for all patients; however for young, healthy patients 
this was the only mechanism for continuity.  Older patients, with chronic conditions also had 
relationship continuity with their chosen GP.  
4.10.2.2 Relationship continuity of care 
Relationship continuity of care is a relationship which is built up over time between the GP and 
their patient and is based on trust. Relationship continuity of care with patients saved time as 
the GPs tended to know information about the patient, which saved patients repeating 
information and enabled the GP to better understand the patient’s context, preferences and 
values.  By having multiple consultations with patients the GPs invested time educating 
patients about their condition. 
4.10.2.3 Knowledge of the patient 
GPs got to know their patients through the patient’s regular visits to the surgery over a period 
of time.  Over time health professionals learned about where a patient lives, about their 
domestic arrangements, whether they were married, single or cohabiting and if they had any 
dependents such as children, or elderly or ill relatives.  They learned about their medical 
history, any significant past medical events and the impact of these on the patient. Also about 
their personality, such as whether they are anxious, nervous or concerned. When patients had 
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concerns, issues or problems about themselves or one of their family members these concerns 
caused stress and on occasion severely impacted on their life.  Also other aspects of their life 
which can cause stress such as whether a patient was happily married or has any financial 
worries may also be known and helped the clinician help the patient. In one consultation 
observed a patient was very anxious and concerned but as the GP knew her he understood why, 
below is an extract from the fieldnotes from the consultation: 
This patient came in and was very concerned about the pain at the bottom of her head/neck 
area; the Doctor examined her and told her he thought it was some ligaments.  She asked him 
about her eyes as well and if they were related, when she is describing these she is going into a 
lot of detail about what she was doing, the type of pain, how long it lasts and asking the Doctor 
lots of questions.  He turns to me during the consultation and says this lady has had a head 
hemorrhage in the past. This explained why she was anxious and really wanted to understand. 
In this practice, the GPs also learnt about their patients from their colleagues, the practice 
nurses, community nurses and the receptionists.  The receptionists were all members of the 
local community and knew many of the patients thus were able to provide contextual 
information. An example of this was observed in the coffee room when two of the GPs were 
talking about a patient and her care issues when one of the receptionists told them one of her 
neighbours goes in regularly and checks on her.  As this was a small community the practice 
looked after a number of relatives from the same family, when relatives where in consultation 
with the GP they would update them on the lives of their relatives particularly if the relative 
was old or young, such as a new born baby. An example:….during the consultation the GP tells 
me he has known this young lady all her life, as a patient but also through the church.  He asks 
after her family and she tells him how her sister is getting on with the new baby, the baby has a 
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tooth coming through and her sister is getting little sleep but that their mother had been taking 
her other child, to give her a break. 
Knowledge of the patient saved time, as patients did not repeat information and allowed the GP 
to better understand the patient’s context and prescribe appropriately if required.  
4.10.2.4 Preferences and Values 
Through numerous consultations the GPs had learned about the patient’s preferences and 
values. They tacitly knew this information.  The GPs knew if the patient preferred taking 
medication or was against taking medication, if they preferred capsules to tablets, preferred 
medication which they could take twice a day rather than three times a day, or ointment to 
cream.   
The GP also knew about the patient’s values, in particular what aspects of quality of life were 
important to them. Did they value how they felt on a daily basis, or did they value what they 
were able to do, did they look to the future and were prepared to endure side-effects now for 
long-term gain.  An example: 
This very large lady had never been bothered by her weight, she always seemed happy and able 
to do what she wanted to do.  However, one day she was motivated to do something about it.  
Her grandson had asked why he could not sit on her knee.  From that day on she was motivated 
to whatever it took to be able have her grandson sit on her knee.  She underwent an 
apronectomy, saw a dietician and was prescribed medication to help her cope with the 
physiological changes. 
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Prescribing was often the easiest option for the GPs to end the consultation.  By knowing the 
patient and having continuity of care the GPs could leave the issue in the present consultation 
and say they will address it again.  
4.10.2.5 Relationship with patients 
To know someone you require some form of a relationship with them.  An important aspect of 
the clinical encounter was good communication, which was facilitated by trust and respect.  
These are fundamental to a good doctor-patient relationship.  A good relationship based on trust 
was important as the patients will openly communicate and tell the health professional what 
was going on in their lives.  They are able to offer support, advice, help, or to be able to 
understand why they are stressed, anxious, and/or upset. It was clear when observing 
consultations when there was trust and the patients were openly sharing private and personal 
information. Some consultations were observed where the GP had to ask questions and prompt 
for information but this could have been due to there being a researcher in the room and they 
did not trust me rather than the GP. 
With a good relationship patients were more likely to be honest and open, the health care 
professional did not need to read as much into what they are saying and how they are acting.  
They did not need to make assumptions or possibly feel like there was more to explore with the 
patient.  When a GP knew a patient well they could more accurately read the signs and signals 
from the patient’s body language. The more information the GPs had helped them engage the 
patient in shared decision-making about the most appropriate medication regime and thus the 
patient was likely to be complaint as it was the most suitable treatment plan for their lifestyle 
and preferences. With trust and respect the patient was more likely to take what the GP has to 
say onboard land engage in the appropriate behaviour to alleviate their symptoms and 
condition.   
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A consultation was observed when a patient asked for a medication and the GP told her he 
would have to give her a different brand and two tablets as it was cheaper.  The patient was 
happy with this as she trusted the GP and they had a good doctor-patient relationship. 
The patient had been suffering from a bad cough and throat for a while. As she has had throat 
cancer in the past and was very anxious she was referred to the specialist, but she was not 
happy as he had not even looked in her throat and did not recommend any medication.  Her 
husband has had the same infection and when he came to see Dr X he gave him a prescription 
for XXXX, she had this written down on a sheet of paper along with the repeat medication she 
would like.  Dr Y said oh, Ok I will give you this if it worked for your husband but he is going to 
give it to her as two separate tablets as it is much cheaper.  She did say to this ‘well how come 
Bert got it?’  To which Dr Y replied, “Well I have to watch these things, the purse strings” to 
which the patient replied “seeing as it is you”.  
As there was a good doctor-patient relationship the patient was happy to take the cheaper, 
generic preparation as she trusted the GP.  The GP gave the patient the medication she asked 
for to maintain this relationship. 
The GPs also gave the impression that they knew the patient well.  Sometimes they did not 
remember who the patients are by their name, they only remembered once they saw the 
patient’s face.  Also they sometimes could not remember the specifics of the last consultation 
but read the patient’s notes before they entered the consulting room to give the illusion they 
remembered and to maintain the doctor-patient relationship. 
  138 
4.10.2.6 Patient Education 
Patient education involves the GP informing the patient about their condition, symptoms, risk 
factors, medication, and any potential side effects.  Patient education is important to help the 
patient understand their condition and treatment regime. Comprehensive understanding 
improves compliance and recall and ultimately gives the patient independence to manage their 
own condition and treatment regime.   
Education helps reduced anxiety and aid reassurance.  Uneducated patients are more likely to 
engage in risky behaviour, they can be non-complaint or can stop taking their medication 
altogether and thus they need more medical intervention, monitoring and more advice and 
education.  Educated patients have the potential to be independent and spend less time in the 
health care setting.  
GPs educated patients using lay language and trying giving the right amount of information to 
aid their understanding and then subsequent recall.  Know the patient meant it was easier to 
know what level to pitch the often complex clinical information. In consultations time was 
limited and the information can be complex, leaflets and/or clinical knowledge summaries were 
handed out to give the patient time to digest the information and come back to formulate a 
treatment plan.  
Dr X commented that in a 10 minute consultation it is very difficult to give enough information 
to allow shared decision making, you barely get enough time to elevate their fears.  He said 
that is why the information leaflets are so good, as they can take them away and then come 
back and discuss it with you. 
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Effective communication, a good relationship with the patient and education resulted in higher 
compliance, which alleviated their workload in the long-term.  These are all positive outcomes 
from relationship continuity.  However, in some cases the doctor could have a negative 
perception of the patient, which is discussed in more detail below.  
4.10.2.7 Perception of the patient 
By knowing and having a relationship with patients the GP formed an opinion.  In some cases 
the GPs had developed a negative perception of their patient.  This was with patients who were 
perceived as difficult; they did not comply with their medication regime, they did not listen, 
engaged in risky behaviour (such as smoking when suffering from angina or lung cancer) 
and/or demanded medication.   
GPs also developed a negative perception of a patient who frequently attended and in the 
clinicians professional judgment there was little physically wrong with the patient. These 
patients were perceived to be time wasters rather than difficult.  During one surgery a GP 
commented about a patient who has been signed off sick with back ache.  When she left the 
room he told me she is one of those patients, she is in here complaining of a sore back, she was 
signed off for two months, yet she enters and leaves here fine and jumps on the couch with little 
effort, if she had a sore back she would be in pain.  
With a negative perception of the patient GPs seemed to have less patience to listen and to ask 
probing questions. When the GP looked to see the next patient to enter the consulting room and 
they saw the patient’s name, these patients caused a reaction of ‘oh no’, they were apathetic and 
frustrated before the patient entered the consulting room.  An example of this is illustrated from 
a field note extract: Before the patient entered the consulting room Dr X said ‘Oh, no!’ This 
patient was seeing Dr Y for a while but now she keeps coming to see me, she is always in pain 
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and is a difficult person, she moans so much and doesn’t really take to leaving without 
something so you end up just giving her pain killers, I know that is bad.’ Illustrating a GPs 
opinion can affect their prescribing decision making. 
4.10.2.8 Shared decision making 
Once the problem has been identified, the clinical and patient perspective established and the 
GP has educated the patient they should plan and decide on a treatment option together. In an 
ideal world both the patient and the doctor should be actively involved in the decision-making 
process.  The theory is based on the premise if the patient has been engaged in the decision-
making process then the treatment regime should be more tailored to their lifestyle, views and 
preferences and thus they are more likely to be more compliant. 
In younger patients who were visiting for a minor or acute problem there frequently were not a 
lot of treatment options, once the decision had been made to treat the condition. The most 
common reason this group visited was for an antibiotic and as the practice prescribed from a 
practice formulary the patient received the first line preparation unless this was not suitable and 
they were prescribed the second line preparation. An example of decision-making was whether 
the patient would prefer liquid or tablets. 
In older patients with multiple co morbidities, the clinical information is complex and these 
decisions involve polypharmacy.  Involving patients in these decisions can be extremely 
difficult.  Many of these were elderly and from a generation who did not engage in shared 
decision-making and thus do not want to be involved. They expected the doctor to tell them 
what to do and they would just get on with it.  As many of them had known their GP for a long-
time the GP was aware of their preferences, views and circumstances and well informed about 
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the most appropriate treatment for the patient.  Many shared decisions were about dosages 
rather than whether to initiate treatment or not.  An example of this is given below. 
....an arthritic patient who is suffering constipation side effects from her medication.  She is 
supposed to be taking 8 a day but is only taking for 4 due to the way they make her feel.  Dr X 
asked if she had anything for the constipation and she said yes, but that she does not like taking 
them.  Dr X said you can also improve things through your diet, to which the patient replied “I 
know, I have prunes every morning.” The doctor said well you should also take some of your 
constipation medication, it is fine for you, and there is no point in suffering in pain.  The patient 
agreed to go up to 6 a day and take some of her constipation medication. 
This practice valued continuity of care and good relationships with their patients. They 
organised their appointment system to be able to give chronic patients and/or complex patients 
continuity of care with their chosen physician.   The practice felt patients who have complex or 
multiple problems need continuity. Their medical history and personal circumstances and 
preferences are also complex and intertwined thus it is very difficult for another clinician to 
pick up and understand and can be frustrating for the patient to go through their story again 
effecting the doctor-patient relationship.  This also saves time, it is limited in a consultation and 
there is not time for complex patients to tell their ‘story’ from the beginning. 
4.11 Conclusion 
This chapter has provided an overview of Rubain, the market town practice in this study.  The 
chapter has been structured around the prescribing model which has been designed to depict the 
various influences and allow a visual comparison between the three practices studied.  Initially, 
the potential influences on the patient and how they impact on the consultation were discussed.  
The external influences on the practice were considered and how the practice formulates them 
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into practice prescribing policy, essentially their macro prescribing decisions.  Discussion of the 
collective and shared decision-making and relationships between practice staff gave context to 
these macro prescribing decisions.  Finally, micro prescribing decisions were discussed in the 
consultation or interaction between GP and patient and the importance of continuity of care to 
patients with multiple and comorbidities. 
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C h a p t e r  5  
‘ROSNISH’ ~ THE RURAL PRACTICE; A DESCRIPTION AND EXPLANATION 
This section will describe the characteristics of the practice; the staff and the practice processes 
and systems.  A model depicting the prescribing influences and how the was practice organised 
is presented and followed by an explanation. 
5.1 The Setting 
5.1.1 The village 
The village was set approximately 45 miles from the nearest city, in a rich agricultural area. 
5.1.2 Practice population and list size 
This practice had a list size of approximately 2000, with a predominantly elderly and affluent 
population.   
5.1.3 The health centre 
The health centre was a large purpose built building constructed under the Private Finance 
Initiative (PFI) and completed in 2005.  It was well equipped with wheelchair access, sensor 
doors for entrance and exit of the building, handrails and low light switches are all round the 
building.  It was light and spacious and was decorated with local art work and old black and 
white photographs of the village.  
5.1.4 Opening times 
The health centre was open 8.30am to 12 noon and 4 – 5pm for appointments; it closed 12-2pm 
for administration and was open 2-4pm but only for telephone calls as this time was allocated 
for home visits. 
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5.2 Staff 
5.2.1 Clinical Staff 
The practice had one full-time GP (4 days) and a part-time GP (1.5 days).  The practice was 
classed as single-handed. These GPs were married.  During the period of observation the 
practice also had a doctor completing post-graduate training.  
The practice pharmacist was part time (one morning per week), and had been with the practice 
for 3 years. She had previously worked in both hospital and community pharmacy. The practice 
pharmacist ran the anticoagulant clinic for the practice, kept the lead GP up-to-date on 
information from the CHP and conducted audits.  Communication between the pharmacist and 
the practice was informal. 
5.2.2 Nursing staff 
The practice did not have a practice nurse.  The community nursing staff did some of the 
practice nurse roles. The practice had three full-time community nursing staff; the senior 
community district nurse, another full-time community nurse and a full-time health visitor. 
5.2.3 Reception/Administrative Staff 
This practice did not have a practice manager. The practice had three part-time receptionists.  
The senior receptionist was also the health care assistant.  She worked four afternoons a week 
as the senior receptionist. She had worked at the practice for 20 years and was married to the 
local community pharmacist. All of the receptionists had lived in the local area of the practice 
all their lives and knew most of the patients registered at the practice.  
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 5.2.4 Relationships 
This practice had a stable workforce with friendly and collaborative working relationships. 
There were two main members of staff at the practice; the lead GP and senior receptionist who 
would discuss and solve clinical and administrative problems and together.  
5.2.5 Ethos and Atmosphere of the practice 
This practice valued being patient-centred, organised and efficient.  The lead GP was the 
dominant personality in the practice and his values predominated but were also valued by the 
other members of staff. He was highly motivated and organised, particularly around prescribing 
and long-term conditions. They valued continuity of care and being a prominent part of the 
local community. The practice invested time educating patients about their condition and 
medication so they could self-manage.  This was a worthwhile investment as they had an 
elderly and stable population. Yoga classes were running in the practice at the request of 
patients.  
Prescribing was valued highly and prescribing policy was regularly reviewed and refined. The 
lead GP valued high quality prescribing. The practice had a population skewed toward the 
elderly which the lead GP felt accounted for a great deal of their higher prescribing costs.    
5.3 Communication 
The staff at this practice communicated face-to-face regularly through-out the day. 
5.3.1 Daily/Informal 
All practice staff would regularly come and go from reception; which was the hub of the 
practice.  All clinical staff would try to have their lunch in the coffee room between 1 and 2pm, 
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in particular the GPs and community nurses which facilitated the regular sharing of information 
and discussing patients.  
5.3.2 Formal 
The practice had monthly clinical and administration meetings, which alternated every two 
weeks.  Present at the clinical meetings were the two GPs, the health care assistant and the 
community nurses and at the administrative meetings were between the GPs and the 
receptionists.   
Communication was core to this practice’s culture.  They valued being organised and efficient 
so regular communication ensured issues were brain-stormed immediately. 
5.4 Organisation 
The practice felt being organised and efficient was fundamental to running a good practice. The 
practice systems are described in turn below. 
 5.4.1 Appointment system 
Patients were usually offered an appointment the day they called, unless they specifically ask 
for an appointment with the female GP.   
5.4.2 Home Visits 
The lead GP tried to discourage home visits (unless housebound or children) by offering 
appointments at the surgery as soon as possible (he would run a surgery till everyone who 
wanted to be seen had been attended to).  Patients would have to wait till the afternoon for a 
home visit.  The GP felt by encouraging patients to come to the surgery, unless it is an 
emergency allowed the practice to be more efficient. 
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5.4.3 Information Technology 
This practice transferred over to Vision from GPASS during the period of observation. They 
began preparing months in advance to try and ensure a seamless transition. Once Vision was in 
operation the GPs entered the hand written notes taken during the transition to learn about the 
new system.  The lead GP had invested time to learn short cuts for drugs he regularly 
prescribed in GPASS and was hoping to learn similar time saving techniques with the new 
system. 
5.4.4 Protocols 
As the current GP took on this single-handed practice in the light of Shipman everything was 
documented and recorded (Shipman was a GP who was a serial killer who went undetected as 
he was single-handed). The lead GP kept up-to-date with the literature and photocopied 
relevant articles as evidence of this. There were protocols for all systems which were kept up-
to-date.  Each receptionist had administrative protocols they were responsible for keeping up-
to-date and the GPs kept the clinical protocols. 
5.4.5 Personal medical services contract (PMS) 
Personal medical services are local service contracts which are negotiated between the general 
practice and the health board.  They are subject to local targets, budgets and monitoring.  This 
contract is an alternative to the nGMS contract. This practice has negotiated a contract with the 
CHP for chronic disease management but was contracted through nGMS for core medical 
services. 
The second GP was employed at the practice through the PMS contract for additional chronic 
disease management.  This allowed the GP to continue to refer to the practice as single-handed.  
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5.4.6 Practice accreditation 
Practice accreditation was awarded to practices before the nGMS contract and was scrapped in 
2005.  The accreditation raised the quality of care and teamwork within practices and was 
essentially an assessment of organisation.  This practice was proud of its accreditation and was 
working towards the Quality Practice Award (QPA). 
5.5 Systems 
The practice systems pertinent to prescribing are described below; 
5.5.1 Repeat Prescriptions 
Once a patient was stabilised on their long-term medication, they were prescribed the 
medication for 3 months. At this point they were given 3 separate scripts, one for each month. 
They would take one to the pharmacy and the other two they kept themselves and would take to 
the pharmacy when their current medication was about to run out.  The prescriptions were 
marked one, two, three, unless there was a specific instruction (such as blood pressure to be 
checked more closely). A prescription form has two sides, one which has the patient’s name, 
address, CHI number, the medication being prescribed and a specific code for the GP who 
signed the prescription. The second side of the prescription had all their repeat medication 
printed out, each with a tick box. At the end of the 3 months, once they handed their last 
prescription to the community pharmacist, they would hand the other side of the script into 
reception or into the community pharmacist who delivers it to the surgery. They use the tick 
boxes to indicate the medications they would like to re-order.  Every day the pharmacy 
assistant walks up to the health centre to deliver the reorder slips and collects prescriptions. 
Some patients are prone to losing their two repeat prescription forms.  The practice is aware 
who these individuals are and give them a one month prescription.   
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Reception staff collected all the re-order forms and if they are regular repeats prescriptions or 
ad hoc medication, such as pain killers, reception go ahead and print the prescription forms.  
These go into what the practice staff refer to as ‘the bundle’, and the lead GP signs them.  On 
some occasions the reception staff were unsure about requests to re-order medications, and 
these go through to the lead GP to check and to print off.  Signed prescriptions were collected 
by the village community pharmacy in the afternoon.  The other community pharmacies also 
come to collect their prescriptions but not as regularly.  The majority of patients do use the 
local community pharmacy in the village. 
5.5.2 Regular acute prescriptions 
Some patients were on medication for a period of time which the GP did not want to make a 
repeat prescription.  The reasons varied according to the medication and the patient.  An 
example is an anti-depressant.  Patients were monitored more closely in the early stages of their 
treatment, going from week to week and then month to month contact with the GP.  The need 
for a face-to-face consultation was reduced as they are stabilised on their medication, but they 
would never be on a repeat prescription. Patients were on regular acute prescriptions rather than 
a repeat prescription to give the GP more control, to monitor more closely or because it is 
medication they will be taking it long-term.  Patients did not need to make an appointment to 
get this medication; they were supposed to fill in a ‘regular acute prescription’ re-order form, 
which are available on the reception desk.  However, the majority of the patients call reception 
and ask for their medication. 
5.5.3 Chronic disease management and medication review 
Each patient’s chronic disease management review was at the time of their birthday to help the 
practice stay organised but it also to stop the patients from being confused.  This was also when 
their medication was reviewed. The nGMS contract requires patients on repeat medication to be 
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reviewed annually but this could be a paper based review, it did not need to be face-to-face. As 
the practice valued continuity of care, face-to-face medication reviews were seen as important 
to maintain this relationship in stable patients who did not attend the surgery regularly, by 
providing a good opportunity to chat to the patient about their medication.  
Initially, the health care assistant and/or the practice pharmacist would run searches in GPASS 
for patients with birthdays approaching the next month on repeat medication. The GP reviewed 
the list and decided who should come in for a review (some patients on repeat medication such 
as cream for psoriasis were not called). An appointment was made with the health care assistant 
for tests and another was made two weeks later with the lead GP, by which time the results 
should be available. A letter is sent by the practice to each patient informing them they are due 
to attend and gives them their two appointment times (GP and healthcare assistant), if these do 
not suit then the patient must call the surgery to rearrange. Initially, the healthcare assistant 
takes the patient’s family history, blood pressure, a blood sample, their weight and tests their 
urine. If the patient has coronary heart disease or a history of depression, they are asked if they 
have been unhappy lately, if they answer yes, they are given a questionnaire to fill at the time.  
This practice reviewed nearly all patients on repeat medication rather than only patients who 
have chronic disease as required by their contractual arrangements (nGMS), and will also 
conduct a review on patients who ask. 
5.6 Practice Prescribing Model 
The prescribing model devised for this practice is presented below, illustrating the various 
influences and how they have an effect on the practice organisation. The following text will 
explain the model in detail. 
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Figure 4: Rosnish prescribing model  
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Rosnish’s prescribing model visually depicts the influences upon the practice and shows how 
the practice values shape how they organise themselves around these influences. A key has 
been provided to help interpretation. A table with supporting empirical evidence can be found 
in appendix 7. A brief description of this model is now given to aid the reader’s interpretation.  
A more detailed description and explanation will follow this section. 
The purple box denotes the patient with the potential influences upon them.  
The blue circles represent the consultation and the depth of these circles represents optimum 
levels of continuity of care. This practice was run as a single-handed practice, with the lead GP 
consulting with most of the practice population and the second GP consulting with the 
respiratory patients.  Therefore, this practice had high levels of continuity of care, indicated by 
the number of blue circles. 
The first green box indicates the prescriber.  The first list indicates the prescribers personal 
influences and the second list indicates the external influences on the prescriber. 
The second green box indicates the influence of other practice staff.  At this practice the 
community nursing staff had more of an influence than at the other practices.  This practice did 
not have a practice nurse and the community nurses would assist in this role. These nurses had 
lunch with the lead GP most days, where they would frequently discuss patients.  In these 
discussions the nursing staff would update the GP on patients in the community.  They would 
also ask for prescriptions and home visits on the patient’s behalf, when needed.  
The reception staff were all part of the local community and knew most of the patients.  As a 
result patients did not report to the reception desk when they arrived at the surgery.  When 
patients called for an appointment the receptionists knew who usually had long appointments 
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and would book a double appointment.  They would also inform the GP of family relations 
within the community.  
The boxes over lap the blue consultation circles to indicate their influence on the prescribing 
decision.  
A detailed description and explanation for the component parts of the model is now given.  As 
the patient description is standard for each practice, a description and explanation of the patient 
influences has been given in the previous chapter (section 4.6.1) and is not repeated here to 
avoid duplication. 
5.7 External influences on practice and prescriber 
Each practice is unique in how they assimilate the external influences into the practice 
prescribing policy.  This practice’s prescribing policy is formulated by the lead GP. The second 
GP has areas of responsibility for which she formulates her own policy.  Each of these external 
influences are not viewed equally but in a hierarchy described in turn below.     
A description of each influence was given in practice one (Rubain) so the processes of each 
influence at this practice are described below. 
5.7.1 Evidence based medicine (EBM) 
The value the lead GP placed on EBM and the processes of implementing evidence into their 
clinical practice is described below.  The second GP felt she did not have time to keep up-to-
date with EBM herself so consulted drug representatives (discussed in section 5.7.4). 
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5.7.1.1 Guidelines 
Guidelines were viewed as the ‘gold standard’ in medical care. As the practice was essentially 
single-handed they did not have a practice meeting specifically about a new guideline.  The 
lead GP would read a journal called ‘guidelines in practice’ which provided helpful advice and 
ideas about implementing guidelines locally. The lead GP would read the guideline and modify 
his behaviour accordingly, and at some point update the appropriate protocol(s). During the 
period of observation a new guideline was published by the British Hypertension Society, 
which was printed off and laminated by the CHP and distributed to practices through their 
practice pharmacists.  Both GPs pinned this is a visible location and were observed referring to 
this poster. 
4.7.1.2 Journal articles 
The lead GP at this practice read a lot, he read the BMJ every week and ‘Prescriber’ every two 
weeks. “Well is it just part of the job, it is good reading really, I scan the titles, and chose what 
I want to read, I don’t read it cover to cover, but if there is something relevant to what I do, 
with topics, that, .....I used to really.....it is just part of keeping up to date.” 
4.7.1.3 ‘Comics’ 
 ‘Doctor’ was seen regularly round this practice and read by the lead GP but not the second GP. 
The lead GP referred to these magazines as a good way of keeping up on what is going on as he 
did not see drug representatives. He felt he did not need to see drug representatives as the 
information comes in the literature anyway. ‘Doctor’ and similar news type journals provide a 
summary of the latest evidence. 
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4.7.1.4 Practice library 
This practice had a library which was kept up to date with the BMJ, Prescriber and ‘Guidelines 
in Practice’ journals.  The lead GP photocopied any articles he felt were relevant and read and 
filed them as a record of what he was doing to improve his practice. 
The lead GP referred to reading evidence presented in journals as not reforming behaviour 
overnight but as updating current knowledge and keeping of top of changes.  “It is not baseline 
reading, you have to keep reading otherwise you will lose it.” 
5.7.2 Community health partnership 
The local Community Health Partnership Head of Pharmacy and lead clinician scheduled a 
visit to this practice.  All clinical staff were present.  At this meeting the head of Pharmacy 
questioned some of the practices prescribing and but accepted the decisions made and respected 
their autonomy, stating it is important for him to get the depth and context in which prescribing 
decisions are made.  The head of pharmacy went through the BNF chapter by chapter stating 
where he thought savings could be made and why such as drugs coming off patent or informing 
them the patent has been extended.  This practice was selected as it is an outlier in the CHP 
prescribing as a high quality but also high cost prescribing practice. 
The GPs referred to the CHP as an influence over their prescribing and a number of points were 
actioned as a result of the CHP visit. 
The practice did not use the CHP prescribing report filtered into the practice by their 
pharmacist.  They were top for prescribing quality and felt their aging population and rising 
numbers meant the cost indicators did not accurately reflect their current prescribing. 
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5.7.3 Health board formulary 
The practice used the Tayside prescribing formulary as the basis of their prescribing policy. 
They adapted the formulary and prescribed out with if they did not agree; such as prescribing 
Citalopram rather than Fluoxetine because it had an effect within days rather than weeks.  
Changes in the Tayside prescribing guide were brought to the attention of the practice by the 
practice pharmacist. 
5.7.4 Drug Representatives and drug companies 
The lead GP did not see drug representatives but the second GP did.  The lead GP had strong 
views against drug representatives but the second GP felt she did not have the same amount of 
time for reading as the lead GP so would see drug representatives to keep up-to-date. The drug 
representatives left pens, mugs, notepads and information brochures of the drugs they had been 
promoting, which have the potential to influence the lead GP.   
5.7.5 Secondary Care 
Secondary care had a strong influence over prescribing at this practice. Patients were 
discharged from hospital on medication and the GPs would read and learn about this 
medication to gain knowledge and experience. The lead GP would go to local meetings held by 
consultants to learn more about the drugs they are recommending.  If the GPs had tried 
numerous medications with a patient and were unsure they would call the appropriate 
department in the local teaching hospital for advice.   
The GPs became aware of what the consultants are prescribing for a particular disease and 
would tend to follow this trend.  As the GPs look after more and more patients on the 
medication they would gradually become familiar with medication and would eventually start 
prescribing the drug themselves.  An example of this is given below: 
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The GP prescribed Metformin for a patient who was overweight and had polycystic 
ovaries(PCO).  After the consultation I asked about this.  The GP explained that Metformin has 
been prescribed for the past few years by gynaecologists.  This patient has been trying hard to 
lose weight with little success so her PCO could be why she is not losing weight, so it is a good 
excuse to try it and see how she gets on. 
On occasion patients had been to an outpatient’s appointment but the letter with their drug 
recommendations had not arrived at the surgery.  The GPs took the patients’ word for it.  On 
one occasion I asked about this, to which to the GP responded ‘where else would they have got 
the name from.’ 
5.8 Other practice staff 
Practice staff had an influence on the practices prescribing policy and behaviour.  The role of 
the different members of staff and how they had an influence on prescribing is discussed in turn 
below; 
5.8.1 Practice pharmacist 
The practice pharmacist in this practice had a different role from the pharmacists in the other 
two practices considered in this PhD.   
5.8.1.1 Tayside initiative and specific practice pharmacist role 
As part of the Tayside practice pharmacist initiative, pharmacists had to do a certain amount of 
INR as their salaries had been secured on this.  As this practice did not have a practice nurse the 
practice pharmacist would do this practice’s INR to count towards the total INR hours 
pharmacists had to do to justify the CHP payment.  This meant the practice pharmacist had less 
time to influence prescribing policy. 
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5.8.1.2 Practice prescribing meeting 
This practice did not have a prescribing meeting.  There were only two prescribers and only the 
lead GP was in on same day as the practice pharmacist.  He left a note in her pigeonhole or 
opportunistically caught her if there was something they needed to discuss.  Likewise, the 
pharmacist operated in the same manner.  They would discuss any information which came 
from the CHP regarding prescribing and any queries which had originated from a patient 
interaction. 
5.8.1.3 Clinical role 
The practice pharmacist was only with this practice for one morning a week.  The majority of 
her work was concentrated on the INR clinic but she would also run searches for the birthday 
bloods of patients on a repeat prescription. Medication reviews and audits were also conducted 
but not as frequently as in practice one. The lead GP liked to do his own medication reviews, as 
he saw it as a good way to keep in touch with the patients who were stable on their medication. 
The medical students ran audits for the practice as part of their project they were required to do 
as part of their time at practices. If a problem arose the lead GP and the second GP would audit 
to find out immediately what was going on rather than waiting for the practice pharmacist.   
This practice pharmacist enjoyed the contact with patients and did not seem to enjoy the 
influencing of prescribing budgets.  The lead GP was good at keeping up-to-date himself with 
‘best practice’ in prescribing and was innovative with a strong vision and values towards doing 
the best for his patients. 
5.8.1.4 Cost-efficiency role 
The CHP had a prescribing budget and it was the practice pharmacist’s role to influence 
prescribing cost-efficiencies. Each practice had a prescribing budget calculated on their list 
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size, however as this calculation was based on the list size 18 months previous and this 
practice’s list size was growing quickly they felt their prescribing budget did not reflect their 
list size.  
The GPs at this practice enjoyed innovative prescribing practices (i.e prescribing new drugs), 
which tends to result in higher prescribing costs.  An example the practice were proud of was 
their chronic disease management prevention policies and procedures as this had been 
implemented here before nGMS contract.  Another reason the lead GP felt they had higher 
prescribing costs was due to their statin prescribing policy, patients were on a statin before this 
was recognised as primary prevention in a SIGN guideline.   
5.8.2 Community nurses 
The coffee room was used by all staff in their lunch hour.  This provided an opportunity for the 
GPs to catch up and chat with the community nurses. They would talk about patients the 
community nurses had seen; they would update the GPs on their patients and provide any 
contextual information, ask for prescriptions, and generally have a discussion about patients out 
in the community and possibly ask the GP to make a visit. 
5.8.3 Receptionists 
All practice staff regularly popped in and out of reception. The receptionists had been members 
of the local community all their lives and knew most of the patients well.  The patients did not 
report to reception when they entered the consulting room, they just went and sat down as the 
receptionists knew who they were.  Two of the receptionists had worked at the practice for 20 
and 16 years respectively.  They provided the GPs with background information about patients, 
if required.  As the lead GP told me on one occasion the receptionists only tell him who is 
related to who and the full story once he has put his foot in it.  
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The GPs would listen to the advice and information provided by colleagues but ultimately the 
GPs made the prescribing decisions. 
5.9 The Prescriber 
The GPs had core influences which affect each prescribing decision.  These influences were not 
given equal weight so are listed in their hierarchy below:  
5.9.1 Experience 
The GP’s experience had the strongest influence over their prescribing.  They had become 
comfortable and knowledgeable about a range of medication. The lead GP had invested time 
with the IT system to create short cuts with the range of drugs he liked to prescribe, which did 
promote habitual prescribing.  
5.9.2 Personal beliefs, attitudes, views and preferences 
Through their experience and years in practice GPs can build and strengthen beliefs, attitudes 
and views.  They had their own preferences of medication which has been established through 
their experience.  They knew this medication well and were comfortable prescribing it.  The 
GPs had also formed opinions of certain medications which other GPs would not agree with, 
such as the efficacy of a drug or the severity of the side effects. 
The GP’s prescribing decisions were also shaped by their values towards quality and cost 
effective prescribing.  At this practice the GPs valued quality prescribing but also appreciated 
the NHS has limited resources. They would prescribe medication they thought the patient 
needed rather than prescribing a generic if they thought it was not as suitable. An example of 
prescribing a more costly drug is in this practices antidepressant prescribing: 
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The CHP prefer GPs to prescribe Fluoxetine as a first line antidepressant but this practice 
tends to prescribe Citalopram because of the length of time it takes to have an effect.  .  The 
lead GP told me Fluoxetine takes 3 to 4 weeks where Citalopram takes 7 to 10 days, and feels it 
usual takes time for patients to present with their symptoms so when people have been low and 
depressed for a long time already you can start to make a difference more quickly with 
Citalopram. 
This provides a good example of the GPs values towards their patients and the CHP budget.  
This practice is prepared to trade off the added expense for the speed with which the drug will 
take effect. 
The GPs at this practice had continuity of care with nearly all their patients so they also had 
knowledge and experience of the current patient, their circumstances and conditions, and 
experience of their views and opinions towards medication. 
5.9.3 Knowledge of the patient 
The lead GP had been at this practice for over 7 years and for most of those years he had been 
practicing on his own.  Thus, he knew the majority of his patients, in particular those who 
attended regularly and those on repeat medication. As this is a small community, the GP knew 
some information about his patients who did not attend, such as where they lived or about their 
lifestyle.  The second GP was responsible for women’s health and respiratory problems so also 
knew the regular attendees well.  
Caring for their patients over such a long period of time they knew about their medical history 
but also to know about their family and social life, their issues, concerns, problems, support 
networks and hobbies.  They were frequently caring for generations of families and for relatives 
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which gave them insights into more medical history than possibly the patients had revealed in a 
consultation.  All this information was dependent on how long the patient had been registered 
and then the frequency of a patients visits and how much of a relationship and trust has been 
established. 
5.10 Interaction/Consultation 
An interaction or consultation is a meeting of a GP and patient in the surgery or at home, in 
some cases they will know each other well (patients with long-term conditions) and in other 
cases not so well (fit and healthy presenting with acute problems).  As one GP does the 
majority of consultations with an elderly practice population the GP seemed to know most of 
his patients well.  Through regular consultations GPs and patients built a relationship, gained 
knowledge (GP learns about patient and patient learns about their condition and treatment) and 
build trust which all together facilitate effective communication.  This communication helped 
gain more knowledge and expedited shared-decision making.  This is known as continuity of 
care and is expressed in the model through the blue circles.  
The structure of an interaction was described and illustrated in practice one.  The influences at 
work in a consultation and their processes specific to this practice are described in turn: 
5.10.1 Continuity of care 
The various aspects of continuity of care are considered below.  Descriptions of each construct 
has been given in practice one. The section will consider how these effect prescribing decisions 
in ‘Rosnish’. 
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5.10.1.1 Patient’s notes 
A medical record of each consultation is kept in a patient’s notes. Each set of notes also contain 
the patient’s name, address, age, past medical history, any medication they are on or have been 
on, allergies and previous visits at a GP with the diagnosis and outcome of the consultation.  At 
this practice the lead GP did not always read the patient’s notes before they entered the 
consulting room.  This very much depended on how frequently they consulted.  However, the 
second GP invariably read their notes.  As this GP only consulted once a week she looked at 
the last or last couple of entries into the medical record. The lead GP was comfortable referring 
to a patient’s notes during the interaction if necessary to check their medication history, 
including any allergies, and the central computer system for biomedical results.  
5.10.1.2 Relationship continuity of care 
Through numerous consultations the doctor and patient built a relationship.  During this process 
of building a relationship the GP came to know the patient, their preferences and values, and 
about their context and circumstances.   Most of this information was not recorded in their 
notes, but known tacitly by the GP.  Through this period of time the GP had educated the 
patient about their condition, listened to their concerns and apprehensions and helped them 
address these issues. As a consequence they established a relationship built on trust and respect. 
5.10.1.3 Knowledge of the patient 
When the GPs knew their patients they frequently saved time as they already knew a lot about 
their patients, they did not need to look up the patient’s notes or ask for more information to aid 
their decision-making, illustrated below: 
A patient was very distressed. She said she had had trouble sleeping.  The GP starts by asking 
her what is wrong.  The patient goes on and tells her what seems to be a multitude of problems 
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which the GP seems to be informed about: well certainly informed about the on-going 
problems, not so much the later ones (I can see her struggling to remember all the family 
details). 
Over time the GPs had learned about where a patient’s domestic arrangements, their medical 
history, any significant past medical events and the impact of these on the patient. Also about 
their personality, their support networks, hobbies to name a few. In one consultation observed a 
patient was suffering from Alzheimer’s disease and was in consultation with the GP by himself, 
below is an extract from the field notes from the consultation: 
This patient was complaining about a cold and said he had been suffering for about 2-3 weeks.  
The GP asked him if he still had his blue inhaler, he said no and was given a prescription to be 
used four times a day until this clears up.  When I asked the GP about the prescribing decision 
he told me the patient was forgetful and the joking was to disguise his dementia, and that he 
had actually seen him about this a week before.  I asked how comfortable he was giving a 
script to a patient who was likely to forget, and the GP told me his wife is very good, she knows 
exactly what he is like and will be waiting for him in reception and will get the required 
information and ensure he complies with the instructions.  
5.10.1.4 Preferences and values 
Through consultations with patients the GPs learnt about their preferences and values. Whether 
the patient liked to be educated about their condition and engaged in some form of decision-
making about their treatment or whether they thought ‘the doc knows best’. With patients who 
consulted regularly the GPs came to know about the patient’s values and preferences.  Often 
the preferences were over liquids rather than tablets as the patient has problems swallowing. 
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They were aware of what aspects of a patient’s life were important to them and where they 
were prepared to compromise. 
5.10.1.5 Relationship with patients 
Effective communication, trust and respect were important aspects of the doctor-patient 
relationship as the patients would tell the health professional about what is going on in their 
lives.  The GPs at this practice spent time building a relationship with their patients and 
befriending them to improve this relationship.  The lead GP liked the patients to come if they 
think they had a problem, he had the view that many problems can be dealt with less pain and 
less invasive treatment if caught in time.  The lead GP had spent time with the patients trying to 
understand their past medical histories and what has been going on and is prepared to spend 
multiple consultations addressing their issues to save time in the future.  The community nurse 
told me “the patients speak very highly of them” when referring to the patients at the practice, 
indicating a good level of trust.  A detrimental aspect of this trusting relationship is described 
below:  
“They discuss the patient that was admitted to hospital this morning……….Whilst they are in 
the waiting room the receptionists find out that the man’s condition had deteriorated whilst XX  
was on holiday but they did not want to see a locum, so they had waited until XX had got back 
before they called. Then they were not forceful about getting a visit or appointment with XX.  
XX was not amused, he was annoyed more than angry, saying that this man could easily die 
now.  Why did they not come in and see the locum?”  
The new purpose build health centre and patients being offered an appointment usually within 
24 hours was also likely to make patients feel more cared for.  Sometimes the GPs did not 
remember the specifics of their last consultation with a patient but read the patient’s notes 
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before they entered the consulting room to give the illusion they remembered, to maintain the 
doctor-patient relationship. 
5.10.1.6 Patient education 
When patients were newly diagnosed they needed to be informed about their condition, 
symptoms, risk factors, medication and any potential side effects.   Good communication 
ensured this information was imparted at a level the patient would understand and/or the patient 
felt comfortable asking questions.  The ultimate aim at this practice was to make patients as 
independent as they can be through education and empowerment. The second GP described 
patient education as: “the building blocks of future prescribing decisions.” Through 
consultations the patient’s understanding deepened and they came to terms with their illness 
and were able to engage in decisions about their treatment.  The GPs did not try to educate the 
patients in one consultation; in some cases they gave the patients information leaflets to help 
them digest the information. 
This patient had a sore back.  The GP examined her and felt she needed some pain relief.  She 
prescribed her some diazepam, explaining it was just a small dose of 200mg.  The patient was 
concerned that she did not want to take anything which will make her drowsy (she was in 
consultation with a small child) and that she was looking for advice. The GP printed off an 
information sheet about back pain and told the patient to take the medication if required and to 
come back if it does not get any better. 
The lead GP at this practice did not believe in ‘heart sinks’ (colloquial term used by GPs to 
refer to patients, where the GP’s heart sinks when they see the patient’s name) and believed 
they are patients who do not understand their condition or have issues which need to be 
addressed.  As a result he was prepared to spend time listening to patient’s issues and concerns, 
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educating them about their condition and trying different treatment options.   He told me “.. 
believes patients attend because they’re uncertain, they‘re scared or they’re stressed either 
because of their condition or because of their medication and if you can alleviate that then they 
are happy to go and they can live with their condition.” In some cases patients needed to learn 
to live with their symptoms or side effects and by spending time ensuring they understood they 
could learn to live with their condition.    
Some patients were hostile to the information being broken by the GP.  They did not like being 
told about their risk factors.  In one consultation a patient was very resistant to coming off her 
HRT.  The GP tried to educate her about her risk factors and kept checking she understood 
what she was being told.  She understood her risk factors but was prepared to take the risk as 
she was scared of her menopausal symptoms returning.  The GP went back through the 
information emphasising her risk factors but she was still very resistant so the GP chose to 
leave this issue till her next consultation.  The patient was also suffering from high blood 
pressure and gastric problems so would be back in the not too distant future.  
Patient education was important for patients to feel equipped and informed to be able to engage 
in discussions about their treatment.  
5.10.2.7 Perception of the patient 
By knowing and having relationships with patients the GPs form an opinion.  In some cases the 
GPs had developed a negative perception of their patient, such as the patient being non-
compliant or always looking for medication.  The frequency of the patient’s visits can also 
affect the GPs perception.  An example is given below:  
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“Whilst observing the second GP at the practice, the medical student came in to update the GP 
on his consultation with the patient.  The GP was not happy that the medical student had sent 
the patient away without having seen her first.  The GP explained to the medical student that 
this lady is not likely to be complaining, if she has come then it will be something worth 
consulting about.  The medical student had told the patient to buy a topical painkiller and a 
strap.  The GP explained that this lady gets free prescriptions and they give out supports to the 
patients at the surgery for free, and the lady would have known this, ‘what will she think’.  The 
GP went on to explain that topical painkillers are expensive and that she would have given her 
a prescription for this.  The GP knew how frequently this patient consulted, deeming each visit 
worthwhile, also demonstrating a knowledge of the patient’s financial circumstances, showing 
that this would influence whether a prescription is written or not.”   
5.10.1.8 Communication with the patient 
The foundation of a good doctor-patient relationship is good communication.  To be a good 
communicator is the ability to both listen and convey information. The GPs have been 
practicing for a number of years so were fluent in these skills.  Communicating with patients 
can be a very difficult job; this depends on the information being disclosed and the emotional 
state of the patient.  In early diagnosis the GP could be communicating difficult information, 
educating the patient about their condition, prognosis and then trying to engage the patient in 
shared decision-making about their treatment.  Treatment options were often not clear and were 
discussed as part of ‘trial and error’, so on occasion the GPs had to make the patient aware of 
the potential side effects and imparted complex information for a decision which may need to 
be reviewed.  Elderly people are more prone to memory loss problems and confusion which 
can mean the information and discussions need to take place more than once.   
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The GPs at this practice saw good communication with patients as the foundation of the doctor-
patient relationship. On my first visit at the practice I was asked to design a poster for the 
practice informing the patients that there would be a researcher at the practice and what the 
project was about. However, most communication between doctors and patients took place in 
interactions either in the surgery or the patient’s home. As stated, medical information is often 
not black and white, which meant it was important for patients to be able to ask questions to 
address their concerns and issues. The lead GP told me he “values communication as it is 
important to talk about emotional aspects” allowing the GP to engage in a discussion with the 
patient about their concerns.  
The lead GP was of the opinion that patients should be informed of their prognosis early on so 
they have time to come to terms with their illness. The organisation of this practices 
appointment system meant the patients had an opportunity to come back the next day if they 
had any issues which they would like addressed.  The organisation also allowed the GP the 
opportunity to ask the patient to come back for another appointment if they felt it was too much 
information to disclose to the patient in one consultation.  Unfortunately, when sensitive issues 
were being addressed in consultations I did not observe these to protect the patient’s privacy 
and to maintain the doctor-patient relationship. 
This practice had a large elderly population, where the practice felt the majority were well 
educated and compliant.  They seemed to be listening to what the GP was telling them.  They 
asked questions and seemed to be taking the information on board.  The lead GP was a firm 
believer in a good relationship with patients; patient education and good communication to 
empower patients to self manage their condition. 
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5.10.1.9 Shared decision making 
Both the patient and the doctor should be actively involved in the decision-making process; 
however this was not always the case. Shared decision-making is based on the premise that if 
patients are engaged in decisions about their treatment then they are likely to be more 
compliant.  
The GPs were constrained by time; they had, on average, less than 10 minutes to convey 
complex information to patients. Those who were suffering from long-term conditions needed 
time to be educated about their condition and for the GP to ensure they understood, which often 
required multiple consultations. Much of the clinical information was complex; in patients with 
multiple morbidities these decisions involved polypharmacy.  Involving patients in these 
decisions was extremely difficult. The practice was also constrained by budgets and finance 
and frequently did have a number of treatment options to offer.  
In young patients with acute problems the GPs at the practice prescribed from the practice 
formulary. As illustrated above with older patients and patients with chronic conditions many 
prescribing decisions were not straight forward. However, some patients, in particular the 
elderly, did not want to be engaged in their decision-making.  An example is given below: 
Although this patient was in the practice for a medication review, they spoke mostly about his 
hips as they have been giving him a lot of bother.  The patient’s blood pressure was high but as 
the patient was over 90 the GP said he would prefer to double the dosage rather than prescribe 
something else.  The patient said he would take and do whatever the Doc tells him to do. 
Some patients had strong views for or against taking medication and despite good 
communication and education about risk factors they were strongly opposed. These prescribing 
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decisions were difficult to observe as discussion often took place over a number of 
consultations. The lead GP was observed trying to get to the root of the patient’s problem and 
then leaving the issue and trying to address it again before the consultation drew to a close.   
At the beginning of the consultation the GP had mentioned her HRT and said that he would like 
to get her off it soon, but it was her decision.  She did not like this idea so the GP left it and 
went on to the matter in hand.  After this issue was addressed the consultation came round 
again to her medication with the GP explaining he felt that he had to put her on something for 
her high blood pressure and explained her HRT was a risk factor. The patient has suffered 
from what the GP thought was a minor stroke but what was the point in putting her for a scan 
when she is at risk. The patient then seemed more open to address the HRT issue. 
Prescribing decision making was based on a good relationship between the GP and patient 
where the patient trusted what the GP was telling them and was open to informing the GP about 
their condition, complying with their medication regime and attending the surgery again if 
anything changes. 
5.11 Conclusion 
This chapter has provided an overview of Rosnish, the rural practice. This chapter has been 
structured around the practice’s prescribing model, illustrating the various influences on the 
practice and how the practice was organised. A description of how each of these influences has 
had an effect and the processes the practice had in place to deal with these issues has been 
provided.  
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C h a p t e r  6  
‘HAUN’ ~ THE URBAN PRACTICE; A DESCRIPTION AND EXPLANATION 
This chapter will describe the characteristics of the urban practice; the staff and the processes 
and systems.  These descriptions provide contextual information to aid explanation of the 
prescribing model, the influences on prescribing and how the practice responds to these 
influences.  
6.1 The Setting 
6.1.1 The city 
This was a city centre practice, located in the heart of a small city centre close to amenities and 
shops. There were a number of community pharmacies within a short distance of the practice. 
6.1.2 Practice population and list size 
This practice had a list size of approximately 8500, although the population of the practice 
could fluctuate by 400-500 when the academic year started and finished due to the large 
number of students registered at the practice. 
This practice population was more deprived and with a wide range of socio-economic 
problems, including drug misuse, in comparison to the other practices studied. Some of these 
patients habitually attended on a frequent basis and could be disruptive. 
6.1.3 The health centre 
The building was old and not purpose built. It lacked the fresh, clinical feel of ‘Rosnish’ but 
was fit for purpose. The majority of consulting rooms came off the waiting area, these rooms 
were not soundproofed and as a result the GPs did worry about patient confidentiality. 
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The patient call system in the waiting area was not liked by the receptionists who reported 
complaints from patients. The patients were issued with a card when they reported to the 
reception desk.  The GPs pushed a button from their room when they were ready for the patient 
and the patients could see by the last number hanging on the hook as to who was next. 
However, as patients did not turn up in sequence, the receptionists tried to give the appropriate 
card for the appointment time but frequently the cards were out of sequence or missing.  
6.1.4 Opening times 
The surgery was open Monday to Friday, 8am to 6pm.  The times of surgeries varied, in the 
morning they usually started 8.30, 9, 10.30 or 11am. The afternoon surgeries started any time 
between 1.15 and 3pm. 
Unlike the other two practices, this practice did not close regularly during the working week. 
This practice would catch up with administration and training during protected learning time 
sessions. 
6.2 Staff 
6.2.1 Clinical Staff 
This practice had seven GPs, two full-time and five part-time. The GPs varied in age and length 
of time with the practice.  
The practice pharmacist worked part-time (3 days a week). She had previously worked as a 
pharmacist in primary care with the role of influencing GP prescribing behaviour.  
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6.2.2 Practice Nurses 
There were one full-time and two part-time practice nurses and a full-time health care assistant.  
The practice also had a specialist nurse who would come in and run their Asthma and COPD 
clinics. 
6.2.3 Reception/Administrative Staff 
This practice had four core administrative/reception staff and a further nine receptionists. The 
core administrative and reception staff were the practice manager, the IT administrator and two 
senior receptionists. The practice manager and the IT administrator (second in command) had 
previously worked as receptionists and were actively involved in the running of reception.  
There were also two part-time senior receptionists who were responsible for the day-to-day 
running of reception.  
With such a large number of part-time staff a large part of the practice manager’s role was the 
organisation of reception, appointments and holidays. She was also responsible for the 
maintenance of the building, the business and finance, and human resources. 
6.2.4 Locums 
The practice used locums to cover holidays and sick leave.  In comparison, to ‘Rubain’ this 
money came from the practice budget and was for ‘crisis management’ rather than routine time 
off for the GPs. 
6.2.5 Practice pharmacist role 
This practice pharmacist primarily worked on reviews of individual patients, reviewing 
discharge medication or providing advice about complex interactions. She also did medication 
reviews and audits but these took a backseat to the immediate requests of advice for individual 
patients.  
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Each practice had opted to organise themselves in different ways and although the practice staff 
had the same job title they did not always have comparable roles.   
6.2.6 Relationships  
All the practice staff seemed to have a good working relationship.  Due to the number of staff 
the practice had groups that were friendly and not exclusive. The receptionists were very 
sociable and dined together at lunchtime. The GPs were never observed together and did not 
have the same jovial relationships as were present in ‘Rubain’, however, seemed to have good 
working relationships when they did get together. 
6.2.7 Ethos & Atmosphere of the practice 
This practice saw themselves as the modern practice with a high number of part-time staff and 
modern communication strategies. They were patient centred and strived to do the best by their 
patients but had not organised themselves to achieve this.  The practice did not have the same 
processes, systems and procedures as had been the case in ‘Rubain’ and ‘Rosnish’.  They did 
not pride themselves on being organised and systematic, and did not value being consistent in 
their prescribing behaviour. The practice did not have a senior partner and was proud of this 
egalitarianism but with their practice manager so heavily involved with reception the researcher 
felt the practice lacked leadership. 
6.3 Communication 
The practice did not place a high value on face-to-face communication as had been the case in 
the previous two practices and communicated via email. 
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6.3.1 Daily 
The clinical practice would communicate via email.  Staff would come and go from reception 
but would not ‘chat’ as in Rubain and Rosnish.  The receptionists communicated with the 
clinical staff by leaving messages on Vision (the clinical IT system see 6.4.3). 
6.3.2 Formal 
The practice had one regular weekly meeting with the community nursing staff on alternate 
Tuesdays and Wednesdays to try and ensure most GPs could attend. The majority of GPs 
worked on a Monday so they had a scheduled coffee break but this was frequently used and 
time to catch up when running behind with appointments. The practice did have meetings with 
the practice pharmacist, business meetings and administrative meetings but these were as and 
when required.  
Arranging prescribing meetings was difficult due the number of part-time GPs and the practice 
pharmacist also working part-time. The pharmacist would meet with one GP to review 
prescribing projects and audits.  This is where decisions were made and then sent round the 
other GPs by email for comment. 
Due to the number of both clinical and administrative part-time staff the primary means of 
communication was via email. 
6.4 Organisation 
6.4.1 Appointment system 
The practice organised itself so that the majority of appointments were bookable on the day.  
70% of appointments were bookable on the day and 30% in advance.  The appointment system 
was monitored by the practice manager to ensure there were sufficient on-the-day appointments 
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to meet the nGMS contractual arrangements; however, this was at the expense of advance 
appointments.  Situations were observed where a GP would like to see the same patient again 
so they would book another appointment themselves during the consultation and were 
frequently left with no option but to book an on-the-day appointment as there were no 
advanced appointments available.  This resulted in the on-the-day appointments being full 
minutes after the phone line opened in the morning.  Some GPs would add extra hours to their 
surgeries to cope with demand but there were only three GPs who did not have young children 
and were able to do this.  
The GPs valued continuity of care with some patients.  This practice struggled to work within 
the constraints of the nGMS contract to offer continuity of care. 
6.4.2 Home visits 
Patients were asked to call before 9am to arrange a home visit. Arrangement was at the 
receptionist’s discretion. These visits were assigned to the GPs but the GPs could see each 
other’s home visits and use their own discretion and common sense and on occasion visit a 
patient assigned to another GP. 
6.4.3 Information technology 
The clinical information technology system used by this practice was Vision during the period 
of observation.  This system was the primary means of communication between the GPs and 
receptionists.  
6.5 Systems 
This practice had two systems which were important for prescribing.  These are described in 
turn below. 
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6.5.1 Repeat systems 
Patients requested repeat medication by ticking the prescription re-order form (the tear off slip 
on the right-hand side of the prescription). The re-order form was posted in a box in the 
surgery, handed into reception, or posted. Alternatively, patients could call the surgery and 
leave a message on an answer machine solely for repeat prescription use, or they could email 
the surgery with their request.  The practice had a policy to process these within two days of 
receipt, although it appeared to be within one working day.  A senior receptionist processed the 
prescriptions and highlighted any issues on the right-hand side of the prescription for the GP to 
see before they sign the prescription (possibly prompting a look at the patient’s notes).  
6.5.2 Special request 
Special requests were for medication which the patient would be taking for a period of time 
where they would need to re-order but where the GP would like more control over than a 
regular repeat prescription. 
6.5.3 Chronic disease management 
The nGMS contract requires patients on repeat medication to annually have their medication 
reviewed.  Reminders would pop up on the clinical information screen during a consultation to 
inform the GP the patient’s medication is due for review.  These pop-ups would also appear for 
QOF related issues such as blood pressure needs to be checked.  If the GP or pharmacist had 
time in their consultation they would do some of these checks and reviews.  However, if the 
consultation was overrunning these would be left until the patient’s next visit. If a patient does 
not attend the surgery they would not be picked up. 
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This section has provided a description of the practice characteristics and organisational and 
clinical systems to give context to the remainder of this chapter.  Some interpretation has been 
given to guide the reader to some of the differences between the practices previously described.  
6.6 Haun practice prescribing model 
A prescribing model has been devised for this practice.  This model has been designed in 
keeping with the previous models to allow the reader to quickly see the differences between 
how the practices communicated and organised themselves around the influences on 
prescribing.   
A brief description and explanation of the model will now be given to aid the reader’s 
interpretation (a table with supporting empirical evidence can be found in appendix 7). A more 
detailed description and explanation of the model will be given in the subsequent sections. 
The purple box represents the patient and their personal influences. 
The first blue circle represents the initial consultation and the second blue circle represents the 
potential level of continuity of care.  Due to the high number of part-time staff this practice 
struggled to offer optimum levels of continuity of care. 
The top green box represents the external influences on the practice.  The following large green 
box represents the prescriber and their personal influences.  The external influences went 
straight to the prescribers, represented by the lines between the influences and the prescriber 
boxes.  Unlike Rubain, the practice pharmacist was not the main mechanism by which these 
influences filtered into the practice. Secondary care prescriptions were checked by the practice 
pharmacist and the CHP influences on prescribing where filtered through the practice 
pharmacist.  This is represented by these boxes and the lines of communication only pointing 
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towards the practice pharmacist.  The practice pharmacist would communicate and provide 
prescribing advice on individual patients; this is represented by the line of communication 
between the practice pharmacist box and the prescriber box.  The pharmacist also consulted 
with individual patients and this is represented by the line between the pharmacist and patient 
boxes. The final green box represents the practice and community nurses who would inform 
GPs about individual patients and on occasion ask for a consultation or prescription on the 
patient’s behalf.  In Rubain, there was a high level of face-to-face communication and shared 
decision-making among the practice staff and this was indicated by the green boxes 
overlapping.  In the Haun’s prescribing model the green boxes are not overlapping to show the 
lack of face-to-face communication and shared decision-making.  
Each of the boxes are now described in detail.  The prescribing model for ‘Rubain’ was 
described in detail, providing a description and explanation of the influence of patients so has 
not been given here to avoid duplication. 
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 Figure 5: The Haun practice prescribing model 
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6.7 External Influences on Practice and Prescriber 
This section presents the standard influences on all practices in Tayside Health Board with an 
explanation as to how Haun assimilates these into practice prescribing policy.  These influences 
were not viewed equally but in a hierarchy and are described in turn below.  
6.7.1 Evidence based medicine 
Evidence based medicine is the process of evidence being implemented in clinical practice.  
Evidence arrived in the practice from various sources such as academic journal articles, 
guidelines and synthesised means in news type journals.  The GPs felt overwhelmed by the 
volume of information they were expected to read, as one GP at this practice explained: in 
primary care you have to keep learning yourself and try and stay on top of it. 
6.7.1.1 Guidelines 
Guidelines were viewed by this practice as the ‘gold standard’ in evidence based medicine and 
had the most dramatic effect on their prescribing behaviour.  When a new guideline was 
published the practice pharmacist would read the guideline and have a meeting informing the 
GPs of the recommendations. In every meeting observed, the GPs who had attended agreed to 
modify their behaviour accordingly with little disagreement or discussion. As this excerpt from 
field notes illustrates; they all agreed with the information in the SIGN guideline, there were no 
real comments, everyone said it was fair enough. They all agreed to treat cholesterol over 8. 
This excerpt is to illustrate the effect new Guidelines had on prescribing behaviour the effect of 
the pharmacist and the practice prescribing meetings are discussed in sections 6.81 and 6.8.1.2. 
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6.7.1.2 Journal Articles 
All GPs at the practice received the British Medical Journal.  This journal was regularly seen in 
the GPs consulting rooms but never being read.  It could be the case the researcher did not see 
the GPs reading. One commented about reading journal articles: 
“Dr X told me his prescribing was shaped by new evidence, through new guidelines coming 
out.  I asked about journals and he said no, he does not read them anymore as he does not have 
the time.  He went on to say he used to when he was younger but he said some of the evidence 
there is flawed and GPs do not have the skills to critically appraise journals.” 
The practice pharmacist subscribed to ‘prescriber’ but reported reading this with a caution as it 
can be drug company biased. 
6.7.1.3 ‘Comics’ 
‘Doctor’ was seen regularly around this practice and one GP was observed reading this 
regularly in the coffee room at lunch time.  She did not read every article but flicked through 
and read what caught her eye. 
6.7.1.4 Practice library 
This practice had a library but was as an office for administrative staff.  There was a wide 
section of books but it did not appear to have been kept up to date. 
In Rubain the practice pharmacist filtered evidence into the practice and Rosnish was organised 
in such a way to allow time for the GP to read.  At this practice only one GP seemed to have the 
time or the motivation to keep up-to-date with the literature and evidence personally (this is a 
requirement of annual appraisal and revalidation for all GPs). The practice pharmacist had 
email communication with other practice pharmacists and would circulate any relevant 
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information round the practice by email; however, it was unclear whether this was read in 
detail. 
6.7.3 Community health partnership 
The practice pharmacists were employed by the CHPs but worked in general practices.  Their 
role was to influence GPs’ prescribing behaviour.  The CHPs were in regular communication 
with the pharmacists through regular meetings and by email, informing the pharmacists of the 
latest topics for change which had been agreed by the CHP clinical leads. The majority of these 
projects were cost related but CHPs encouraged the pharmacists to put a quality slant on their 
pitch to the GPs.  In the Haun the practice pharmacist would circulate emails informing the GPs 
of the required changes to their prescribing.  These cost changes were not always warmly 
received by the GPs and were de-motivating for the pharmacist. For example: The practice 
pharmacist complained  about doctors having to switch patients between generic medications 
for very little money, but she is pressured by her boss and yet they have just written a 
prescription for medication at £35,000 for one course of medication for one patient. The cost 
efficiency switches resulted in extra work; reviewing lists of patients on the medication, the 
actual switch on the computer and generating letters to patients informing them of the change.  
In some cases the patients were not happy with these changes or could not tolerate their new 
medication which resulted in additional consultations with the GPs.  The cost savings in one 
patient were minimal but across the population of patients the savings could be significant. 
The GPs and the practice pharmacist did appreciate the NHS has limited resources but found 
changing medications for minimal cost savings frustrating as they would be changing them 
again when another drug was cheaper. 
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An expensive prescription was authorised by the lead pharmacist for the CHP.  This excerpt 
from field notes gives the context behind the prescribing decision:  
There was a note in reception for the practice pharmacist from Dr XX asking her to check a 
prescription dose and the monitoring which is required.  The patient had broken his leg, but is 
a drug user so his leg won’t heal and he has a deep infection in the bone.  Dr XX wants to 
prescribe an antibiotic which is very expensive.  The practice pharmacist checked the patient’s 
notes and Martindale’s pharmacopoeia.  He needed weekly monitoring and blood tests but the 
pharmacist felt it was highly unlikely he would turn up to the practice each week.  She did not 
see any contraindications so printed off the prescription and writes a note to Dr XX 
recommending weekly dispensing so they can do the blood testing.  She also typed an email to 
the lead CHP pharmacist detailing the context and circumstances and explaining it will cost 
£33,780. 
This excerpts helps explain some of the frustration felt by GPs and pharmacists when they are 
asked to make cost based switches for minimal savings in patients who have paid their taxes, 
which results in increased workload, yet they are asked to write expensive prescriptions for 
patients who do not seem to care about their health. 
The CHP compares practices against one another by various prescribing indicators and presents 
this in a report.  The practice pharmacists are expected to present and interpret this report to the 
GPs; however the Haun did not use this report.  They did not believe the indicators and the data 
in the report were robust and valid enough as they did not take account of the practice 
population.  This data is only based on cost and volume and does not account for 
appropriateness of prescribing.  This practice had a large student population and therefore had 
low cost prescribing.  The pharmacist’s views towards these measures are shown in this excerpt 
  186 
from field notes: The practice pharmacist tells me that the indicators are flawed as they use 
very crude analysis tools.  They do not take account of the differences in populations, such as 
this practice has significantly less old patients which could skew the data. The practice 
pharmacist was keen to see other prescribing indicators which would more accurately measure 
quality and cost effective prescribing.  This practice performed well against the cost based 
indicators but not for the quality indicators. 
The CHP prescribing indicator report was a big influence on the GPs prescribing in Rubain but 
Rosnish and the Haun did not place the same value on the report due to their skewed practice 
populations.  The report appeared to be one of the CHPs behaviour change mechanisms but had 
no effect if it was not valued by the practice. 
6.7.4 Health board formulary 
Unlike Rubain and Rosnish, the Haun did not have its own formulary.  They used the Tayside 
prescribing formulary, which was available through their clinical prescribing system, but they 
did not modify it as the other practices had chosen to do. 
It was not clear how much the prescribers adhered to the prescribing formulary, as one GP 
stated “the longer you are qualified the more you move away from formularies.” 
6.7.5 Drug representatives and drug companies 
The practice had a diary for drug representatives with one appointment per month.  The senior 
receptionist informed the researcher the diary opens in January and is usually full by March, 
but they also get drug reps in for protected learning time.  During the period of observation 
meetings were scheduled and drug representatives were invited to conduct a short presentation 
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and provide lunch.  The representatives provided lunch in exchange for a five to ten minute 
presentation about their company’s latest drug. An extract from field notes are presented below: 
The rep is in to promote XXXX which are second line after Metformin. The drug rep quickly 
mentioned they were on the Tayside formulary, and asked how much of this is prescribed and 
no one answers, after a silence the practice nurse tells him they only have two or three patients 
on it.  No one seemed keen to tell the rep about their prescribing practices.  He made a 
comment/joke about this being a hard audience and Dr X stepped in and made a comment.  The 
drug representative recited a marketing spiel about how good their drug is over others and 
how cheap it is.  The practice pharmacist asked him when should you initiate someone on it? 
She then asked what happens when you have tried X and Y?  He told her it could be that they 
have not tolerated it but usually 90% tolerate them. 
This is the first time I have seen the rep being used as a source of advice and I asked the 
practice pharmacist about this after the meeting.  She said they can be a good source as they 
know a lot about their drugs but their answers have to be interpreted with caution “it is not 
what they tell you, it is what they don’t tell you” she commented.  
The practice claimed to only see drug representatives once a month and at protected learning 
time event (PLT) but additional meetings were scheduled with drug representative input.  All 
the practices saw drug representatives and all reported them having little influence.  However, 
it was highly likely they felt obliged to say this to a researcher.  It was very difficult to observe 
how much of an effect drug representatives and drug companies actually had on each practice. 
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4.7.6 Secondary care 
Secondary care influences prescribing in primary care by recommending medication after a 
patient’s outpatient visit or consultation with a consultant and after a hospital visit patients are 
frequently discharged on new medications.  The GPs in the Haun considered that they had to 
learn about the medications which secondary care was prescribing.  They spoke of secondary 
care as an influence on their prescribing behaviour as they became aware of the trends in 
consultant prescribing. The GPs generally followed the consultant’s advice although the 
outpatient and discharge letters went to the practice pharmacist for review before the patient 
was initiated on the medication. Many of these recommendations were handwritten and 
frequently hard to decipher and were for medicines which were expensive in primary care so 
the pharmacist would recommend a cheaper alternative. The excerpt from fieldnotes presented 
below illustrates the influence secondary care has on primary care; 
The practice pharmacist conducted an audit of their PPI prescribing and found they have a 
high number of patients on the expensive PPI.  As the GP helps the pharmacist identify patients 
for review she says “secondary care have definitely influenced some of these patients.” 
6.8 Other practice staff 
This section describes the influence the practice staff had on GPs prescribing behaviour.  
6.8.1 Practice pharmacist 
The Tayside practice pharmacists’ initiative provided practices with a pharmacist to aid their 
prescribing.  As practices and their populations were diverse pharmacists were given a wide 
remit and autonomy to meet the needs of their practices.   
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6.8.1.1 Specific practice pharmacist role 
The Haun was a laid back practice, which was the style adopted by their pharmacist.  The 
practice and the pharmacist were aware that the NHS has limited resources, so the practice 
pharmacist viewed part of her role as cost efficiency.  She also had a clinical role in providing 
advice to GPs on individual patients, reviewing outpatient discharge letters and consulting with 
patient in medication review clinics. 
6.8.1.2 Practice prescribing meeting 
The general, day-to-day operational prescribing work such as running and reviewing audits was 
discussed between one GP and the practice pharmacist and emailed round the other GPs for 
comment.  If there was a more strategic issue the GP and the practice pharmacist would 
brainstorm the issue, formulate a proposed plan of action and then send round the other GPs for 
comment.  Usually the GPs tended to agree, their comments were about excluding certain 
patients because they were aware of their current circumstances.   
The practice pharmacist goes on to tell me they have good communication.  She has a 
prescribing meeting with Dr X where she raises the prescribing issues she has and Dr X helps 
her refine the question and then she emails it round asking yes or no for the target area.  The 
other GPs usually reply back and say ‘send me the list of patients’, or ‘yes fine, but exclude X, 
Y, Z’. 
The practice would also have ad hoc prescribing meetings to review prescribing policy.  These 
were prompted by the publication of a new guideline or any major changes in CHP policy.  As 
the pharmacist and a number of the GPs were part-time these were scheduled for a Friday to 
include as many prescribing staff as possible but this did mean some prescribers were excluded.  
The practice manager, one practice nurse and two GPs were seen at every practice meeting 
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observed.  The meetings were not punctually attended, but the staff would discuss other issues 
or ask advice from one other about an individual patient while they waited for the other GPs.  
The practice pharmacist took the lead in the meetings and would present issues for discussion 
one by one.  The pharmacist did not present these issues by PowerPoint, as was the case in 
Rubain, the meeting was less formal with the issues written/highlighted on various slips of 
paper and post-it notes.  
The topics of the meetings observed were cost saving initiatives from the CHP, advice from 
secondary care and the publication of a new SIGN (97) guideline.  The first meeting the 
researcher observed was a meeting about cost saving initiatives which resulted in the GPs 
expressing their frustration in the cost saving switches (this has been presented in 6.7.3 
Community health partnerships), although agreeing for these switches to take place, albeit 
grudgingly. The subsequent meetings observed resulted in little discussion and debate.  To 
encourage more discussion the pharmacist prepared a summary of the SIGN 97 guideline and 
sent it round the GPs for comment and suggestions.  This excerpt from fieldnotes continues this 
narrative; 
Dr Y was the only GP to email back.  He wanted dietary advice for people who want a statin 
but don’t have enough risk factors to warrant a prescription. The practice pharmacist had 
prepared this information and patient education leaflets and aids to help patients understand 
their risk factors and help them manage their condition.  However, the GPs felt this was not 
necessary and they could collect a leaflet from the practice nurse if they felt a patient needed 
one.  The practice pharmacist tried to generate discussion around the new guideline but the 
GPs were happy with the SIGN recommendations and did not have any comments for debate.  
The practice staff did debate how they were going to measure patients’ cholesterol rather than 
what they would prescribe.  
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In comparison to Rubain these practice meetings had little discussion and debate.  In Rubain 
they would discuss whether the prescribing was appropriate, would discuss various scenarios 
and then discuss how they were going to modify their prescribing formulary. In the Haun they 
would agreed to modify their prescribing behaviour by the recommendations but not discuss 
their individual prescribing preferences. 
6.8.1.3 Clinical role 
The practice pharmacist enjoyed the clinical side of her role and was keen to increase her 
involvement in this type of work.  The GPs were observed regularly asking for advice on 
individual patients, such as to check dosages or for contradictions or from outpatient 
recommendations and conducting face-to-face medication reviews with patients.  
6.8.1.4 Cost-efficiency role 
Each CHP had a prescribing budget and part of the practice pharmacist’s role was cost 
minimisation with their practice.  This practice performed well against the health board cost 
prescribing indicators so this practice pharmacist did not spend as much of her time looking at 
the practice’s prescribing from a cost perspective as she felt her time was better spent on the 
clinical aspects of her role. 
“The practice pharmacist does not use the prescribing indicator report as it evaluates 
prescribing data but it is very cost driven, she tells me she does not use it as much as other 
practices where cost is an issue.  She goes on to tell me that she does not chase money month 
after month, if there is a huge blip she would consider investigating further but she would 
rather be doing something clinical.” 
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The practice pharmacist felt they had to be perceived as part of the practice team to be able to 
influence the GP’s prescribing. “Our strength lies in being part of the team and not the CHP.  
If we harp on too much about the CHP initiatives we could be perceived as an outsider.  We 
have worked hard at the culture to be members of the primary care team, but yes we are 
employed by the CHP.  Part of our role with the CHP is cost-effectiveness as well as clinical 
work and this has to be done to justify our salaries.”  
This practice pharmacist had more of an operational role than a strategic role.  She had limited 
success at influencing practice prescribing policy but was valued by the GPs in her advice 
giving role. 
6.8.2 Practice nurses 
The practice nurses ran some of the practices chronic disease management clinics.  Part of this 
role was altering doses. 
The practice had a specialist asthma/COPD nurse who would come into the practice one 
morning a week and consult with these patients.  She could make dose changes but would make 
requests to the GPs for drug changes, which the GPs tended to follow.  
6.8.4 Community nurses 
The GPs met with the community nurses one morning a week, where the nurses would update 
the GPs on patients in the community.  They would frequently ask the GPs to visit a patient or 
to prescribe a medication and would engage in discussions about treatment options.  
The practice had good working relationships, with the GPs trusting their colleagues and taking 
their advice on board.  
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6.9 Prescriber 
Each GP has personal influences which affect each prescribing decision.  As this practice did 
not have a clear prescribing policy the GPs referred to experience as the biggest influence on 
their prescribing.  The GPs did not give equal weight to each influence; the hierarchy of 
influences they spoke of is listed below: 
6.9.1 Experience 
The GP’s experience was the strongest influence over their prescribing.  As they worked with 
limited time and resources they prescribed drugs they knew well and were comfortable 
prescribing.  Initiating medication they did not know well required additional reading and 
consultations.  As one GP commented “what you prescribe depends on where you are in your 
career. When I first started I was more familiar with hospital medication but as time goes on 
you get more confident and you learn yourself and you try different medications.” As GPs 
initiate more patients on medications and look after patients on medication which was initiated 
in secondary care they become more knowledgeable and comfortable prescribing the 
medication themselves. 
This excerpt from fieldnotes illustrates how prescribing by experience rather than a formulary 
can result in different prescribing between the GPs.  “I know I prescribe things that the young 
Doctors would not agree with.  It is based on experience, but when they get older and young 
people come in they will be the same, it all goes in cycles.”  
6.9.2 Medical training 
Medical training was referred to as the core of the GPs’ knowledge but influenced their 
behaviour less as they became more experienced practitioners. 
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6.9.3 Personal beliefs, attitudes, views and preferences 
As this practice did not have specific prescribing formulary the GPs were free to select their 
own preferences of medication which were established through their experience.  The GPs were 
constrained by the Tayside health board prescribing formulary but this was still comprehensive 
and allowed freedom of choice.  They habitually prescribed medication which they knew well.  
The GPs did not spend time discussing individual prescribing decisions as had been the case in 
practice one.  
The ethos of this practice was laid back, informal, friendly without rigid management and no 
clinical lead.  All the GPs were interested in the clinical side of their work and were less driven 
by external influences and initiatives from the CHP. They did not monitor their prescribing by 
the CHP prescribing indicator report as they felt it did not account for their skewed practice 
population.  All the GPs were aware the NHS had limited resources and generally prescribed 
the cheaper, generic alternative.  The GPs and the practice pharmacist did report a change in 
some of the practice organisation since the introduction of the nGMS contract.  They have 
tightened up on procedures and become more organised with the clinical areas of QOF, which 
are now divided up under a clinical lead which has given more consistency in the overall care 
among therapeutic groups. 
In Rubain and Rosnish they regularly had meetings where they discussed their prescribing and 
were proactive in regularly reviewing their practice.  This practice was more reactive and 
change was brought about from a change in policy by the CHP or a new guideline.  
6.9.4 Knowledge of the patient 
As this was a large urban practice, with a large student population the GPs did not have the 
same knowledge and continuity of care as was present in Rubain.  The GPs did know their 
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more elderly patients and/or complex patients but lacked the depth of knowledge which was 
gained in Rosnish.  Patients with more complex conditions did try to consult with the same 
clinicians however, this was not always possible as the majority of appointments at the practice 
were on the day and patients were offered the next available appointment which might not have 
been with the clinician of their choice.  This was a source of frustration for the GPs: 
“It really annoys me here, we have patients who have been in to see one Doctor and they need 
to come back for another consultation and it is not their fault they are offered the next available 
consultation and they can end up seeing a few different GPs, you go back through the story, 
you get a different version, you have to interpret the other GPs’ thoughts.” 
When the GPs know their patients and are used to caring for them they are able to make clinical 
decisions much quicker. 
“....this helps you in your decision-making; you can make that intuitive leap quicker.  You know 
more about them and what they are saying, how they present themselves....”  
The influence of the doctor patient relationship is discussed in more detail overleaf.  This 
section has discussed the influences upon the prescriber.  The next section discusses the 
consultation between the doctor and patient, where the prescribing decisions are made.  
6.10 Interaction/Consultation 
This section will discuss the influences in a consultation, in particular continuity of care. 
6.10.1 Continuity of care 
With the majority of GPs working part-time and their appointment system this practice 
struggled to maintain information and relationship continuity of care with their patients.  
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Information and relationship continuity was present in the GPs who worked full-time and/or 
had practised at the surgery for a number of years.  As this practice had a large student 
population they were looking after fewer patients with long-term conditions (the fewer blue 
circles in the model depict the practices level of continuity of care compared to the other 
practices).  
The structure of an interaction was described in practice one, Rubain.  The influences present in 
a consultation and their processes specific to this practice are described in turn: 
6.10.1.1 Patient’s notes 
The GPs all looked at a patient’s notes before they entered the consulting room.  This allowed 
the GP to familiarise themselves with their last consultation with the patient and to see if the 
patient had consulted with another clinician since their last interaction.  The extent to which 
they looked at the notes depended on the frequency of visits by the patient to the practice.  On 
occasion the GP knew why the patient was attending without looking at their notes.  The 
patient’s notes seemed to be an effective method of jogging the GP’s memories although on 
occasion it was not until the patient entered the consulting room that the GP seemed to 
recognise the patient. 
6.10.1.2 Doctor-patient relationship 
Through consultations the doctor and the patient build a relationship. By building this 
relationship the GP gets to know the patient, their preferences and values, and about their 
context and circumstances.   
To have a good doctor-patient relationship, good communication is required.  Communicating 
with patients can be a difficult job; this depends on the information being disclosed and the 
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emotional state of the patient.  In early diagnosis the GP can be communicating difficult 
information, educating the patient about their condition, prognosis and then trying to engage the 
patient in shared decision-making about their treatment. Also in early diagnosis, the GPs at this 
practice did not know their patients tacitly and were working hard to build a relationship.  The 
treatment options were often not clear and discussed as part of ‘trial and error’, so they would 
have to make patients aware of the side effects and impart complex information for a decision 
which was likely to be reviewed. The organisation of the practice’s appointment system meant 
patients had to wait to see their chosen GP and had to wait to have their questions answered.  
The GPs would use their own discretion and book on-the-day appointments with certain 
patients to avoid distress.  
The practice population was deprived and with a large student population.  In consultations the 
GPs often had to work hard to get the student population to open up and the GPs frequently 
suspected an alternative agenda to the presenting problem. The GPs also suspected an 
alternative agenda with the drug addicts; it was only in consultations with drug addicts that the 
researcher observed the GPs saying ‘no’ to patients. Many of these patients were not consulting 
for advice, reassurance, education or a prescription but for a letter, a form to be signed or to 
have the consultation recorded in their notes.  Experience and knowledge of the patient was 
invaluable to the GPs in interpreting the situation and establish what was going on in these 
patients’ lives.  However, in some patients they could only deal with the presenting problem.  
6.10.1.4 Patient education 
Patients need to be informed about their condition, symptoms, risk factors, medication and any 
side effects.  Good communication ensured the information is imparted at a level the patient 
understands and the patient is comfortable in asking questions.  This allowed the clinician to 
engage in shared decision-making with the patient about appropriate medications. Patient 
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education ensured the patient understood their condition and was more likely to be compliant 
with their medication regime. Patients are less likely to require repeat appointments if they can 
self manage.  However, providing education in one consultation is difficult: 
Dr X commented that in a 10 minute consultation it is very difficult to give enough information 
to allow shared decision-making.  She emphasised there is barely enough time to alleviate their 
fears.    
This practice had recently had a partner retire.  This partner had some dated prescribing 
practices which the patients had come to expect.  The GPs struggled with some of these 
patients to convince them to change their medication.  To maintain a good doctor-patient 
relationship the GP would engage in education but would prescribe the patient’s chosen 
medication.  The GPs struggled to maintain this education as the patients would see more than 
one clinician.  
6.10.1.5 Shared decision-making 
Prescribing decisions should in theory be a joint decision between the doctor and patient; 
however this was not always the case.  The premise of shared decision-making is that if patients 
are engaged in decisions about their treatment then they are likely to be more compliant.  
Nevertheless, GPs are constrained by budgets and formularies so the treatment options are 
limited. In young patients with acute problems there was frequently a generic preparation 
which should be tried first, which gave the GP little option to offer the patient. In older patients, 
the clinical information is more complex.  Patients have multiple morbidities and, thus, these 
decisions involve polypharmacy, so involving the patient can be difficult.  The practice worked 
within the constraints of the Tayside prescribing formulary and was aware the NHS had limited 
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resources so would prescribe a generic preparation first line. So invariably the options were 
limited and all the GP could offer was tablets instead of capsules.  
Some patients had strong views for or against medication.  Few patients were observed being 
against taking medication but many drug addicts were observed demanding medication.  It was 
only in consultations with drug addicts the GPs were observed saying ‘no’ and being forceful 
against patient demands. 
This patient was an alcoholic and came in asking for more diazepam and dihydrocodeine.  Dr 
X said no, and went on to say she gave him enough diazepam on Friday and this was only 
Wednesday and he has none left, so if he cannot take them properly she is not going to give 
them to him.  He then started going on about his chest and his cough and Dr X told him that his 
lungs were clear but he was still going on about needing antibiotics and telling her which 
antibiotics he wanted, Dr X said that she would only give him amoxicillin..he threw a tantrum 
and stormed out. 
This practice relied on the patient’s notes to provide continuity of care.  In some older patients, 
with chronic conditions the GPs would use their discretion and book on-the-day appointments 
in advance for some patient they felt they should see again in the near future.   
6.11 Conclusion 
This chapter has provided an overview of the Haun, the urban practice in this study.  This 
chapter is structured around the practice prescribing model.  The chapter has discussed how 
reactive the Haun was to the nGMS contract, struggling to meet the contractual requirements of 
offering patients an appointment within 48 hours at the expense of relationship and 
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informational continuity of care.  The practice had a laid back, egalitarian structure, valuing 
clinical autonomy over tight organisation and consistency between prescribers.  
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 C h a p t e r  7  
THE COMPARATIVE CHAPTER 
The previous chapters described each of the three practices; their setting, structure, 
organisation, communication and systems.  Through the analysis it emerged that practices make 
two different kinds of prescribing decision, macro and micro. This chapter interpretatively 
compares the three practices by these two different types of prescribing decision. 
Macro prescribing decisions are defined here as policy decisions made by considering the 
evidence in light of the average patient, whereas micro prescribing decisions were made in the 
consultation with the patient, considering a unique individual, in light of the evidence and their 
personal context, preferences and values.  
Initially this chapter describes macro prescribing decisions, then the influences which come to 
bear on these decisions are compared across the three practices by their values, organisation 
and communication strategies.  The second section of this chapter describes micro prescribing 
decision-making and the influences which come to bear on these decisions, highlighting the 
differences between the three practices. 
7.1 Macro Prescribing 
There are a number of influences on macro prescribing which are considered and compared 
across the three practices in the next section.  How practices responded to these influences and 
formulated a macro prescribing policy, and organised and communicated as a practice was 
affected by their practice values and practice identity.  This section will now expand on these 
points.  
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7.1.1 Context 
General practices work in the context of the NHS with many prescribing quality improvement 
influences and policies introduced to practices through the Community health partnerships.  
Community health partnerships are units of a health board designed to make service delivery 
more local, to suit the needs of the population they serve.  These are partnerships between 
primary, secondary care and social work services aimed at collaborative working.   The CHPs 
are accountable, through clinical governance, to continuously improve the quality of their 
services.  Within each CHP there is a primary care pharmacy division which has a 
responsibility to ensure patients have access to the most clinically and cost effective medicines, 
they operate within a limited drugs budget so try to encourage rational and cost effective 
prescribing. 
The CHPs try to influence practice prescribing behaviour by producing a comparative 
prescribing report which feeds back their prescribing data, by employing practice pharmacists 
and by financially incentivising changes in prescribing.  The health board also tries to influence 
prescribing by producing a health board prescribing formulary.  These contextual influences are 
described in turn; 
7.1.1.1 Health board prescribing formulary 
The health board produces a prescribing formulary, which is a list of health board 
recommended drugs.  This list is compiled on the basis of rational, safe and cost effective 
prescribing.  All three practices accepted the rationale and attempted to prescribe generically 
from this list where appropriate. 
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7.1.1.2 Practice prescribing formulary 
The Tayside area formulary is a guide of recommended drugs. The formulary is intended to 
guide choice and awareness of a rational section of drugs which has been selected on the basis 
of clinical efficacy, safety, patient acceptability and cost-effectiveness.  Rubain and Rosnish 
modified the health board prescribing formulary by creating a practice formulary.  
“We have a practice formulary which has been sort of developed from the regional guidelines 
but with some practice tweaks of what drugs we choose to use” (GP 2 interview, Rubain). 
Practice formularies are a means by which the practices could rationalise their prescribing 
decision-making but still retain a degree of autonomy.  The local health board had a prescribing 
formulary as a guide and Rubain and Rosnish amended it to suit their preferences, values, 
experience and population.  The Haun opted not to have a practice formulary and work from 
the local health board one.  By working within a practice formulary Rubain and Rosnish 
retained more clinical autonomy but were also able to maintain consistent behaviour across 
their prescribers.   Amendments to the formulary were discussed at prescribing meetings in 
Rubain and informally in Rosnish.  The Haun did not place the same value on consistency; they 
tended not to discuss what they prescribed and placed trust in individual professional opinion.  
As a practice they seemed to feel prescribers were capable of rationalising their own 
prescribing decision-making. 
“I have to say I think that prescribing policy is something that perhaps we could be tighter on 
in this practice, we don’t really have a formal, this is the drug that we use for this situation in 
this practice, we tend to prescribe what we want to prescribe ourselves as individuals” (GP 1 
interview, the Haun). 
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Clinical governance and CHP policy seek consistency and standardisation.  Through Rubain 
and Rosnish adopting practice prescribing formularies they had a mechanism in place to limit 
variation in their prescribing practice.  By modifying the local health board formulary they 
retained an element of clinical autonomy but also achieved more consistency.   
7.1.1.3 Prescribing indicator report 
The CHPs produce a report compiled of a number of quality and cost-efficiency prescribing 
indicators.  These indicators are applied to PRISMs data and the practices in the CHP are 
ranked by their performance against these measures.  The intention is to motivate practices by 
peer comparison where it is assumed they will not want to be seen as ‘bad’ next to their peers.  
Rubain accepted these performance indicators and seemed to respond to the sense of 
competition.  At the practice prescribing meetings they would collectively review their 
performance and the areas where they were underperforming were discussed and debated and 
often identified as areas for a clinical audit.  
“...We have meetings with (practice pharmacist) once every four weeks, the last Friday of the 
month. First of all, we look at, because of our prescribing, a monthly update in terms of how 
our prescribing compares with the CHP average and so on and he (practice pharmacist 
named) recommends changes to our prescribing patterns...” (GP 1 interview, Rubain). 
Rosnish did not find the prescribing indicator report of value due to the limitations of PRISMs 
prescribing data (this data measures cost and volume and is not linked to case mix).  This 
practice had an elderly population and a growing list size.  The practice felt the data did not 
account for differences in population and as the data was not very timely it did not reflect their 
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true practice numbers.   The quote below illustrates the GPs views towards the limitations of 
these data; 
“I’ve got a high percentage of an elderly population and that skews the number of items per 
patients and it has an influence on the cost.”  (GP 2 interview, Rubain). 
The Haun did not value the CHP prescribing indicator report, as it did not consider the practice 
population and only measured cost and volume.  This practice had a skewed younger 
population.   
“...very much weighted towards a student population.  So relatively young, fit and healthy and 
the proportion of older patients are a lot less.” (Practice pharmacist interview, the Haun). 
Generally, the Haun did not place the same value on these management control initiatives, 
valuing professional autonomy and being able to use professional values and knowledge to 
make the decision of what is appropriate therapy for their patient.  There was a feeling that the 
bureaucratic control being implemented was pushing too much responsibility onto the GPs and 
ultimately patients are responsible for their own health and GPs are merely there to advise. 
“I view myself as a professional and I think if patients come to me for advice I will give them 
the best advice I can.  But I am not here to hold their hands and to force them.  You know they 
can consult me and what a consult means, you are asking for advice.”  (GP 2 interview, the 
Haun) 
The nGMS contract and the CHP prescribing reports attempt to use performance measurement 
as a form of management control or at least influence over general practices.   All practices 
embraced the nGMS contract as this is the mechanism by which they are paid, however, 
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through discussing the nGMS contract Rosnish’s values towards such initiatives became clear.  
Rosnish, valued organisational control from a practice perspective not from a national 
perspective, and did not value control of clinical decision-making. 
“… I don’t mind the fact that there is a monitoring financially I don’t mind that.  What I do 
mind is that they monitor you for clinical aspects.  This is my biggest gripe against all the other 
GPs in the NHS that they signed up to this new contract….They could have done this without 
having, and okay now they’re getting paid extra for chronic disease but they could have take 
the lead for it….Whether that’s the BMA or whether that’s the College but they’ve faulted and 
just by default accepted a contract which now is the thin edge of a wedge which is giving 
everything away to the government who is just slowly but surely going to erode any 
satisfaction, clinical satisfaction of looking after patients.” (GP1 interview, Rosnish) 
Although this study is looking at quality, the CHP was perceived as primarily interested in 
constraining costs.  The prescribing indicator reports measured practice prescribing by both 
quality and cost-efficiency indicators.  Rubain was ranked as high quality and low cost; 
Rosnish was the highest performing practice in the health board for quality but was also a 
costly prescribing practice.  The Haun was ranked low quality and low cost. Each practice 
attributed the financial costs of their prescribing to their population rather than their prescribing 
preferences and behaviour.  
 Rubain appreciated that the NHS has finite resources and they must tailor their prescribing in 
line with this.   
“Well, it’s both. You’ve got to be aware of cost because at the end of the day, obviously funds 
are limited” (GP1 interview, Rubain). 
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Rosnish had preferences for certain medication which was more expensive than the generic 
preparation.  Also this was an innovative and progressive practice, which meant they had 
higher prescribing costs but considered this was how prescribing practices would be in the 
future.   For example, most of the practice’s patients over 65 were on a statin before the SIGN 
guideline and nGMS contract promoted this prescribing behaviour, which meant they had much 
higher costs than the other practices in the CHP.  
The CHP had run financial incentives for cutting the cost of prescribing in the past. The Haun 
had responded to these incentives and changed patients’ medication for what they felt were 
minimal cost savings.  They felt that this increased their workload and caused distress to some 
patients.  With the additional consultations and administrative tasks required to change patients’ 
medication they were not sure if there were any true savings.    
“…the older I get, the more times I see that prescribing is mucked around, to try and save a few 
pounds here and there and the more I see patients, who get upset by having their drugs 
changed for no good reason, I tend to not even worry about the costs anymore.”  (GP 2 
interview, the Haun) 
Responding to the CHP cost mechanisms was a much smaller cultural shift for Rubain than the 
other two practices.  This practice had been a fundholding practice so was more responsive to 
financial rewards than the other practices and as a result also had experience of organisational 
reform. As a practice they had re-organised to suit the contractual changes of fundholding and 
then again when fundholding was abolished.  As a fundholding practice they had controlled 
their own budget (major part of which was prescribing) and to contract out services, and in turn 
they retained what they saved to spend as they wished on patient services. 
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 Practices were monitored through fundholding, which is perhaps why this practice responded 
positively to current CHP monitoring. Hence, this practice was accustomed to scrutinising it’s 
prescribing; looking at cost, efficiency, generic prescribing and financial incentives. They were 
more used to organising themselves to make group decisions.  
7.1.1.4 Practice pharmacists 
The main role of practice pharmacists was to influence the practice’s prescribing policy by 
implementing CHP prescribing policy (both quality and cost); implement new guidelines; 
conduct clinical audits; and giving prescribing advice. This remit was very wide, so the role and 
responsibilities of each pharmacist varied widely and became what they were comfortable 
doing and what the GPs were happy for them to do. 
“…..because our roles have generally evolved rather than being dictated.  They tend to evolve 
within the practice depending on what the practice priorities are and I suppose the interests of 
the practice pharmacist and the GPs as well.” (Practice pharmacist interview, the Haun) 
In Rubain the practice pharmacist took more of a strategic role spending most of his time 
influencing the practice’s prescribing policy.  He helped them keep on top of the latest 
evidence, constrain the cost of their prescribing and conducted medication reviews.  In Rosnish 
the pharmacist took more of an operational role where she carried out the practice’s INR clinic, 
provided advice and problem solving and conducted the occasional medication review.  In the 
Haun, the practice pharmacist carried out both an operational and strategic role.  She was 
involved in influencing the practice’s prescribing policy but not to the same extent as the 
pharmacist in Rubain, as she undertook more of an operational role, carrying out audits, 
medication reviews, processing and checking secondary care recommendations and providing 
advice and problem solving support for individual patients.   
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In each of the practices, the pharmacist’s role suited the needs of the clinical staff at the 
practice.  The Haun had a young and more deprived practice population, with some of their 
patients illicit drug users who required advice about complex interactions and help with dosing 
and contraindications for babies and young children. The lead GP at Rosnish liked to keep on 
top of EBM and problem solve himself, limiting the opportunity for the practice pharmacist to 
set policy.  The culture of Rubain was competitive, where they liked to be ‘one of the best’ so 
their prescribing policy was of importance to them providing opportunity for the practice 
pharmacist to led prescribing policy and develop a strategic role. 
7.1.14.1 Strategic role 
The practice pharmacist’s strategic role, influencing prescribing policy, was essentially a 
prescribing leadership role in the two larger practices.  The Haun and Rubain relied on their 
practice pharmacist to inform them of the latest evidence, usually guidelines. Most practitioners 
felt they did not have sufficient time to keep up-to-date and to reflect on new evidence.  The 
practice pharmacists would also inform practices of the latest CHP and health board policy 
(usually cost-efficiencies) and try and persuade them to engage, change their prescribing and 
incorporate the changes into their macro prescribing.  New information and changes in 
prescribing policy might then result in an audit (operational role) to identify patients for review 
and the results of these were feedback at prescribing meetings. The prescribing data was 
complex and required interpretation in light of the practice population and the context of 
changing evidence. The practice pharmacists had a key role in translating this data into 
information to help inform macro prescribing decision-making. In Rubain, the CHP prescribing 
report was also an important tool used by the pharmacist to influence their prescribing policy.  
The practice pharmacists would filter this information to the practice by way of a practice 
meeting, to try to engage practitioners in discussion and debate around reviewing their macro 
prescribing and refining their associated systems.  
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In Rubain the practice pharmacist broke this information down and presented it by PowerPoint 
presentation. Presenting more detail ensured all practitioners were aware of the evidence and 
justification of the guideline and allowed the practice pharmacist to present practice specific 
prescribing information from interpretation of their prescribing data.  Breaking down the 
information generated discussion around some of the CHP cost saving initiatives, as a practice 
they generally accepted the evidence, information and pharmacist’s advice but they would 
challenge some of the CHP cost-efficiency policies. Rubain valued being informed of the new 
evidence and formulating a practice policy in line with their practice culture and values, as the 
quote below illustrates; 
“First of all, we look at, because of our prescribing, a monthly update in terms of our 
prescribing compared with the CHP average and so on and he recommends changes to our 
prescribing patterns. Obviously usually with evidence based in terms of recommendations from 
NICE or SIGN guidelines or whatever, and we discuss it and almost invariably we agree with 
what he says” (GP1 interview, Rubain). 
Although the GPs in the Haun valued the practice pharmacist filtering new evidence into the 
practice their prescribing meetings were poorly and not punctually attended (they were also not 
regularly scheduled). The Haun accepted these meetings were difficult to arrange rather than 
trying to find ways to maximise opportunities. At these meetings the practice pharmacist shared 
the evidence from guidelines, interpretation of prescribing data, recommendations of changes 
to prescribing policy from the CHP but did not present the CHP prescribing indicator report or 
the results of audits.  The quote below from a GP who does not regularly attend the meeting 
conveys her perspective; 
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“...prescribing policies, other than (practice pharmacist named) who mainly does all that kind 
of thing, as far as looks at all the SPA data and all the rest of it and looks at areas where we 
might think to improve things” (GP 3 interview, the Haun). 
The meeting was held in an informal manner to suit the practice culture; the pharmacist would 
have the agenda on various pieces of paper (many scrap) and the GPs and nurses would accept 
her suggestions but did not engage in the same level of debate as in Rubain. The information 
was not broken down or given as much interpretation as by the practice pharmacists in Rubain. 
On occasion the pharmacist circulated information in advance to try and aid more in-depth 
discussion but this had little impact.  This practice respected clinical autonomy and did not 
value consistency in their prescribing. 
In summary, the practice pharmacists played a strategic role leading prescribing quality 
improvement by filtering evidence and CHP prescribing quality improvement mechanisms into 
the larger practices. The practice pharmacists also had a key role in interpreting the practice 
system data in the context of the changing evidence. The practice pharmacist’s strategic role of 
influencing prescribing policy was facilitated by a practice that values consistency in 
prescribing behaviour thus values a practice prescribing formulary and policy and values 
collective decision-making. For a practice pharmacists to have an effect at the macro 
prescribing level the practice had to value consistency in their prescribing, value macro 
prescribing and have an effective communication channel (this final point is compared in more 
detail in section 7.1.3).  
7.1.1.4.2 Operational role 
At the operational level the practice pharmacist’s roles were similar but the time they spent on 
these tasks varied.  All three pharmacists carried out clinical audits and provided advice on 
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individual patients.  In the Haun the pharmacist processed secondary care discharge letters.  
This section will now compare the pharmacist’s role in clinical audits and the process for 
checking secondary care recommendations.  Advice on individual patients was too unique to 
compare but is discussed in the micro prescribing section (7.2).  
The main task carried out by all three practice pharmacists at the operational level was clinical 
audits. All the practices valued the pharmacist’s activities in audit and feedback however, the 
amount of time they spent on this varied. The practice pharmacist in the Haun spent a 
considerable amount of her time on clinical audits, whereas the  practice pharmacist in Rosnish 
did not have the same amount of time in the practice and as the lead GP liked to be involved in 
the audits himself to retain control she only conducted more complex audits.  Audit is the 
mechanism by which by practices can find out what is going on and identify clinical areas and 
patients for review of their medication. Accurate and effective auditing requires consistency in 
recording.  Rubain used the IT system with ‘hooks’ (discussed in section 7.1.2.3) and as 
Rosnish only had two prescribers with their own areas of responsibility the data recording was 
consistent. Since the nGMS contract the Haun employed a retired nurse as an administrative 
assistant to consistently code their data; 
“All the major diagnosis ....we highlight and send it to (administrator) who is, does our 
summaries. Sshe is a semi-retired nurse, so she has a list of codes which are standard, so we 
don’t actually, for major diagnosis we don’t actually add the data codes on ourselves” (GP 1 
interview, the Haun). 
The prompts for audits were generally changes to guidelines or recommendations, changes to 
CHP prescribing policy or changes to macro prescribing policy. The CHP inform practices 
through their pharmacist when drugs are off patent or when licensing has changed.  Many of 
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the CHP recommendations were intended to influence new prescribing rather than to change 
existing prescribing, but in reality, particularly with cost-efficiency pressures this involved 
changing existing prescribing which was reviewed through audits by the practice pharmacists. 
The CHP quality improvement mechanisms were based on PRISMS data, so to link these 
measures to diagnosis and find out if the prescribing was appropriate required practice system 
data.   
Practice pharmacists monitored prescribing by conducting audits, through matching PRISMS 
data to the practice system data. All three practices regularly engaged in audit and feedback.  
However, the Haun did not use tight audit definitions due to the historical inconsistencies in 
their data recording.  Running these audits on Vision (the IT system) took skills in Boolean 
searching, so the more variables the more complex and time consuming the search. Therefore, 
audits of prescribing were harder to conduct in the Haun as they tended to prescribe what they 
wanted as individuals, so would take more time and resources; especially the more tightly the 
audit was defined. Without tight audit definitions and mechanisms for consistent recording a 
number of patients could be missed.  Whereas in Rubain and Rosnish where they had 
consistency in their prescribing and valued knowing what was going on, tight audits provided 
the mechanism by which they could oversee their prescribing behaviour and identify patients 
for review.  
The practice pharmacist in Rubain informed GPs of CHP recommendations at the practice 
meetings, where they were discussed and then their prescribing policy and formulary were 
updated.  These changes would prompt an audit and the results of these were fed back at these 
meetings.  In Rosnish the practice pharmacist had informal discussions with the GP and if these 
recommendations were in line with his values the pharmacists would audit and then implement 
the changes.  In the Haun the practice pharmacist would check how many of their patients this 
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affected.  If this was a small number she would change the patient’s medication on the 
computer and not inform the GPs of the recommended changes.   For larger numbers of 
patients she would audit and feedback the results to one GP face-to-face and together they 
would discuss the issues and send a summary round the other GPs for comment. The GPs 
would inform the practice pharmacist which patient’s medication she could change, not change 
or call in for a medication review. This would result in changes at the micro, individual patient 
level, but did not result in any changes at the macro level.   
“...I’ll communicate that back individually to (GP) although I may then cascade that out to the 
rest of the group.  Or it may be that when I do audits like this it’ll flag up that there’s one 
particular GP who’s initiating that combination more although it’s usually secondary care 
initiated. But if by doing audits like this I find that there’s one GP who’s practice is different 
from their peers then I’ll zoom in on that GP and just have an individual discussion with 
them.”  (Practice pharmacist interview, the Haun). 
Due to the lack of face-to-face communication and the difficulties with organising practice 
meetings new prescribing and audit issues were often not collectively discussed in the Haun, 
therefore the GPs could be ill informed when making their prescribing decisions.   This point is 
discussed in more detail in the communication section 7.1.3. 
All the GPs referred to secondary care as a big influence on their prescribing.  However, the 
pharmacists in Rubain and the Haun provided advice to GPs on secondary care 
recommendations.  The GPs have come to understand with many drugs it is a class effect rather 
than a specific drug; 
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“….we had one of the research professors speaking …. one of his slides referred to the 
prescribing police and made some really derogatory comments about practice pharmacists 
who he sees as being totally stifling to the use of new drugs or drugs that have appeared in 
trials that some of the hospital consultants are handing out because that’s what was used in the 
trial, that’s where the evidence is so, therefore, we’ll give them, say, Perindopril and 
Indapamide, to prevent a stroke or after a stroke, whereas the pharmacist would say 
Indapamide is actually quite expensive and it’s really a class effect isn’t it, so you don’t have to 
use the exact drugs, you can use …” (GP2  interview, Rubain). 
Many patients are discharged from hospital on medication which is expensive to prescribe in 
the community. In the Haun, outpatient and discharge letters went directly to the practice 
pharmacist, whereas in Rubain they went to the appropriate GP.  Rubain had the practice 
formulary on the IT system via ‘hooks’ which ensured that the GPs were aware if the 
medication was outside practice policy (discussed in detail in the IT section 7.1.2.3). If the GPs 
were unsure they would refer the request on to the pharmacist.  As this extract from field notes 
illustrates: 
 “Ninewells do influence but (practice pharmacist named) helps us fine tune their 
recommendations” (GP 3 fieldnotes, Rubain). 
In the Haun the pharmacist spent a considerable amount of her time processing requests from 
secondary care, ensuring they were appropriate and cost-effective and frequently selecting the 
appropriate generic preparation.   
“I think the big part of the routine stuff is hospital communications.  That would be like patient 
discharges or outpatient communications so there are changes to the patient’s therapy.  They 
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may or may not flag up changes to a patient’s therapy and for instance outpatient 
communication often says please supply this patient with this medicine.”  (Practice pharmacist 
interview, the Haun). 
By Rubain having their macro prescribing policy and formulary on the IT system via hooks, 
GPs were able to process these requests themselves and only contact the pharmacist when they 
were unsure.  This saved the pharmacist time which could be spent on other tasks, such as their 
strategic role.  
7.1.1.4.3 Part of the practice team 
Each of the practice pharmacists felt that being perceived as part of the practice team was 
invaluable to their ability to influence policy.  Rubain’s pharmacist had been with that practice 
the longest period of time and Rosnish’s pharmacist had been with the rural practice for the 
shortest period of time and was in the practice for the least amount of time per week.   Only 
being in a practice for four hours a week when the majority of that time the GPs were in 
surgery does limit the opportunity to build a rapport and establish trust.  Rosnish’s pharmacist 
did not feel part of the practice team whereas the pharmacists in Rubain and the Haun felt they 
had worked hard to establish this position which allowed them to take on more of a strategic 
role and have an impact on prescribing policy.  
“…I definitely feel when you’re sitting in the surgery you’re perceived as a member of the team 
rather than as an external health board person.”  (Practice Pharmacist interview, the Haun).  
Their role remit is wide and the practice pharmacists tended to focus on the aspects of the job 
they enjoyed, for the two female practice pharmacists at Rosnish and the Haun, this was the 
face-to-face interaction with patients. They were influenced by the altruistic reasoning of 
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helping people understand their medicines, enjoying the patient contact and helping them rather 
than being motivated by the budgets and finance side of their role. Whereas the pharmacist in 
Rubain was motivated by influencing practice policy and having a real and quantifiable impact 
on their collective prescribing behaviour.   Rubain valued consistency and collective 
prescribing behaviour.  As a practice they were used to scrutinising their prescribing from when 
they were a fundholding practice. It was much harder for the pharmacists in Rosnish and the 
Haun to impact on macro prescribing so they naturally enjoyed the micro prescribing aspects of 
their job.  
7.1.1.5 In summary 
Practice engagement with quality improvement, EBM and clinical governance was made at the 
macro prescribing level; albeit in different formats.  Rubain and the Haun engaged through 
practice prescribing meetings and Rubain and Rosnish by formulating a practice prescribing 
policy and formulary. 
This study found formulating a practice prescribing policy and formulary was a way of 
engaging with EBM and CHP mechanisms and rationalising and standardising practice 
prescribing but retaining an element of autonomy.  The CHP indicator report was only valued 
by one practice as it was seen as cost orientated and did not take account of skewed practice 
populations. In both Rosnish and the Haun there was scepticism towards the CHP, feeling that 
recommendations were marketed to improve quality of care but often felt it was merely cost 
savings.  It is unclear the extent to which this is rhetoric as both these practices did not value 
monitoring or management control. 
This study found practice pharmacists were effective in leading prescribing quality 
improvement in the larger practices by filtering EBM and CHP policy and mechanisms into the 
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practices. The practice pharmacists had a key role in interpreting practice system level data and 
translating it into information in the context of this changing evidence. All the practices valued 
the pharmacist’s activities in audit and feedback. The feedback of audits resulted in changes at 
the micro, individual patient level, but changes at the macro level required audit data to be 
feedback to the majority prescribers face-to-face to facilitate discussion and collective decision-
making. For the practice pharmacists to have an effect at the macro prescribing level practices 
had to value consistency in prescribing. Also practices had to be organised, with effective 
processes and systems, and communication channels in place for the pharmacist to influence 
macro prescribing (discussed in the sections below).   
7.1.2 Organisation 
All the practices placed being organised and efficient high on their list of values; however the 
practices definitions and how they achieved these varied.  This section will compare the three 
practices by their values towards organisation, their leadership styles and their IT and chronic 
disease management systems.  
Rubain and Rosnish were systematic and organised.  The Haun was also coming to increasingly 
value being organised and was undergoing a culture shift towards tighter processes and systems 
during the period of observation.  Rubain and Ronish had valued tight systems, protocols and 
organisation prior to the nGMS contract whereas the Haun was coming to value these features 
as the nGMS contract had forced them to start to organise in this way and they were starting to 
appreciate the benefits;   
“I think from the point of view of making the practice more organised and tightening up on the 
systems that are in place for the disease registers and things, I think it has been good for that 
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and I think it focuses your mind and it means people don’t slip through the net” (GP 1 
interview, the Haun). 
Rubain and Rosnish were proactive, holding meetings to anticipate change and to plan, 
devising procedures and ensuring resources were in place. For example, Rosnish planned 
extensively for the transfer of IT system, learning from other practices but also brainstorming to 
meet their needs and circumstances and minimise impact to their daily work.  The Haun was a 
reactive practice; they did not invest the same amount of resources to planning and organising 
clinical systems and processes. The quote below illustrates this point; 
“I think it is, you do things the way you do them because it’s the way you do them and you are 
used to doing them that way, and I think sometimes it is hard to take a step back and look and 
see what you could be doing differently, because you just assume that you are doing things and 
it is working well, and it is not until there’s a problem that you think well we should really have 
had a system to try and stop that problem happening, if only we’d been doing this and this, this 
would never had happened. But until, I think you just plod along, you are busy doing other 
things, you don’t have a lot of time to sit and think about it” (GP 1 interview, the Haun). 
Rubain and Rosnish valued structure, simplicity, efficiency and organisation.  They liked to 
have everything organised, documented, and systems and processes in place and worked to 
refine these, as this quote from the lead Rosnish GP illustrates;  
“I mean I apply all these criteria and all these things before the contract came out because I 
think chronic disease management, I think, is a huge thing and it’s a caring aspect and the 
more you can organise these things the less work you’ve got. My intention is just to try and help 
people but I also have a job to do and I want to do as little as possible so my way of doing that 
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was to try and organise and educate my patients as good as possible so I have to see them as 
little as possible.” (GP 1 interview, Rosnish). 
The Haun was more chaotic with fewer resources invested in being organised (this also made it 
a difficult practice to observe).  This practice was keen to change, which is why they had 
agreed to take part in this research.  Rubain and Rosnish had invested time developing systems 
and thus were able to be proactive rather than reactive. We return to this point later in this 
section. 
7.1.2.1 Leadership 
The two practices which performed well against the prescribing measures used in the sampling 
for this study both had leadership, albeit different styles.  Rubain had clinical and 
administrative leadership and Rosnish had a form of leadership from the primary GP who did 
not employ a practice manager and took on this role himself.  The Haun was an egalitarian 
practice, with no clinical leadership and the practice manager heavily involved with managing 
reception taking her away from managing the GPs and other organisational aspects of the 
business.  
Leadership was important for practice organisation and managing change. Practices had 
intrinsic values and culture but were constantly being forced to manage change with reviews of 
policy and practice from CHP, HB and Government and through modifying behaviour and 
practice to be in line with the latest evidence-based medicine.  Leadership involved ensuring 
these issues were addressed and dealt with.  (Specific prescribing leadership is discussed in 
section 7.1.1.4).  Rubain and Rosnish had a GP who would oversee the clinical and 
organisational aspects, albeit with different styles.  These clinical leaders ensured issues were 
addressed, would drive change and be involved in co-ordinating the practice organisation. 
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Rubain and the Haun also had practice managers who were important in leading the 
organisational aspects, however, again with different roles and responsibilities. These different 
in leadership roles are discussed below. 
Rubain did not have a senior partner with all the GPs having equal status.  However, the 
behaviour of the longest serving GP demonstrated leadership style.  He regularly engaged with 
staff asking them about their daily work and offering advice and support, as a means of 
‘keeping an eye’ on the practice organisation and administration.  This GP would meet 
regularly with the practice managers formally but also informally, on a day-to-day basis 
providing advice, support and background clinical information. This interest provided drive and 
motivation and thus improved the practice performance and organisation.  He was the only 
clinician who attended all the practice meetings and punctually.  He took an interest in all 
aspects of the practice, both clinical and organisational.  He engaged in decision-making but 
would also ensure these decisions were followed up.  This was more a paternal leadership style, 
sharing his expertise and overseeing the practice. He also adopted a mentoring or parent type 
role for the students. The other GPs did not seem to mind this form of leadership; they overran 
in surgeries and seemed to enjoy the patient interactions and contact rather than the specifics of 
the practice organisation. Few practice decisions were made without the other GPs 
participating.  The researcher felt this behaviour demonstrated a clear leadership style.  
However, he did not share this view to the same extent, feeling the practice was more 
egalitarian; 
 “I think the practice manager is probably the one that would take credit for that. They like to, 
it’s like herding cats, I think, looking after GPs. They tend to try and keep, ensure the meetings 
run properly and things maybe actually happen. Maybe I have niggle a bit in the background, 
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just to make sure that things get done, but I wouldn’t say I had any greater influence or how 
they get done as compares to anybody else” (GP 1 interview, Rubain).  
Rosnish was a two GP practice but referred to as a single-handed practice, with the lead GPs 
values permeating throughout the practice.  This GP had an autocratic leadership style.  He had 
strong views as to how the practice should be organised; valuing organisation and simplicity.  
His vision and values were strongly reflected in both the clinical (including prescribing) and 
organisation aspects of the practice. Taking on a single-handed practice in light of the Shipman 
inquiry which criticised such practices, the lead GP wanted to demonstrate that single-handed 
practices could provide good quality care and thus had control over all aspects of the practice. 
He conducted the majority of consultations himself and gave close direction and guidance to 
the administrative staff, although he did seek their advice and the advice of the practice 
pharmacist. 
“...I make things simpler and simpler every month and so the need for me to be here at some 
point I think is not that big but on the other hand it’s partly my personality that plays a role in 
this and so I’m struggling to let go completely because I know that I can’t leave it all to (the 
second GP)” (GP 1 interview, Rosnish).  
The Haun was an egalitarian practice with no GP having any clinical leadership role. 
7.1.2.2 The practice manager role 
In Rosnish the lead GP was also the practice manager, whereas Rubain had invested heavily by 
employing two practice managers.  Both these practices valued organisation and control.  In the 
Haun, due to the high number of part-time staff, (both clinical and administrative) the practice 
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manager spent a considerable amount of her time organising reception, rotas and the day-to-day 
practice management.  
The roles of the practice managers were different in all three practices, with Rosnish opting not 
to have a manager and Rubain and the Haun’s managers having different input, roles and 
responsibilities. Essentially, the practice managers all had an organising and administrative role 
with Rubain opting to have two mangers and less GP intervention.  Rubain opted to handover 
full responsibility of the practice’s organisational and administrative tasks to the practice 
managers.  They were constantly chasing the GPs for signatures and the GPs seemed not to 
question their requests and were happy to be left to their clinical responsibilities.   
 “Well, I think where we’ve given them the role of making decisions, yes, but I think quite often 
they haven’t been given an executive role to make decisions about a lot of practice policy so we 
still have to meet together to talk through ….our days are spent more in clinical work and 
keeping up with the clinical work which is quite heavy, we gave up a part time partner who 
hasn’t been replaced so we use locums quite a lot more than we used to…”  (GP 2 interview, 
Rubain). 
The Haun’s practice manager was managing rather than leading. Practice managers are 
employees of the GPs at the practice and only have a certain amount of influence and control.  
In a practice with a laid back culture such as the Haun it would be very difficult for the practice 
manager to impose stringent systems or to be too pushy in her managerial approach. 
It was hard to gauge whether there was a great difference in the roles of the managers between 
Rubain and the Haun as the Haun communicated so much information via email it was harder 
to observe the practice manager at work with these administrative tasks.  With Rubain having 
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two practice managers, the majority of their GPs working full-time and communicating face-to-
face the turnaround in organisational and management decisions seemed to be more efficient. 
In Rubain the practice managers took pride in the practice being efficient and organised.  
The practice manager in the Haun oversaw reception which was the senior receptionist’s role in 
Rubain.  With the high number of part-time receptionists a large amount of time was spent 
organising the rota and holidays. The practice manager was seen very much as part of the 
receptionist subculture as oppose to Rubain where they did not seem to be part of the clinical or 
receptionist subcultures.  This distinguished the Rubain practice managers from the 
receptionists and facilitated a clear leadership role whereas in the Haun the professional 
boundary of the practice manager seemed less clear. 
The role of the practice managers reflected the practice culture.  Rubain and Rosnish valued 
organisation and control, in the larger practice two managers were required and in the smaller 
practice the control was retained by the GP.  The Haun had a more laid back culture preferring 
less systems and control, however it is not clear whether the practice manager’s role reflected 
the practice culture or if the practice manager could have been more active in shaping the 
practice culture.   
Leadership was important for practice coordination.  The leaders, clinical and administrative in 
the two high performing practices had an overseeing role which ensured issues were addressed 
and the practice was moving forward. In the Haun where the practice had a laid back, 
egalitarian culture, there was no clinical leadership and the practice manager was more heavily 
involved with reception than the other practice managers in Rubain.  The practice culture of the 
Haun was laid back and a strong leadership role would have been out of place.  However, it is 
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not clear if a leader had been in place the practice would have had a different culture and valued 
more organisation and control. 
7.1.2.3 IT system 
This observation was conducted in a period of turbulence for all practices, they had to transfer 
over to a new practice IT system at the health board’s request.  Rubain was on Synergy and did 
not transfer over during the period of observation, Rosnish transferred from GPASS to Vision 
during the researcher’s observational time period at the practice and the Haun had transferred 
from GPASS to Vision before the researcher’s period of observation with the practice.   
Rubain was the most proficient with their IT system.  The practice pharmacist had set hooks on 
the practice system to remind GPs they were about to prescribe something which was not on 
the practice prescribing formulary.  This ensured when they changed their formulary they had 
an immediate and consistent behaviour change across the practice.  These hooks were valued 
by the GPs but were part of Synergy and the practice lost them when they transferred over to 
Vision (period between observation and interviews);  
 “I think, we don’t have those hooks anymore and it’s not quite as … the IT system isn’t quite 
as slick for prescribing…there has been some inconsistencies in prescribing without the 
hooks…… because the hooks gave us exactly what was agreed the approach to take whereas 
now you’re kind of left to give a reasonable approach ” (GP 2 interview, Rubain). 
Rosnish did not need such a system as there were only two prescribers who had their own 
clinical areas of responsibility which maintained consistency in prescribing.  In the Haun as 
they did not value a practice prescribing policy there was no need for such a mechanism.   
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Rubain also used the IT system to embargo, monitor and release appointments.  The practice 
managers monitored the availability of appointments to improve the availability of 
appointments to aid continuity of care and meet the requirements of the nGMS contract.  This 
system allowed the practice managers to monitor the availability of both on-the-day 
appointments and those bookable in advance and release appointments as required. Despite 
transferring over to Vision this was a mechanism they were able to retain from their old IT 
system.   
In the Haun all secondary care prescribing recommendations would go straight to their practice 
pharmacist who would change the medication to a generic medication or a cheaper medication 
from the same class if there was one.  In Rubain and Rosnish these recommendations would go 
straight to the patient’s GP.  Rubain’s IT system would inform the GPs that there was a cheaper 
medication available but in practice two there was no such mechanism in place.   
Rubain was the most proficient practice with their IT system, utilising it to prompt GPs to 
consider the practice prescribing policy and to offer continuity of care to patients who valued it.  
In all three practices the IT system was key to their chronic disease management systems, for 
monitoring and recall. This is addressed in the next section below. 
7.1.2.4 Chronic disease management 
As a requirement of the nGMS contract, practices must review patients on medication for 
chronic diseases annually.  The practices organised their chronic disease management systems 
differently. Rubain and Rosnish opted to review patients at the time of their birthday.  In both 
practices all patients on repeat medication are invited to the practice for their ‘birthday bloods’, 
where the health care assistant or practice nurse would take their bloods and any other tests 
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which may need to be taken.  However, the practice systems now varied, with Rosnish opting 
to call all patients in for a consultation with the GP once their results were through.   
“On the important things that I find important, yes because I think the reviewing of the chronic 
condition and so on and medication I think that is important and it’s not purely for the 
medication, it’s more to have seen the patient, have a discussion…Because when the patient 
comes in I don’t’ need to look at this screen, I’ve done that before they’ve come in so I can talk 
to them…And that’s what the important thing is to me, okay.  I need to find out how are they, 
are they coping with their medication, are they coping with their limitations.” (GP 1 interview, 
Rosnish). 
Practice three has reminders pop up on the IT system which reminds the clinician to carry out 
the appropriate tests.  However, if the consultation would over run, as they often did, this would 
be left till their next appointment.  If patients did not come into the surgery for a consultation 
they would not be picked up in the system. 
By comparing the practice’s chronic disease management systems it was clear to see Rubain 
and Rosnish had invested time thinking about a system which would ensure all patients on 
repeat medication were annually reviewed.  As the Haun was a reactive practice they had 
organised themselves to meet the requirements of the nGMS but they had a system which did 
not ensure all patients on repeat medication were annually reviewed. 
7.1.2.5 Practice population 
Each practice had different populations.  Prescribing decisions are context dependent so each 
practice had to interpret the evidence to suit their local population thus each practice had 
policies in place to suit their local populations needs.  Rubain had a mixed practice population 
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with both young and old patients, urban and rural, affluent and deprived populations within its 
remit.  Rosnish had an elderly, rural, affluent population and practice three had a young, urban, 
deprived population.  The practice populations affected each practice’s culture and 
organisation.  With Rosnish being in an affluent and well educated population they looked after 
patients who were generally compliant and with little social problems.  This is in comparison to 
the Haun’s population which a large number of social problems as well as medical problems.   
The Haun looked after a much larger number of patients with mental health, drug addiction and 
other social and psychological patients than the other two practices.  These patients were less 
compliant, many were not well educated so it took more time to explain and educate them 
about their condition, and they required more consultations and more reassurance and were 
frequently more disruptive.  These were confounding factors to practice’s organisation.  
Frequently communication in the Haun was about individual disruptive patients distracting 
them from discussing practice policy for therapeutic groups as tended to be the case in the other 
practices. 
Implementing new policy and changing medication was easier in Rubain and Rosnish where 
they had a more compliant practice population.  Both these practices had time allocated to 
discuss individual patients but also allocated time to discuss practice prescribing policy.  Due to 
the higher number of part-time partners, limited opportunities for face-to-face communication 
and their practice population meant any opportunities for face-to-face discussion in practice 
three centred on individual patients.  
The populations of Rubain and Rosnish were less disruptive and more compliant, whereas the 
Haun had a minority of patients who were very disruptive to the practice.  These factors all 
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contributed to the atmosphere in the practice, the time pressures and topics of face-to-face 
communication. 
7.1.2.6 In summary 
The two practices which performed well against the prescribing measures used in the sampling 
of this study were systematic and organised, valuing structure, efficiency and organisation.  
These practices were proactive, holding meeting to anticipate and plan for change whereas the 
practice which did not perform as well was reactive; they had not invested the same amount of 
time planning and organising.  Leadership, both clinical and administrative, was important to 
drive and manage change and this study has shown IT systems can remind GPs of macro 
prescribing policy to improve consistency in prescribing policy across a number of prescribers.   
Being organised, allowed practices to be more efficient as they knew what was going on; they 
had control over the day-to-day running of the practice. This involved working as a team rather 
than individuals, knowing who and where to access the information required. Rubain showed 
how useful the IT system is to being organised and consistent in their prescribing behaviour. 
Being organised is a dynamic process, demanding rethinking and renegotiating systems.  
Rubain and Rosnish were organised because they invested time in planning and thought about 
how they could do things differently.  This required time for communication and reflection, 
which required practices to be organised to allow time for collective reflection.  
7.1.3 Communication 
The previous sections have alluded to how important communication is to practice organisation 
and macro prescribing.  This section will explore the differences and draw comparisons across 
the three practice communication systems.  
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Communication is a fundamental part of any organisation.  General practice teams have to 
work together to deliver care.  General practices operate in a dynamic environment; EBM is 
constantly being up-dated so practices needed to communicate to engage in macro prescribing 
decisions. Practice systems and processes had to be redefined and amended to keep up with the 
pace of change. Communication was important for the practices to respond to change and 
function as a team, for all members of the practice team to build professional working 
relationships but also to be aware of what is going on, what has changed and why.   
All three practices had formal and informal communication strategies, for redefining and 
maintaining shared work practices such as decision-making.  The table below shows the 
different communication strategies and the frequency.  
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Table 1 Communication strategies and their frequency 
 
7.1.3.1 Daily interactions 
Rubain and Rosnish had forums in place for daily interactions through either 11am meeting or 
during their lunch hour.  These interactions provided the GPs with an opportunity to discuss 
individual patients and provided an opportunity to the other staff to communicate with the GPs. 
Through discussing patients GPs would learn about changes to their condition which provided 
opportunity to improve informational continuity of care and for informal learning. The Haun 
did have a weekly coffee break scheduled for the same purpose but it was poorly attended.  
Instead they relied on email, door knocking, opportunistically meeting in the corridor, or their 
IT system (which had a facility for administrative staff to leave messages for the GPs). These 
forums had the potential to limit the discussion to the matter in hand, offered less time for 
elaboration and discussion, and for tacit knowledge exchange.   
Rubain and Rosnish’s daily conversations would involve clinicians sharing work but also 
narratives about patients, on occasion just letting off steam but on other occasions looking for 
advice. Reciprocal stories would be shared.  These conversations were an important way of 
sharing and validating values and norms and modifying them.  
 Daily Weekly Monthly Ad hoc 
Rubain 11 am meeting 
 
Coffee room at 
lunch time  
 
Meeting  
practice 
managers  
 
Prescribing 
meeting  
 
Rosnish Coffee room at 
lunch time  
 Admin and 
clinical meetings  
 
The Haun Email Meeting  
community 
nurses  
 Prescribing 
meeting  
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“...I mean I think we do have similar values here to, you know, practice good medical care for 
our patient population as a team, and therefore we do collaborate and work as closely....” (GP 
2 interview, Rubain). 
Without regular meetings the Haun was reliant on email as their primary means of 
communication. By communicating through email less information is passed on than would be 
the case in a face-to-face interaction as people write less than they would speak and body 
language and tone of voice are missed.  There is also an opportunity for misinterpretation and 
miscommunication.  Thus email did not facilitate consistency and corroborate prescribing 
norms in the same manner as through face-to-face interactions, but as a practice they did not 
place huge value in consistency in prescribing.  It was unclear if they engaged in face-to-face 
communication about their prescribing they would also engage in more consistent prescribing 
behaviour. 
In Rubain and Rosnish, suggestions and ideas would be generated through informal discussions 
and be raised as an issue they need to sit down and talk about in a formal meeting. 
7.1.3.2 Practice meetings 
Meetings were where shared decision-making took place, examining practice protocols, 
systems and structure; where agreement for change in behaviour took place. Most formal 
communication in each of the practices was between the clinical staff and the practice 
managers, however, Rosnish and the Haun had meetings with the community nurses. 
Regular monthly clinical meetings were held in Rubain and Rosnish but tended to be ad hoc in 
the Haun.  Having the meetings at set times seemed to help the clinicians remember they were 
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taking place. In Rubain and the Haun the main clinical meetings were chaired by the practice 
pharmacists and attended by GPs, practice nurses and practice manager(s).   
“I think the role of the practice pharmacist is a huge one,  in practice of getting the partnership 
together and looking at our prescribing and we do that on a monthly basis, Friday lunchtime 
meeting.” (GP 2 interview, Rubain) 
Whereas in the Haun, 
“Well we have fairly regular meetings with..., I mean probably she arranges a meeting every 3 
or 4 months with us particularly to discuss perhaps prescribing issues or things she had 
flagged up from the prescribing data, from the trust, what they want to have a look at with 
us.....she just contacts by email and if there’s anything she needs to discuss in particular she 
will let us know” (GP 1 interview, the Haun). 
In Rosnish, these meetings were attended by the GPs and the community nurses due to this 
practice not having a practice manager or nurse and the limited role of their practice 
pharmacist.  
Rubain and the Haun relied on their practice pharmacist to inform them of the latest guidelines 
and communicate information from the CHP.  In Rubain, the practice pharmacist also presented 
the CHP prescribing indicator report, which motivated the GPs to discuss why they were an 
outlier and make the decision of how they were going to change their prescribing behaviour.   
“Quite often we rely on the pharmacist to gather … you know, you hear about evidence but we 
rely on X to review the current evidence and present it at the meeting where we discuss it” (GP 
2 interview, Rubain).  
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In the Haun these meetings were poorly and not punctually attended, where as in Rubain all 
clinical staff attended punctually, unless they were on holiday. The atmosphere at the meetings 
was very different; Rubain had a formal feel with the pharmacist presenting the research 
evidence and CHP prescribing report by PowerPoint presentation.  The pharmacist at the Haun 
had the issues which needed to be discussed and addressed on pieces of paper and sticky notes.  
The discussion and debate was not as in-depth, with the GPs agreeing or disagreeing with the 
issues.  By presenting more detail in a guideline generated discussion around some of the finer 
points and ensured all practitioners were aware of the evidence and justification of the 
guideline.  This also provided an opportunity for practitioners to allocate time to engage and 
reflect with the evidence.   These meetings provided an opportunity to share values, 
experiences and collectively reflect before modifying prescribing norms. As a practice, Rubain, 
valued discussing evidence, engaging in collective learning and having ownership of the 
prescribing decision-making, as the quote below illustrates;  
 “I would try and follow the practice decision which is formulated at these meetings and there’s 
obviously, usually influenced by what (practice pharmacist named) says. I think its handy 
having a meeting. If you want ownership of a decision then it’s the best format, I think, is to 
have a meeting where everyone can turn up and usually as many people turn up as can, unless 
of course, you’re on holiday or ill or whatever and then you discuss it. There’s not usually any 
great arguments about it. I think we usually agree that, I can’t remember any meeting where 
the collective decision’s been to prescribe one particular medicine and someone’s put their 
hand up and says, well, you can if you want, I’m not going to do it. I think once we arrive at a 
practice decision then we do follow it. Although, as I mentioned, there are occasions when 
some of the doctors, for whatever reason, may not follow it to the letter, but generally, I think 
we try to follow it.”  (GP 1 interview, Rubain).  
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This quote from another GP at the practice shows the value Rubain placed in collective 
decision-making;  
“…you know there is the sort of collaborative decision making seems to have a lot more 
strength to it than you know giving an edict from a group…” (GP2 interview, Rubain) 
Visually focusing the clinicians’ attention to the same issue and going through the issues in 
more detail seemed to generate more debate in Rubain and influenced practice policy; however 
it is not clear whether this strategy would have worked for the Haun.  The pharmacist in the 
Haun felt they did have debate but through observation at a number of meetings in both 
practices it was clear Rubain engaged in much more.  Despite the poor attendance at the Haun’s 
meetings the pharmacist felt everyone had the opportunity to have their views heard.  
“Yes.  I enjoy the debates.  I think you came along to one of the good meetings which was really 
interesting because it was when there was atorvastatin to simvastatin switch and that was a 
really, really good example where the Health Board would suggest therapeutic switch on the 
basis of cost.” (Practice pharmacist interview, the Haun).  
A GP expressed that she did not think they had communication issues; 
“I don’t think there’s a problem with communication, we never sort of feel that we are not able 
to communicate. I think you spend your life organising meetings and never actually do 
anything, so you don’t want to be over, you know let’s meet for every tiny thing to discuss it, 
you know you’ve just got to get on with it. I don’t think we suffer too badly from lack of 
communication....we are seeing each other regularly to catch up.”(GP 1 interview, the Haun) 
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With a large number of part-time staff attendance and collective decision-making was difficult, 
however, all the GPs did not seem to make the same effort to attend or punctually.  The practice 
did not seem to place the same value on collective decision-making, allocating time to reflect 
and modify their prescribing norms and behaviour. As a practice they did not value consistency 
in their prescribing behaviour so did not value collective decision-making. The researcher was 
unclear whether they did not value this activity or had not recognised the potential of such an 
activity.  
In Rosnish clinical meetings would involve reviewing the results of audit, discussing patients in 
the community or an issue raised through clinical practice.  In this practice they also engaged in 
the issues in depth and discussed the finer points.  The practice pharmacist had informal 
discussions with the GP around CHP recommendation and policy and if these 
recommendations were in line with values the changes were implemented.  
7.1.3.3 In summary 
Rubain and Rosnish were organised to ensure face-to-face communication, shared learning and 
decision-making meant consistency and compliance to a prescribing formulary was easier to 
maintain.  By discussing the practice formulary prescribers have more ownership over the 
decision-making and were more likely to comply.  The Haun felt they had good 
communication, but they did not meet regularly to discuss their prescribing as they did not 
value this as a practice. The practices organisational issues did make collective decision-
making and consistency harder to achieve, with so many part-time staff having regular 
meetings to discuss prescribing was difficult to time-table.   However, evidence from Rubain 
has shown in practices with multiple GPs, face-to-face meetings with summarised research 
evidence engaged practitioners with the evidence and provided an opportunity to present CHP 
prescribing policy.   
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Practices needed to value collective decision-making and consistency in prescribing behaviour 
to engage in discussion and debate around reviewing macro prescribing. Where collective 
decision-making was valued all practitioners engaged in discussion and debate which gave 
ownership of their macro prescribing policy. In the practice which did not value macro 
prescribing the practitioners attended these meetings to maintain competence and to keep up-to-
date with the evidence, but these meetings were poorly and not punctually attended.  
Through working and communicating practices develop shared values, beliefs and 
assumptions, which are defined and shared through communication.  How a practice is 
organised and its culture is established, maintained and changed is through communication.  
GPs do not work on their own so communication is an important part of information, 
knowledge exchange and trust.  
7.1.4 Practice values 
Each practice valued looking after their patients but the associated values as to how this should 
be achieved varied. Some values were held dearer in one practice compared to another. Values 
towards communication, EBM, performance measurement, quality versus cost prescribing, 
continuity of care, organisation and leadership were pertinent values which emerged through 
the research. The practice values directed their motivation and inspiration and thus shaped the 
practice norms; how the practice was organised, how they communicated and worked as a team 
and how they implemented EBM.  
Rubain valued teamwork, cohesiveness, competition (with other practices in the CHP), shared 
decision-making and consistency in their behaviour.  Rosnish valued simplicity, creativity, 
innovation and change.  Both these practices valued organisation, processes and systems.  The 
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Haun valued egalitarianism, informality, and clinical autonomy and tended to shy away from 
formal organisational processes and systems.   
Rubain’s values of teamwork, shared decision-making and consistency in their prescribing 
behaviour led them to organise themselves to have regular face-to-face meetings, tight 
protocols and systems and to utilise their IT system to implement their decisions.  Rosnish’s 
values of innovation were instigated and implemented by the lead GP who invested time and 
effort into regularly thinking about how the practice’s systems and processes could be 
improved.  This GP valued simplicity and constantly thought about how to simplify systems 
and processes to allow him more time to focus on quality of care and prescribing. Both Rubain 
and Rosnish valued reviewing the evidence where suggestions and ideas for change were 
instigated, along with ideas through practice. The Haun valued clinical autonomy which led 
them to shy away from tight processes and systems and consistency in their prescribing 
behaviour.  Their egalitarian value led them away from having any leadership and less 
formality, with the recent change instigated through the contractual change of the nGMS 
contract rather than any in-house refinements.   
Both Rubain and Rosnish had a practice identity which saw themselves as ‘one of the best’ and 
believed prescribing was core to this.  Rubain measured and monitored their performance 
against other practices in the CHP by the prescribing indicator report.  Rosnish valued EBM 
and quality of care and quality of prescribing and invested a great deal of time in ensuring this 
was achieved across the practice.  In the context section it was clear practices engaged with 
EBM and CHP quality improvement mechanisms they valued.  They recognised that responses 
to EBM and CHP mechanisms required collective decision-making and macro prescribing 
decisions. Both these practices believed that the way to achieving high quality care and being 
‘the best’ was not just providing high quality clinical care based on EBM but also improving 
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the organisation of that work.  These practices invested time communicating, organising 
themselves but also refining their processes and systems.  
7.1.5 Practice identity 
Weick (2001)’s work on “organisational sensemaking” provided a useful lens with which the 
researcher could interpret her findings.  Although it is not appropriate to refer to the literature in 
a results chapter, the author felt, in this case it was appropriate to refer to this literature.  
“Sensemaking” is about how organisations make sense of all the factors which impact on their 
work, through their values and identity (Weick, 2001). This macro prescribing section has 
shown the number and extent of influences on practice prescribing behaviour and how practices 
organised and communicated to deal with these influences.  Sensemaking is about developing 
an identity through engagement with ongoing circumstances and influences. This identity then 
shapes future behaviour. The practice’s values guided their organisational structure and 
processes, and communication strategies and shaped their practice identity. 
Through working and communicating practices develop shared values, beliefs and 
assumptions, which were defined and shared through communication.  How practices are 
organised and their culture is established, maintained and changed was through 
communication.  GPs do not work on their own so communication was an important part of 
developing and reinforcing shared values and the practice identity. Rubain and Rosnish 
engaged in regular face-to-face communication and thus had a strong practice identity, of 
seeing themselves as one of the best and believed through their prescribing and being organised 
was how this could be achieved. The practice identity drove their practice organisation, 
especially their communication channels, but was also driven by their organisation 
characteristics (such as number of part-time staff).   Rubain and Rosnish had a strong 
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prescribing identity but they also had effective communication channels, tighter processes and 
systems and co-ordinated practice organisation.  
The Haun was reactive to their organisational structure.  They had a high number of part-time 
staff so relied on IT for communication.  By not communicating face-to-face they did not seem 
to have such a strong practice identity.  They were autonomous rather than collective which 
could be why they did not have a strong identity.  The other two practices were clear they 
wanted their identity and they regularly engaged in communication which reinforced their 
identity. As the Haun did not have co-ordinated practice organisation or collective face-to-face 
communication their prescribing practice identity was weak.  It is not clear that if they engaged 
in more collective macro prescribing and face-to-face decision-making they would develop a 
strong practice prescribing identity.  
7.1.6 Macro prescribing summary 
Macro prescribing decisions are collective prescribing decisions about populations or groups of 
patients.  Practices make prescribing decisions about the ‘average’ patient.  These macro 
decisions were shaped by the practice’s identity.  The practice’s identity shaped how practices 
were organised and how they communicated and thus how they made macro prescribing 
decisions.  
Practice prescribing meetings were shown to be useful to engaging practices with EBM and 
CHP and HB policy.  Practitioners felt they did not have the time to engage and reflect on EBM 
themselves, so practice prescribing meetings provided an opportunity for practitioners to 
collectively engage and reflect and modify their prescribing behaviour. The practice 
pharmacists had an important role in leading these prescribing meetings and helping practices 
interpret their prescribing data into prescribing information.  Face-to-face communication, 
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shared learning and decision-making meant consistency and compliance to a prescribing 
formulary was easier to maintain. 
The practices which implemented macro prescribing policy were systematic and organised.  By 
being organised the practices created time which could be used to hold meetings to anticipate 
and plan for change.  Also by being organised the practices had control over the day-to-day 
running of the practice and were working as a team.  Rubain has shown that these macro 
prescribing decisions can be implemented consistently across all practitioners by use of the IT 
system. 
Practices which performed well against the prescribing measures used in this study were 
systematic and organised.  These practices valued collective decision-making.  Without these 
values and an organised and systematic practice the practice pharmacist was limited in the 
effect they could have at the macro prescribing level.  
7.2 Micro prescribing 
Micro prescribing decisions are about applying EBM and macro prescribing to the individual 
patient. Each patient is unique with their own views, values, preferences and circumstances. In 
elderly and complex patients prescribing decisions were rarely black and white and were 
influenced by presence and severity of multiple symptoms and conditions. Micro prescribing 
decisions require interpreting macro prescribing policy using the clinical judgement and 
experience, in light of a patient’s preferences, values and circumstances.  This PhD found two 
strong influences on micro prescribing decision-making; prescribing mindlines and continuity 
of care.  Each of these is considered in turn; 
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7.2.1 prescribing mindlines 
During consultations with patients GPs did not look up information about medicines and relied 
on their knowledge and experience.  This knowledge and experience had been developed into 
personal formularies. Again, although it is not appropriate to refer to the literature in a results 
chapter the author felt it was appropriate in this case to refer to the paper which helped her 
interpret her findings and led her to recognise these personal formularies (Gabbay and le May, 
2003).  Gabbay and le May’s (2003) work showed how clinicians rarely used explicit evidence 
and relied on tacit guidelines, which they referred to as mindlines (further information and 
discussion of the impact on the findings is given in the discussion chapter). Hence, to maintain 
consistency personal formularies will be referred to as prescribing mindlines. The GPs in all 
three practices relied on social networks to update these prescribing mindlines, such as their 
colleagues, secondary care, and prescribing meetings and advice from their practice pharmacist.  
These discussions were where practitioners engaged in sensemaking at the micro prescribing 
level. This section will discuss these various sources of information for ‘prescribing mindline’ 
development. 
7.2.1.1 Experience 
Every GP placed experience as their highest valued and strongest influence over their 
prescribing. Experience is knowledge which is gained over a period of time, through medical 
training, years of practice and exposure to a number of different prescribing decisions and their 
outcome.   
“….I think a lot of us probably were doing a lot of habit prescribing, and we probably still do 
that, because you just prescribe what you’re familiar with….” (GP 3 interview, the Haun)  
As another GP illustrates; 
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“..I mean things are definitely habitual, I always prescribe a particular drug, I know those off 
the top of my head, why would you prescribe an alternative that you didn’t know so much 
about” (GP 1 interview, the Haun). 
By prescribing drugs the GPs knew well they could make prescribing decisions quickly and 
with confidence.  When the GP initiated medication they did not know well the GPs would 
prefer to see the patient more frequently and would consult colleagues and the practice 
pharmacist for further advice and reassurance.  Experience was variable between the clinician’s 
length of time in practice and the training the received; therefore in the Haun where they did 
not have a practice prescribing formulary there were differences in prescribing behaviour 
between the GPs. 
An important part of experience gained in ‘years of practice’ was seeing patient’s experiences 
of various medications.  Experience or knowledge of the patient was also important for their 
prescribing decisions.  Knowing the patient helped the GPs make intuitive decision-making.  
They knew what the patient would tolerate and how they would cope with various treatment 
regimes. Also, the GPs understood and could read the dynamics of the consultation more 
accurately.  
7.2.1.2 Secondary care 
All the GPs referred to secondary care as being one of the strongest influences over their 
prescribing.  The GPs would follow prescribing advice and trends from secondary care and also 
learn about new medications, through looking after patients on medication which had been 
initiated by secondary care.  
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With new medications initiated in secondary care the GPs had limited knowledge, which 
required them to read and learn more about the medication to adequately look after the patients 
in their care.  As they looked after more and more patients on the medication they gained 
experience.  Through their experience GPs came to form views and opinions of various 
medications prescribed by secondary care and build preferences of certain medication which 
they would come to prescribe more of themselves. 
“….there’s been new drugs that have come onboard and the way they’re being used is 
according to the local specialist and how they prescribe, so we do have some influence with the 
specialists..” (GP 2 interview, Rubain) 
Another GP more strongly illustrates this point; 
“The only thing that changes for me is if a new drug comes in and the consultants at the 
hospital are telling me to use it because they think it is good and they get feedback from other 
professionals and consultants that it is good and then I’ll start using a new drug. I don’t tend to 
use it off my own back, I tend to use it from recommendations from other people and doctors 
and consultants. So the only changes in my prescribing are basically new drugs” (GP 2 
interview, the Haun). 
All GPs referred to consultants as an influence on their prescribing and in Rubain and Rosnish 
the strongest reason why they would deviate from the practice prescribing policy/formulary.  
GPs tended to follow recommendations from consultants.  On occasion GPs would consult with 
the pharmacist before prescribing but generally followed the consultant’s recommendations.  
The GPs would start to notice a trend in consultant prescribing, and if they felt comfortable and 
knew the medication they would also come to prescribe like this.  Thus, prescribing initiated in 
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secondary care and consultant recommendations were an important part of the iterative 
development of prescribing mindlines. 
7.2.1.3 Interactions with colleagues 
All practices valued their colleagues as an important source of information; they would share 
experiences and ask advice from colleagues.  
Within each practice, often a number of GPs had an individual area of interest and the other 
GPs would ask them for advice. The quote below illustrates the influence colleagues had on 
each other’s prescribing.  When asked about what influences her prescribing a Haun GP 
replied;   
 “I guess the other doctors in the practice. I mean if you are, if I have got a difficult problem I 
will take to my other doctors and take advice about what they would do. Seeing what the people 
have done when you look at notes, somebody is prescribing this or somebody treats that way, 
what comes out of hospital, hospital doctors recommend”  (GP 1 interview, the Haun).  
The researcher observed these interactions in Rubain and Rosnish opportunistically and openly 
discussed in meetings and the coffee room.  Whereas the organisational features of the Haun 
meant this was more difficult so they tended to have these conversations one to one, with 
trusted others and behind closed doors.  Discussing individual patients was a sensitive issue 
which may also have been why the GPs in the Haun chose to interact differently.   
GPs would also discuss secondary care recommendations with colleagues and seek advice. 
Rubain and Rosnish had regular daily conversations which would involve clinicians sharing 
work but also narratives about patients, on occasion just letting off steam but on other 
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occasions looking for advice.  Reciprocal stories would be shared. These conversations were an 
important way of sharing and validating values and norms and modifying them.  
 “….I mean I think we do have similar values here to, you know, practice good medical care 
for our patient population as a team, and therefore we do collaborate and work as closely….” 
(GP 2 interview, Rubain).  
The GPs would also ask their practice pharmacist for advice on an individual patient; advice on 
dosing, interactions or suggestions of what to prescribe. The practice pharmacist would search 
the relevant literature, BNF and Martindales for the GPs.  
“...people who are on drug interactions or side effects from the drugs, she is very good at, if 
we’ve got queries about drugs or dosages or interaction she’s very good at that.” (GP 1 
interview, the Haun) 
These interactions and information sharing resulted in the iterative development of prescribing 
mindlines.  As discussions were not exclusive in Rubain and Rosnish these prescribing 
mindlines were collective and shared, whereas they were only shared among a trusted few in 
the Haun.  The large number of part-time staff and the lack of face-to-face communication 
channels mitigated the collective sharing of stories and mindlines. Through regular 
communication and discussions in Rubain and Rosnish the prescribers developed shared 
prescribing mindlines but retained a degree of individual interpretation based on their personal 
experience, preferences and values. 
7.2.1.4 Prescribing meetings 
The practice pharmacists in the larger practices held prescribing meetings where they would 
filter evidence and CHP prescribing policy into the practice (see section 7.1.1.4).  At these 
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meetings the practice pharmacists would also interpret this evidence in light of the practice 
system prescribing data and through discussions this information would become internalised. 
This information was another source of knowledge for the iterative development of their 
prescribing mindlines and in Rubain an opportunity to help develop shared prescribing 
mindlines.  
“….what you find at the prescribing meeting is that when we’re discussing how we use the 
guideline sometimes things come out ‘oh, maybe I’ve not been using it right’ and some of your 
colleagues can … you can discover that yes you should actually be checking the untreated 
blood pressure…”  (GP 2 interview, Rubain). 
7.2.1.5 Journal articles 
All GPs appreciated the importance reading of journal articles, which was viewed as an 
informal and personal task for each GP in each practice.  However, in Rubain and the Haun the 
GPs seemed to struggle to regularly allocate time to review journal articles. In Rosnish, the lead 
GP enjoyed searching the literature.  He dedicated part of his time to reading the BMJ every 
week and would conduct literature searches himself to inform practice. He viewed reading and 
taking part in research as an important part of being a good practitioner and keeping a rural 
practice engaged with developments  so the practice was organised which allowed a regular 
review of EBM. In Rubain and the Haun, (the larger practices) they had practice prescribing 
meetings which kept them up-to-date with the evidence. However, journal articles did not have 
the same immediate effect on his behaviour as a new guideline did.  They provided background 
information and would plant ideas and encourage reflection.  Their effect was accumulative, 
through reading numerous articles over a period of time, gradually integrating the evidence in 
practice.   
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“… I read the BMJ every Friday when it comes in or Saturday morning, okay, now if you read 
that there’s a lot of things you can take away from it.  But it’s often not directly applicable to 
next week’s patients or…… It adds background noise or reading……. And evidence, yes but the 
thing is if we used a guidelines extremely strict then, I don’t know how to put it really.”  (GP1 
interview, Rosnish) 
7.2.1.6 Drug representatives 
All three practices played down their engagement with drug representatives.  In Rubain, the 
drug representatives were occasionally used to provide a ‘free’ lunch and in return at least one 
GP had to converse with the representative.  The representative would also leave promotional 
material, e.g. leaflets, pens and post-it notes which would be left in the coffee room.  In 
Rosnish, the second GP felt she did not have the time to keep up with the evidence and relied 
on drug representatives to provide her with some information.  The lead GP claimed to have 
nothing to do with the drug representatives but was observed on one occasion having to 
converse with the representative in the second GPs absence.  Also promotional materials were 
left lying round the coffee room after a drug representative visit.  In the Haun, the practice 
claimed to only see drug representatives once a month in the practice and at PLT meetings.  
However, drug representatives were used to provide a ‘free’ lunch at meetings which were ad 
hoc.  
In Rosnish and the Haun, their practice pharmacists referred to GPs in these practices who liked 
to prescribe new drugs.  As the Haun did not have a prescribing formulary and as it was much 
easier to change the formulary with few prescribers in Rosnish, it was more likely drug 
representatives could have had some kind of effect in these practices. With Rubain adhering to 
a prescribing formulary and the strong presence of the practice pharmacist, it is likely they had 
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less opportunity to have an effect.  The quote below is an example of the type of response the 
researcher received when she asked about drug representatives in Rubain;  
“....they used to be more of an influence in the old days. They don’t tend to influence things so 
much these days because we always tell them that for any change in our prescribing it would 
have to be discussed with (practice pharmacist named) and so they should really speak to 
(practice pharmacist named). You do tend also to find that, they tend to all be promoting the 
same type of medicine anyway. They’re not often coming along with a completely new thing, 
it’s just an alternative. Proton pump inhibitor, an alternative, seratonin uptake inhibitor, so it’s 
not all that often they come along with a completely new product and then you quite often find 
that the new product hasn’t even been approved for use in Scotland anyway, or in (health 
board named)” (GP 1 interview, Rubain). 
Although, all practices saw drug representatives the GPs reported viewing the representatives 
with scepticism and thus them having little or no influence on their prescribing behaviour.  As 
changes in prescribing were slow it was difficult to observe how much of an effect drug 
representatives had on each practice, particularly as GPs tended to prescribe drugs they were 
familiar with rather than new medications.  Due to the social nature of GP learning, one GP in a 
practice conversing with drug representatives could potentially have an effect on their 
colleagues.   
7.2.1.7 In summary 
Changing prescribing habits is very difficult.  This PhD has shown prescribing behaviour does 
change but gradually and in and a cumulative manner accumulatively influenced by a number 
of different sources.  GPs tend to prescribe from personal formularies or prescribing mindlines, 
which are iteratively developed from experience, macro prescribing policy, secondary care, 
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advice from the practice pharmacist and from conversations with colleagues.  It is possible drug 
representatives also play a minor role in prescribing mindline development; however GPs 
tended to prescribe medication they were familiar with.  Prescribing from mindlines allowed 
expeditious prescribing decisions to be made with confidence.  Through regular 
communication and discussions these prescribing mindlines were shared with clinicians 
retaining a degree of personal interpretation.  In the Haun, ‘prescribing mindline’ development 
and refinement was between a few trusted individuals.  
7.2.2 Continuity of care 
The nGMS contract provides financial incentives to practices to achieve targets on speed of 
access (within 48 hours) therefore, relationship continuity of care was harder to achieve. 
Continuity of care was valued by all practitioners however, Rubain and Rosnish organised 
themselves to achieve optimal levels of relationship continuity.  With relationship continuity 
present the GP and patient had a trusting relationship, the GP knew about the patient’s 
background, circumstances and often their values and preferences. This study also found GPs 
were not keen to change medication in a patient who usually consulted another GP, so with 
problems maintaining continuity of care patients could wait to have their medication changed. 
With relationship continuity, the GPs were frequently able to make expeditious prescribing 
decisions, encourage patients to take their drug of choice and thus adhere to macro prescribing 
policy.  In more complex cases, prescribing decisions were not always made in the initial 
consultation; patients could be given time to consider treatment options and/or GPs would 
consult their colleagues to gain information to aid this complex prescribing. These findings are 
considered in turn by comparing the different values and organisation of continuity of care in 
the three practices.  
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Rubain placed high value on relationship continuity.  They relied on locum cover for on-the-
day appointments leaving patients to have continuity of care with their chosen clinician. They 
used their IT system to embargo and monitor appointments to try to maximise the availability 
of appointments bookable in advance with their permanent GPs.  The IT system allowed the 
practice managers to monitor the availability of on-the-day appointments and they could release 
more appointments for ‘on-the-day’ or ‘bookable in advance’, if they were required.  The 
practice collectively developed and refined protocols which improved management continuity 
and as relationship continuity was valued but not always achieved they utilised informational 
continuity (the patient’s notes). 
Rosnish valued relationship continuity of care and with only one full-time, one part-time GP 
and the smallest list size this was easier to achieve, particularly as they had their own areas of 
responsibility.  With a rural and elderly population, their population was more stagnant so they 
invested a great deal of time educating patients about their condition and ensuring they 
understood.  This practice felt once patients understood their condition they could self manage.  
Investment such as this was more likely to pay off when you have few GPs.  Many of their 
patients with a long-term conditions and stable on their medication were only seen annually at 
their medication review clinic, which is why this practice managed such a large list size for the 
full time equivalent number of GPs. To maintain a good doctor - patient relationship the GP 
liked to conduct all medication reviews face-to-face with his patients;    
“….But the thing is when you do it yourself you’ve got that relationship, everything is quite 
clear whereas if you delegate it then it’s done in a very formal and rational way and I don’t 
know how well it’s gone down and it’s sometimes I get people over who want to discuss it 
anyway… Because they want to know what I think.  Luckily not too many but, yes.” (GP 1 
interview, Rosnish) 
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Informational continuity was also high at Rosnish as the receptionists were all members of the 
local community and had been all their lives.  The receptionists were an invaluable source of 
information to the GPs about patients, informing them of who was related to whom, their 
family history, how they had coped and what their attitudes had been in the past.  The senior 
receptionist was also married to the local community pharmacist so there was a direct link of 
information back to the practice. 
The Haun valued continuity of care but struggled to achieve high levels of relationship 
continuity.  With the majority of their appointments bookable on-the-day and the majority of 
their GPs working part-time, meant this was hard to achieve.  Clinicians could override the 
system and book on-the-day appointments in advance for patients they would like to see again, 
but this resulted in lack of availability of on-the-day appointments. Although the practice 
valued relationship continuity they did not balance this with the high number of part-time 
partners and their appointment system.  This had a negative impact on the small number of full-
time partners; 
 “a patient will come to a doctor who then goes away, they come to me for follow up a few days 
later, I don’t know the patient, their condition and I’ve got to sort out what the previous doctor 
has done so the patient may get side-effects or problems or have a development in their 
condition when the doctor they have been seeing for that condition is off. And so it actually 
increases my workload, I am often having to look at patients I don’t know very well, and I think 
that’s not very good because continuity is so important” (GP 2 interview, the Haun). 
When patients were seen by different GPs, the practitioners relied on the patient’s notes and 
patient’s accounts of their ‘story’ to decipher the previous GP’s train of thought.  When seeing 
another GP’s regular patients the GPs tended not to change any medication.  They were not 
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keen to change medication another GP initiated as there could have been a valid reason for that 
decision they are not aware of. The Haun did not value tight protocols, a practice prescribing 
formulary (referred to in the literature as information and management continuity of care) or 
consistency in prescribing and did not discuss prescribing practices as a group.  Without these 
systems the GPs relied more on clinical autonomy, which resulted in  inconsistencies in their 
prescribing practices and made deciphering another GPs train of thought more difficult.  As a 
practice, the Haun had been reactionary to the nGMS contract, which states patients have to be 
offered an appointment within 48 hours.  They had met with the contractual requirements, but 
had not invested time to try and manipulate the appointment system to improve relationship 
continuity of care.  There was an assumption that by being able to book on-the-day 
appointments in advance the practice was achieving continuity of care where necessary.   
The techniques and strategies for prescribing quality improvement and to rationalise clinical 
decision-making can be perceived as a threat to patient-centred decision-making. In all three 
practices, all prescribers would prescribe a generic preparation first line which resulted in 
patients being given little choice.  When GPs were prescribing generic preparations the options 
to offer patients were limited, such as capsules over tablets but even then the CHP did try to 
influence these decisions on the basis of cost.  The clinicians seemed to appreciate they had to 
make rational decisions and much of patient-centred decision-making centred around making 
patients feel engaged in the decision-making process which involved making sure they 
understood why they are proposing a certain medication and make patients aware of the 
constraints within which they operate.  Many prescribing decisions are ‘trial and error’ and with 
relationship continuity GPs were able to encourage patients to try their suggestion first or the 
patients were happy to trust the GPs recommendations.  With more complex patients, where 
important considerations had to be given to different treatment regimes patients were offered 
more choice based on their preferences. This did lead to greater variation in practice however, 
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these were in much smaller numbers of patients thus consistency was less important and 
continuity of care, in particular trust between the doctor and patient became much more 
important. 
The Haun was the practice that reported much more upheaval and upset to patients as a result 
of changing medication for prescribing incentives or as a result of recommendations from the 
CHP.  They reported that patients were not happy their drugs had been changed; they would not 
accept change and this resulted in increased administration time informing patients of the 
changes and more consultation time dealing with the fall out.  This practice was also the 
practice which had the lowest levels of continuity of care, without the fundamental element of 
relationship continuity of care, trust; patients could easily have felt that their care is being 
compromised.  
All the GPs enjoyed looking after patients they know, where they could see where they had 
made a difference to the patient’s life, this was an aspect of their job all GPs took some 
satisfaction.   This is only achieved through relationship continuity and with the nGMS contract 
this was harder to maintain.  As Rubain and Rosnish valued relationship continuity of care so 
highly they had organised and invested time into their appointment system and practice 
management to ensure they could deliver maximum levels of relationship continuity to those 
patients who valued it.  The Haun did not seem to have considered the possibility of investing 
time and resources to think about how they could manipulate their appointment system to 
improve relationship continuity.   
7.2.2.1 In summary 
This study found all GPs valued continuity of care but the high performing practices organised 
themselves to offer maximum levels of continuity of care. This has shown multi-partnered 
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practices can manipulate their appointment systems in sophisticated ways to offer relationship 
continuity to those who value it.  This study also found GPs were not keen to change 
medication in a patient who consulted with another practitioner, however, due to the nGMS 
target this could have been the only appointment a patient could access. Therefore, without a 
system for continuity patients would need to visit the practice again to consult with their regular 
practitioner. 
This study found that relationship continuity enabled GPs to implement macro prescribing 
policy where possible.  By having a relationship with patients GPs were able to make patients 
feel part of the prescribing decision by explaining why they were proposing this medication and 
making patients aware of the constraints within which they operate.  
7.2.3 Micro prescribing summary 
Micro prescribing is about applying EBM and macro prescribing policy considering the 
patient’s circumstances, views and preferences.  Therefore, GPs have to interpret EBM and 
macro prescribing using their clinical judgement and experience.  The GPs used prescribing 
mindlines, iteratively developed from years of experience and information and advice from 
trusted colleagues (other GPs, practice pharmacist and secondary care consultants) to make 
expeditious prescribing decisions.  Relationship continuity of care also allowed expeditious 
prescribing decisions as the GP had a relationship with the patient, they knew the patient’s 
background, circumstances, preference and values but also the patient’s trusted the GP’s 
recommendations.   
In the practices which performed well against the prescribing measures used in this study these 
prescribing mindlines were shared by all GPs in the practice.  Also both these practices had 
invested time to offer optimum levels of relationship continuity to the patient’s who valued it.  
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In the Haun, where relationship continuity was not present the GPs were not keen to change 
medication initiated by a GP the patient regularly consults with.  As a practice they only 
discussed prescribing with a trusted few therefore prescribing mindlines were not shared and 
interpreting another GPs train of thought was more difficult, so a patient’s medication was less 
likely to be changed.   
7.3 Chapter summary 
Practices made two different kinds of prescribing decision; macro and micro.  Macro 
prescribing decisions are influenced by EBM and CHP policy.  When making macro 
prescribing decisions practices consider the ‘average’ patient and formulate macro prescribing 
policy to rationalise and standardise prescribing.  Practice pharmacists are effective in leading 
prescribing quality improvement in larger practices, filtering EBM and CHP policy into the 
practices and interpreting the practice system level data in the context of changing evidence.  
Practices needed to value collective decision-making and consistency in their prescribing 
behaviour to formulate macro prescribing policy. Consistency in prescribing behaviour requires 
effective communication, and effective communication is important for shared values and 
practice identity.  The practice identity influenced the practice values, communication and 
organisation thus having a direct impact on their macro prescribing policy formulation as well 
as implementation.   
As macro prescribing considers the average patient, some patients, in particular the elderly or 
those with complex or co-morbidities, justify deviation from macro prescribing policy.  In these 
situations the GPs relied on prescribing mindlines.  In the practices with effective 
communication strategies these prescribing mindlines were shared so consistency was 
maintained through an ‘informal prescribing formulary’.   Continuity of care was important for 
a relationship between the GP and the patient where GP was aware of the patient’s 
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circumstances and preferences and could make a recommendation in line with these and the 
patient would trust the GPs recommendations.  
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C h a p t e r  8  
THE DISCUSSION CHAPTER 
8.1 Introduction 
The previous chapter compared the three practices and presented the results of this PhD under 
the important concepts which emerged from the analysis.  In this chapter, theories have been 
applied to the data to help define and explain these concepts. These theories provided important 
frameworks to allow the researcher to critically understand the data and concepts and provided 
greater explanatory power. 
This PhD had started with an open-mind as to ‘what influences prescribing decision-making’ 
but as the fieldwork and analysis became more focused it became clear prescribing decisions 
were made by GPs at two levels; macro and micro.  The macro prescribing decisions were 
strategic decisions shaping practice prescribing policies and practice organisation, and the 
micro level prescribing decisions are made about the individual patient.  Through this PhD it 
became clear the influences on and mechanisms for macro and micro prescribing decisions 
vary and were made in different contexts; macro decisions were made as a group and micro 
prescribing decisions were made by the individual.  Before the discussion of the findings the 
methods used for this study are considered. 
8.2 Methodology 
This section will discuss whether the methods in this study facilitated answering the research 
questions and if the research findings are transferable to a different population. 
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8.2.1 Choice of method 
The intention of this study was to explore the influences on the prescribing process in primary 
care to better understand why practices do not always engage with evidence based medicine.  
Previous studies have explored influences on type of drug (Crowe et al., 2009, Cantrill et al., 
2000, Butler et al., 1998), focused clinical area (Walker et al., 2001, Bertoni et al., 2009), 
guidelines (Eccles et al., 2002, Grol et al., 1998, Wathen and Dean, 2004) or the doctor/patient 
relationship (Gibson et al., 2006, Britten et al., 2004, Virji et al., 1991) but no study to date has 
been found which explored all influences on practices in a holistic manner.  An ethnographic 
methodology allowed the researcher to explore the various influences in context and without 
applying a predetermined hypothesis, allowing the findings to be derived inductively from the 
data.  Using participant observation as the main method of data collection allowed direct and 
sustained contact with prescribers, who were able to inform the researcher when she was 
misunderstanding and misinterpreting their behaviour.  There are a huge number of factors 
influencing prescribing but the iterative-inductive nature of ethnography allowed the researcher 
to constantly move between the research questions and data to refine the questions and 
subsequent line of enquiry into a more focused piece of work with inductively derived findings 
verified by participants. 
The strength of this ethnographic work was the number of hours of observation (over 390; 
appendix 6) carried out across the three practices, which allowed relationships to be built with 
the members of each practice and access to all aspects of prescribing.  By repeated visits over a 
period of time the researcher was able to test and validate the emerging analysis and 
interpretation, to produce a rich and in-depth representation of their prescribing behaviour and 
influences.  As the social world is constantly changing this was only a ‘true’ representation at 
the time of observation.  
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As this study observed GPs, practice staff and patients but only informally interviewed GPs and 
practice staff this research does lack the voice of patients, however some data was gathered on 
their perspectives through observed consultations, albeit inferred.  Ethnographies in health and 
medicine are still rare due to the practical and ethical issues associated with observing research 
participants (O'Reilly, 2005), particularly patients.  At the time of designing this study it was 
felt the study may not get ethical approval if the researcher was to track patients.  Therefore, 
some of the issues raised about ‘the patient’ are from observed interactions, practice staff and 
the researcher’s perceptions and from what is already known in the literature.  
By using ethnographic methods the research is shaped by the researcher-subject interactions 
making this study more interpretative than if other methods had been used however, the 
detailed methods chapter containing reflexive accounts of the researcher’s decisions during the 
study allow the reader to assess the transferability of these findings (discussed below).  
8.2.2 Generalisation and transferability of the findings 
The aim of this research was to produce information that can be shared and applied to general 
practices outside the sample and health board area in which the research was conducted.  
However, no study, regardless of the methods used, can provide findings which are universally 
applicable (Murphy et al., 1998). This section discusses what is meant by generalisability and 
transferability and guides the reader to consider whether the study findings can be applied to 
their own areas of interest. 
Generalisability is concerned with whether the findings of a study can be relevant beyond the 
sample and context of the research (Lewis and Ritchie, 2003).  Thus generalisation is aided by 
using methods which include a study population that is representative of the population it 
wishes to generalise. This has different issues for qualitative and quantitative research; where 
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quantitative research uses sampling methods such as random sampling to increase the 
likelihood of being able to generalise the findings.  However, “the particular value of 
qualitative research lies in its ability to explore issues in depth and from perspectives of 
different participants, with concepts, meanings and explanations developed inductively from 
the data” (Lewis and Ritchie, 2003; 267).  This PhD adopted a constructivist epistemology, 
thus qualitative research should focus on the more modest goal of ‘transferability’ (Lincoln and 
Guba, 1985).  Lincoln and Guba (1985) argue that transferability is dependent on the 
congruence between the context in which the research has been conducted and the context to 
which the research will be applied.  Thus this research has provided ‘rich’ descriptions of the 
three practices so the reader can gauge and assess the meanings attached and consider whether 
the findings can be applied to their area of interest. 
The nature of description in ethnographic work is always selective. “It is not possible to give an 
exhaustive account of any locale.  In producing descriptions we always rely on criteria of 
selection and inference” (Hammersley and Atkinson, 2007; 32).  Chapter three, the methods 
chapter has attempted to provide sufficient information about the researcher’s ontological and 
epistemological perspective and the decisions made during the research process to allow the 
reader to decide in what ways and to what extent the research findings can be transferred to 
their setting. 
To guide the reader in their consideration of the transferability of these findings, the author 
discusses the sampling strategy adopted in this PhD and considers whether it supported the 
aims and objectives of the study. 
A purposeful sample of general practices was identified by using Audit Scotland (2003) 
prescribing quality indicators (Appendix 2) and applying these to a year of PRISMs data. 
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Prescribing indicators are a quality improvement technique used to monitor and change 
prescribing. These indicators were currently being used by the CHPs to identify variation 
between practices and by benchmarking practices against one another, motivating them to 
change. The intention was to recruit practices by their responsiveness to these indicators. 
The quality of prescribing is hard to measure. Prescribing indicators are frequently used 
however they generally have low validity (Campbell et al., 1999). The Audit Scotland 
prescribing indicators had limited validity because they could only link into PRISMS data, 
which could measure cost and volume but could not link to diagnosis.  However these were the 
best available indicators and data at the time of sampling.  Now with improved recording of 
data in general practices with nGMS and QOF it is possible to link to diagnosis but the 
informatics for extracting the data from practice IT systems was not yet developed. A recent 
study used the same sampling method on the population used in this study but with more up-to-
date and revised prescribing indicators and ranked the practices in similar positions. (This study 
is not published but further information is in appendix 5).  Therefore, although these 
prescribing indicators had limited validity, they provided a reliable method of identifying and 
ranking practices which respond to quality prescribing performance measures.  
This research was conducted in a health board area which is unique in its investment in practice 
pharmacists in Scotland. The three practices which took part in the study had different 
demographics; one urban, one rural and one market town practice.  The practices varied in size; 
by list size and number of GPs and they varied in their responsiveness to the CHP prescribing 
quality indicators.  By sampling three different practices the transferability of these findings 
was improved. The researcher also sampled within cases by observing different aspects of the 
practice at different times.  All GPs were observed in consultations, practice meetings were 
observed, the informal spaces such as the coffee room and reception were observed at various 
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times and days and the practice, specialist nurses and practice pharmacists were  observed on 
various days in various roles to give a comprehensive overview of all aspects of prescribing 
from the perspective of different roles.  The practice business meetings were not observed as 
the researcher became aware in the first practice the sensitivities of discussing finance.  
Prescribing issues could have been discussed at these meetings.  However, it would have taken 
much more time and effort to gain access which may not have revealed any further information.  
The gatekeepers in each practice informed the researcher of any events or issues she missed 
when not at the practice.  Therefore, the researcher is reasonably confident if there was a 
prescribing issue discussed at these meetings the gatekeepers would have informed the 
researcher.  
The aim of the study was to explore ‘what influences prescribing in primary care’ but there are 
a huge number of factors at play.  Researching more than one practice improved the potential 
transferability of the study.  By sampling practices which performed well and poorly against 
prescribing quality indicators facilitated exploring variations in context, identifying different 
kinds of prescribing behaviour, processes and systems.  Comparison of the practices allowed 
deeper analysis by opening the researcher to different perspectives and being able to identify 
similarities across the practices which performed well against the performance measures. 
In conclusion, this study was unique in the approach and intensity of the research.  The 
researcher spent time in the practices to build a relationship or at least a rapport with the 
practice staff.  This allowed the researcher to get under the skin of three quite different 
practices and to be confident in her observations.  The methods and the sampling strategy of 
this research aided achieving the study objectives and have been described in detail to allow the 
reader to assess the transferability of the findings.  
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8.3 Discussion of the findings 
This PhD has found general practitioners engage with the evidence and decision-making at two 
levels within their practice; macro and micro and there are different prescribing decisions made 
in different contexts with different influences at play. This chapter will now discuss these 
different types of prescribing decisions in the light of the existing literature. Macro prescribing 
decisions are population based, grounded in science and based on EBM. Micro prescribing 
decision-making is with an individual patient and is less an exact science; patients are unique 
with different health problems, biology, perspectives and context.  Micro prescribing can be 
‘trial and error’ with many patients, especially those with complex co-morbidities.  The 
macro/micro divide decision-making illustrates the ‘science’ versus ‘art’ nature of prescribing.  
The two different prescribing-decisions are discussed in turn. 
8.3.1 Macro prescribing 
There are two reasons ‘why’ macro prescribing is important to consider; in UK general practice 
the vast majority of GPs work in groups, they tend to be accessible to the practice population 
rather than work personal lists and sign repeat medication which has been authorised originally 
by a colleague, therefore prescribing has become a team based activity.  Also, strategies such as 
guidelines and clinical governance focus on population based recommendations which are 
grounded in EBM. Therefore macro prescribing decision-making is more collective behaviour 
which requires co-ordinated action.  Macro prescribing decisions are practice policy decisions 
and made by all key clinical staff in the high ranking practices. In the lower ranking group 
practice, the Haun, the practice organisation made collective decision-making by all GPs 
problematic.  
Macro prescribing decisions are both influenced and shaped by the contextual influences, the 
practice organisation and communication channels.  These are interconnected and influence 
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each other so the author needed to grasp each to understand the other.  This discussion has 
attempted to write these as discrete sections to discuss how each is influenced and influences 
macro prescribing decision-making. 
Initially engagement with the contextual influences will be discussed in light of Sheaff et al.’s, 
(2003) work on soft governance and then focus on the importance of organisation and 
communication for macro prescribing.  By drawing on Weick’s (2001) work on organisational 
sensemaking this study found the practice identity was instrumental in shaping their 
engagement with EBM and clinical governance and influenced the practice organisation and 
communication channels. These three constructs are pulled together under practice identity and 
macro prescribing decision-making is discussed in light of Weick’s (2001) organisational 
sensemaking.  
8.3.1.1 Context 
General practices are independent businesses and therefore, cannot be manipulated by 
traditional command and control mechanisms. This study identified two main quality 
improvement channels which aimed to influence prescribing in primary care; evidence-based 
medicine and clinical governance.  Findings showed all practices valued quality improvement 
and engaged with EBM at the macro prescribing level.  However, implementation required 
practices to be organised and have effective processes and systems.  Practices’ engagement 
with CHP mechanisms was variable and guided by their values and practice identity. This 
section will discuss these contextual influences by drawing on Sheaff et al.’s (2003) work on 
soft governance to explain the practices engagement with EBM and the CHP quality 
improvement mechanisms. 
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8.3.1.1.1 Evidence based medicine 
In the UK, evidence based medicine is at the core of the health system.  The evidence based 
medicine movement produces a large amount of guidelines, with the aim of bringing clinicians 
activities more in line with the scientific evidence (Grol et al., 1998).  EBM is a strategy for 
quality improvement which aims to rationalise and standardise clinical decision-making in 
accordance with the evidence. Ferlie et al., (2000) argue from an organisational behaviour 
perspective that the EBM model depends on clinical practice to be grounded in the data in a 
systematic and rational way, moving away from the more traditional approach based on tacit 
knowledge. Quality improvement strategies are advocating consistency and standardisation at 
the practice level based on EBM, shifting evaluation and management decisions away from the 
individual doctor (Harrison and Ahmad, 2000). Therefore, this study’s finding of practice 
engagement with quality improvement and associated decision-making made at the macro 
prescribing level is in line with the existing literature. How practices engaged and valued EBM 
is discussed later on in this section. 
8.3.1.1.2 Clinical governance 
Clinical governance is "a framework through which NHS organisations are accountable for 
continually improving the quality of their services and safeguarding high standards of care by 
creating an environment in which excellence in clinical care will flourish" (Scally and 
Donaldson, 1998). In Scotland, health boards are responsible for the planning and delivery of 
services, one of which is primary health care services where the health boards provide these 
services through contracts with independent contractors (general practitioners). Health boards 
devolve some of this responsibility to CHPs, where they plan and provide services at a local 
level to suit local need.  The CHPs are also responsible for various budgets, one of which is 
prescribing.  
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CHPs have a statutory responsibility for the quality of medical services through clinical 
governance, which includes the monitoring and implementing quality of care.  Prescribing is a 
major concern as CHPs have responsibility to ensure patients have access to the most clinically 
and cost effective medicines, as they operate within a limited health budget they try to 
encourage rational and cost effective prescribing. They have the responsibility of endeavoring 
to influence the performance of general practices; this includes influencing poor quality and 
expensive prescribing (Britten, 2001). 
There is a “long-established proposition that ‘science push’ is by itself a weak influence on 
behaviour” (Ferlie et al., 2000; 100). As general practices are independent businesses CHPs 
cannot rely on traditional hierarchical command and control mechanisms (Grimshaw et al., 
2006).  Instead the CHPs used a range of soft governance mechanisms (Sheaff et al., 2003) to 
influence prescribing behaviour; practice pharmacists, education, a prescribing indicator report 
and the health board area wide prescribing formulary (the same mechanisms were used in each 
of the CHPs across the health board). Soft governance mechanisms are sophisticated 
management strategies designed to appeal to shared professional values (Sheaff et al., 2003) as 
the CHP must work with GPs rather than against them.  Soft governance is based on building 
relationships and rapport, demonstrating understanding and using persuasive arguments (based 
on EBM and prescribing data). This section will now discuss each of the CHP soft governance 
mechanisms in turn. 
8.3.1.1.3 CHP prescribing indicator report 
 The CHP prescribing indicator report benchmarked practice against that of other local GP 
practices and was designed to generate competition between practices within the CHP (this is 
the same prescribing indicators and data that were used in this studies sampling frame, see 
section 3.3.3).  The report published a number of both quality and cost indicators. The 
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indicators were not intended to be penalising but designed to feedback to practices and 
encourage them to explore their prescribing.  Only Rubain accepted the relevance of these 
measures as the other practices argued they had atypical patient populations. The limitations of 
current practice level data and the associated cost and volume indicators are recognised.  Audit 
Scotland (2003) has called for new measures that combine prescribing and diagnostic data and 
more accurately assess the appropriateness of prescribing.  
The majority of the prescribing indicators were seen as cost efficiency rather than quality 
measures and seen to be changing frequently. Therefore, the GPs lacked motivation for these 
changes which also increased workload and inconvenience for patients. The CHP 
communicated a message of quality but the measure (prescribing indicator report) was 
primarily based on cost. NHS Tayside acknowledged the majority of their measures were 
primarily cost driven due to the health boards large over spend (personal communication, Lorna 
Scahill, Head of Medicines Management, NHS Tayside).  This mechanism resulted in n unclear 
message from the CHP to the general practices.  Prosser and Walley (2007; 21) illustrate this 
tension “although managers talked of quality, they measured success in terms of saving 
money.” Rubain engaged with these cost driven mechanisms because they saw cost-efficiency 
as part of their professionalism and they liked to be seen as ‘the best’, even in this domain.  
8.3.1.1.4 Formulary  
The health board produced a prescribing local area formulary of drugs which are approved on 
the basis of maximising effectiveness and minimising cost.  This formulary is aimed at 
standardising prescribing.  All three practices used the formulary and accepted the rationale 
behind it, so accepted the NHS has finite resources and prescribed ‘generic’ medication when 
appropriate and when in line with their views and values (with exceptions). The two high 
ranking practices accepted the formulary with exceptions; they adapted this formulary to suit 
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their values by creating an internal practice formulary.  The other practice prescribed from the 
health board formulary, which was more extensive. In keeping with soft governance, these 
practices engaged with evidence and reflected on their values and modified the health board 
prescribing formulary accordingly. (This is discussed in more detail in the communication 
section). 
8.3.1.1.5 Practice pharmacists 
Practice pharmacists were employed by the CHP but worked within general practices. Their 
role was to rationalise and standardise prescribing and were given a wide remit in the way they 
operated to suit the practice culture. Being based in the practices allowed these pharmacists to 
build a relationship and rapport with the staff and gain an understanding of their values and 
practice identity. This study found practice pharmacists were conducive in leading prescribing 
quality improvement and interpreting prescribing data to identify areas for improvement. The 
practice pharmacist interpreted the practice level data in the context of the changing evidence 
and turned this data into information. Consistent data recording is required to be able to 
efficiently and effectively audit and identify areas for improvement and practice pharmacists 
were instrumental to the practices audit and feedback activities.  All the practices valued the 
pharmacist’s activities in audit and feedback. The feedback of audits resulted in changes at the 
micro, individual patient level, but changes at the macro level required audit data to be 
feedback to the majority prescribers face-to-face to facilitate discussion and inform collective 
decision-making. This could then inform new prescribing as well as changing old prescribing. 
However, for the practice pharmacists to have an effect at the macro prescribing level, practices 
had to be organised, with effective processes and systems, and communication channels in 
place and practitioners had to value the messages disseminated.  (These issues are explored in 
more detail under the organisation and communication sections).  
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The larger practices were happy for the practice pharmacist to lead prescribing quality 
improvement and filter EBM into the practice by holding educational sessions summarising 
new evidence in light of the practice context and values.  The GPs felt they did not have the 
time to individually engage with the evidence and valued the pharmacist resource in this 
activity. The GPs trusted what the pharmacist said and did not question the EBM sources but 
they did challenge some of the CHP cost-saving initiatives.   The single-handed practice 
‘Rosnish’ was unique in respect that the lead GP had organised the practice to allow him 
sufficient time to review EBM. 
These findings correlate with the current literature where lack of time has been identified as a 
major barrier to clinicians engaging with EBM (Gabbay and le May, 2004), (McColl et al., 
1998b), (Davidoff et al., 1995) and GPs lacking the skills to search and critically appraise the 
literature (McColl et al., 1998b, Cranney and Walley, 1996). Gabbay and le May (2004) found 
GPs rarely use guidelines, when a new guideline is published GPs flick through it and if any 
changes to practice are required they discuss it with colleagues. Practice pharmacists are 
increasingly facilitating educational interventions, where they present data and research 
evidence to support changes in prescribing (Beney et al., 2009, Watkins et al., 2004, Nazareth 
et al., 2002, Freemantle et al., 2002). A systematic review of 85 trials found audit and feedback 
can improve professional practice (Jamtvedt  et al., 2006) but effectiveness varies and variation 
may be related to different methods or contextual factors (Grimshaw et al., 2004).   Hysong et 
al., (2006) found if data is presented in a less punitive way it is less likely to be resisted and 
customising the data engages the individuals with the data and makes them an active participant 
in the sense-making process rather than a passive recipient. Thus, leadership is a core condition 
for quality improvement (Rushmer et al., 2004).  
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Although GPs were happy to engage with the evidence, engaging practices in in-depth 
discussion and debate about changing practice and implementing these changes was dependent 
on their values.  The practice’s needed to recognise these were macro prescribing decisions and 
value consistency in their prescribing behaviour before the pharmacist could standardise and 
rationalise prescribing.  Consistency requires organisation, processes and systems, without 
these in place it was difficult for the practice pharmacist to have any major impact.  In the 
practice with a large number of part time staff, few practitioners were in attendance at the 
pharmacist led educational sessions and email summaries were not circulated so it is not clear 
how informed and engaged all practitioners were with the new evidence. This suggests a 
practice’s organisational arrangements can be a barrier to educational sessions but also that this 
practice accepted these were difficult to arrange rather than trying to find ways to maximise 
opportunities. Without educational sessions the practice pharmacist was dependant on informal 
and opportunistic communication channels which were inefficient and ineffective at the macro 
level which led her to do micro level work instead.  
These findings are in line with research around the organisation of care.  Freemantle et al., 
(2002) found organisational size a barrier to educational sessions.  A systematic review of 
continuing educational meetings found educational meetings alone or combined with other 
interventions, can improve professional practice and healthcare outcomes for the patients but 
educational meetings alone are not likely to be effective for changing complex behaviours 
(Forsetlund et al., 2009). Powell et al., (2009; 66) argue “successful sustained quality 
improvement requires not merely changes in formal structures and visable processes...but in 
addition (and more importantly) profound changes in attitudes, beliefs and customs.” Moss et 
al. (1998) argue for systems and the organisation of care for quality improvement strategies to 
have an effect.  These last two points; the requirement for communication, discussion and 
debate and the requirement for processes and systems are addressed in the following sections.  
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This section has highlighted there are two main quality improvement strategies which have had 
limited effect as they rely on soft governance mechanisms due to the unique contractual status 
general practitioners enjoy. These mechanisms are designed to appeal to shared professional 
values.  Practice pharmacists were an important resource in filtering CHP messages and new 
findings from the literature. Practice engagement with EBM and CHP mechanisms required 
macro prescribing decisions, which necessitate consistency in implementation. The CHP uses a 
number of mechanisms to influence these macro prescribing decisions but engagement was 
variable due to the limitations of current prescribing data and the mixed messages of quality 
and cost, so only the practice which viewed cost-savings as part of quality and ‘good practice’ 
engaged with the full range of mechanisms. Although, practice pharmacists led quality 
improvement and introduced evidence to practitioners, implementing change to good effect 
required practices to be organised with effective processes and systems in place and for GPs to 
value the changes. 
This section has discussed the context and mechanisms which aim to influence general 
practices but general practices are organisations with unique structures and values which 
influence their engagement and uptake of EBM and clinical governance.  The next sections will 
discuss the importance of organisational processes and communication channels.  
8.3.1.2 Organisation 
Much of the research around organisational systems views ‘the organisation’ as the whole 
health system, such as the NHS (Garfield et al., 2009, Howard et al., 2008), rather than seeing a 
general practice as an organisation.  Checkland (2007) recommends viewing general practices 
as organisations as this gives insights into factors which influence change.  
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Prescribing quality improvement and rational prescribing require collective decisions and 
collective behaviour.  To be able to engage in collective decision-making and behaviour, 
practices need to have co-ordinated practice organisation which is supported by considered 
processes and systems. Engagement with quality improvement requires practices too use 
information to improve the quality of care they provide. This requires practices to accurately 
and consistently record data so improvement can be measured. This study found implementing 
quality improvement and EBM requires practices to be systematic and organised; leadership 
was important for practice organisation and managing change; and IT systems provided an 
opportunity for macro prescribing policy to be implemented consistently across the practice 
team.  Being organised created time and an opportunity for practices to forecast and plan for 
future changes. Due to the nature of prescribing data, quality improvement measures the 
practice prescribing behaviour rather than individual GP behaviour.  Therefore, this section will 
argue macro prescribing decision-making and quality improvement needs to be supported by 
organisational processes and systems for consistent implementation of practice prescribing 
policy and the systematic identification of patients for review. 
Quality improvement is about knowing what is going on in the practice and identifying areas 
for improvement. The CHP quality improvement mechanisms are based on PRISMS data, so to 
link these measures to diagnosis and find out if the prescribing was appropriate requires 
practice system data. Audit is the mechanism by which by practices can find out what is going 
on and identify clinical areas and patients for review of their medication. Accurate and effective 
auditing requires consistency in recording and tight audit definitions.  Without these systems in 
place a number of patients could be missed.  All three practices regularly engaged in audit and 
feedback.  However, the Haun did not use tight audit definitions.  Due to the lack of 
consistency in their prescribing and recording of data made it harder to run tighter searches. 
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Rubain and Rosnish valued knowing what was going on and audit provided the mechanism by 
which they could oversee their prescribing behaviour and identify patients for review.  
Leadership was important for co-ordinated practice organisation and leading prescribing quality 
improvement. The next section will show how important the practice pharmacists were to 
leading prescribing quality improvement in the larger practices.  Rubain and Rosnish both had 
a clinical lead who would oversee the clinical and organisational aspects of the practice, albeit 
with different leadership styles.  Clinical leaders ensured issues were addressed, would drive 
change and be involved in co-ordinating the practice organisation. In Rosnish the lead GP was 
also the practice manager, whereas Rubain had invested heavily by employing two practice 
managers.  Both practices valued organisation and control.  In the Haun, due to the large 
number of part-time staff, (both clinical and administrative) the practice manager spent a 
considerable amount of her time organising reception, rotas and the day-to-day practice 
management.  The practices which performed well against the prescribing indicators had more 
effective clinical and administrative leadership. 
Systems can be effective for the systematic identification of patients for chronic disease 
management and medication review. Practices had two systems which were an important part 
of quality improvement; the IT system and their communication strategies (discussed in the 
next section). The IT system was important for monitoring and recall of patients in all three 
practices and also in Rubain to reinforce their practice formulary (high ranking practice with a 
number of prescribers) through the use ‘hooks’ on their IT system. This study found practices 
need to value these systems and invest time refining them in light of changes otherwise they did 
not support consistency in recording and auditing for effective quality improvement and 
accountability. 
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In summary, macro prescribing is a collective behaviour which requires co-ordination and to be 
supported with systems in place for quality improvement.  Efficient and effective quality 
improvement requires accurate and consistent data, which requires co-ordination and 
communication across prescribers. Leadership was important for practice organisation and to 
drive and manage change.  
These findings are aligned with the literature. A process evaluation of a RCT concluded EBM 
and in particular guidelines are not purely ‘medical’ they also involve organisational aspects so 
practices need to make organisational agreements as well as clinical decisions (Jansen et al., 
2007). Organisational performance and change is known to be influenced by the organisational 
characteristics (Spooner et al., 2001, Davies and Nutley, 2000).  Sustained quality 
improvement requires changes in structures and processes (Powell et al., 2009), systems and 
organisation of care (Moss, 1998). Organisational change has to be internally led and a 
systematic review identified there was a need for organisational assessment tools to stimulate 
development (Rhydderch et al., 2005). 
A systematic review concluded audit and feedback can be effective in improving professional 
practice but the effects are small to moderate (Jamtvedt  et al., 2006). A review of the evidence 
on audit and feedback concluded they can be effective in changing behaviour but need the right 
organisational conditions and processes (Foy et al., 2005). Delivering feedback in a timely and 
non-punitive way has been associated with higher quality care (Hysong et al., 2006). 
Leadership is important for quality improvement (Lukas et al., 2009, Rushmer et al., 2004, 
Palmer et al., 1996) and is associated with successful team engagement for quality 
improvement (Rubenstein et al., 2002). 
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8.3.1.3 Communication 
Macro prescribing decision-making is a team based activity, based on reviewing the scientific 
evidence and making population based decisions. Therefore practices need to collectively 
engage with new evidence to revise macro prescribing. This study found in practices with 
multiple GPs, face-to-face meetings with summarised research evidence engaged practitioners 
with the evidence and provided an opportunity to present CHP prescribing policy.  However, 
practices needed to value collective decision-making and consistency in prescribing behaviour 
to engage in discussion and debate around reviewing macro prescribing and refining their 
associated systems. Where collective decision-making was valued all practitioners engaged in 
discussion and debate which gave ownership of their macro prescribing policy. In the practice 
which did not value macro prescribing the practitioners attended these meetings to maintain 
competence and to keep up-to-date with the evidence. This section will argue face-to-face 
communication channels are required to engage practitioners with EBM. 
EBM is constantly being revised so practices need to keep up-to-date.  Most practitioners felt 
they did not have sufficient time to keep up-to-date and to reflect on new evidence.  Having 
practice meetings where summarised research evidence on a topic and the results of audits were 
fed back provided an opportunity for practitioners to allocate time to engage and reflect.  As the 
meetings were face-to-face they presented an opportunity for practitioners to share values and 
experiences and collectively reflect before modifying prescribing policy.  However, in the 
practice with a large number of part-time staff attendance at meetings was problematic so 
collective decision-making was difficult.  In response this practice created a practice identity of 
valuing clinical autonomy. 
In the context section it was shown practice pharmacists were well placed to lead prescribing 
quality improvement and run these face-to-face meetings.  Tayside Health Board is unique in 
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its investment in practice pharmacists in comparison to other Scottish health boards so these 
findings may not be a transferrable model to another health board.  Practitioners felt practice 
pharmacists had specialist skills (interpretation of evidence in the context of the practice 
population) which could be brought to the discussion.  Data are fundamental to quality 
improvement and this study found the practice pharmacists had an important role in mediating 
between the prescribing data and the practice, where they interpreted the data and translated in 
the context of changing evidence.  This has highlighted that quality improvement needs some 
form of leadership for interpretation and co-ordinated practice engagement.  EBM is constantly 
being updated so practices need to collectively review and revise their macro prescribing 
accordingly and without leadership they can become stagnant.  The practices had prescribing 
leadership which drove their quality improvement agenda and engagement with EBM but 
without valuing collective decision-making, macro prescribing decisions were not made.  
These findings are consistent with the existing literature.  The PRICCE project (Spooner et al., 
2001) found team working and ownership of decision-making management, which needs to be 
aligned with professional values, were important to engagement with quality improvement. 
They recommended a macro-management approach which leaves practitioners autonomy as to 
how to deliver care, rather than tight control of day-to-day processes. Good teamworking 
(Campbell et al., 2001, Firth-Cozens, 2001) and effective communication channels are a key 
part of providing high quality care across a range of areas (Howard et al., 2008, Flottorp et al., 
2003) but may need specific support if quality of care is to be improved (Campbell et al., 
2001). Lipman and Price (2000) found a specific educational meeting was more successful at 
changing practice than at a partners meeting with another agenda.  In a practice that was 
motivated enough to employ a pharmaceutical adviser and had an explicit policy of reviewing 
its prescribing, the original decision was not well disseminated and only partially implemented 
(Lipman and Price, 2000). A randomised controlled trial of educational outreach visits found, 
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educational outreach alone was unlikely to achieve worthwhile change in larger practices, 
whereas there was good evidence to support the use of educational outreach visits in small 
practices (Freemantle et al., 2002).  Protected time and reflective practice are important 
conditions for practices to learn (Rushmer et al., 2004).  Walker and Mathers (2004) found in 
meeting together changes in prescribing occurred from the support of group policies and 
greater sense of group cohesion was the greatest benefit from practice meetings. Strong 
mechanisms and processes for transferring information and developing shared meanings for the 
negotiation of action are crucially important (Carlile, 2004, Carlile, 2002). 
8.3.1.4 Practice Identity 
The previous sections have shown general practices are independent businesses which cannot 
be controlled through traditional command and control mechanisms.  EBM and CHP 
mechanisms try to influence practices through soft governance which aims to appeal to shared 
values.  Practices engaged with CHP quality improvement mechanisms they valued but also 
needed effective systems and processes in place, in particular effective communication 
strategies for macro prescribing decisions. Practice values also guided their organisational 
structure and processes and shaped their practice identity. This section will discuss the practice 
identity in shaping practices engagement with quality improvement in terms of “Organisational 
Sensemaking” (Weick, 2001). 
Other theories were explored to help explain the various influences upon practices and how 
they have an effect. Initially the audit culture (Power, 1997, Strathearn, 2000) was explored as 
quality improvement, EBM and CHP mechanisms define, measure and regulate professional 
work, however this was exploring the mechanisms rather than the practice values and 
organisation which shaped engagement with these mechanisms. The theory of planned 
behaviour (Ajzen, 1991) was excluded as this theory assumes that the ‘motivation’ or 
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‘intention’ to do something is the key determinant of behaviour and tends to focus on 
individuals rather than organisations. With current repeat prescribing systems this study was 
exploring collective rather than individual behaviour.  The findings of this PhD were that all 
practitioners were motivated and engaged with EBM at the macro level, therefore this theory 
could not account for the differences between macro and micro prescribing.    
From the previous sections it is clear to see general practices have multiple influences and 
operate in a complex context.  “Sensemaking” is how organisations make sense of all these 
factors to organise themselves they way they do, through their values and identity.  It is a 
retrospective activity which rationalises what people are doing. Sensemaking is about 
developing an identity context and through engagement with ongoing circumstances through 
which they extract cues and make sense retrospectively (Weick et al., 2005). Every now and 
again practices stop and take stock of their circumstances and form this into words, and the 
identity ‘created’ then feeds into future behaviour.  Reading, writing and conversing are crucial 
actions which shape conduct and practice identity (Gioia et al., 1994). “Sensemaking is a 
process that is ongoing, instrumental, subtle, swift, social and easily taken for granted” (Weick 
et al., 2005).  
Sensemaking is rooted in identity; ‘what kind of practice are we?’ This study has shown each 
practice had an identity which was constructed from their values, circumstances and 
experiences. Macro prescribing decisions are strategic decisions which shape prescribing 
policy.  EBM and CHP mechanisms were identified as the main contextual influences on macro 
prescribing and how practices responded was influenced by their practice identity. The two 
practices which performed well against the prescribing indicators had a practice identity of 
striving to be the best and saw prescribing as core to this. The practice which did not perform as 
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well had an identity of providing good care for patients but was laid back and but had business 
issues which they prioritised more at the time of this research. 
Essential to sensemaking is effective communication (Huby et al., 2008).  The two practices 
which performed well against the prescribing measures engaged in regular face-to-face 
communication and had a strong practice identity. They recognised that responses to EBM and 
CHP soft governance mechanisms required macro prescribing decisions. They responded to the 
influences by reflecting on their knowledge, experience and values and engaging in collective 
decision-making about strategic macro prescribing policy. Although, the Haun had prescribing 
meetings they did not collectively reflect.  In the case of new guidelines they accepted the 
recommendations and agreed to meet the bio-medical markers but did not discuss how this 
could be achieved. These face-to-face meetings were about sensemaking, ‘what do we value? 
What cues do we notice? How are we going to respond to these?’ so the prescribing meetings 
were invaluable to prescribing sensemaking. Sensemaking is an iterative process where 
practices extracted cues from their context; the action which is taken results in changes which 
play a part in determining which cues are noticed in the future. The Haun had not recognised 
that these guideline recommendations may require changes to macro prescribing or practice 
organisation, as they had not recognised or did not value macro prescribing. 
Practice identity drove their organisation, especially their communication channels, but practice 
identity was also driven by their organisation characteristics (such as number of part-time staff).   
The practices with a strong prescribing identity had effective communication channels, tighter 
processes and systems and co-ordinated practice organisation.  These practices believed being 
the best was achieved through being organised and having good, reliable and consistent data to 
be able to identify areas for improvement. They also valued continuity of care with patients and 
had developed practice systems to achieve optimal levels of continuity of care (discussed in 
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micro prescribing section). These practices had recognised the importance of the IT system for 
quality improvement and had invested time reflecting, modifying and improving their systems.  
The Haun had not recognised that organisation was also important to quality improvement. Due 
to the high number of part-time staff they had developed an organisational identity which saw 
themselves as modern and advocated clinical autonomy rather than collective decision-making 
or sensemaking.  
The Haun’s identity was reactive to their organisational structure. They were not aware they did 
not have a co-ordinated practice organisation or that lack of discussion and debate was not 
effective for sensemaking as they had not noticed these cues. Their identity as the modern, 
egalitarian practice was borne from a large number of part-time staff, reliance on IT for 
communication and a lack of leadership (which assists co-ordination).  The other two practices 
were clear they wanted their identity and they regularly engaged in communication which 
reinforced their identity. As the Haun did not have co-ordinated practice organisation or 
collective face-to-face communication often their practice identity or policies were weak and 
prescribing sensemaking was difficult to achieve.  Without effective communication and co-
ordinated practice organisation there was little the practice pharmacist could do to lead their 
prescribing quality improvement. 
This study has suggested practices need to be co-ordinated and have face-to-face meetings, or 
other as effective communication strategies in place to consider external influences and form a 
strong practice identity.  The practices which performed well against the prescribing indicators 
had a strong identity based around their competitive prescribing behaviour.  Practices without 
these mechanisms should think about their relationship to the various influences and construct 
an identity which helps them deal with these in a coherent and systematic way.  
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A practice identity is not something external influences can do anything about; it is about how 
practices respond to their values, circumstances and experience.  What this PhD had suggested 
is that face-to-face communication is important for a macro prescribing policy but also for 
organisational sense-making.   
This section has discussed the importance of practice identity for driving engagement in EBM 
and clinical governance.  The next section will give an overview of micro prescribing and 
illustrate the barriers to implementing macro prescribing at the micro level.  
8.3.1.5 Macro prescribing summary 
In summary, macro prescribing is about practice prescribing policy, which involved population 
based decisions that require collective behaviour and co-ordinated action.  All practices valued 
EBM and quality improvement however, implementation required organisation and effective 
processes and systems.  Practices engagement with EBM and CHP mechanisms was variable 
and guided by their values and practice identity.  Practice pharmacists were instrumental in 
leading prescribing quality improvement.  They also had a key role in interpreting practice level 
data in the context of changing evidence and identifying areas for improvement. When the 
practice pharmacist informed GPs of changes to evidence and fed the results of audits back to 
the practice face-to-face this resulted in changes to new prescribing as well as changes to old 
prescribing. Practice prescribing meetings were an important communication channel for the 
pharmacist to engage with the practice and to filter new evidence and the results of audits into 
the practice. These prescribing meetings allowed the practices to share values, experience and 
modify their macro prescribing. This is an important part of sensemaking, where practices 
make sense of the multiple influences upon their prescribing through their values and practice 
identity.  
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8.3.2 Micro prescribing  
Micro prescribing decisions were made in a consultation between the GP and the patient. These 
decisions required interpreting the evidence and macro prescribing policy using clinical 
judgement and experience, in light of a patient’s preferences, values and circumstances.  Macro 
decision-making was made with reference to the ‘average patient’ whereas individual patient 
circumstances will sometimes justify deviation from standard practice.  
Recent literature on evidence based decision-making has recognised that evidence is not 
enough to inform decisions and clinicians must use their expertise to assess the patient’s 
problem and must assimilate the evidence with the patient’s preferences and values (Hurwitz, 
1999, Haynes et al., 2002). Sackett et al (1996) argue EBM is about using “...the conscientious, 
explicit and judicious use of current best evidence in making decisions about the care of 
individual patients...It requires a bottom up approach that integrates the best evidence with 
individual clinical expertise and patient’s choice...External clinical evidence can inform, but 
can never replace, individual clinical expertise, and it is this expertise that decides whether 
external evidence applies to the individual patient at all and, if so, how it should be integrated 
into a clinical decision.”  Context and practitioner values also have an impact (Fairhurst and 
May, 2006). The health boards recognise these influences and are using ‘soft governance’ 
mechanisms to encourage practices to explore their prescribing. Therefore, there is a movement 
recognising the limitations to implementing macro prescribing policy at the micro level 
(Fairhurst and May, 2006, Gabbay and le May, 2004).   
As the introduction to the discussion of these findings explained, there are different influences 
at play between macro and micro prescribing decisions.  Macro prescribing decisions are 
population decisions considering the ‘average’ patient, based on research and consider one 
disease in isolation. Whereas, micro prescribing decisions are about applying EBM and macro 
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prescribing to the individual patient, and may involve considering more than one disease.  
Patients are unique, with their own views and preferences which should be considered and 
often present with problems which EBM cannot be applied to such as poly pharmacy and 
comorbidities.  
The previous section illustrated the collective behaviour and co-ordinated nature of macro 
prescribing decision-making and the need for practice organisation, process and systems to 
support macro prescribing.  This section will show how GPs assimilate information at the 
micro level, in particular with complex patients and how continuity of care was important for 
the implementation of macro prescribing policy at the micro level. 
8.3.2.1 Prescribing mindlines 
In the organisational learning literature it has been suggested that learning takes place in 
communities of practice (Wenger, 1998), and is supported by the findings of this PhD.  A 
seminal paper by Gabbay and le May (2004) was a key piece of literature in shaping this PhD, 
however, the results of this study found the development of Gabbay and le May’s (2004) 
mindlines to be most prominent at the micro prescribing level, particularly in the practice which 
did not engage well in collective prescribing decision making. In the practices with macro 
prescribing this policy was generally followed by all practitioners.  However, complex patients 
with difficult prescribing decisions could challenge adherence to macro prescribing.  
Gabbay and le May (2004) showed how clinicians rarely accessed and used explicit evidence 
from research. Clinicians use social networks to access information (Prosser et al., 2003; 
McGettighan, 2003) from sources they trust such as colleagues to iteratively develop mindlines 
which were relied upon to make decisions. Gabbay and le May (2004; 3) define mindlines as 
“collectively reinforced, internalised tacit guidelines, which were informed by brief reading, 
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but mainly by their interactions with each other and with opinion leaders, patients and 
pharmaceutical representatives and by other sources of largely tacit knowledge that built on 
their early training and their own and their colleagues experience.”  
Micro prescribing is not black and white, patient’s symptoms and circumstances may not ‘fit’ 
with the treatment recommendations, making it harder to stick to guidelines and the practice 
prescribing policy or formulary. This study found GPs used mindlines to aid their decision-
making in cases of more complex prescribing.  
This study found prescribing mindlines were iteratively developed from personal experience 
(experience gained from their medical training and from looking after patients), secondary care, 
and advice from the practice pharmacist and from conversations with colleagues.  Drug 
representatives are likely to have had an influence but the extent was hard to gauge in this 
study. mindlines were also iteratively developed from the practice prescribing meetings (EBM 
and CHP policy) in Rubain. Each of these influences is now discussed in turn; 
Mindlines were ‘personal formularies’ primarily developed from experience, their experience 
gained in medical training and from consulting with patients since qualifying. GPs regularly 
applied and tested their mindlines in consultation with patients and revised them by patient’s 
experiences of medication.  
All GPs referred to consultants as an influence on their prescribing and in the practices with 
macro prescribing policy the strongest reason why they would deviate.  GPs tended to follow 
recommendations from consultants; on occasion GPs would consult with the pharmacist before 
prescribing but generally followed the consultant’s recommendations.  The pharmacist would 
provide information or they would read about the medication and learn through looking after 
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patients.  GPs would also discuss secondary care recommendations with colleagues and seek 
advice.  By following consultant’s recommendations the GPs gained experience of medications 
and some of which would become part of their prescribing mindlines.  
GPs would also converse and seek advice from their colleagues about their prescribing which 
was an important part of their iterative mindline development. They would seek advice from 
their practice pharmacist, who would search the literature and pharmaceutical information 
(Martindales and specialist websites) and make recommendations.  However there was rarely a 
straight answer and trade-offs were involved.  Clinicians would share their concerns with GP 
colleagues who would in turn share their experience and frequently gave advice.  Discussing 
specific patients was a sensitive issue so GPs had these informal discussions with trusted 
others.  In the middle sized and small practices, Rubain and Rosnish, all GPs were trusted.  
However, in the larger practice GPs tended to rely on certain colleagues. These interactions and 
information sharing resulted in the iterative development of mindlines.  As discussions were 
not exclusive in the middle size practice these mindlines were collective and shared, whereas 
they were only shared among a trusted few in the large practice.  The large number of part-time 
staff and the lack of face-to-face communication channels mitigated the collective sharing of 
stories and mindlines. Through regular communication and discussions, prescribers developed 
shared mindlines but retained a degree of individual interpretation based on their personal 
experience, values and preferences. 
The practice prescribing meetings were an important way of filtering evidence into the 
practices.  In Rubain where there was collective discussion around the new evidence and macro 
prescribing policy this became internalised.  Through discussion with colleagues, in particular 
about applying the new evidence to individual patients was an important part of learning and 
this new evidence would eventually become part of their shared mindlines.  
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All practices had drug representatives visit the premises. Although, not all GPs conversed with 
the representatives, drug company sponsored materials were left in the coffee rooms and all 
GPs picked up the mugs, pens and post-it notepads.  All but one GP claimed they had no 
influence but it was not clear if this was just rhetoric.  It is likely drug representatives could 
have an influence on mindlines but they were not as strong an influence as experience and 
colleagues.  
Iterative mindline development was an important part of sensemaking at the micro level.  
Through collective discussions these mindlines were shared and developed prescribing norms 
which have importance for consistent prescribing behaviour.  This shows the gradual and 
accumulative nature of mindline development (Armstrong et al., 1996, Jones et al., 2001b). In 
Rubain and Rosnish these mindlines were a refinement of their macro prescribing policy and 
aided consistency in their prescribing behaviour through these mindlines being shared across all 
prescribers in each practice.  However, in the Haun, the largest practice, which did not value 
consistency in prescribing behaviour, mindline development was between a few trusted 
individuals.  
Most decisions to prescribe drugs are a combination of factors (Jones et al., 2001b). Research 
evidence and written information is only one influence (Freeman and Sweeney, 2001, Prosser 
et al., 2003) on the micro prescribing decision. Colleagues and opinion leaders are important 
social influences (Armstrong and Ogden, 2006, Prosser et al., 2003), illustrating individual and 
organisational learning can take place at the same time (Elkjaer, 2004) but requires a well 
functioning team (Firth-Cozens, 2001). Experience shapes the way research evidence 
influences clinical practice (Ferlie et al., 2000) at the micro prescribing level.  All these factors 
contribute to the development of mindlines which ultimately influence prescribing decision-
making (Barley et al., 2008, Gabbay and le May, 2004) at the micro prescribing level. 
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This section has illustrated that although prescribers could not always adhere to macro 
prescribing policy in the two high ranking practices they commonly had developed shared 
mindlines across prescribers which maintained consistency through an informal formulary. 
Gabbay and le May’s (2004) mindlines ‘fit’ with this data but only as part of a larger picture 
which includes macro prescribing.  This point will be addressed again in the summary to this 
chapter, but first this research will now illustrate how important continuity of care was for the 
implementation of macro prescribing or shared mindlines at the micro level.  
8.3.2.2 Continuity of care 
Continuity of care primarily refers to how a patient’s health care is linked over time. Continuity 
of care is an important part of modern medicine for elderly and complex patients (Kearley et 
al., 2001, Schers et al., 2002).  Trust is a fundamental part of continuity and tends to arise 
between individuals rather than between systems (Checkland et al., 2004) or practices. The 
nGMS contract has made relationship continuity harder to maintain (Windridge et al., 2004).  
This section will discuss the importance of relationship continuity for consistency and 
standardised behaviour and for patient care, and the erosion of relationship continuity by the 
nGMS contract. 
Relationship continuity builds trust between the patient and health professional over time. 
Through this relationship GPs are able to educate patients about their condition(s) for self-
management. Consulting with the same GP also saves time as patients do not have to repeat 
their ‘story’ (Guthrie and Wyke, 2006) and GPs take responsibility for the long-term care of 
patients they have a relationship with (Guthrie et al., 2008).  Patient’s value consulting a doctor 
they know well (Cheraghi-Sohi et al., 2008) and feel more comfortable and find it easier to ask 
questions and be involved in the consultation and decision-making process (Guthrie and Wyke, 
2006). This study found that relationship continuity enabled GPs to implement macro 
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prescribing policies.  By having a relationship with patients GPs knew how to encourage 
patients towards their treatment recommendations.  Many prescribing decisions are ‘trial and 
error’ and with relationship continuity GPs were able to encourage patients to try their 
suggestion first or the patient was happy to trust the GPs recommendations. This trust 
relationship was also important if GPs wanted to make changes to recommendations from 
secondary care (however, these were generally cost based switches). In the practice which did 
not engage in macro prescribing GPs generally proposed medication they personally knew well 
and were comfortable prescribing.  This was also the practice with the lowest levels of 
continuity; the part-time GPs felt they offered continuity whereas the full-time GPs found the 
lack of continuity a source of frustration. 
Freeman and Sweeney (2001) found GPs knew how to phrase their ‘sell’ of medication to the 
patient to ensure they were willing to take the drug of choice.  Another study has shown that 
clinician’s recommendations may significantly influence the patient’s decision (Trewby et al., 
2002).  So these two studies support the findings of this PhD.  In contrast, Carlsen and 
Norheim’s (2005) study concluded GPs found it difficult to engage in rational prescribing at the 
micro prescribing level due to their relationship with patients and Checkland et al., (2008) 
argue that claims to holism and continuity of care is rhetoric as GPs have moved smoothly into 
the biomedical requirements of the nGMS contract. There is little research on the effects of 
continuity of care on adhering to macro prescribing policy. Much of the literature focuses on 
GPs responding to patient demands to maintain the doctor-patient relationship (Little et al., 
2004, Dowell et al., 2001, Butler et al., 1998), rather than GPs using this trust to help 
implement prescribing policy. 
The nGMS contract provides financial incentives for practices to achieve nationally set targets 
on speed of access, which reduces relationship continuity for those who want it.  To be 
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financially remunerated practices must offer patients an appointment within 48 hours, which 
results in fewer appointments available for patients to book with their chosen practitioner in 
advance. There is some evidence that pressure to achieve targets reduces relationship 
continuity, and therefore leads to less appropriate care in the consultation for those with more 
complex problems (Windridge et al., 2004).  This study found all GPs valued continuity of care 
but the high ranking practices organised themselves to offer optimum levels of continuity of 
care. Multi-partnered practices can manipulate their appointment systems in sophisticated ways 
to maintain high levels of relationship continuity for those who value it. Current research has 
shown most patients value consulting a GP they know, particularly those who are older, sicker 
or attending more frequently (Kearley et al., 2001, Schers et al., 2002) or those with chronic or 
emotional problems (Guthrie and Wyke, 2006).  This study found GPs were not keen to change 
medication for a patient who regularly consulted with another practitioner.  However, due to 
the nGMS target this could have been the only appointment a patient could access. Therefore, 
in the practice without a system for continuity patients may need to visit the practice again to 
consult with their regular practitioner. Relationship continuity has been associated with higher 
levels of satisfaction for the patient (Guthrie et al., 2000, Hjortdahl and Laerum, 1992) and for 
the professional (Fairhurst and May, 2006).  
In summary, some patients justify deviating from macro prescribing policy, in particular elderly 
patients, patients with co-morbidities and those with complex needs.  Clinicians used 
cognitively developed mindlines in these situations.  These mindlines were developed from 
experience (medical training, years practicing as a GP and from patient’s experience of 
medication) and from looking after patients on medication initiated in secondary care, patient 
specific advice from the practice pharmacist and conversations with colleagues.  In the 
practices with macro prescribing policy, this and the discussions around their policy were an 
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important part of shared mindlines.  Conversations with colleagues were important for the 
development of shared mindlines rather than personal mindlines.  
Continuity of care also proved to be important at the micro prescribing level for implementing 
macro prescribing policy and/or shared mindlines.  The trusting relationship between GP and 
patient provided opportunity for the GP to persuade the patient to try their drug of choice first. 
8.3.2.3 Micro prescribing summary 
Micro prescribing decisions are made in the consultation between the GP and patient.  These 
decisions involve interpreting the evidence and macro prescribing in light of clinical judgment 
and experience and patient’s preferences and values.  Micro prescribing decisions had two 
strong influences; mindlines and continuity of care. GPs used prescribing mindlines, which are 
personal prescribing formularies, rather than explicit evidence to shape their prescribing 
decisions. These prescribing mindlines are iteratively developed through personal experience 
and information from social networks; secondary care, practice pharmacists, GP colleagues and 
interactions with patients. When there was collective discussion and sharing of information 
among the GPs in the practice these mindlines were shared.  This shared mindline development 
was an important part of sensemaking at the micro prescribing level, where the GPs developed 
shared prescribing norms which was important for consistent prescribing behaviour. 
Continuity of care refers to how health care is linked over time and is commonly referred to as 
having three parts; relationship, information and management. Relationship continuity of care 
enabled GPs to implement macro prescribing policies.  By having a relationship with the 
patient GPs knew how to encourage patients towards their treatment recommendations.  As 
many prescribing decisions are trial and error, GPs would try to persuade patients towards their 
treatment recommendation first. The nGMS contract potentially reduces relationship continuity 
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but this study has shown it is possible for practices to organise themselves to offer optimum 
levels of continuity of care to those patients who value it. GPs were not keen to change 
medication in a patient who usually consulted with another practitioner, so being able to offer 
relationship continuity was important for some patients.  
8.4 Chapter Summary  
Prescribing decision-making is complex and takes place in two different contexts within 
general practice, at the macro, strategic prescribing level and the micro level, in consultation 
with patients.   
CHPs use a range of soft governance mechanisms to influence GP prescribing and to rationalise 
and standardise prescribing based on EBM. All practices valued prescribing quality 
improvement and engaged with EBM at the macro prescribing level, however, this engagement 
was guided by their values and practice identity. Tayside health board had invested heavily in 
practice pharmacists, they were given a wide remit to be able to understand the practice culture 
and values and build relationships and rapport. The practice pharmacists led prescribing quality 
improvement in the larger practices and filtered EBM and CHP policy into the practices via 
prescribing meetings. The practice pharmacists had a key role in interpreting practice system 
level prescribing data in light of the changing evidence. The practices had to be organised with 
effective systems and communication channels and practitioners need to value the messages 
disseminated for the pharmacists to have an effect. 
Prescribing quality improvement and macro prescribing require collective decisions and 
collective behaviour.  Practices had to value consistency to be able to standardise and 
rationalise their prescribing. Consistency requires organisation and communication. Face-to-
face communication and prescribing leadership was required to engage practitioners with 
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EBM. Prescribing meetings provided an opportunity for GPs to share values and experiences 
and collectively reflect before modifying their macro prescribing policy.  
Sensemaking was how the practices made sense of all the influences and factors to organise 
themselves the way they do through their values and identity.  How practices responded to 
EBM and CHP mechanisms was influenced by their practice identity. Face-to-face 
communication was essential for macro prescribing and for sensemaking. Prescribing meetings 
were an important part of collectively reflecting about prescribing and shaping a strong practice 
prescribing identity and guiding their future prescribing behaviour.  
This study found sensemaking took place at two primary points however, sensemaking is 
ongoing, subtle and easily taken for granted (Weick et al., 2005) so was likely to continually be 
ongoing in all their activities. Practices also engaged in sensemaking at the micro level during 
informal conversations, where they were iteratively developing prescribing mindlines.  
GPs used mindlines when making prescribing decisions at the micro prescribing level. GPs did 
not refer to explicit sources when seeking information but used personal prescribing 
formularies, termed prescribing mindlines.  These mindlines were iteratively developed from 
social networks with colleagues, secondary care and patient specific information from the 
practice pharmacist and from past experience.  Through effective communication with 
colleagues these mindlines were shared.  A practices organisational arrangements and 
communication channels can mitigate the collective sharing of stories and thus mindlines. 
The researcher felt the best way to succinctly summarise the findings of this study was in a 
model.  The model below shows how evidence was filtered into the high performing practices,  
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illustrating the sensemaking ‘sites’ and the importance of communication for prescribing 
decision-making. 
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Figure 6: Model showing the filtering of 
evidence into prescribing decision-making 
 
 
 
 
 
 
Continuity of care, in particular relationship continuity was important for prescribing at the 
micro prescribing level.  Micro prescribing decisions are made in the consultation between the 
GP and patient and relationship continuity refers to a trusting relationship between a GP and 
patient.  Relationship continuity of care facilitated the implementation of macro prescribing 
policy and prescribing mindlines as patients tended to trust the GPs recommendations. The 
nGMS contract has the potential to erode relationship continuity but this study has shown 
practices can organise themselves to offer optimum levels of relationship continuity for those 
who value it.  
This shows there is complex and interdependent relationship between macro and micro 
prescribing decision-making.  Both are dependent on effective communication channels, 
organisation, values and practice identity, illustrating the importance of social networks for 
prescribing behaviour. Macro prescribing policy provided a useful function for consistency in 
EBM 
Macro 
Prescribing 
Micro 
Prescribing 
Prescribing 
Decision 
Sensemaking 
Communication 
Prescribing 
Meetings 
Informal 
conversations 
Interactions 
with patients 
  296 
care across practitioners within a practice however, adherence was not always appropriate so 
clinician’s should relied on judgement and prescribing mindlines. When strong networks were 
in place these prescribing mindlines were shared.  
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C h a p t e r  9  
CONCLUSION 
This study was concerned with understanding ‘what influences prescribing in general practice’. 
Previous chapters of this thesis have provided a detailed understanding of the influences at play 
on GP prescribing described in the literature, the methods used in this study, and described, 
compared and analysed the prescribing behaviour in three different practices.  This PhD thesis 
has tried to provide a detailed understanding of GP prescribing behaviour.  
The main aim of this study was to understand the influences at play on prescribing behaviour in 
primary care in an in-depth manner.  By better understanding the influences GPs recognise and 
don’t recognise when making prescribing decisions, quality improvement initiatives can be 
designed to take account of this knowledge. Therefore, this chapter highlights and describes 
several implications and recommendations for future quality improvement work but also 
highlights some organisational issues practices may want to recognise.  As well as making 
recommendations for prescribing quality improvement work, this chapter will also consider the 
implications of these findings for future research.  
Initially this chapter will present the main findings from this study and followed by a discussion 
of the implications of these findings for future quality improvement work and further research.  
The final section will consider the transferability of these findings from this study in light of the 
study’s strengths and weaknesses.  
9.1 Summary of the main findings from the study 
To facilitate the reading of this chapter the author felt it would be useful to summarise the main 
findings of this study.  A key finding was that prescribing decisions are made at two levels; 
  298 
macro and micro.  As the findings have already been presented and discussed, the findings 
under macro and micro prescribing decision-making are succinctly described in the table below 
to minimise repetition. 
KEY FINDING: Prescribing decisions are made at the macro and micro level. 
MACRO prescribing decisions – practice policy decisions made by all key clinical staff in the 
high ranking practices.  These were collective prescribing decisions made considering the 
‘average’ patient and one disease. 
MICRO prescribing decisions – were made in a consultation between the GP and the patient.  
These decisions required interpreting the evidence using the clinician’s judgement and 
experience in light of the patient’s preferences and circumstances.  Many of these decisions 
considered more than one disease.  
MACRO PRESCRIBING DECISIONS 
• All practices valued quality improvement and EBM and engaged at the macro 
prescribing level; however implementation was facilitated when practices were 
organised with effective processes and systems in place. 
• Practices engagement with CHP prescribing quality improvement mechanisms was 
variable and guided by their values and practice identity. 
• Creating an internal practice formulary allowed practices to retain a degree of clinical 
autonomy and be consistent in their prescribing behaviour. 
• Practice pharmacists were instrumental in leading prescribing quality improvement; 
they had a key role in interpreting practice level prescribing data in light of the 
evidence; and were instrumental in the practices audit and feedback activities. 
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• Quality improvement strategies should be multi-faceted. 
• Pharmacists had more of an effect at the macro prescribing level when practices were 
organised, with effective processes, systems, communication channels and valued the 
messages disseminated. 
• In practices with multiple GPs, face-to-face meetings with summarised research 
evidence facilitated engaging practitioners with the evidence and provided an 
opportunity to present CHP prescribing policy. 
• When practices valued collective decision-making and consistency in prescribing 
behaviour they engaged in discussion and debate around reviewing macro prescribing 
and refining their associated systems.  
• Prescribing quality improvement is facilitated by some form of leadership for 
interpretation and co-ordinated practice engagement. 
• Each practice had an identity which shaped their engagement with EBM and drove their 
organisation, especially their communication channels but was also driven by their 
organisational characteristics.  
• Face-to-face communication is important for macro prescribing policy and 
organisational sensemaking. 
MICRO PRESCRIBING DECISIONS 
• Prescribing mindlines were used to make prescribing decisions at the micro level. 
• Prescribing mindlines were iteratively developed from personal experience (experience 
gained from their medical training and from looking after patients), secondary care and 
advice from the practice pharmacists and from conversations with colleagues.  
• In the practice with full attendance and discussion and debate at their prescribing 
meetings their mindlines were also iteratively developed from the EBM, CHP policy 
and macro prescribing policy discussions. 
• Regular face-to-face communication facilitated the sharing of mindlines which 
maintained consistency and an informal formulary.  
• Multi-partnered practices can manipulate their appointment system to maintain high 
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levels of relationship continuity for those who value it and meet the nGMS access 
targets. 
• GPs were not keen to change medication for a patient who consulted regularly with 
another practitioner.  
• Relationship continuity enabled GPs to implement macro prescribing policies better. 
• Limited research on the effects of relationship continuity of care on adhering to EBM 
and macro prescribing policy. 
 
The main aim of this study was to holistically understand all the influences at play on 
prescribing within general practice.  The aim was to better understand how GPs make 
prescribing decisions and make recommendations for further research.  A detailed description, 
interpretation and comparison of the influences at play in three different practices have been 
given.  Through the analysis and interpretation recommendations became clear to the author; 
however, as this research is based on a small number of practices the recommendations should 
be interpreted by the reader to the extent the findings are transferable to their context. 
9.2 Recommendations for Future Quality Improvement Work 
This study has illuminated that prescribing decisions are made at two levels with general 
practices.  The evidence has suggested there are opportunities for future quality improvement 
work.  These recommendations generally follow under this macro and micro prescribing 
divide; therefore the majority of the following recommendations are made under these 
headings: 
9.2.1 Recognise both macro and micro prescribing decisions 
Recognising the practices made prescribing decisions at two different levels may help CHPs 
and other organisations that try and influence GP prescribing.  Current, quality improvement 
strategies are advocating rational and standardisation at the practice level, moving decision-
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making from the individual doctor (Harrison and Ahmad, 2000). Recognising there are two 
different kinds of prescribing decision suggests quality needs to be measured at the micro level 
as well as the macro level.  An “assessment of whether the receipt of a particular health care 
intervention by a particular patient is appropriate should also be informed by awareness of that 
individual patient’s personal preferences” (Barratt, 2008; 408). However, patient variables are 
not typically represented in the evidence supporting clinical recommendations (Graham et al., 
2000).  Assessing individual patient needs, values, priorities and contextual influences will be 
difficult but ignoring them is undermining the efforts of quality improvement at the macro level  
9.2.2 Macro prescribing recommendations 
Practices need to develop the capacity to be proactive 
CHPs use a range of soft governance mechanisms to engage practices with quality 
improvement.  As practices are independent businesses the CHPs cannot use traditional 
command and control mechanisms so rely on appealing to values and using persuasion (Sheaff 
et al., 2004).  As a result practices engagement was guided by their practice values (Davies et 
al., 2000) and practice identity.  Practice identity and deep-seated values are something 
researchers, CHPs and other organisations can do little about. When values were aligned, 
practices engaged with EBM and the CHP mechanisms at the macro level but practice wide 
implementation was impeded by the practice’s organisation and communication strategies.  
This suggests practices need to better understand the implications of organisation and 
communication for their macro prescribing policy.  In particular, these organisations need to 
develop a capacity to be proactive and to forward plan to be able to see key cues in the dynamic 
primary care context. For example, in the low ranking practice their narrative of being the 
modern practice, valuing clinical autonomy concealed the problems the practice had 
collectively engaging in decision-making.  As this practice was reactive they had not organised 
themselves to allow time to reflect and plan.  The other two practices in this study had 
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recognised the organisational benefits of the nGMS contract (Department of Health and NHS 
Confederation, 2003) before the contract came into existence and were doing much of this 
work already.  The lower ranking practice had failed to notice the cues.  
Develop skills for interpreting practice system data in light of new evidence and CHP policy 
Practice pharmacists were conducive to prescribing quality improvement.  They had an 
important role in the larger practices filtering EBM and CHP policy and mechanisms into the 
practices and interpreting the practice system data in light of this evidence and policies. Tayside 
health board invested heavily in practice pharmacists and at the time of writing this the UK was 
in a recession and funds were tight so the health board was considering reducing the number of 
pharmacists working in general practices.  At the time of publication, the health board was 
looking for practice pharmacists to demonstrate the influence and impact they make within 
practices (personal communication, Jan Jones, pharmaceutical prescribing advisor). It is not 
clear from this study if the level of intervention NHS Tayside invested in practice pharmacists 
at the time of the fieldwork was needed.  However, it was clear in this research all GPs valued 
and trusted their pharmacists. Without as much interaction and time spent in practices 
pharmacists may not be seen as part of the team and GPs may not trust the pharmacist’s advice 
to the same extent.  Opinion leadership and personal contact was found to be important for 
prescribing quality improvement (Prosser et al., 2003). 
Quality improvement mechanisms should be multi-faceted 
It is recognised in the literature that there are ‘no magic bullets’ (Davis et al., 1995) quality 
improvement should be multifaceted (Grol and Grimshaw, 2003, Grimshaw et al., 2004, 
Haines and Jones, 1994) to appeal to as wide a range of practice values as possible.  The 
findings of this PhD support these recommendations.  The practices in this study engaged with 
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CHP mechanisms which were aligned with their practice values, therefore, CHPs should 
commission a wide range of quality improvement mechanisms. 
CHPs should provide practices with the tools to identify their own quality improvement needs 
Although, it has already been stated deep-seated practice values and identity is something 
researchers, CHPs and other organisations can do little about, practice pharmacists in Tayside 
were in a unique position.  As part of the practice team, the practice pharmacists were aware of 
the practice culture and values, they knew how to ‘pitch’ their communication with individual 
practitioners and with the practice as a group. Practices responded to the CHP mechanisms 
which were aligned with their values and practice identity.  Rather than imposing externally 
developed measures, practice pharmacists are well placed to identify individual practice needs 
and enable practices to become proactive.  The CHPs could provide practice pharmacists with 
the tools to identify and evaluate their own practice quality improvement needs rather than 
these being externally imposed. It is not about imposed change but providing practices with the 
knowledge, foresight to see and recognise these changes and be motivated to do these changes 
themselves.   
Consider prescribing leadership 
Practices need prescribing leadership to filter evidence into the practices and drive their quality 
improvement agenda. GPs did not actively go looking for evidence but were happy to receive it 
and actively engage (Prosser and Walley, 2003, McGettigan et al., 2001). If the health board 
are to reduce or withdraw practice pharmacists, without prescribing leadership practices should 
consider developing the capability to regularly filter new evidence into the practices and to 
interpret the practices system data in light of this evidence. This would require training as the 
interpretation and processing of primary care data is a complex task (de Lusignan et al., 2006). 
Practices should consider to putting forward a GP and an administrative member of staff. A GP 
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could be trained to interpret the data but the work of running searches and collating the 
information from various sources within the practice system could be carried out by the 
practice manager or another member of staff.  
Recognise the importance of practice organisation 
The recognition of the importance of practice co-ordination, process and systems (Garfield et 
al., 2009) for prescribing quality improvement may help motivate practices to modify their 
organisational structure.  Setting a prescribing formulary and macro prescribing policy allowed 
the practices to retain a degree of clinical autonomy and be consistent in their prescribing 
behaviour (Avery et al., 1997, de Bakker et al., 2007).  There is potential to use the practice IT 
system to remind GPs of the formulary to ensure a practice standard of prescribing is delivered 
consistently across all practitioners (Barber, 2004). It is not always possible to implement 
macro prescribing policy so when practitioners deviate they should record in the patient’s notes 
the reason(s) why.  So when relationship continuity of care is not present another GP can more 
easily interpret the GPs thought process.  An aim of EBM is to reduced variation within the 
NHS but complying with macro prescribing policy and practice formulary can facilitate less 
variation between prescribers within the practice.  
The nGMS contract provides financial incentives for practices to achieve targets on speed of 
access of appointments for a consultation (Department of Health and NHS Confederation, 
2003).  Practices are encouraged to offer patients an appointment within 48 hours which has 
resulted in relationship continuity of care being harder to maintain (Windridge et al., 2004).  
The results of this study have shown practices can organise themselves to offer optimum levels 
of relationship continuity to those patients who value it.  All practitioners valued continuity of 
care, feeling they provided a better service but also gained job satisfaction with relationship 
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continuity (Fairhurst and May, 2006).  Therefore this study recommends practices consider 
how they can best offer and organise for optimum levels of continuity.  
Recognise the importance of communication 
This study found face-to-face communication facilitated both macro and micro prescribing 
decisions therefore the author recommends practices should organise for both formal and 
informal communication (Carter et al., 2009).  The educational sessions provided protected 
time for practices to collectively engage with new EBM and reflect (Watkins et al., 2004, 
Lipman and Price, 2000).  By recognising the value of macro prescribing policy practices can 
engage in discussion, debate and collective decision-making.  Being involved in the discussions 
gave ownership of the macro prescribing policy. Therefore, this study recommends educational 
prescribing meetings; with clinical prescribing leadership (practice pharmacist or GP) to run 
formal education meetings where they interpret the practice system prescribing data and 
translate this into practice specific information in context of the changing evidence.   As EBM 
is constantly changing, practices should consider regularly scheduling these meetings.  These 
formal practice educational meetings should take place on the same day at the same time to 
ensure all practitioners know when the meetings are taking place. Attendance at these 
prescribing meetings can facilitate new evidence becoming part of the GPs prescribing 
mindline development, so practices should consider organising themselves to ensure all GPs 
work on a certain morning or afternoon to ensure attendance.   
Face-to-face communication formally and informally provided practitioners with the 
opportunity to share values, experiences and iteratively develop their prescribing mindlines 
(Gabbay and le May, 2004).  Practices should recognise the benefits of face-to-face 
communication (Lipman and Price, 2000, Howard et al., 2008, Firth-Cozens, 2001, Campbell 
et al., 2001).  Face-to-face communication in an informal setting helped built relationships, 
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trust and reciprocity. Communication facilitated the development shared meanings (Carlile, 
2004, Carlile, 2002).  In the practice with a large number of part-time staff and lack of face-to-
face communication channels mitigated the collective sharing of stories and mindlines.  In the 
practices with more face-to-face communication trusting relationships seemed to be present 
across all practitioners and as a result prescribing mindlines were collective and shared which 
helped maintain consistency and informal formulary. 
Communication facilitated on-going and continuous change in practices systems and processes.  
Through the formal and informal communication channels practitioners discussed the practice 
systems which raised issues, ideas and suggestions for refinement.  
Consider leadership 
This study identified three different kinds of leadership within the practices; clinical, 
prescribing and administrative.  Prescribing leadership is discussed above. The two high 
ranking practices had a form of clinical leadership; one practice showed this did not need to be 
formal and authoritarian but ensuring progress is being made and issues have not become 
stagnant.  This study is not recommending clinical leadership but suggesting practices consider 
this as an option if change is proving difficult.  Leadership has been shown to be important for 
quality improvement (Lukas et al., 2009, Rushmer et al., 2004, Palmer et al., 1996).  GPs are 
the business owners and as employees of the GPs the practice managers are limited in their 
ability to lead the clinical aspects.  
9.2.3 Micro Prescribing recommendations 
This study found GPs use prescribing mindlines (Gabbay and le May, 2004) to make decisions 
at the micro level.  As these were iteratively developed from experience (medical training and 
from consulting with patients) (Wathen and Dean, 2004, Armstrong and Ogden, 2006), 
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secondary care (Armstrong and Ogden, 2006, Prosser and Walley, 2003), advice from the 
pharmacist and from interactions with colleagues (Prosser et al., 2003, Armstrong and Ogden, 
2006), which shows the influence of networks on GP prescribing behaviour (Fairhurst and 
Huby, 1998) and the gradual accumulation of knowledge (Jones et al., 2001b, Armstrong et al., 
1996).  Recommendations around interactions with colleagues are given above in the 
communication section; however an important point is to try and facilitate EBM becoming an 
influence on GP iterative development of mindlines. 
Secondary care 
This PhD showed secondary care as a influence over GP prescribing (Armstrong and Ogden, 
2006, Prosser and Walley, 2003, Jacoby et al., 2003, Feely et al., 1999, Avery et al., 1997).  
Secondary care was the most common reason the practitioners would deviate from macro 
prescribing policy but was also where GPs would learn about new medications.  As GPs trust 
the consultant’s advice shows the importance of EBM and prescribing quality improvement 
within the secondary care setting.  Thus it is important to target quality improvement at 
secondary care as changes made in prescribing at this level will eventually filter through to 
primary care. 
Medical training 
A GPs medical training was part of their experience and mindline development.  Medical 
education should consider making future doctors aware of the two different prescribing 
decisions at the macro and micro level and the importance of communication with colleagues.  
When teaching EBM students should be made aware of the advantages and disadvantages of 
using social ‘networks’ to learn. 
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Advice from practice pharmacist 
The practice pharmacists were in a position of trust where all the GPs valued and trusted their 
advice.  Practice pharmacists had an important role at micro level providing patient specific 
advice.  In elderly or complex patients with co-morbidities practice pharmacists were able to 
advise on complex prescribing, particularly with interactions.  This knowledge and advice was 
a source of information for iterative mindline development.  The effects of this were hard to 
gauge.  As mentioned above NHS Tayside was questioning their level of investment in practice 
pharmacists, suggesting the practice pharmacists may not be around the practices as much.  
This implies practice pharmacists will be not able to give as much patient specific advice face-
to-face and contribute to the ‘coffee room’ discussions but from the accounts given by GPs it is 
important for the GPs to have email contact with a pharmacist they trust to ensure this source of 
advice is still available.   
Limited research on the effects of continuity of care on treatment decisions 
Relationship continuity of care allowed GPs to use their trusting relationship with patients to 
help implement the practice prescribing policy.  There is limited research on the effects of 
relationship continuity for adhering to EBM and macro prescribing policy.  However (Dowell 
et al., 1996) showed patients are willing to try new treatments when they know it was 
suggested on the basis of cost due to the power of the doctor-patient relationship.  Clinicians 
have been shown to use their knowledge of the patient to affect a successful outcome (Freeman 
and Sweeney, 2001, Fairhurst and May, 2006).  However, it has been shown clinician’s 
recommendations influence patient’s decisions (Greenfield et al., 2005, Trewby et al., 2002).  
Further research is required on the effect of continuity of care for implementing EBM and 
macro prescribing policy.  
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9.3 Recommendations for Further Research 
This was a qualitative research project conducted in a small number of research sites therefore, 
these findings are useful to give a deeper understanding of prescribing behaviour and make 
suggestions for future research.  A number of recommendations for further research are given 
below: 
As this study was only conducted in three general practices within one health board in Scotland 
these findings should be tested and refined in a larger number of settings with a larger number 
of variables between the practices, such as quality ranking and number of part-time partners. 
Further research is required into the effects of networks and social capital within general 
practices and primary care organisations.  The results of this study suggest GPs learn through 
social ‘networks’.  This implies an opportunity for quality improvement efforts to focus on 
‘protected learning time’ and other face-to-face ‘continuous professional development’ events. 
Weick’s (2001) organisational sensemaking was a useful model to help illuminate how the 
practice identity impacted on their macro prescribing behaviour.  Gabbay and le May’s (2004) 
work on mindlines was a useful model at helping explain how GPs cognitively manage all the 
influences at play at the micro prescribing level and constantly develop this learning.  Shared 
‘mindline’ development is another form of organisational sensemaking at the micro level.  
Exploring prescribing mindlines suggests there are other types of mindlines present in primary 
care, the author suggests further work could be carried out exploring collective sensemaking 
within primary care. Further work is required exploring the processes of collective 
sensemaking to better understand how research becomes internalised.  
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Current quality improvement efforts focus on EBM and standardising prescribing behaviour at 
the macro level, however, quality improvement has been underdeveloped at the micro 
prescribing level.  Further exploratory research should focus on exploring measuring patient 
and practitioner level variables at the micro prescribing level.  
Further research is required to explore the impact of the nGMS contract on continuity of care 
and also to explore the impact of continuity of care for macro prescribing and governance.  
9.4 Study Strengths and Limitations 
The main aim of this study was to holistically understand all the influences at play on 
prescribing within general practice.  The aim was to better understand how GPs make 
prescribing decisions rather than to assess and measure the impact of each of these influences.   
The intention was never to quantify the influences but rather to give a deeper understanding to 
the influences on GP prescribing.  
The strength of this research lies in the concepts of macro and micro prescribing.  This study 
found that GPs make two different kinds of prescribing decision and there were different 
influences on the different types of prescribing decision. These findings generate a number of 
hypotheses which can be tested in a larger number of practices or by quantitative methods.   
Three theories were used to help the researcher understand the influences upon prescribing and 
practice’s reactions to these influences; Sheaff et al (2003, 2004), Weick (2001, 2005), Gabbay 
and le May (2004).  Sheaff et al (2003, 2004) and Weick’s (2001, 2005) work was used give 
greater explanatory power, although Gabbay and le May’s (2004) work was also used for this 
purpose the researcher was able to transfer their model of knowledge management to 
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prescribing behaviour.  This allowed the researcher to apply and develop Gabbay and le May’s 
work in an area which has previously been unexplored by the model. 
Ethnographic work is often carried out in one location.  Strength of this research was the three 
different general practices studied.  The researcher was able to do a comparison across the 
practices.  The deviant case provided the most useful comparison and illuminated some 
important findings.  
A further strength of this study was the length of time spent observing in each of the three 
practices. The researcher was able to extensively explore each practice’s prescribing behaviour, 
culture and organisational structure.  The extended period of time also allowed the researcher to 
build relationships or rapport with prescribers gaining an insight into their personal views and 
preferences.  
Although the researcher spent an extended period of time in each practice and contact was 
maintained with the gatekeepers for a year after observation, this research is still a snap-shot of 
the influences at play in three different practices at a given period of time.  Therefore, this study 
did not capture changes over time. In an ideal world longitudinal observation over a number of 
years would show the dynamic and shifting of prescribing behaviours, beliefs and patterns.  
The GPs were aware they were being observed and taking part in research.  This may have 
affected their behaviour although this would have been difficult to maintain considering the 
length of the period of observation.  
All the practices which took part in this study agreed to take part when approached and all had 
a relationship with the Tayside Centre for General Practice.  It is possible practices that not 
have a relationship with the academic department could be different in some way. 
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This study did not explore the patient perspective, patient involvement or patient autonomy.  
Patient’s views and reactions in consultation were observed however as the researcher did not 
speak or interview patients, this data was the researcher’s interpretation of their perspective. 
The findings of this research are from a small number of practices in one Scottish health board 
area.  Due to the limited sample size it is likely this study does not represent the full range of 
views and influences that exist.  The GPs and the practices may not be representative of GPs 
generally. The practices which took part in this study were ranked by prescribing quality 
indicators.  These indicators do not represent the full range of characteristics GPs may attribute 
with quality prescribing or being a good practitioner.  
9.5 Conclusion 
Previous research has focused on specific aspects or influences on prescribing; however, little 
in-depth research has been carried out focusing on all aspects of prescribing in a holistic 
manner.  This research study sought to fill this gap. Participant observation was conducted in 
three different general practices over an extended period of time, which provided a detailed 
description and understanding of the three practices and their prescribing processes and 
influences.  Semi-structured interviews with key members of staff in each practice allowed the 
researcher to further explore the respondent’s views and values, and test and validate some of 
the research findings.  The data from both these research methods has provided a thick 
description and comparison of three disparate general practices.  The analysis has answered the 
original research questions and objectives of this study.  
In conclusion, this PhD has provided a rich description and understanding of general 
practitioners prescribing decision-making; the influences which impact on these and an 
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understanding of how these influences are processed by practitioners into two types of 
prescribing decision; macro and micro.  
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Appendix 2: Audit Scotland indicators of prescribing 
quality 
 
• Proton Pump Inhibitor (PPI) maintenance doses as a percentage of maintenance and 
treatment doses 
• 2.5mg bendrofluazide as a percentage of 2.5mg and 5mg 
• Single diuretics as a percentage of single and combined diuretics 
• ACE Inhibitors per 1000 adjusted population per quarter 
• Low dose aspirin per 1000 adjusted population per quarter 
• Statins per 1000 adjusted population per quarter 
• Hypnotics and anxiolytics per 1000 adjusted population per quarter 
• Established antibiotics as a percentage of all oral antibiotics 
• Amoxicillin as a percentage of amoxicillin and co-amoxiclav. 
 
Taken from: Audit Scotland (2003) Supporting prescribing in general practice – a progress 
report.  Auditor General for Scotland. 
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Appendix 3: Poster 
  344  
Research Project  
In XXX Health Centre 
• XXX Health Centre is taking part in a research project, run by University of 
Dundee, looking at prescribing in primary care. 
 
• If you have an appointment you may be asked if the researcher can watch 
your consultation – the researcher is watching the Doctor not you – this will 
not affect the care you receive. 
 
• It is up to you whether you take part or not. 
 
Researcher: Miss Aileen Grant MSc BA(Hons), Community Health Sciences, 
University of Dundee. 
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Appendix 4: Interview schedules 
Interview Schedule - GP 
Why did you go into medicine? 
What attracted you to (name of practice)? 
What do you bring to (name of practice) from your past experience? 
Where do you want to be in 5 years time? 
 
Has the practice made any changes in your prescribing policy in the last 6 months? 
What? Why? How? 
Any changes in your prescribing for long –term conditions? 
 
How does the practice formulate prescribing policy? 
What prompts change? 
Communication and decision-making 
 
Quality and/or  cost? 
 
Describe a positive scenario - an example of doing well 
Describe a scenario – when it has not gone so well 
 
What motivates you? 
What 3 things would you get into policy? 
What is wrong with the current system? 
What do you think is good about the system? 
 
What influences your behaviour? 
What is really important to you? 
What legacy would you like to leave behind? 
Did my presence have an impact on normal behaviour? 
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Interview Schedule – Practice Pharmacist 
Structured Questions 
How long have you been a practice pharmacist? 
What is your background? 
How long did you worked at the practice? 
Do you enjoy working there? 
What were your responsibilities? 
Did your role and responsibilities change in your time there? 
Exploratory Questions 
Does GP 1 or GP 2 come to you for advice?  If so can you give me a scenario? 
Why do you think Rosnish is the best? 
What do you think other practices can learn from Rosnish? 
What influences their prescribing? 
How did you try and influence their prescribing? 
What are your responsibilities at other practices? 
How do you influence their prescribing? 
What motivates you? 
What would you like a PP’s role to be? 
What do you think is wrong with the current system? 
What do you think is good about the system? 
 
(Example from Rosnish practice this was adapted for the Haun).
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Interview Schedule – Healthcare assistant/Senior Receptionist 
 
Structured Questions 
How long have you worked at the practice? 
Have you seen many changes in that time? 
Has your role changed as the GPs have changed? 
Can you describe your role for me? 
You have a lot of clinical and administrative responsibility has this always been the case or has 
your responsibility increased since GP 1 took over? 
 
The GP seems to keep tight control but you have a lot of autonomy, would you agree with this? 
Is a one month prescription for 28 days?  Or per monthly calendar month? 
 
Exploratory Questions 
Has the relationship with patients changed? 
Where do you see the hub of the practice?  Where is most information exchanged? 
Do you think change is implemented quickly? 
Why do you think Rosnish is the best for quality? 
What do you think other practices can learn from Rosnish? 
 
Triangulation Questions 
Double check information for repeat prescribing system and chronic disease management, and 
explore what she thinks about the model, in particular the reception part 
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Appendix 5: Data-driven quality improvement in 
primary care; study two. 
Introduction 
Developments in informatics and improvements in the quality of general practice electronic 
clinical data since the introduction of the Quality and Outcomes Framework (QOF) create new 
opportunities to routinely implement evidence-based interventions to change professional 
practice. This study part of a large programme of work which aims to create and test an 
evidence based quality improvement intervention for the safety and quality of prescribing. The 
research programme aims to design and implement innovative informatics tools to make 
existing primary care data more useful for quality improvement. The programme follows the 
MRC framework to develop and evaluate complex interventions.  Part of the MRC framework 
recommends understanding the context in which the intervention will be delivered, so the aim 
of this study was to define the quality improvement and governance context and inform the 
design and components of the complex intervention. 
Methods 
A purposeful sample of general practices was made by ranking practices within a health board 
by their responsiveness to current indicators of prescribing quality used by the respective health 
boards.  Practices at the high and the low end were invited for interview.  A GP and/or the 
practice pharmacist from 20 practices from NHS Tayside were invited for interview, 10 
practices which had performed well and 10 practices which were ranked at the bottom end of 
the scale.  11 interviews were conducted with general practices in NHS Tayside, six with a GP 
and five with a practice pharmacist, as a GP and a pharmacist were interviewed from more than 
one practice, three high ranking practices and four low ranking practices were recruited. 
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Appendix 6: Practice visit details 
Rubain practice visits 
 
Date Hours Task 
1.02.08 1 Recruitment of practice 
12.02.08 9 Observation of reception & 
GP surgery (GP 2) 
13.02.08 6.5 Observation of GP surgeries 
(GP 1 & GP 4) 
14.02.08 9 Observation of GP surgery 
(GP 4) 
15.02.08 6.5 Observation of GP surgeries 
(P & JF) 
21.02.08 7.5 Observation of  Practice 
Pharmacist cardiovascular 
clinic and observation with 
practice managers 
25.02.08 8.5 Observation of GP surgeries 
(GP 1 and GP 5 - registrar) 
and reception 
26.02.08 9 Observation of GP surgeries 
(GP 3) & (GP 5 - registrar) 
28.02.08 5 Observation of GP surgery 
(GP 3) and Practice 
Pharmacist medication review 
clinic 
29.02.08 8 Observation of GP surgeries 
(GP 4, GP 2 & GP 1) and 
observation of practice 
meeting 
13.03.08 3 Observation with practice 
pharmacist 
27.03.08 2.5 Observation of surgery with 
locum 
28.03.08 2 Practice prescribing meeting 
24.06.08 4 Observation with practice 
nurse, triage and asthma 
clinic. 
TOTAL 78.5  
 
The coffee room and reception was observed during these visits at every given opportunity. 
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Rosnish practice visits 
 
Date Hours Task 
11.01.07 1 1
st
 meeting 
16.01.07 4 Chat/informal interview with 
GP 1 
25.01.07 4 Review practice 
documentation 
27.01.07 4 Review practice 
documentation 
1.02.07 1 Observation of clinical 
meeting 
2.02.07 10 Observation of reception 
7.02.07 4 Observation of Practice 
Pharmacist 
20.02.07 3 Observation of CHP 
prescribing meeting 
23.02.07 4 Observation district nurse in 
practice nurse role 
6.03.07 8 Observation of surgery with 
GP 2 
8.03.07 5 Observation surgery with GP 
1 
9.03.07 4 Observation surgery with GP 
1 
12.03.07 7.5 Observation of district nurse 
prescriber 
13.03.07 8.5 Observation of foundation 
Doctor surgery. 
Observation of GP 1 and 
foundation Doctor visit to 
nursing home 
14.03.07 4 Observation of surgery with 
foundation Dr. 
16.03.07 4 Observation of surgery with 
foundation Dr. 
27.03.07 8.5 Visit to nursing home with 
GP 1, observation of surgery 
with GP 1 and out for dinner 
30.03.07 10 Observation of surgery with 
GP 1 
12.04.07 3 Observation of surgery with 
locum 
13.04.07 4 Observation of surgery with 
locum 
18.04.07 6 Observation with Health 
care  assistant 
20.04.07 5 Observation of surgery with 
GP 1 
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08.05.07 10 Observation of surgery with 
GP 2 
12.07.09 3 Observation of surgery with 
GP 1 
TOTAL 118.5  
 
The coffee room and reception was observed during these visits at every given opportunity. 
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The Haun practice visits 
 
Date Hours Task 
 1 Meeting with practice 
manager 
06.06.06 1.5 Meeting with Practice 
Pharmacist 
20.07.07 1.5 Meeting with GPs 
08.08.07 6 Observation of reception and 
with IT administrator 
10.08.07 4.5 Observation of reception 
14.08.07 4 Observation repeat 
prescription administration 
15.08.07 3 Observation of reception 
22.08.07 8 Observation with practice 
pharmacist 
04.09.07 4 Observation with COPD 
nurse 
07.09.07 8.5 Observation of reception and 
Practice Pharmacist 
11.09.07 5.5 Observation with COPD 
nurse, of practice meeting. 
19.09.07 2 Observation with practice 
pharmacist 
24.09.07 5 Observation of surgery with  
GP 3 
27.09.07 7 Observation of surgery with 
GP 3 
03.10.07 3 Observation with Practice 
Pharmacist 
09.10.03 3.5 Observation of repeat 
prescription administration 
10.10.03 3.5 Observation of meeting with 
community nurses and with 
Practice Pharmacist 
16.10.07 9.5 Observation of meeting with 
community nurses and 
observation surgery with GP 
6 
17.10.07 7 Observation of  surgery with 
GP 4 and observation with 
Practice Pharmacist 
19.10.07 6 Observation with practice 
manager 
22.10.07 1.5 Lunch with 2 practice 
pharmacists 
23.10.07 4 Observation of surgery with 
GP 1 
24.10.07 6 Observation of surgery with 
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GP 4 and observation of 
surgery with Practice 
Pharmacist 
26.10.07 3.5 Observation of surgery with 
GP 7 
29.10.07 8.5 Observation of surgery with 
GP 5 
31.10.07 4 Observation of surgery with 
GP 7 
2.11.07 8.5 Observation of surgery with 
GP 4 
5.11.07 5 Observation with Practice 
Pharmacist and meeting with 
other CHP Practice 
Pharmacists 
7.11.07 2 Observation  with Practice 
Pharmacist 
9.11.07 9.5 Observation of surgery with 
GP 2 
13.11.07 9.5 Observation of meeting with 
community nurses and 
observation of surgery with 
GP 2 
14.11.07 9.5 Observation of surgery with 
GP 5 
7.12.07 7 Observation of surgery with 
GP 1 
10.12.07 6 Observation of surgery with 
GP 3 
14.12.07 2.5 Observation of practice 
meeting with researchers and 
drug rep lunch 
22.01.08 8 Observation of surgery with 
GP 6 
23.01.08 2 Meeting with CHP Practice 
Pharmacists 
20.02.08 3 Observation with Practice 
Pharmacist 
14.03.08 2.5 Observation of practice 
meeting 
Total 196.5  
 
The coffee room and reception was observed during these visits at every given opportunity. 
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Appendix 7: Tables with empirical supporting 
documentation for the practice prescribing models. 
Rubain practice prescribing model – Table with supporting empirical data. 
 
Elements of the model Supporting empirical evidence 
Patient Patient pressure One patient had been suffering from 
her symptoms for less than 48 hours 
so the GP told her to rest and come 
back if symptoms did not clear by 
themselves.  She did not get up from 
her chair and in the end was given a 
‘delayed prescription’. (Fieldnotes) 
 Patient’s views A patient who was given a 
prescription for a new inhaler in her 
last consultation and returned as she 
did not like the new delivery system 
which spits out medication rather 
than old inhalation technique.  The 
patient was prescribed her old 
inhaler.(Fieldnotes) 
 Patient’s expectations A patient presented a list of 
medication she would like to be 
treated with.  Her husband was a 
clinician.  She was given the 
medication she requested despite 
them not being a generic 
preparation. (Fieldnotes) 
 Patient’s experiences A consultation was observed where 
HRT had made such a dramatic 
difference to one woman’s life she 
was against coming off the 
medication despite the health risks. 
(Fieldnotes) 
 Patient’s circumstances A patient was suffering from a 
cold/flu and would not normally 
have been given an antibiotic but as 
her husband suffered from severe 
COPD the GP did not want an 
infection brought into the home so 
the prescription was given as a 
precaution. (Fieldnotes) 
Prescribers Patient notes “Before the patient came in the room 
the doctor gave me a quick summary 
of their background whilst she read 
the notes. Most of the patients she 
seemed to know who they were and 
appeared to remember quite a lot 
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about them, the information in the 
notes seemed to jog her memory.” 
 
 Prescriber experience The GP tells me that the other GPs 
(not the registrar) are more 
comfortable in what they are doing 
as they know what a drug does and 
what it doesn’t.  Just from experience 
they do not need to look so much 
information up.  He goes on to tell 
me, they are more comfortable in 
what they are doing and will step 
outside protocol if they feel it is 
necessary, but this decision is based 
on experience. (Fieldnotes) 
 Prescriber preferences The patient has asked for some 
Ibrophen gel.  The GP tells the 
patient they are supposed to 
prescribe transvasen cream but she 
does not like it so she will prescribe 
the patient the more expensive 
cream. (Fieldnotes) 
 Medical training As one GP commented “what you 
prescribe depends on where you are 
in your career.”  When this GP first 
started she was more familiar with 
hospital medication but said as time 
goes on you get more confident and 
you learn yourself and you try 
different medications. (Fieldnotes) 
Continuity of care Relationship with the patient During the consultation the GP tells 
me he has known this young lady all 
her life, as a patient but also through 
the church.  He asks after her family. 
She tells him the baby has a tooth 
coming through and her sister is 
getting little sleep but that their 
mother had been taking her other 
child, to give her a break. 
(Fieldnotes) 
 Knowledge of the patient This patient came in and was very 
concerned about the pain at the 
bottom of her head/neck area; the 
Doctor examined her and told her he 
thought it was some ligaments.  She 
asked him about her eyes as well and 
if they were related, when she is 
describing these she is going into a 
lot of detail about what she was 
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doing, the type of pain, how long it 
lasts and asking the Doctor lots of 
questions.  He turns to me during the 
consultation and says this lady has 
had a head hemorrhage in the past. 
This explained why she was anxious 
and really wanted to understand. 
(Fieldnotes) 
 Perception of the patient Before the patient entered the 
consulting room Dr X said ‘Oh, no!’ 
This patient was seeing Dr Y for a 
while but now she keeps coming to 
see me, she is always in pain and is a 
difficult person, she moans so much 
and doesn’t really take to leaving 
without something so you end up just 
giving her pain killers, I know that is 
bad.’ (Fieldnotes) 
 Shared decision making The patient was if he would prefer 
liquid or tablets. (Fieldnotes) 
Influences Guidelines The managed clinical networks 
(MCN) give local advice.  The 
practice pharmacist had waited to 
act on the new SIGN guideline until 
he received MCN advice. Due to the 
volume of information to be 
discussed at prescribing meetings the 
practice pharmacist aims to discuss 
this guideline over 3 meetings. In the 
first meeting he would like some 
decisions made on the way forward. 
(Fieldnotes). 
 CHP The practice pharmacist informs me 
of previous CHP led projects they 
have run in the past; repeat 
prescribing system, simvastation, 
fluoxetine, and NSAIDs. (Fieldnotes) 
 Secondary care This patient has polymalgia and 
recently had an angioplasty and was 
in for her results.  She admitted she 
was feeling sore herself.  She had 
been at a 50th birthday party, and 
although she had nothing to drink 
she admitted she did vigorously jive 
to 4 or 5 songs.  She increased her 
dose herself after this event from 5 to 
6.  The Doctor checked the 
consultant’s recommendations on the 
computer and it said if she has a 
flare up increase by 2.  The patient 
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admitted this but said she wanted to 
see if she could get away with one 
but no, she was sore.  They had a 
discussion and agreed between them 
to increase the steroid dose by 2 for 
a month, and then down by 1 for a 
month and then down again by 1 for 
a month.  This was the Doctor’s 
suggestion and she agreed. 
(Fieldnotes) 
 Cost The practice has recently carried out 
an audit on their fluoxetine 
prescribing.  This was a CHP driven 
initiative, which was supported by a 
financial incentive. All practices in 
this CHP were below the health 
board and Scottish average. 
(Fieldnotes) 
 Drug representatives “....they used to be more of an 
influence in the old days. They don’t 
tend to influence things so much 
these days because we always tell 
them that for any change in our 
prescribing it would have to be 
discussed with (practice pharmacist 
named) and so they should really 
speak to (practice pharmacist 
named). You do tend also to find 
that, they tend to all be promoting 
the same type of medicine anyway. 
They’re not often coming along with 
a completely new thing, it’s just an 
alternative. Proton pump inhibitor, 
an alternative, seratonin uptake 
inhibitor, so it’s not all that often 
they come along with a completely 
new product and then you quite often 
find that the new product hasn’t even 
been approved for use in Scotland 
anyway, or in (health board named)” 
(GP 1 interview, Rubain). 
 
Other practice 
staff 
Practice nurses The practice pharmacist informs me 
the practice nurses are the main 
drivers of respiratory prescribing. 
(Fieldnotes) 
 Community nurses One of the community nurses was 
observed hanging around the coffee 
room.  She was chatting to the 
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receptionists and a practice manager 
but kept looking at the door.  This 
went on for about 5 minutes. Once 
Dr X appeared it became clear they 
she was waiting to talk to him about 
a patient.  She asked him to go and 
visit the patient and also to prescribe 
xxx. (Fieldnotes) 
 Receptionists An example of this was observed in 
the coffee room when two of the GPs 
were talking about a patient and her 
care issues when one of the 
receptionists told them one of her 
neighbours goes in regularly and 
checks on her.  (Fieldnotes). 
Practice 
pharmacist 
Practice based data In preparation for the practice 
prescribing meeting the practice 
pharmacist has identified the 
prescribing indicators where there is 
room for improvement.  The practice 
pharmacist is now looking at all 
patients prescribed this medication 
in the practice system. (Fieldnotes) 
 PRISMS data/prescribing reports The practice pharmacist presented 
data on one indicator showing the 
practice was an outlier.  Prescribing 
simvastatin 10mg was considered as 
poor prescribing by the indicators 
used in the CHP report and the 
presented quarterly report indicated 
the practice was prescribing a lot. 
The GPs argued that if the patient 
was responding well and was stable 
why should they increase the dose. 
However, the evidence behind the 
indicators suggests that 10mg was 
not effective.  This sparked 
discussion and debate. (Fieldnotes) 
 Practice IT system The GP had received a letter from a 
consultant in secondary care telling 
him to prescribe xxxx but when the 
GP had gone to prescribe this a hook 
on the computer had told the GP that 
the drug was not licensed for the 
patient’s condition.  The GP was 
delighted the computer system had 
flagged up such an error and was 
informing the practice pharmacist 
the benefits of the current IT system. 
(Fieldnotes) 
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CHP CHP evidence filtered into 
practice by the pharmacist 
“...We have meetings with (practice 
pharmacist) once every four weeks, 
the last Friday of the month. First of 
all, we look at, because of our 
prescribing, a monthly update in 
terms of how our prescribing 
compares with the CHP average and 
so on and he (practice pharmacist 
named) recommends changes to our 
prescribing patterns...” (GP 1 
interview, Rubain). 
Communication Shared decision-making The practice debated how they could 
assess the risk factors, such as the 
various risk factor calculators 
available on websites and computer 
systems as to the most appropriate. 
They also discussed how they 
measure cardiovascular risk and if 
there were improvements that could 
be made when the nurses are taking 
the clinical recordings. It took the 
three prescribing meetings to discuss 
and debate all the relevant 
information and agree on their 
revised practice policy.  (Fieldnotes) 
 Practice pharmacist filtering 
evidence into the practice 
I asked what prompted the change on 
the prescribing formulary. The 
practice pharmacist told me the 
guidance for clopidogrel has 
changed.  Patients should now only 
be taking clopidogrel for 3 months as 
oppose to the previous guidance of 
one year.  It costs £400 per year so 
there is a financial implication as 
well as a quality issue.  (Fieldnotes) 
 
The model acknowledges potential influences on the prescriber so there is not supporting 
evidence for all influences.  Such as the health board is a potential influence but this was not 
observed, all potential health board influences were filtered into the practice through the CHP 
and practice pharmacist.  Also drug companies are a potential influence however their influence 
was through drug representatives. 
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Rosnish practice prescribing model – Table with supporting empirical data. 
 
Elements of the model Supporting empirical evidence 
Patient Patient pressure This patient had just suffered a mild 
stroke.  It was visible at the back of 
the brain but the patient seemed fine.  
The GP prescribed Preistane and I 
asked why, he said because the 
patient had asked for it by name. 
(Fieldnotes) 
 Patient’s views This patient had high blood pressure 
and the GP said he would like to 
prescribe something for it.  The 
patient said he does not like to take 
tablets and thought there may be a 
white coat element as well. 
(Fieldnotes) 
 Patient’s expectations This patient presented at the surgery 
because she had been suffering from 
a headache for about 3 hours.  She 
had called NHS 24 and expected her 
GP to know about this phone call. 
(Fieldnotes) 
 Patient’s experiences This patient had fallen and had 
severe bruising.  After an 
examination, the GP tested his urine 
and there were no signs of a kidney 
infection. The GP told the patient to 
go for an xray and filled in a short 
form which he handed to the patient.  
The patient informed the GP he had 
tried paracetamol and ibrophen and 
it was not touching the pain.  The GP 
prescribed him tramadoll.  The GP 
informs me that as the patient had 
tried paracetamol and ibrophen he 
had to prescribe something and 
would have normally prescribed 
codyradamol but because this patient 
works offshore on the oil rigs he 
cannot come back to try something 
else if it is not strong enough.  The 
GP said it was obvious he is in great 
pain so he felt he had to give him a 
strong analgesia. (Fieldnotes) 
 Patient’s circumstances The CHP prescribing lead was 
interested in why the practice was 
prescribing IRN testing strips.  The 
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GP explained when he took on the 
practice the patient in question had 
little time left to live.  So the GP 
encouraged him to enjoy his life and 
live a little.  The patient was living in 
a caravan so he decided to take off to 
Spain during the winter.  Here, years 
later and the patient is still here and 
very stable on his warfarin.  The GP 
enquired and found you can 
prescribe IRN strips, which allows 
this man to manage his own 
condition. (Fieldnotes) 
Prescribers Patient notes The GP informs me despite knowing 
the regular attenders at the practice 
well, he still relies on the notes, 
especially for medication review. 
(Fieldnotes) 
 Prescriber experience “the longer you are qualified the 
more you move away from 
formularies.” (Fieldnotes) 
 Prescriber preferences The CHP prefer GPs to prescribe 
Fluoxetine as a first line 
antidepressant but this practice tends 
to prescribe Citalopram because of 
the length of time it takes to have an 
effect.  The lead GP told me 
Fluoxetine takes 3 to 4 weeks where 
Citalopram takes 7 to 10 days, and 
feels it usual takes time for patients 
to present with their symptoms so 
when people have been low and 
depressed for a long time already 
you can start to make a difference 
more quickly with Citalopram. 
(Fieldnotes) 
 Medical training I ask the lead GP about the influence 
of his medical training on his 
prescribing behaviour.  He tells me 
this is the basis of his knowledge but 
as time moves on experience and 
new evidence influence his behaviour 
more. (Fieldnotes) 
Continuity of care Relationship with the patient “They discuss the patient that was 
admitted to hospital this 
morning……….Whilst they are in the 
waiting room the receptionists find 
out that the man’s condition had 
deteriorated whilst XX  was on 
holiday but they did not want to see a 
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locum, so they had waited until XX 
had got back before they called. 
Then they were not forceful about 
getting a visit or appointment with 
XX.  XX was not amused, he was 
annoyed more than angry, saying 
that this man could easily die now.  
Why did they not come in and see the 
locum?” (Fieldnotes) 
 Knowledge of the patient A patient was very distressed. She 
said she had had trouble sleeping.  
The GP starts by asking her what is 
wrong.  The patient goes on and tells 
her what seems to be a multitude of 
problems which the GP seems to be 
informed about: well certainly 
informed about the on-going 
problems, not so much the later ones 
(I could see her struggling to 
remember all the family details). 
(Fieldnotes) 
  The GP tried to educate her about 
her risk factors and kept checking 
she understood what she was being 
told.  She understood her risk factors 
but was prepared to take the risk as 
she was scared of her menopausal 
symptoms returning.  The GP went 
back through the information 
emphasising her risk factors but she 
was still very resistant so the GP 
chose to leave this issue till her next 
consultation.  The patient was also 
suffering from high blood pressure 
and gastric problems so would be 
back in the not too distant future. 
(Fieldnotes) 
 Perception of the patient “Whilst observing the second GP at 
the practice, the medical student 
came in to update the GP on his 
consultation with the patient.  The 
GP was not happy that the medical 
student had sent the patient away 
without having seen her first.  The 
GP explained to the medical student 
that this lady is not likely to be 
complaining, if she has come then it 
will be something worth consulting 
about.  The medical student had told 
the patient to buy a topical painkiller 
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and a strap.  The GP explained that 
this lady gets free prescriptions and 
they give out supports to the patients 
at the surgery for free, and the lady 
would have known this, ‘what will 
she think’.  The GP went on to 
explain that topical painkillers are 
expensive and that she would have 
given her a prescription for this.  The 
GP knew how frequently this patient 
consulted, deeming each visit 
worthwhile, also demonstrating a 
knowledge of the patient’s financial 
circumstances, showing that this 
would influence whether a 
prescription is written or not.”   
(Fieldnotes). 
 
Influences Guidelines New guidelines from the British 
Hypertension society have been 
published recently.  The CHP 
distributed laminated copies of a 
flow diagram. This was copied and 
placed on the back of the doors of 
the consulting rooms. (Fieldnotes). 
 Research / Journal articles “Well is it just part of the job, it is 
good reading really, I scan the titles, 
and chose what I want to read, I 
don’t read it cover to cover, but if 
there is something relevant to what I 
do, with topics, that, .....I used to 
really.....it is just part of keeping up 
to date.” (Fieldnotes) 
 CHP The practice pharmacist opens a 
letter from the CHP.  They are 
questioning the efficacy of two drugs.  
The pharmacist tells me she knows 
the two patients and why they are on 
it.  One patient had been transferred 
from a practice down south and it 
was clear from her notes, she had 
been tried on something else and it 
had not worked. Therefore the 
pharmacist said she was not going to 
change her medication. The 
pharmacist said it was the same with 
the other patient, ‘they are happy 
with their medication so why change 
it’.  She told me the point is to ensure 
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no more patients are started on these 
medications.  (Fieldnotes) 
 Secondary care The GP prescribed Metformin for a 
patient who was overweight and had 
polycystic ovaries(PCO).  After the 
consultation I asked about this.  The 
GP explained that Metformin has 
been prescribed for the past few 
years by gynaecologists.  This 
patient has been trying hard to lose 
weight with little success so her PCO 
could be why she is not losing 
weight, so it is a good excuse to try it 
and see how she gets on. 
(Fieldnotes). 
 Cost The CHP pharmacy lead and the 
lead GP for the CHP paid a visit to 
the practice. The pharmacist 
commented that they are trying to get 
round most of the practices but at the 
moment they are focusing on the 
outliers. During the meeting the 
pharmacist went through the BNF by 
chapter and picked out drugs where 
he thought they could make savings 
and justified why.  The pharmacist 
was polite explaining drugs had 
come off patent, and giving examples 
of where it is much cheaper to 
prescribe capsules rather than 
tablets.  He GP accepted these 
recommendations. (Fieldnotes) 
 Drug representatives The second GP at this practice sees 
drug reps.  In the coffee room at 
lunch time there was a lunch 
provided by a drug rep.  The rep was 
just laying out all the food when I 
arrived.  The second GP at this 
practice arrives just after me.  They 
exchange polite pleasantries very 
briefly and then the rep tells her 
about new asthma drug.  He seems to 
give her a brief run down, some 
leaflets and pens and then leaves 
again.  The rep did not appear to 
have been in the practice for very 
long. (Fieldnotes). 
Other practice 
staff 
Practice nurses This practice does not have a 
practice nurse.  The health board 
release the community district nurse 
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for 2 hours a week and the health 
visitor for 2 hours a week, which the 
practice pay for.  (Fieldnotes) 
 Community nurses The foundation doctor comes and 
chats to the lead GP about a patient.  
The patient was a young lady who 
has recently had a baby. This lady 
had suffered preeclampsia and from 
another condition I did not catch. 
The patient is on a lot of medication 
from the hospital which they discuss 
and also a prescription the GP 
started.  The midwife had told the 
GP this lady had mastitis so he wrote 
a script without consulting with the 
patient. (Fieldnotes) 
 Receptionists The lead GP tells the researcher 
“The receptionists only tell me who 
is related to who and the full story 
once I have put my foot in it.” 
(Fieldnotes) 
Communication Shared decision-making All the practice staff are present at 
this meeting. They are discussing 
how they are going to manage and 
hopefully cope with the transfer of 
GPASS to Vision. The lead GP 
suggests they ask to have their 
training brought forward and they 
all agree. They make comments 
about practicing before the system 
goes live. (Fieldnotes) 
 
 
The model acknowledges potential influences on the prescriber so there is not supporting 
evidence for all influences.  Such as the health board is a potential influence but this was not 
observed, all potential health board influences were filtered into the practice through the CHP 
and practice pharmacist.  Also drug companies are a potential influence however their influence 
was through drug representatives. 
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The Haun practice prescribing model – Table with supporting empirical data. 
 
Elements of the model Supporting empirical evidence 
Patient Patient pressure This patient was an alcoholic and 
came in asking for more diazepam 
and dihydrocodeine.  Dr X said no, 
and went on to say she gave him 
enough diazepam on Friday and this 
was only Wednesday and he has 
none left, so if he cannot take them 
properly she is not going to give 
them to him.  He then started going 
on about his chest and his cough and 
Dr X told him that his lungs were 
clear but he was still going on about 
needing antibiotics and telling her 
which antibiotics he wanted, Dr X 
said that she would only give him 
amoxicillin..he threw a tantrum and 
stormed out. (Fieldnotes) 
 Patient’s views This patient said she was struggling 
to cope with everything life was 
throwing at her at the moment.  She 
said she wanted something to perk 
her up every now and again when 
she was having trouble sleeping or 
was having a particularly bad day.  
Dr X suggested anti-depressants and 
diazepam but highlighted the 
dependence and suggested 
counselling.  The patient made it 
clear she did want to go onto 
antidepressants but liked the idea of 
diazepam. Dr X said she had never 
had an opiate based medication 
before so she was just going to give 
her a very low dose and she how she 
gets on with it.  (Fieldnotes). 
 Patient’s expectations This patient has ME and does not 
want to take her medication.  She 
wants to go on a trip to Edinburgh 
and is looking for the GP to say it is 
OK.  He took this opportunity to try 
and gently persuade her to start on 
some medication. (Fieldnotes). 
 Patient’s experiences The GP explains this lady has had 
terrible depression in the past.  She 
is fine now but likes to come in every 
  367 
6 months to make sure she is OK.  
The lady gets her tests done and 
when she gets her results back she is 
fine but the GP explains she needs 
this reassurance from the GP. 
(Fieldnotes) 
 Patient’s circumstances A patient comes in and starts talking.  
It is hard to establish why the patient 
is here due to the familiarity between 
the GP and patient. Straight away 
the GP gives him a prescription for 
diazepam and citalopram, without 
much communication about this.  
The patient complains of sore ears 
and the GP takes a look and says 
‘you have ear wax.  I would not 
normally prescribe ear drops but 
considering your situation. Through 
the consultation it becomes clear this 
patient is homeless.  He had no 
permanent address.  (Fieldnotes) 
Prescribers Patient notes This patient came into the 
consultation room saying that he has 
constantly been getting tonsillitis.  
Dr X examined him and took a swab.  
He said he didn’t have tonsillitis on 
this occasion as he does not have 
mucus on the back of his tonsils.  Dr 
X checked his notes and gave him a 
prescription for clarithromyn.  The 
GP then turns to me and said he 
gave it to him because he had 
received this before although it may 
not have been the cheapest. 
(Fieldnotes) 
 Prescriber experience “what you prescribe depends on 
where you are in your career. When 
I first started I was more familiar 
with hospital medication but as time 
goes on you get more confident and 
you learn yourself and you try 
different medications.” (Fieldnotes) 
 Prescriber preferences “..I mean things are definitely 
habitual, I always prescribe a 
particular drug, I know those off the 
top of my head, why would you 
prescribe an alternative that you 
didn’t know so much about” (GP 1 
interview, the Haun). 
 Medical training In between consultations I tell the 
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GP I only see her using the BNF and 
patient notes during the 
consultations.  I ask her if there are 
any other influences and she told me 
experience.  I asked her if her 
medical education has an impact and 
she said “not so much these days, it 
is more past experience”. 
(Fieldnotes) 
Continuity of care Relationship with the patient “It really annoys me here, we have 
patients who have been in to see one 
Doctor and they need to come back 
for another consultation and it is not 
their fault they are offered the next 
available consultation and they can 
end up seeing a few different GPs, 
you go back through the story, you 
get a different version, you have to 
interpret the other GPs’ thoughts.” 
(Fieldnotes) 
 Knowledge of the patient “....this helps you in your decision-
making; you can make that intuitive 
leap quicker.  You know more about 
them and what they are saying, how 
they present themselves....” 
(Fieldnotes) 
 Perception of the patient A patient had consulted with the GP 
complaining of hot sweats.  The 
patient had consulted recently and 
the doctor had done a blood test but 
the results had not shown anything.  
The GP said she would refer the 
patient up to the hospital. The patient 
made a comment when leaving the 
room I didn’t quite catch.  Once the 
patient left the GP informed me she 
is a hypochondriac and had been 
consulting with one of the other GPs 
in the practice but this GP had got to 
the end of his tether with her and had 
refused to give in to her. The GP 
goes on to explain the patient has 
now decided to come and see her. 
(Fieldnotes) 
Influences Guidelines “Dr X told me his prescribing was 
shaped by new evidence, through 
new guidelines coming out.  I asked 
about journals and he said no, he 
does not read them anymore as he 
does not have the time.  He went on 
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to say he used to when he was 
younger but he said some of the 
evidence there is flawed and GPs do 
not have the skills to critically 
appraise journals.” (Fieldnotes) 
 CHP In a practice prescribing meeting the 
pharmacist is trying to filter CHP 
recommendations into the practice.  
There was only 2 GPs present and 
one practice nurse.  The first request 
the practice pharmacist makes was 
to move patients from esopeprazole 
to another PPI, the GPs agreed 
although one GP did comment 
saying, “I think we only have 
patients on it who need to be on it.”  
The second request was to move 
patients from one statin to another.  
Dr Y was totally against it.  He said 
“they will have another initiative 
soon where they will want to move it 
again.  The amount of work that is 
involved calling patients in, 
changing their medication when they 
are happy and stable on, to 
something which will just confuse 
them and require them to come back 
to the surgery more often till we get 
them stable again for the sake of 
saving a few pennies. No!  They have 
no idea how difficult it is to get a 
patient to take 5 different types of 
medication without changing it.  
They sit in their ivory tower.” 
(Fieldnotes) 
 Secondary care The practice pharmacist conducted 
an audit of their PPI prescribing and 
found they have a high number of 
patients on the expensive PPI.  As 
the GP helps the pharmacist identify 
patients for review she says 
“secondary care have definitely 
influenced some of these patients.” 
(Fieldnotes) 
Or 
“The only thing that changes for me 
is if a new drug comes in and the 
consultants at the hospital are telling 
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me to use it because they think it is 
good and they get feedback from 
other professionals and consultants 
that it is good and then I’ll start 
using a new drug. I don’t tend to use 
it off my own back, I tend to use it 
from recommendations from other 
people and doctors and consultants. 
So the only changes in my 
prescribing are basically new drugs” 
(GP 2 interview, the Haun). 
 Cost “…the older I get, the more times I 
see that prescribing is mucked 
around, to try and save a few pounds 
here and there and the more I see 
patients, who get upset by having 
their drugs changed for no good 
reason, I tend to not even worry 
about the costs anymore.”  (GP 2 
interview, the Haun) 
 Drug representatives This is the first time I have seen the 
rep being used as a source of advice 
and I asked the practice pharmacist 
about this after the meeting.  She 
said they can be a good source as 
they know a lot about their drugs but 
their answers have to be interpreted 
with caution “it is not what they tell 
you, it is what they don’t tell you” 
she commented. (Fieldnotes) 
Other practice 
staff 
Practice nurses After a consultation has finished and 
the patient has left the room the 
practice nurse knocks on the door.  
She informs the GP of the patient she 
has in with her and asks for a 
prescription for XXX.  The GP prints 
and signs the prescription without 
really asking many questions. 
(Fieldnotes). 
 Community nurses The health visitor came into the 
room where the receptionist was 
processing repeat medications.  The 
health visitor asks for a prescription 
and also asks for it to be placed on 
repeats.  This medication has not 
been authorised by a GP.  I ask the 
receptionist about this and she said 
they are only allowed to print scripts 
and place medication on repeat if a 
district nurse or health visitor asks. 
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(Fieldnotes) 
 Receptionists I return to observing the repeat 
prescribing system.  I tell the 
receptionist I found it interesting 
how many decisions regarding 
prescribing they make.  She told me 
they do not really make any 
decisions.  They quickly check the 
notes and print the script and then 
highlight any potential issues on the 
right hand side of the script.  It is the 
doctor who makes the decisions.  She 
tells me if the GPs do not agree with 
her decision to print the prescription 
they can delete it from the system. 
(Fieldnotes) 
Practice 
pharmacist 
Practice based data The practice pharmacist has a 
pharmacy technician in with her 
today running audits. She is looking 
at specific medications to see if there 
are any interactions.  The practice 
pharmacist tells me she is not skilled 
enough to look at complex 
interactions. She is looking at 
NSAIDs, she checks to find out why 
they are on it, are they ordering it 
regularly, are they on any disease 
modifying medication, have they 
been prescribed any gastric 
protection, are they over 75 or at 
risk of heart disease.  The 
recommendations by the technician 
for to one of the GPs to check and 
then make any appropriate changes. 
(Fieldnotes). 
 Advice on individual patients “...people who are on drug 
interactions or side effects from the 
drugs, she is very good at, if we’ve 
got queries about drugs or dosages 
or interaction she’s very good at 
that.” (GP 1 interview, the Haun) 
CHP CHP evidence filtered into 
practice by the pharmacist 
The practice pharmacist informs the 
researcher during observation “Our 
strength lies in being part of the team 
and not the CHP.  If we harp on too 
much about the CHP initiatives we 
could be perceived as an outsider.  
We have worked hard at the culture 
to be members of the primary care 
team, but yes we are employed by the 
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CHP.  Part of our role with the CHP 
is cost-effectiveness as well as 
clinical work and this has to be done 
to justify our salaries.” (Fieldnotes) 
Communication Shared decision-making The practice pharmacist goes on to tell 
me they have good communication.  
She has a prescribing meeting with Dr X 
where she raises the prescribing issues 
she has and Dr X helps her refine the 
question and then she emails it round 
asking yes or no for the target area.  
The other GPs usually reply back and 
say ‘send me the list of patients’, or ‘yes 
fine, but exclude X, Y, Z’. (Fieldnotes) 
 Practice pharmacist filtering 
evidence into the practice 
The practice pharmacist tells me she 
had a prescribing meeting with one 
of the GPs but as there was nothing 
to discuss they just had a coffee.  
(Fieldnotes) 
 
 
The model acknowledges potential influences on the prescriber so there is not supporting 
evidence for all influences.  Such as the health board is a potential influence but this was not 
observed, all potential health board influences were filtered into the practice through the CHP 
and practice pharmacist.  Also drug companies are a potential influence however their influence 
was through drug representatives. 
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Appendix 8: From data to interpretation: an example of process of analysis. 
 
Data was collected primarily by typing fieldnotes.  To keep the researcher’s 
views/opinions/thoughts separate from the data, the researcher wrote these as memos which 
were attached to the fieldnotes in Atlas.ti. 
 
The section below gives an example of the analysis process.  This section is not intended to be 
comprehensive but to illustrate how the researcher carried out her analysis.  Thus this section 
does not start at the coding stage and does not illustrate every thought/idea and finding in this 
process. 
 
The macro/micro divide 
During an interview with a GP from the Haun, the doctor mentioned the practice did not feel 
strongly about consistency in their prescribing behaviour.  “So it can be quite difficult to 
always stick to a formulary anyway. But I say it’s something I thought other practices have, this 
very tight..., should it be something we should be looking at?  But we’ve never kind of done 
anything about it. I don’t think anybody feels particularly strongly about it” (GP 1 Interview, 
the Haun). The researcher went through all the fieldnotes to search for evidence of this claim. 
 
The researcher found some evidence in her fieldnotes.  This came from a discussion with the 
practice pharmacist in the Haun after a prescribing meeting.  “The practice pharmacist 
explained it is difficult to get agreement for changes to prescribing from all the GPs due to so 
many of the GPs working part-time. The practice pharmacist explained she has to go ahead 
with audits and changes with agreement from only two or three GPs (there were two GPs in 
attendance at the meeting observed)” (Fieldnotes, the Haun). 
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The researcher felt these examples demonstrated a lack of value of consistency in their 
prescribing behaviour.  As the researcher was carrying out her analysis in Atlas.ti she coded 
these pieces of text ‘consistency’ and linked them to her ‘values’ memo.  Memos were used by 
the researcher to collect ideas and thoughts linked to the data.  Memos provided opportunity to 
develop ideas, and to then explore these ideas in the data already collected and the data still to 
be collected. 
 
Data recording or coding in the practice IT system was also related to consistency.  The nGMS 
contract had put incentives in place to improve the quality of the data in general practice IT 
systems and for the Haun an important part of this was ensuring consistency in data recording.  
At the time of observation “the practice had employed a retired nurse to code their diagnosis 
and prescribing data.  The nGMS contract covers a number of disease areas so the practice 
had organised themselves to make each GP a lead of one or more disease areas.  These GPs 
had decided on the codes which were to be used and this information was placed on notices in 
each office”. 
 
The researcher coded this data consistency and added to the ‘values’ memo.  The researcher felt 
this showed the practice was moving towards consistency in their data recording.  Further 
evidence was found from Rosnish practice. 
 
Much of the consistency data was also indexed under another code. It was apparent from these 
pieces of data that consistency was related to the practice formulary, practice pharmacist, 
prescribing meetings, practice organisation, IT system and practice values. 
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At this stage the researcher was starting her field work in the third practice.  Through this 
consistency analysis she had a heightened awareness to the ‘consistency’ concept and the 
related codes. 
 
The researcher could see the practice IT system was important for maintaining consistency in 
Rubain’s prescribing behaviour.  Rubain used pop-ups when prescribing to remind GPs of the 
practice formulary. Through her period of observation in Rubain the researcher was able to 
collect data related to the practice formulary, IT and consistency.  More importantly, the 
researcher was able to explore the practitioner’s thoughts/ideas/values towards the pop-ups and 
consistency in prescribing behaviour.  This gave material for the ‘value’ memo. It became clear 
the GPs in this practice saw value in these pop-ups (referred to by the practice as hooks) for 
drugs they prescribed less frequently. 
 
The extract from fieldnotes explains some of this point.  The quote from the interview carried 
out with this GP explores this point further. 
 
“A GP explained without the hooks the GPs were left to give a reasonable approach but now 
the hooks tell them exactly what to prescribe.  For prescribing such as smoking cessation and 
the detoxification of alcohol this GP felt there could be wide variability in prescribing and 
inconsistencies in prescribing” (Fieldnotes, Rubain). 
 
This issue was explored in the GP interviews.  The extract below shows the practice saw value 
in the pop-ups for medication they prescribe less frequently. 
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“But you can’t be … you do become familiar with common things in common and you do 
become familiar with what you use commonly but it is useful for the drugs you prescribe less 
frequently” (GP 2 Interview Rubain). 
An important part of valuing the practice formulary, consistency and the pop-ups was being 
involved in the prescribing decision-making process.   This was an idea the researcher had been 
exploring in her memos but it was not until the interviews that this idea was confirmed. 
“I would say yes, you know there is the sort of collaborative decision making seems to have a 
lot more strength to it than you know giving an edict from a group”  (GP interview 2, Rubain). 
The GPs had been part of the decision-making process of which drugs to include and exclude in 
the formulary.  These decisions had been made in prescribing meetings chaired by their 
practice pharmacist.  This also gave material to add to the ‘values’ memo but also showed a 
link between the formulary, practice pharmacist, communication and shared decision-making. 
 
“I would try and follow the practice decision which is formulated at these meetings and there’s 
obviously, usually influenced by what Kevin says. I think it’s handy having a meeting. If you 
want ownership of a decision then it’s the best format, I think, is to have a meeting where 
everyone can turn up and usually as many people turn up as can, unless of course, you’re on 
holiday or ill or whatever and then you discuss it” (GP 1 Interview Rubain). 
 
As the researcher was building on the consistency analysis she was also working on other ideas 
and concepts which were related; communication and the role of practice pharmacist.  Rubain 
engaged in large amounts of face-to-face communication.  This had been similar to the 
behaviour in the first practice observed, Rosnish. Coding the fieldnotes collected in Rubain the 
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researcher was using codes under the ‘communication’ concept; ‘formal communication’ and 
‘informal communication’.   Formal communication referred to practice meetings and informal 
communication referred to discussions in the coffee room and the corridor, essentially 
unplanned conversations.  Initially, the researcher noticed that practitioners were talking about 
individual patients and specifics of their situations during the informal conversations.  It was 
only whilst observing Rubain’s prescribing meetings the researcher came to notice they were 
making population based decisions in these meetings.  If an individual patient was mentioned 
in a prescribing meeting this was anecdotally to illustrate a point. After recognising Rubain was 
making population based prescribing decisions the researcher re-visited her fieldnotes and 
memos from Rosnish and the Haun. 
 
The researcher found evidence in her fieldnotes of the pharmacist in the Haun explaining the 
difference in the way pharmacists and GPs think. 
 
“The practice pharmacist explained to me the difference between a GP and pharmacist is the 
way they think.  She explained that GPs think about the single patient as they deal with patients 
individually whereas a pharmacist in this role thinks in whole populations” (Fieldnotes, the 
Haun). 
 
The practice pharmacist in the Haun had also referred to the two different types of role carried 
out by the practice pharmacists; strategic and operational. 
 
“The practice pharmacist referred to practice pharmacists having two different types of role.  
She described the operational role as ‘day to day things, day to day communications’ and the 
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strategic role as ‘doing policies or audits or extra, getting involved in meetings and other 
things’” (Fieldnotes, the Haun). 
 
This had helped the researcher organise her data coded under practice pharmacist and link the 
researcher’s analysis of the practice pharmacist roles to formal and informal communication, 
and population based and individual prescribing decision-making. 
 
Realisation of the practice pharmacist roles being operational and strategic, communication 
being formal and informal and the different types of prescribing decisions, population and 
individual patient decisions helped the research recognise the macro/micro prescribing divide.  
As a result the researcher explored these ideas and concepts in memos labelled ‘macro’ and 
‘micro’ prescribing. 
 
The researcher at this point the researcher was also looking to the literature at possible theories 
to help explain her data.  Prior to her realisation of macro and micro prescribing decision-
making the researcher had not come across any theories which helped her gain greater 
explanatory power of the ideas she was developing. 
 
The researcher was working with the macro prescribing idea.  With macro prescribing being 
described as population based, strategic decisions influenced by EBM and clinical governance.  
Sheaff et al’s work on ‘soft governance’ helped the researcher understand the influences on 
macro prescribing decisions. ‘Soft governance’ highlighted to the researcher that practices are 
independent businesses and cannot be manipulated by traditional command and control 
mechanisms therefore health boards use persuasive techniques. Despite being aware the 
practice practices were employed by the CHP the researcher had seen them as part of the 
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practice team. Sheaff et al. helped the researcher understand the CHP prescribing indicator 
report and practice pharmacists were persuasion mechanisms designed to appeal to professional 
values.  To the researcher a clear link was then made to ‘practice values’. Through exploring by 
revisiting codes and memos in light of these changes it became clear CHP prescribing indicator 
report, the health board formulary and practice pharmacists all fitted well under soft 
governance which in turn sat well under macro prescribing.  Also it was clear practices only 
engaged with the soft governance mechanisms they valued. The practice pharmacist had 
previously been important under the concepts of practice organisation and communication 
through being part of the practice team.  By reorganising the data under macro prescribing and 
soft governance the researcher could see practice organisation and communication were 
impeding factors to the practice pharmacist engaging with macro prescribing. 
 
At this stage the researcher was confident the practice values influenced their engagement with 
CHP soft governance mechanisms, consistency in prescribing behaviour and their practice 
organisation (including communication strategies). 
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Appendix 9: Conceptual differences between the central concepts of the thesis. 
 
In order to aid the reader’s understanding of the central concepts of this thesis a table has been 
provided below which illustrates the conceptual differences between macro and micro 
prescribing decision-making. 
The following paragraphs discuss the relationship between these two concepts and prescribing 
mindlines.  
 
Distinctions 
 Macro prescribing Micro prescribing 
Type of decision Practice policy decision on a 
clinical population 
An idiosyncratic decision 
about an individual patient 
Who makes the decision?  All clinical staff  Individual GP and patient 
Where is the decision 
made? 
In prescribing meetings In consultations 
How is the decision made? Considering the research 
evidence in light of the 
average patient and one 
disease 
Considering the individual 
patient’s circumstances, 
preferences, views and if 
necessary other conditions. 
What are the influences? EBM, clinical governance, 
practice organisation and 
systems, communication 
strategies. 
Prescribing mindlines * and 
continuity of care 
 
*Prescribing mindlines - The GP’s prescribing decision-making at the micro prescribing level 
was influenced by prescribing mindlines.  Prescribing mindlines are a personal prescribing 
formulary.  These prescribing mindlines were developed from knowledge and experience.  GPs 
relied on social networks to update these prescribing mindlines, such as their colleagues, 
secondary care, prescribing meetings and practice pharmacist. 
 
Relationship 
Macro prescribing decisions were made in practice prescribing meetings.  Evidence based 
medicine and clinical governance was filtered into the practices and discussed at these 
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meetings.  In these discussions GPs would share their views, opinions and anecdotal stories 
about individual patients.  Through these discussions GPs would share their values and 
experiences, and come to develop and reinforce shared values and the practice identity. 
Decisions were made about what to prescribe to the average patient in light of the evidence and 
their practice values.  
 
Micro prescribing decisions were made in the consultation between the GP and an individual 
patient.  Micro prescribing decisions required GPs to interpret macro prescribing policy using 
their clinical judgement and experience, in light of a patient’s preferences, values and 
circumstances.  During consultations with patients GPs did not look up information but relied 
on their knowledge and experience.  This knowledge and experience had been developed into 
personal formularies, termed prescribing mindlines.  The GPs relied on social networks to 
update these prescribing mindlines, such as their colleagues, secondary care, prescribing 
meetings, their practice pharmacist and through consultations with patients.    
 
GPs internalised some of the information they receive at macro prescribing meetings. Through 
their experience or the experience of others, GPs would learn more and the information and/or 
the medication may slowly become part of their prescribing mindlines.  
 
Prescribing mindlines were more complex than practice formularies or macro prescribing 
policy.  Mindlines were developed from experience, looking after patients where medication 
was initiated in secondary care and from interactions with colleagues.  Mindlines’ have also 
been referred to as personal formularies to help the reader understand what the author has 
meant by mindlines.  Essentially, mindlines are a group of drugs the prescriber knows well and 
from which they are most likely to prescribe.  These mindlines were updated and revised from 
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informal, but trusted sources such as colleagues and hospital specialists. GPs viewed their 
colleagues as an important source of information and would share experiences and ask for 
advice or their opinion.  These conversations tended to be informal and patient specific, often 
considering more than one disease and the individual patient’s circumstances and views.  These 
conversations were an important way of sharing, validating and modifying values and norms, 
and for the development of shared mindlines.   
 
EBM filtered into the practice and was interpreted through their shared values and practice 
identity.  This formulated their macro prescribing policy.  These discussions and information 
would help inform their prescribing mindline development. Informal conversations about 
individual patients and complex prescribing decisions also helped share prescribing knowledge, 
experience and values. As a result the GPs came to have shared values and shared mindlines 
but retained a degree of personal interpretation based on their personal values and experiences.  
The experiences GPs gained at the micro level in consultations with patient’s feedback and 
informed their values and decision-making at the macro prescribing level. 
  
In conclusion, macro prescribing decision-making informed micro prescribing decision-
making, and vice versa.  Micro prescribing decision-making was more complex than macro 
prescribing due to the wider number of factors at play.  GPs relied on prescribing mindlines 
which were based on tacit knowledge and experience to inform their prescribing decision-
making at the micro level.  These prescribing mindlines were iteratively developed through 
information and discussions at the macro and micro level and through interactions with 
patients.    
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